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Thesis abstract 
Background 
On-going surveillance of behaviours during pregnancy is an important but overlooked 
population health activity that is particularly lacking in Ireland. Few, if any, nationally 
representative estimates of most maternal behaviours and experiences are available. 
While on-going surveillance of maternal behaviours has not been a priority thus far in 
European countries including Ireland, on-going surveillance was identified as a key 
priority in the United States (US) during the 1980’s when the Pregnancy Risk 
Assessment Monitoring System (PRAMS), was established. Today, PRAMS is the only 
surveillance programme of maternal behaviours and experiences world-wide. 
Although on-going prevalence estimates are required in Ireland, studies which examine 
the offspring health effects of maternal behaviours are also required, since various 
questions regarding maternal exposures and their offspring health effects remain 
unanswered. Gestational alcohol consumption is one such important maternal 
exposure which is common in pregnancy, though its offspring health effects are 
unclear, particularly at lower or moderate levels. Thus, guidelines internationally have 
not reached consensus on safe alcohol recommendations for pregnant women. 
The aims of this thesis are to implement the PRAMS in Ireland (PRAMS Ireland), to 
describe the prevalence of health behaviours around the time of pregnancy in Ireland 
and to examine the effect of health behaviours on pregnancy and child outcomes 
(specifically the relationship between alcohol use during pregnancy and infant and 
child growth). 
Structure 
In Chapter 1, a brief background and rationale for the work, as well as the thesis aims 
and objective is provided. A detailed description of the design and implementation of 
PRAMS Ireland is described in Chapter 2. Chapter 3 and Chapter 4 describe the 
methodological results of the implementation of the PRAMS Ireland pilot study and 
PRAMS Ireland main study. In Chapter 5, a comparison of alcohol prevalence in two 
Irish studies (PRAMS Ireland and Growing up in Ireland (GUI)) and one multi-centre 
prospective cohort study, Screening for Pregnancy Endpoints (SCOPE) Study is detailed. 
Chapter 6 describes findings on adherence to National Clinical Guidelines on health 
behaviours and nutrition around the time of pregnancy in PRAMS Ireland. Findings on 
exposure to alcohol use in pregnancy and infant growth outcomes are described in 
Chapter 7 and Chapter 8. The results of analysis conducted to examine the impact of 
gestational alcohol use on offspring growth trajectories to age ten are described in 
Chapter 9. Finally, a discussion of the findings, strengths and limitations of the thesis, 
direction for future research, policy, practice and public health implications are 
discussed in Chapter 10. 
xxi 
 
Results 
Implementation of PRAMS: PRAMS may be an effective system for the surveillance of 
health behaviours around the time of pregnancy in the Irish context. PRAMS Ireland 
had high response rates (67% and 61% response rates in the pilot and main study 
respectively), high item completion rates and valid prevalence estimates for many 
health behaviours. 
Examining prevalence of health behaviours: We found high levels of alcohol 
consumption before and during pregnancy, poor adherence to healthy diets and high 
levels of smoking before and during pregnancy among women in Ireland. Socially 
disadvantaged women had higher rates of deleterious health behaviours before 
pregnancy, although women with the most deleterious behaviour profiles before 
pregnancy appeared to experience the greatest gain in protective health behaviours 
during pregnancy. 
The impact of alcohol use on infant and offspring growth: We found that low and 
moderate levels of alcohol use did not impact on birth outcomes or offspring growth 
whereas heavy alcohol consumption resulted in reduced birth length and birth weight; 
however, this finding was not consistently observed across all studies. Selection, 
reporting and confounding biases which are common in observational research could 
be masking harmful effects.  
Conclusion 
PRAMS is a valid and feasible method of surveillance of health behaviours around the 
time of pregnancy in Ireland. A surveillance program of maternal behaviours and 
experiences is immediately warranted due to high levels of deleterious health 
behaviours around the time of pregnancy in Ireland. Although our results do not 
indicate any evidence of harm, given the quality of evidence available, abstinence and 
advice of abstinence from alcohol may be the most prudent choice for patients and 
healthcare professionals respectively. Further studies of the effects of gestational 
alcohol use are required; particularly those which can reduce selection bias, reporting 
bias and confounding.  
 
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
1 Introduction 
  
2 
 
Maternal behaviours and experiences have a significant impact on maternal wellbeing, 
birth outcomes and future offspring health (1-5). Although birth cohorts collect 
information on maternal behaviours and experiences during pregnancy and examine 
the offspring and maternal health effects of various exposures throughout the life 
course (6, 7), surveillance of behaviours and experiences in an on-going, systematic 
manner is still vital, in order to provide timely estimates of important pregnancy 
exposures, monitor their trends over time and set strategic targets for health 
improvement. 
As a number of birth cohorts across Europe continue to follow mothers, 
children and families across the life course establishing important relationships 
between behaviour and disease outcomes, and the extent to which relationships are 
potentially causal or non-causal (6-10), on-going surveillance of behaviours during 
pregnancy at a more fundamental level is lacking across Europe. Among European 
countries, timely, nationally representative prevalence estimates of important health 
behaviours are lacking (11). In Ireland specifically, the infrastructure of either birth 
cohort or surveillance studies of maternal and child health is considerably poorer than, 
for example, in the United Kingdom (UK) where the first birth cohort began in 1946 
(12). Similarly, although numerous cross sectional studies have been conducted in 
Ireland, their estimates are now dated and few, if any, nationally representative 
estimates of most maternal behaviours and experiences are available.  
Although on-going surveillance of maternal behaviours has not been a priority 
thus far in European countries, on-going surveillance was identified as a key priority in 
3 
 
the United States (US) during the 1980’s when infant mortality and low birth weight 
were high and racial and socio-economic disparities in maternal and infant health were 
a concern (13). As a result, the Pregnancy Risk Assessment Monitoring System (PRAMS) 
was established in 1987 to measure maternal behaviours and experiences in an on-
going and systematic manner, and today PRAMS is the only maternal health behaviour 
surveillance system worldwide. Since 1987, PRAMS data has been used in planning, 
implementing and monitoring health programs and policy (14) in the US through on-
going monthly sampling and self-report maternal surveys administered two to six 
months after a woman’s delivery of a live born baby. Today, PRAMS continues to play 
an integral role in maternal health improvements in the 40 US states in which it 
operates.  
Even though surveillance systems such as PRAMS and a number of longitudinal 
birth cohorts have contributed to substantial understanding in maternal and child 
health and life course perspectives on disease, various questions regarding maternal 
exposures and their offspring health effects still remain unanswered. Furthermore, 
despite the relative uncertainty of the effects of such exposures, their prevalence 
remain common during pregnancy though their offspring health consequences remain 
unclear. Alcohol use during pregnancy presents an example of such an exposure which 
has proven difficult to measure accurately due to reporting, recall and selection biases 
but is known to be prevalent during pregnancy (15). Consequently, due to problems 
with measurement, the impact of alcohol use on offspring health continues to remain 
controversial and thus, international guidelines have not reached consensus on safe 
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alcohol recommendations for pregnant women. For example, UK guidelines currently 
advise that one to two units of alcohol not more than twice per week is safe during 
pregnancy, whereas Irish guidelines advise complete abstinence from alcohol during 
pregnancy (16, 17). Furthermore, the prevalence of alcohol use during pregnancy is not 
well characterised in Ireland despite the high prevalence of alcohol use in the female 
general population (77%), with four in ten women in Ireland reporting harmful drinking 
patterns (18).  
Using PRAMS as a model for surveillance, the only on-going surveillance system 
of maternal behaviours and experiences worldwide, this thesis aims to address a lack 
of timely data on maternal behaviours and experiences in Ireland by implementing the 
PRAMS system. Secondly, through the use of the PRAMS system and three existing 
secondary data sources, this thesis aims to examine the measurement of alcohol 
prevalence during pregnancy through development of i) new questions on alcohol use 
during pregnancy, ii) comparison of newly collected PRAMS Ireland estimates with 
prevalence from existing data sources and iii) examination of the impact of alcohol use 
during pregnancy on offspring growth outcomes.  
In Section 1.1, the literature is discussed in relation to alcohol use during 
pregnancy, birth outcomes and long term child growth. This leads to and sets up the 
hypotheses for the thesis including the specific research questions followed by an 
overview of the thesis layout. 
 
 
5 
 
 Literature review 1.1
Many observational studies have been published on the effect of gestational alcohol 
use on the development of the foetus and child (19). The greatest proliferation of 
epidemiological studies occurred largely between the 1970’s and 1990’s during which 
the research community paid substantial attention to delineating the foetal effects of 
gestational alcohol use. In recent times, interest in discerning foetal alcohol effects has 
reduced considerably; however, the nature of the association between gestational 
alcohol consumption and birth outcomes or postnatal trajectories of growth is far from 
resolved or agreed upon by the scientific community, and recent systematic reviews 
and meta-analyses of the effects of alcohol use on infant and child growth have 
provided little resolution to over five decades of research on the relationship between 
gestational alcohol use, birth outcomes and growth (19). Here, an overview of the 
literature on the association of alcohol use during pregnancy and birth outcomes is 
provided, followed by a review of the association of gestational alcohol use with 
postnatal growth trajectories. Subsequently, the complexity of alcohol measurement 
during pregnancy and major biases which have impeded a full understanding of foetal 
alcohol effects is discussed. Thereafter, and in conjunction with a discussion of the 
merits of using multiple cohorts with a variety of different features (population and 
measurement related), the specific research hypotheses and research questions of the 
thesis are provided. 
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1.1.1  Alcohol and birth outcomes 
Evidence of the association between alcohol use during pregnancy has been accruing 
for many decades with numerous conflicting results, all having been supported by 
some data regarding plausible biological mechanisms which has impeded achieving 
consensus on safe alcohol recommendations for pregnant women. For example, in 
1984, evidence of harm at all levels of alcohol consumption from low to high was 
shown in relation to small for gestational age in a large cohort of women in the United 
States conducted between 1974 and 1977 (20). Later, in 1992 McDonald and 
colleagues demonstrated that light consumers of alcohol had a small but statistically 
significant reduction in the risk of low birth weight, preterm birth and small for 
gestational age compared to total abstainers with no evidence of an association at 
moderate and heavy levels of alcohol use (21). Subsequently, two other studies during 
the same time period in Italian and Dutch (22) (23) populations illustrated no 
association between any level of alcohol use and adverse birth outcomes. However, in 
1995, a large US study emerged providing strong evidence of harm for low birth weight 
and intrauterine growth retardation (24) which was later followed by a study by 
Whitehead and Lipscomb on patterns of alcohol use during pregnancy showing that 
only heavy drinking in late pregnancy was significantly associated with small for 
gestational age while light drinking in late pregnancy was associated with a lower risk 
of small for gestational age, albeit not statistically significant (25).  
 In the 1990’s data from large Scandinavian and other potentially more robust 
and very large prospective cohorts began to emerge. In 2000, Kesmodel and colleagues 
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demonstrated, in their large prospective Danish hospital based birth cohort that low 
and moderate alcohol intake of one to two, three to four, five to nine drinks per day 
was not harmful and that ten drinks per week increased risk of preterm delivery; the 
risk ratio of preterm delivery was 0.91 (95% Confidence Interval (CI) 5 0.76 –1.08), 0.86 
(95% CI 5 0.64 –1.15), 0.89 (95% CI 5 0.52–1.52), and 2.93 (95% CI 5 1.52–5.63) 
respectively, compared with intake of one drink per week at 16 weeks gestation, and 
0.69 (95% CI 5 0.56–0.86), 0.82 (95% CI 5 0.60 –1.13), 0.97 (95% CI 5 0.58 –1.64), and 
3.56 (95% CI 5 1.78 –7.13) at 30 weeks (26). In 2004, another Danish cohort emerged; 
here Albertsen and colleagues found that compared with those who abstained during 
pregnancy, women who consumed from four to less than seven drinks and seven or 
more drinks per week during pregnancy did not experience any statistically significant 
increased risk in harm; relative risk of 1.15 (95% confidence interval: 0.84, 1.57) and 
1.77 (95% confidence interval: 0.94, 3.31), respectively (27). However, they found that 
among women who consumed seven or more drinks per week, the relative risk of very 
preterm delivery was 3.26 (95% confidence interval: 0.80, 13.24) compared with that 
of non-drinkers. This lack of evidence of harm between lower levels of alcohol use and 
foetal growth was later replicated in another robust Dutch study conducted by Bakker 
and colleagues in 2010 (28), while in 2011 the question of protective effects at lower or 
moderate levels was again re-introduced to the literature with the findings of a large 
Irish cohort  in Dublin (29).  
In 2011, Patra and colleagues collated over five decades of this evidence (from 
over 30 studies) in a systematic review and meta-analysis (19). When results of these 
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studies were combined, findings showed that compared with abstainers, the overall 
dose–response relationships for low birth weight and small for gestational age showed 
no effect up to ten g pure alcohol/day (an average of about one drink per day). 
However, preterm birth showed no effect up to 18 g pure alcohol/day (an average of 
1.5 drinks/day).  Thereafter, the relationship showed a monotonically increasing risk 
for increasing maternal alcohol consumption. Consequently, the authors concluded 
that heavy alcohol consumption during pregnancy increased the risks of all adverse 
birth outcomes such as small for gestational age, whereas light to moderate alcohol 
consumption showed no effect.  
1.1.2 Alcohol and postnatal growth 
While numerous studies of the association between alcohol use during pregnancy and 
birth outcomes have been conducted, large population based prospective cohort 
studies with repeated measurement of growth across childhood are sparse and of 
those that do exist, results have, as with the literature on birth outcomes been highly 
conflicting. Numerous studies have reported deleterious effects. For example, in a 
1984 study by Barr and colleagues, alcohol use in early pregnancy even at levels 
generally considered to be within the realm of social drinking, was significantly related 
to smaller size at eight months of age even when many possible confounding and 
contributing variables were adjusted for in a white, middle class, educated cohort (30). 
A later study by Day and colleagues found that children exposed to alcohol use during 
pregnancy were significantly smaller in height, weight, head circumference and 
skinfold thickness at age ten in a disadvantaged cohort in the United States (31), a 
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finding replicated in children up to age six among  disadvantaged teenage mothers in 
Pittsburgh (32), disadvantaged African American women (33) and socio-economically 
disadvantaged women in South Africa (34).  However, in other more advantaged 
cohorts; for example in Sampson and colleagues middle class, white, married  Seattle 
cohort published in 1994 (35), it was shown that foetal alcohol effects are overcome 
with age.  
1.1.3 Explaining variation in findings 
The discussions in 1.1.1 and 1.2.2 are not intended to be an exhaustive overview of all 
past literature in relation to alcohol and birth outcomes or postnatal growth. However, 
they summarise some of the keys studies conducted thus far, in conjunction with their 
limitations helping to highlight how difficult reliable conclusions on the association of 
alcohol, birth outcomes and childhood growth are to make. In this section, reasons for 
discordance between studies is provided with a view to providing insight into the 
drivers of opposing associations of alcohol use with growth in different cohorts.  
1.1.3.1 The role of population differences  
While evidence of the harmful effect of heavy levels of alcohol use on birth outcomes 
has been more consistent across the literature and remained robust and consistent in 
meta-analysis, given the inconsistent observed associations of low and moderate use 
across past literature, evidence in any direction must be qualified in the context of the 
population in which it has been studied. For example, in the larger more recent robust 
Scandinavian studies by Kesmodel and colleagues in 2000, Bakker and colleagues in 
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2011 and Albertsen 2004, women were predominantly white, middle class and more 
affluent that the general population, explaining lack of evidence of harm was 
consistently shown at lower and moderate levels. Thus, it is plausible that detrimental 
effects of gestational alcohol use could be masked due to the compensatory effect of 
social advantage which produces effect estimates toward the null or even in a 
protective direction. Alternately, the persistence of the deleterious effects of alcohol 
use during pregnancy across both advantaged and disadvantaged cohorts could be 
explained by the fact that the deleterious effects of heavy use are less sensitive to 
population differences and less likely to attenuate in the context of social advantage. 
However, just as the negative effects of lower alcohol levels may be attenuated by 
social advantage, the negative effects of heavy alcohol use may be exacerbated in less 
advantaged cohorts of women. This may have been the case for example, in studies of 
postnatal growth trajectories where many of the cohorts that have reported 
deleterious effects across childhood have been conducted among disadvantaged 
African-American women  teenagers in Pittsburg (32) and  socioeconomically 
disadvantaged women in South Africa (34). Therefore, it is plausible that growth 
deficits resulting from heavy alcohol use may be more difficult to overcome in adverse 
social conditions compared to catch-up growth evidenced in a more advantaged cohort 
(35). Therefore, population differences can have a significant impact on susceptibility 
to adverse foetal alcohol effects which interact to distort associations between alcohol 
use and birth outcomes or postnatal growth and produce studies with conflicting 
results. 
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1.1.3.2 Methodological differences across cohorts 
The processes of recruitment to studies and methodological differences across studies 
including timing of alcohol measurement are key contributors to variation in results,  
since they may influence participation in the study and reporting of alcohol use, 
introducing selection, reporting and response biases in various, often unquantifiable 
ways that bias results in differential ways for different alcohol consumption groups and 
outcomes.  If differential participation occurs across cohorts, selection to the cohort 
based on certain drinking patterns or reporting patterns can occur. As a result, the 
association between alcohol consumption across cohorts would be confounded by 
social and demographic characteristics or alcohol consumption or reporting itself 
associated with methodological differences that initially influenced women’s 
participation. As a result, findings may be conflicting across studies due to a number of 
different types of bias caused methodological differences and by varying levels of 
residual confounding across studies. In addition, analyses differences may explain 
variation in findings. For example, in relation to childhood growth many studies have 
included analysis of repeated measurements of growth across childhood as single 
outcomes in separate analyses using regression (30, 35-39) rather than the use of 
multilevel models which may be more appropriate for the data. Findings could also be 
attributed to differential measurement of and adjustment for confounders across 
studies which may result in residual confounding. This can occur  even when socio-
economic characteristics, as often measured in questionnaires, for example, through 
income and education, are adjusted for because residual confounding can still persist, 
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since such measures may not full capture or capture accurately socio-economic 
position and relative social advantage. Consequently, if such residual confounding 
persists differentially across studies, results may be discordant.  
1.1.4 Biological plausibility of gestational alcohol effects 
Numerous biological mechanisms for the relationship between alcohol use during 
pregnancy and birth outcomes or postnatal growth have been proposed which support 
separately, deleterious and beneficial effects at different levels. Here, some biological 
underpinnings of associations observed in epidemiological studies are discussed, to 
provide context to epidemiological findings with a view to forming the hypotheses of 
the thesis.  
1.1.4.1 Birth outcomes 
Studies of associations with birth outcomes which have proposed beneficial or 
protective associations of alcohol use at lower and moderate levels are supported by 
some evidence on the tocolytic effect of alcohol in inhibiting labour through release of 
endogenous oxytocin and relaxation of the myometrium (40) and a number of trials 
examining the effect of alcohol in inhibiting labour compared to other tocolytics were 
conducted in the 1960s and 1970s (41-43).  In addition, the increased risk among heavy 
drinkers is supported by evidence that alcohol may induce preterm delivery by 
increasing the production of prostaglandins (44). Increased productions of 
prostaglandins are often found in alcoholic mothers and their offspring (40) (44). In 
relation to birth weight, the protective effect of low levels of alcohol use on 
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cardiovascular disease and suggested vascular etiology of small for gestational age may 
imply a shared pathway that supports a potential finding of a protective effect on birth 
weight through alcohols role in stimulating vascular endothelial growth factors which 
could result in improved placental development and higher birth weight (45). 
1.1.4.2 Postnatal growth 
Exposure to ethanol during pregnancy has been suggested to increases insulin growth 
factor I and II and decrease leptin during early childhood (46). Previous work has 
shown that leptin has no known effect on growth and development up to birth, but 
low levels in cord blood from  infants is related to increased weight gain among infants 
in the first 4 months of life (47). Insulin growth factors are also positively associated 
with birth weight and adiposity (48). Thus, findings of reduced birth weight among 
heavy drinkers may be explained by reduced insulin growth factor levels during 
pregnancy which are induced by heavy alcohol exposure (46). Thereafter birth, insulin 
growth factors and leptin increase coupled with reductions in leptin levels which 
reduce satiety, increase appetite and result in “catch up growth”.  Importantly, 
availability of food and advantaged social and environmental conditions in more 
affluent settings may moderate the potential for “catch up” or “catch down” growth 
such that in disadvantaged settings catch up growth is constrained (49). This may 
explain and validate variation in findings in different populations such that findings of 
growth effects of gestational alcohol use at birth that are overcome with age in 
affluent cohorts compared to the persistence of weight and height deficits in some 
previous more disadvantaged settings.  
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 Research hypotheses and research questions 1.2
Hypothesis #1: PRAMS is a feasible and valid approach to surveillance of maternal 
experiences and behaviours in Ireland 
Specific research questions in relation to Hypothesis #1 
a. Can PRAMS be effectively and resourcefully implemented in Ireland? 
b. What are the methodological issue in implementing PRAMS in Ireland? 
c. Are estimates from PRAMS Ireland valid and reliable? 
d. Is the PRAMS Ireland instrument acceptable and well received by Irish 
women? 
e. Should PRAMS be implemented as a nationwide, ongoing surveillance 
programme? 
 
Hypothesis #2: The prevalence of deleterious health behaviours is high in Ireland and 
these harmful health behaviours are socially pervasive across many socio-demographic 
groups 
Specific research questions in relation to Hypothesis #2 
a. What is the prevalence of deleterious health behaviours during pregnancy 
in Ireland? 
b. How does prevalence of deleterious health behaviours vary according to 
various socio-demographic and health characteristics? 
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Hypothesis #3: All levels of alcohol use (including low, moderate and heavy use) during 
pregnancy have a deleterious impact on birth outcomes but these effects are 
overcome with age in socially advantaged cohorts 
Specific research questions in relation to Hypothesis #2 
a. What is the impact of low, moderate and high levels of alcohol use 
during pregnancy in a large representative retrospective cohort? 
b. What is the impact of low, moderate and high levels of alcohol use 
during pregnancy in a prospective nulliparous cohort study? 
c. What is the impact of alcohol use during pregnancy on postnatal growth 
trajectories throughout childhood in a prospective British cohort? 
 
 Rationale for using multiple cohorts of alcohol use and outcomes 1.3
Research and clinical care guidelines around gestational alcohol consumption have 
focused on setting a safe alcohol consumption threshold for pregnancy below which 
harm to the foetus does not occur (19). However, consensus on safe alcohol 
consumption recommendations for pregnant women has not been reached as the 
effects of gestational alcohol consumption are particularly difficult to measure and 
quantify reliably. As highlighted, population and measurement differences often 
explain variation in findings across studies and impede more in-depth insights into the 
patterns of alcohol use during pregnancy as well as its effect on offspring health. In this 
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thesis, three cohorts will be used to examine both the prevalence of alcohol use during 
pregnancy and foetal alcohol effects drawing upon the following rationale which 
emanates from the earlier literature reviewed for the thesis: 
i) Estimates from single cohorts alone are insufficient to reliably measure 
gestational alcohol effects due to the complexity of alcohol 
measurement and persistence of bias and residual confounding. 
ii) Alcohol use is a strongly socially patterned behaviour that is likely to 
vary substantially from cohort to cohort, therefore making assessment 
of foetal alcohol effects across multiple cohorts essential given such 
variation. 
iii) Comparing prevalence and offspring health effects across multiple 
cohorts with different populations and designs 
a. Provides insight into plausible prevalence estimates and related 
social patterns of alcohol use 
b. Increases understanding on the type and nature of bias that may 
present in different study designs in relation to gestational alcohol 
effects 
c. Provides comparative context for study results for each included 
cohort, potentially yielding understanding on what the likely true 
impact of gestational alcohol use is, above and beyond what single 
cohort analyses have previously revealed due to the persistence of 
bias and residual confounding. 
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Table 1.1 provides a summary of the cohorts to be examined in the thesis. 
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Table 1.1 Summary of cohorts examined in thesis 
 GUI ALSPAC SCOPE PRAMS 
Year 2008-2009 1991-1992 2004-2011 2012 
Population Primary caregivers of 
infants registered for 
child benefit in Ireland 
Pregnancies in Bristol 
based health district of 
Avon 
First time, healthy 
pregnancies across 
centres in Ireland, UK, 
New Zealand and 
Australia 
Mothers of live born 
infants at Cork University 
Maternity Hospital in 
Ireland 
Time of instrument Retrospective Prospective Prospective Retrospective 
N participants 10,953 7,977 5,628 718 
Strengths  Large 
population 
based cohort 
 Nationally 
representative 
 Large 
population 
based cohort 
 Prospective 
measurement 
 Repeated 
measures 
 Prospective 
measurement 
 
 Dose, pattern and 
timing of alcohol 
use collected 
 Trimester by 
trimester use 
 Anonymised postal 
survey 
Weaknesses  Retrospective  
 Only live born 
infants 
 No alcohol use 
before  
 Loss to follow-
up 
 Only early and 
mid-pregnancy 
alcohol 
 Nulliparous 
participants 
only 
 Voluntary 
recruitment  
 Retrospective 
 Only includes live 
born infants 
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 Methodological outline of the thesis 1.4
The thesis is comprised of a number of papers which aim to describe  
i) the methodological processes involved in implementing PRAMS Ireland 
ii) the prevalence of health behaviours during pregnancy in Ireland  
iii) the impact of alcohol use during pregnancy on offspring growth outcomes 
Chapter 1: Introduction and thesis outline: this chapter describes the rationale for both 
the PRAMS study in Ireland as well as the relevant literature and research hypotheses 
of the thesis. 
Chapter 2: Data collection methods: this chapter describes the data collection methods 
used in the PRAMS study. As an appendix to this chapter, the statistical methods of the 
thesis are described (see Appendix II). 
Chapter 3: Pilot study of PRAMS Ireland: this chapter describes a pilot study of the 
implementation of PRAMS in Ireland. 
Chapter 4: Main study of PRAMS Ireland: in this chapter the methods of the pilot study 
in Chapter 3 are extended and improved upon in a larger study of PRAMS in Ireland. 
Chapter 5: A comparison of alcohol prevalence in pregnancy across three studies: this 
chapter compares prevalence and predictors of alcohol use in the PRAMS study, GUI 
and SCOPE (rationale for this described earlier in 1.2 and a summary of the cohorts in 
Table 1.1). 
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Chapter 6: Adherence to National Clinical Guidelines on behaviours in pregnancy. This 
his chapter describes adherence to protective health behaviours around the time of 
pregnancy in Ireland. 
Chapter 7: The impact of pattern and timing of alcohol use on birth outcomes.  Here 
the associations of alcohol use with outcomes are described in the GUI cohort. 
Chapter 8: Association between maternal alcohol use and birth outcomes. In this 
chapter, the associations of alcohol use with birth outcomes is analyses in SCOPE, a 
prospective cohort study.  
Chapter 9: Association between maternal alcohol use and childhood growth. The 
associations of alcohol use and postnatal growth are described in the ALSPAC cohort. 
Chapter 10: Thesis discussion and conclusion. In line with the aims of the thesis, the 
value of PRAMS in Ireland, prevalence of health behaviours and effects of gestational 
alcohol use are discussed. 
Figure 1.1 provides an overall outline of the thesis.
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Figure 1.1 Thesis outline 
• Chapter 2: Data collection 
methods 
 
• Chapter 3: Surveillance during 
pregnancy: methods and 
response rates from a hospital 
based pilot study of the 
Pregnancy Risk Assessment 
Monitoring System in Ireland 
 
• Chapter 4:  Pregnancy Risk 
Assessment Monitoring 
System in Ireland: methods 
and response rates 
Aim #1 To implement PRAMS in 
Ireland 
• Chapter 5: Prevalence and 
predictors of alcohol use during 
pregnancy: findings from 
international multi-centre 
cohort studies 
 
• Chapter 6: Adherence to 
National Clinical Guidelines on 
peri-conceptual health 
behaviours in Ireland: a cross 
sectional study 
Aim #2 To  describe the 
prevalence of health 
behaviours around the time 
of pregnancy 
• Chapter 7: The effect of timing and 
pattern of alcohol use during 
pregnancy on gestational age and 
birth weight: a cross sectional study 
 
• Chapter 8: Association between 
maternal alcohol consumption in 
early pregnancy and pregnancy 
outcomes 
 
• Chapter 9: Maternal alcohol use 
during pregnancy and offspring 
trajectories of height and weight: a 
prospective cohort 
Aim #3 To examine the effect of 
health behaviours on child 
outcomes (specifically alcohol use 
and infant and child growth) 
Monitoring behaviours and experiences before, during and after pregnancy in Ireland 
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2 Data collection methods 
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 Selecting a sampling frame 2.1
The first step in implementing PRAMS Ireland involved identifying a sampling frame 
which would provide a representative sample. Thus, the merits of three sampling 
frames were evaluated for their potential to provide representative populations; the 
Irish birth certificate file, the Irish national Child Benefit Register and a hospital based 
sampling approach at Cork University Maternity Hospital (CUMH); a large urban 
obstetric unit in the south of Ireland delivering almost 9,000 babies per year (50) (12% 
of all Irish births and 2/3 of births in the health services region (51)).  
Table 2.1 compares the attributes, advantages and disadvantages of each. The 
first sampling strategy reviewed was the hospital based approach. This approach 
required using monthly delivery books at the hospital to sample women to PRAMS 
Ireland. Month after month a different group of women would be repeatedly sampled 
to PRAMS Ireland using delivery records, possibly of the preceding month or preceding 
two months. It would require manual counting and extraction of maternal name and 
postal address and available demographic and clinical information. Subsequently, the 
PRAMS Ireland survey would be sent to women. Advantages of the hospital based 
sampling frame would include exclusion of out of state births and adopted infants since 
the goal of PRAMS Ireland and remit of the questionnaire is to characterise the 
experiences of biological mothers of live born infants occurring within the country. 
Other advantages of this system would be an ability to identify and exclude stillbirths 
and neonatal deaths since the questionnaire is designed specifically around delivery of 
a live born infant. It would also be possible to control recall bias through sampling very 
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close to the birth month using the preceding months delivery records, since the 
completion of birth records at hospitals do not suffer time lags. Disadvantages of the 
hospital based sampling frame would include the possibility of a very fragmented and 
labour intensive approach due to the use of paper based records at CUMH. This 
sampling strategy would not allow stratified sampling to oversample more vulnerable 
population groups or groups on women typically less likely to respond in postal 
surveys. In addition, although sampling through CUMH would provide a sample largely 
representative of the geographic location surrounding the hospital, the sample would 
not be nationally representative. 
The second approach evaluated was the use of the birth certificate to sample 
women to PRAMS Ireland via the General Registrations Office (GRO). Major advantages 
to this approach included the nationally representative nature of the birth certificate 
file, ability to carry out over-sampling or stratification of population subgroups who 
would typically be expected to be hard to reach and less likely to respond, its electronic 
nature and hence, the relative ease with which monthly samples could be generated. 
However, to sample from a birth month that would be complete for all births in Ireland 
for that month, PRAMS Ireland would need to sample women who delivered live births 
six calendar months before the start date of each months data collection to reduce 
selection bias, since women with delays in processing of birth certificates not included 
in our sampling frame might differ to women who registered their birth soon after 
delivery. Alternately, by sampling from the calendar month six months prior to the 
study start date, the risk of recall bias for most items under surveillance would be very 
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high with a recall of almost 15 months for behaviours of the first trimester and up to 
two and a half years for behaviours in the year before pregnancy. The other major 
obstacle in using this approach at the time of review of sampling strategies included 
problems with data protection legislation which we anticipated would prohibit the use 
of the birth certificate for PRAMS Ireland.  
The third sampling approach investigated was the Child Benefit Register of 
Ireland, previously used by the Growing up in Ireland (GUI) cohort study in 2008 and 
2009 to carry out Ireland’s first longitudinal study of parents and children (52). The 
Child Benefit Register would naturally exclude stillbirths and neonatal deaths, since 
only women with live births would register to receive child benefit. However, births to 
non-residents would be included. As with the birth certificate, considerable delays in 
registration for child benefit among women with recent live births would have 
potential to introduce selection bias, particularly if choosing to sample close to the 
birth month to reduce recall bias. For example, if we chose to use the Child Benefit 
Register to sample women to PRAMS in May 2012 with infants born in March and April 
2012 to reduce maternal recall bias, selection bias could be introduced, since some 
babies born in March and April 2012 would not be registered up to six months after 
birth. Babies and their mothers with delays in registration for child benefit could be 
different in some way (i.e. potentially more disadvantaged) compared to infants and 
mothers who have registered soon after birth. Alternately, if we sampled women and 
babies born six months before the start date of the study to reduce selection bias, the 
risk of recall bias for most items under surveillance would be increased.  
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Having weighed up the advantages and disadvantages of each strategy, and 
particularly keeping biases which could impact on both the internal and external 
validity of the data being collected in mind, the birth certificate and Child Benefit 
Register appeared to be somewhat more advantageous in relation to aspects such as 
representativeness, whereas the hospital based approach at CUMH was more 
advantageous in terms of reducing selection and recall biases. Initially, we explored the 
possibility of using the two national sampling frames (namely the birth certificate file) 
to sample women to PRAMS, since our goal was to implement PRAMS as a national 
surveillance system in Ireland. However, a number of challenges arose in gaining 
approval to the use of the birth certificate and Child Benefit Register to sample women 
to PRAMS. For example, the GRO were contacted on numerous occasions relating to 
the use of the birth certificate to sample women to PRAMS Ireland. However, by the 
time PRAMS Ireland was ready to commence, little progress toward potential access 
had been made. Consequently, given the time and resource constraints of the project, 
we chose to test the hospital based sampling strategy at CUMH to sample women to 
PRAMS Ireland.
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Table 2.1 Sampling strategies assessed for PRAMS 
 Hospitals GRO Child Benefit Register 
Description Use of monthly delivery books of the 
previous month or two months to 
sample women, month on month to 
achieve on-going monthly 
surveillance. 
 
Manual counting and selection 
based on a pre-specified sampling 
fraction would be required, followed 
by extraction of date of birth, name, 
address, age, marital status, 
gravidity, parity, gestation, 
induction, mode of delivery, sex of 
baby, weight, and “Appearance, 
Pulse, Grimace, Activity, 
Respiration” 
(APGAR) score. 
Use of birth certificate filed with 
GRO to sample n = x women per 
month, month on month to achieve 
on-going monthly surveillance. 
Children under the care of an adult 
in the state must be registered to 
receive child benefit within six 
months from their birth, within six 
months of the child joining the 
family or the family entering the 
country. Benefit is normally paid to 
the mother or step-mother but if the 
child does not live with the mother it 
is paid to the father or step-father or 
person who cares for the child. This 
sampling frame would involve 
sampling n=x infants born in Ireland 
whose biological mothers are in 
receipt of child benefit. 
Completeness Complete for all births in the 
hospital as they occur. 
Complete for all Irish live births but 
with a time lag of six months after 
birth. 
Complete for mothers of live births 
(Irish and new citizens) with a six 
month time lag after birth.  
Not complete for women who 
deliver a live birth that subsequently 
dies. 
Potential for selection bias Delivery books are completed 
immediately for each woman 
delivering a baby in the hospital. 
Women have up to six months to 
register their birth. Sampling from 
the preceding birth month to reduce 
A child must be registered for child 
benefit within six months after birth. 
Sampling from the preceding birth 
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Thus, they are complete for all births 
in the hospital. 
 
 
Minimal risk of selection bias 
recall bias excludes women with 
delays in registering their baby. 
 
 
Moderate/high risk of selection bias 
month to reduce recall bias excludes 
women with delays in registering 
their baby. 
 
Moderate/high risk of selection bias 
Impact on recall bias Sampling very close to the birth 
month is possible to reduce recall 
bias. 
 
 
 
 
 
 
Minimal risk of recall bias 
Sampling close to birth month is 
possible to reduce recall bias but 
increases selection bias. Reduction 
of selection bias by sampling from 
births that occurred six calendar 
months before the study start date 
will increase recall bias and reduce 
reliability of estimates. 
 
Moderate/high risk of  recall bias 
Sampling close to the birth month is 
possible to reduce recall bias but 
introduces selection bias. 
 
 
 
 
 
  
Moderate/high risk of  recall bias 
Representativeness Representative of the geographic 
region. 
  
Nationally representative. Nationally representative. 
Advantages Stillbirths and neonatal deaths can 
be excluded. 
  
Demographic and clinical 
information available. 
  
Sampling through hospitals may give 
PRAMS a personal touch. 
 
Stillbirths and neonatal deaths can 
be excluded. 
  
Demographic and clinical 
information available. 
Naturally excludes stillbirths and 
neonatal deaths. 
  
 Some demographic information 
available. 
  
  
Previously used successfully for GUI. 
  
  
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Disadvantages Fragmented and labour intensive. 
  
 Hospital keeps paper records. 
  
Ethical approval for access may not 
be granted. 
Does not include women who have a 
live born that died like the other 
sampling frames. 
  
 Frame includes non-biological 
mothers, non-female biological 
parents and non-biological parents. 
  
 Over-sampling options relevant to 
PRAMS not available such as low 
birth weight. 
Stratification /oversampling 
options 
Not feasible due to paper records. Low birth weight, race, preterm 
birth and marital status. 
Country of residence, nationality, 
marital status, number of children 
on claim. 
Conclusion This approach is likely to yield a 
population representative of the 
region in which CUMH is located 
with low risk of selection and recall 
bias. However, this approach would 
be labour intensive and 
unrepresentative nationally. 
Stratified sampling would also not 
be permitted. 
This approach is an efficient, non-
labour intensive strategy but access 
to sampling frame is likely to be 
prohibited. Balancing selection and 
recall biases may be a challenge. 
This approach is an efficient, non-
labour intensive strategy but recall 
and selection biases threaten 
validity of data collected. 
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 Designing the PRAMS survey 2.2
The development of the PRAMS US questionnaire has been a collaborative process 
between participating states and the Centers for Disease Control and Prevention (CDC) 
and has undergone considerable revisions since PRAMS was introduced in 1987. When 
PRAMS US was first introduced, some of the significant maternal and child health 
concerns at that time included, for example, racial disparities in birth weight and infant 
mortality and high rates of Sudden Infant Death Syndrome (SIDS). Over time, health 
priorities and data needs have changed, with which, PRAMS US has evolved in order to 
be responsive to changing health needs and public health priorities among women in 
the United States. Thus, in designing PRAMS Ireland, we wished to ensure that the 
survey was specifically tailored to meet Irish data needs.  
The PRAMS US questionnaire contains core questions, which are included in all 
states’ surveys (53) and a range of standard questions from which states can choose, 
depending on their specific data needs and state health priorities. Furthermore, all 
questionnaire data is supplemented by important demographic and clinical information 
provided through the birth certificate of each state. To begin the process of designing a 
PRAMS Ireland questionnaire to uniquely address Irish maternal health needs, we 
began identifying key areas of importance to be covered in the survey. In PRAMS US, 
detailed clinical and demographic information are provided through the sampling 
frame (the birth certificate). However, as we chose a hospital based approach which 
would not provide this information, the first step in developing a PRAMS Ireland survey 
involved selection of validated questions to cover clinical and demographic areas not 
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covered by our sampling frame. In some cases, even where data was available from our 
sampling frame, such as age, we chose to include these in the study for validation 
purposes. However, after a pilot study of PRAMS Ireland, the questionnaire was revised 
in order to remove some items to make room for other questions of interest. These 
demographic and clinical questions primarily formed the beginning of the 
questionnaire.  
Following selection of demographic and clinical questions for our questionnaire, 
we began a process of question selection based on perceived data needs and value of 
inclusion of questions based on criteria previously used by the CDC in their PRAMS 
protocol (13) to determine the content of the questionnaire. These criteria are 
summarised in Table 2.2 and were used to select questions for inclusion in PRAMS 
Ireland from a wide range of PRAMS core and standard questions (53). In addition, we 
also selected questions from other validated surveys such as Growing up in Ireland 
(54), Growing up in Australia (55), The Irish Survey of Sexual Health and Relationships 
(ISSHR) (56), Survey of Lifestyles, Attitudes and Nutrition (SLÁN) (57) and Avon 
Longitudinal Study of Parents and Children (ALSPAC) (58), when questions addressing 
the area of interest were not available in PRAMS US questionnaire. In other instances, 
for comparability purposes, we sometimes selected questions previously used in the 
Irish setting over PRAMS US questions. Table 11.1 in Appendix I details the source and 
rationale for each question included in the final PRAMS Ireland survey.  
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Table 2.2 Criteria used for selection of PRAMS Ireland questions 
 Criteria 
#1 The usefulness of the information to develop and target specific 
interventions to reduce infant morbidity and mortality.  
#2 The likelihood that valid information can be collected from the mother 
two to six months after delivery. 
#3 The estimated prevalence of the behaviour, attitude, or experience.  
#4 The strength of the association between the behaviour, attitude, or 
experience, and infant morbidity and mortality.  
#5 The availability of information from other data sources.  
#6 The importance of the information as a covariate for the association 
between the behaviour, attitude, or experience, and infant morbidity and 
mortality. 
#7 The likelihood that sensitive information will be reported by the mother.  
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 Investigating alcohol use in PRAMS 2.3
Given the specific focus of this thesis on alcohol use during pregnancy, we carried out 
more detailed research on the appropriate investigation of alcohol use using the 
PRAMS Ireland questionnaire. This involved a review of a number alcohol questions 
used in longitudinal and cross sectional surveys in recent years (see Table 11.2 in 
Appendix I for a brief over-view). We critically reviewed all questions in terms of their 
strengths and limitations in addressing the key dimensions of alcohol use which could 
be important in determining risk to the foetus, including, number of occasions of 
drinking during pregnancy, total quantity consumed per week, quantity consumed per 
occasion, binge use, and drinking data in the first, second or third trimester separately 
to investigate patterns of use. As none of the questions reviewed fully addressed all 
criteria, we chose to design new questions based on direction given in O’Leary et al., 
2010 which suggested that future alcohol surveys should address dose, pattern and 
timing of alcohol use during pregnancy (59). In addition, due to particular problems of 
recall and reporting bias in alcohol research, we also critically reviewed the layout, 
structure and location of alcohol questions in the questionnaire for any potential 
features that would influence response biases (detailed in 2.3.1). The final questions 
included in the PRAMS Ireland survey are shown in Figure 2.1- Figure 2.4. The final 
PRAMS questionnaire is provided in Appendix VI.  
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2.3.1 Reducing bias in alcohol questions 
Previous surveys of gestational alcohol use have typically used an initial statement 
and/or filter question introducing women to the content of the questions such as “We 
would now like to ask you about alcohol consumption during pregnancy”. However, we 
chose to avoid this introduction. The primary reason for this was to avoid social 
desirability bias caused by alerting women to upcoming alcohol questions which could 
bias women’s responses. In the opening page of alcohol questions, we also developed 
a number of illustrations to display standard drinks equivalents for commonly 
consumed drinks (Figure 2.1 & Figure 2.2), to help women answer questions as 
accurately as possible. On page two of our alcohol questions (Figure 2.2), we 
elaborated on this using an example illustrating a woman’s alcohol consumption, 
thereby indicating that answering in such a way was not of any consequence in terms 
of desirability. In the questions themselves (Figure 2.3 & Figure 2.4), we did not use 
filter questions, again, to remove any possibility of suggesting that alcohol use during 
pregnancy is undesirable. We did not ask any binge drinking questions directly. This 
was also done to reduce social desirability bias since the use of the term “binge” has 
negative connotations. However, through the design of the questions with dose, 
pattern and timing, we were able to assess binge drinking in our analyses through 
examining number of drinks per drinking occasion. After an original draft of the alcohol 
questions was prepared, we reviewed and revised the questions based on feedback 
with colleagues in the National Perinatal Epidemiology Centre and Department of 
Epidemiology and Public Health at University College Cork. 
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 Exploring the validation of PRAMS alcohol data 2.4
Self-reported alcohol consumption data can suffer substantially from recall and 
reporting biases. Presently, objective measures of alcohol consumption during 
pregnancy are lacking. Hence, research which is concerned with examining foetal 
alcohol effects must often rely on self-reported consumption data. As one of the aims 
of this thesis was to collect new data on alcohol use during pregnancy, we explored the 
possibility of validating the alcohol data collected through examining its correlation 
with available biomarkers collected at the hospital during routine visits. Using blood 
test results of 51 women who reported heavy alcohol consumption in PRAMS Ireland, 
the correlation between Mean Corpuscular Volume (MCV) and women’s reported 
alcohol use was examined in order to explore the validity of MCV as a biomarker of 
heavy alcohol use during pregnancy. MCV was available at three time points as women 
attended hospital at 12-13 weeks, 28 weeks and 36 weeks gestation, where they had 
their Full Blood Count (FBC) taken. No correlation between MCV at the three time 
points and heavy alcohol consumption in the first, second or third trimester was found. 
Thus, because MCV did not appear to be strongly correlated with heavy alcohol use, it 
would be unlikely to be valid objective marker for light or moderate alcohol use.  
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Figure 2.1 Alcohol questions in PRAMS: introduction page
Use of illustrations to 
convey standard drinks 
equivalent for commonly 
consumed drinks 
37 
 
Figure 2.2 Sample alcohol question completed 
Use of detailed pictorial to 
assist women in answering 
alcohol questions 
38 
 
Figure 2.3 Alcohol questions in PRAMS 
Frequency: No of 
occasions of drinking per 
week/month 
Timing and Pattern: Asking 
questions on the three 
months before pregnancy and 
each trimester separately 
Filter questions not used: to 
avoid influencing women 
towards a socially acceptable 
response 
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Figure 2.4 Alcohol questions in PRAMS 
 
 
Quantity per occasion/ 
dose of alcohol 
Binge drinking defined as 
reporting more than 5 drinks per 
occasion without direct binge 
drinking questions to avoid 
response bias 
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 Nutrition around the time of pregnancy 2.5
Diet around the time of pregnancy has a substantial impact on maternal and infant 
health but remains one of the key determinants of health that has never been 
addressed in PRAMS US. In Ireland, evidence from the SLÁN surveys has shown that 
adherence to dietary guidelines in the female general population is low (60). 
Furthermore, although national prevalence estimates of overweight and obesity in 
pregnancy do not exist, a recent study in a large maternity unit in Dublin found that 
one in two Irish women presenting for antenatal care in the first trimester were 
overweight or obese (61).  
During the processes of question selection, diet arose as an area of importance 
and one which could potentially be assessed using PRAMS Ireland. PRAMS US does not 
collect data on diet potentially due to feasibility issues and the impact on response. 
However to our knowledge, PRAMS US has never formally assessed the impact of 
collecting data on maternal diet on response rates. Thus, we chose to include a 
nutritional component in the initial PRAMS Ireland pilot study to assess its impact on 
response through randomising participants to receive a validated semi-quantitative 
Food Frequency Questionnaire (FFQ) to collect information on maternal diet. This FFQ 
was previously adapted from the European Prospective Investigation of Cancer (EPIC) 
study (60), validated in the Irish general population (62) and used in SLÁN 1998, 2002 
and 2006 (60) in the Irish general population. 
 
41 
 
 Layout and design decisions of PRAMS  2.6
Once the process of question selection was complete, modification of questions was 
required to ensure that the specific content and language of all questions was relevant 
to Ireland. Furthermore, we made modifications to questions by adding additional but 
relevant response options or merging questions to optimise the use of space in the 
survey. Table 11.3 in Appendix I lists all questions which included some modification. 
Examples of language changes included changes from “prenatal” to “antenatal”, “birth 
control” to “contraception” and from “health care worker” to “health care 
professional”. 
Although PRAMS US has undergone review periodically since it was first 
introduced in 1987, due the use of questions from a range of longitudinal and cross 
sectional surveys conducted at different times over the last two to three decades, it 
was important to ensure that the layout and design of all questions was consolidated. 
We also wished to ensure that the layout and design of the questionnaire incorporated 
the most recently available evidence on methods to increase response rates. Thus, 
evidence from a recent Cochrane review on increasing response rates to postal surveys 
was reviewed to ensure that the design of the questionnaire would optimise response 
(63). In addition, we used evidence from this review to make other decisions on the 
design of the study, including decisions on the contact being made with women and 
features of other materials used. Table 2.3 displays a selection of evidence which was 
shown in this review to increase response rates to postal questionnaires. This evidence 
was used directly in PRAMS Ireland to improve response rates. One of the key changes 
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which we implemented across almost all survey questions included changing response 
categories to a horizontal rather than vertical layout. In addition, we used other 
evidence from this review showing evidence on features with no impact on response in 
order to make cost-effective and practical decisions on appearance, delivery, contact, 
content, origin and communication of PRAMS Ireland without concern about effects on 
response rates. This evidence is summarised in Table 11.4 of Appendix I and a brief 
overview of the rationale behind these decisions is detailed here. 
Where features evaluated by this Cochrane review did not impact response, 
evidence was used to make decisions which were i) cost effective ii) practical and ii) 
potentially most desirable to the invited participants. For example, for cost reasons we 
chose not to offer survey results compared to offering them, used a white 
questionnaire compared to color, use a brown envelope compared to white, black ink 
versus color, smaller versus larger paper size, standard paper, requested response on 
the questionnaire itself rather than on a separate form, used a franked outward 
envelope versus stamped, and a standard small envelope versus larger, since these 
features did not impact response compared to more expensive features against which 
they were evaluated.  
In relation to choosing among some other questionnaire features which were 
found not to impact response, we made decisions based on what was more practical. 
For example, we chose to time order the questions wherever possible, send the 
questionnaire to the woman’s home rather than work address (since we did not have 
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work address available), ask more general questions first, include demographic items 
first, use closed ended questions and not include do not know options. 
Other decisions made were chosen based on the perceived aesthetic benefit of 
doing so. For example, we had all letters signed versus not signed, used headers on 
letters, had letterheads printed in color, used a booklet rather than stapled pages, used 
letter quality print rather than dot matrix and used large font, since these would 
possibly be more appealing to participants. We also used a pre-paid envelope and 
stamped addressed return envelopes for the same reasons. Furthermore, we sent the 
survey nine to 14 weeks after hospital discharge because evidence from this review 
showed no effect of timing since hospital discharge on response. Letters sent with the 
survey were signed by both investigators who were male and female and participants 
were given a choice to opt-out of the study, since it was perceived that, on average, 
these features would be more appealing to the participant. 
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Table 2.3 Evidence used in PRAMS decisions about length, appearance, content, contact, origin and communication 
Evidence used to increase response rates in PRAMS n OR (95% CI)* Included in PRAMS 
Length    
Shorter vs. longer questionnaire 56 1.64 (1.43, 1.87) Shorter 
Appearance    
White background vs. black 1 1.31 (1.10, 1.56) White 
Simple vs. complex header 1 1.23 (1.03, 1.48) Simple 
Text presentation of response categories vs. visual representation 1 1.19 (1.05, 1.36) Text 
User friendly vs. standard questionnaire 1 1.46 (1.21, 1.75) User friendly 
Horizontal vs. vertical orientation of response options 1 3.12 (1.65, 5.96) Horizontal 
More vs. less personalised 58 1.14 (1.07, 1.22) More personalised 
Content    
Easier questions first vs. last 2 1.61 (1.14, 2.26) First 
Sensitive questions vs. no/fewer/less sensitive questions asked 10 0.94 (0.88, 1.00) Sensitive 
More relevant questions first vs. last 1 1.23 (1.10, 1.37) More relevant 
User friendly vs. standard questions 1 1.46 (1.21, 1.75) User friendly 
Contact    
Pre-contact vs. no pre-contact 47 1.45 (1.29, 1.63) Pre-contact 
Follow-up vs. no follow-up 19 1.35 (1.18, 1.55) Follow-up 
Postal follow-up including vs. excluding questionnaire 11 1.46 (1.13, 1.90) Including 
Text message vs. postcard reminder 3 1.49 (1.23, 1.81) Text message 
Origin    
University sponsor/source vs. other 14 1.32 (1.13, 1.54) Both 
Communication    
Assurance of confidentiality vs. none 1 1.33 (1.24, 1.42) Assurance 
 
*Odds ratio (OR), 95% Confidence interval (CI)
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 Implementing PRAMS in Ireland 2.7
In the first instance, we chose to conduct a pilot of PRAMS Ireland at CUMH to test 
both the questionnaire and sampling strategy previously described in 2.1-2.6. 
Subsequently, based on feedback from the pilot study, we expanded the PRAMS 
Ireland study as a cross sectional study rather than an on-going surveillance study due 
to difficulty in completing on-going, repeat surveillance within the time and resource 
constraints of the project. The pilot study was conducted using hospital delivery 
records at CUMH. However, for the expanded PRAMS Ireland study, we identified a 
more efficient hospital based sampling frame (albeit still paper based) to derive our 
sample for the main study through the Patient Information Management System 
(PIMS) of the hospital.  
PRAMS US administers the questionnaire by two modes of data collection: 
postal survey and telephone administered survey over a 90 day data collection cycle. 
Because of the advantages of postal surveillance, particularly cost and in the case of 
PRAMS, this mode is used as the primary form of data collection. Up to three self-
administered surveys are posted to sampled women. Women who do not respond to 
the mailings are followed up by telephone and encouraged to complete a telephone 
interview (13). In keeping with this protocol, letters and information sheets were 
prepared to accompany the PRAMS Ireland survey (see Appendix I for all 
correspondence with participants). Due to feasibility issues, the phone follow-up phase 
was not included in either study. Ethical approval for the PRAMS Ireland pilot study and 
main study was granted by the Clinical Research Ethics Committee of the Cork Teaching 
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Hospitals (CREC) (see 11.8, Appendix I for ethical approval letters). An overview of the 
methods and findings from both the PRAMS Ireland pilot study and main study are 
reported in Chapter 3 and Chapter 4. 
 Database management 2.8
The co-ordination of PRAMS including entry and management of PRAMS data was 
conducted using three key programmes; Microsoft Excel, Epidata and Stata v12. For 
the co-ordination effort of PRAMS, Microsoft Excel was used to record each initial 
invitees name, address, demographic and clinical information as taken directly from 
the delivery record when a woman was sampled. For each separate phase or mailing of 
the study, a new and separate excel file was created with participants who opted out, 
refused the survey or whom had already responded to the survey removed in order to 
keep an up to date list of participants to be included in the next PRAMS mailing or text 
message contact. When data collection was completed, this data was reorganised into 
one complete excel file creating columns to correspond to each mailing or contact and 
additional columns indicating whether the participant responded to that particular 
mailing or contact. All string or text information were converted to numeric 
information and confidential data removed including participant contact information in 
order to prepare the file to be exported to Stata for initial analysis of response rates 
and demographics. This file was the master file for the study and was later merged 
with the questionnaire data reported by women. 
For the pilot study, data entry of the reported survey data was conducted 
directly in excel appended to this original master excel file as described above. For the 
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main study in order to reduce data entry error and complete data entry more 
efficiently, Epidata was used. For this, a database corresponding to the exact layout of 
the questionnaire was designed. Fields were restricted where appropriate, to ensure 
that only valid values for that particular question could be entered. Appropriate skip 
patterns were also put in place to avoid further data entry error. All data was entered 
by Linda O’Keeffe (80% of data) and Leanne O’Connor (20% of data). Once data entry 
was complete a random number generator was used to select 10% of participants for 
whom data was entered. For this 10%, data was re-checked and all data entry errors 
recorded. Mistakes were qualitatively examined for systematic data entry error. Total 
data entry error over total number of field’s per survey was calculated to get an error 
rate which was less than 0.6%. As no consistent and systematic data entry error was 
identified and as the error rate was deemed almost negligible, the data was exported 
to Stata and data cleaning commenced. 
 Data cleaning was carried out in Stata. This included tabulating each variable in 
the dataset, followed by a thorough examination of implausible values or clear outliers. 
Where any implausible values were identified, the paper version of the questionnaire 
completed by the participant was consulted. Cross checking was carried out across the 
questionnaire to ensure respondent’s data in one field was consistent with data in 
other fields that would corroborate this; for example, if a participant indicated that 
they had not been pregnant before but indicated they had a previous miscarriage; the 
original questionnaire was consulted to investigate whether a data entry error had 
occurred or whether this had been a mistake on behalf of the participant. In cases 
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where the participant had indicated two opposing answers, other data in the survey 
was used to judge the most plausible answer for the given participant. For example, if a 
woman had indicated she had not been pregnant before but later reported a variety of 
information on past pregnancy outcomes, the initial answer relating to pregnancy was 
amended. Once these processes were completed, each variable was labelled and given 
values. Finally before the dataset was analysed, we used the “codebook” command in 
Stata to again examine each variable individually for inconsistencies before beginning 
data analysis. 
 Covariates 2.9
Where available and possible confounder selection and adjustment was consistent 
across all studies with some variation across studies depending on (1) a priori 
hypotheses specific to that study, (2) availability of data and (3) sample sizes. However, 
we ensured that key and well established confounders of birth weight and growth 
were adjusted for in all studies. These included gender and smoking. Gestational age 
was adjusted for in all studies; however, in some cases it was not retained in the final 
models reported if it did not result in substantial changes in estimates.  
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 Sample size and power for cohorts examined 2.10
2.10.1 PRAMS Ireland sample size calculation 
Pilot study 
The sample size for the pilot was based on methods recommended by Thabane et al., 
2010 (64) using a confidence interval approach to estimate sample sizes for pilot 
studies.  To estimate a projected response of 65% (based on CDC minimum weighted 
response rates) with a lower confidence limit of 60% and upper confidence limit of 
75%, we sampled 124 women to the study. 
Main study 
We calculated a sample size calculation for PRAMS assuming a conservative 2% 
prevalence of binge/heavy alcohol consumption, 95% confidence and 80% power. 
Based on this, we required 753 women to participate in the study. However, assuming 
a minimum 65% response rate, we needed to oversample in the study by 459 women 
to ensure adequate power, leading to a total minimum sample of 1,159 women to be 
invited to participate in PRAMS. 
2.10.2 Power calculations for secondary data analysis 
Detailed below are a number of post hoc power calculations for analyses in the thesis 
involving secondary data sources, using the “powerreg” and “powerlog” commands in 
Stata. 
GUI 
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Gestational age 
Based on a r2 value of 0.0559 for the full model, r2 value of 0.051 in the reduced model 
(without the exposure, alcohol use), six predictor variables and one test variable 
(alcohol use) at alpha significance level (0.05), we would have 80% power to detect a 
true effect with 1,689 observations in our model, if it existed. 
Birth weight 
Based on a r2 value of 0.0321 for the full model, r2 value of 0.0290 in the reduced 
model (without the exposure, alcohol use), nine predictor variables and one test 
variable (alcohol use) at alpha significance level (0.05), we would have 80% power to 
detect a true effect with 2,464 observations in our model, if it existed. 
SCOPE 
Severity of consumption and birth weight 
Based on a r2 value of 0.5119 for the full model, r2 value of 0.5116 in the reduced 
model (without the exposure, severity of consumption), 13 predictor variables and one 
test variable (severity of consumption) at alpha significance level (0.05), we would have 
80% power with 12,720 observations in our model to detect a true effect, if one 
existed. 
Quit status and birth weight 
Based on a r2 value of 0.5121 for the full model, r2 value of 0.5116 in the reduced 
model (without the exposure, quit status), with 13 predictor variables and one test 
variable (quit status) at alpha significance level (0.05), we would have 80% power to 
with 7,620 observations in our model to detect a true effect, if one existed.  
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Binge drinking and birth weight 
Based on a r2 value of 0.5126 for the full model, r2 value of 0.5116 in the reduced 
model (without the exposure, binge drinking), with 13 predictor variables and one test 
variable (binge drinking) at alpha significance level (0.05), we would have 80% power 
to with 3,810 observations in our model to detect a true effect, if one existed.  
ALSPAC 
For weight at two years, based on a r2 value of 0.2332 for the full model, r2 value of 
0.2327 in the reduced model (without the exposure, alcohol use), 11 predictor 
variables and one test variable (alcohol use) at alpha significance level (0.05), we would 
have 80% power to detect a true effect, if it existed with 12,064 observations in our 
model. For weight at ten years, based on a r2 value of 0.1168 for the full model, r2 
value of 0.1158 in the reduced model (without the exposure), 11 predictor variables 
and 1 test variable (alcohol use) at alpha significance level (0.05), we would have 80% 
power to detect a true effect with 6,864 observations in our model, if it existed. 
For height at two years, based on a r2 value of 0.4571 for the full model, r2 value 
of 0.4561 in the reduced model (without the exposure), 11 predictor variables and one 
test variable (alcohol use) at alpha significance level (0.05), we would have 88% power 
to detect a true effect, if it existed with 5,357 observations in our model. For height at 
ten years, based on a r2 value of 0.1796 for the full model, r2 value of 0.1788 in the 
reduced model (without the exposure), 11 predictor variables and one test variable 
(alcohol use) at alpha significance level (0.05), we would have 80% power to detect a 
true effect with 8,112 observations in our model, if it existed. 
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 Dealing with specific ethical and sensitive issues 2.11
The PRAMS questionnaire covers a variety of experiences before, during and after 
pregnancy. Prior to commencement of the study, we considered carefully the ethical 
considerations as well as our potential duty of care to women reporting highly sensitive 
issues such as physical abuse or violence around the time of pregnancy. In consultation 
with the CUMH social worker, we developed a protocol for dealing with the disclosure 
of such data.  
PRAMS USA includes a standard list of helplines with its survey to allow women 
to make contact with help services. In consultation with the hospital social worker, it 
was advised that this not be provided in PRAMS Ireland as it was felt that if an 
aggressive or violent partner encountered these items, it may aggravate a situation of 
domestic violence in the home. Alternately, the study investigators were counselled on 
how to deal with any direct contact from women regarding sensitive issues; this 
included referral to the hospital social worker followed by provision of information and 
contacts with other services to provide further assistance. 
Further to this, we considered our role in the disclosure of violence and abuse 
in the survey itself. Having considered our duty in such a situation, we selected not to 
intervene or act in these instances. As with all of the data collected in the study but in 
particular due to the highly sensitive nature of some of the content of the 
questionnaire, all study materials were anonymised using automatically generated 
study identification numbers, stored in locked cabinets in a swipe access room in a 
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secure location within CUMH which has a 24 hour security desk and various security 
measures to prevent unauthorised access. Therefore, all information related to each 
woman in the study was only accessible by the study investigators. 
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 Abstract 3.1
Background 
Many European countries including Ireland lack high quality, on-going, population 
based estimates of maternal behaviours and experiences during pregnancy. PRAMS is a 
CDC surveillance program which was established in the United States in 1987 to 
generate high quality, population based data to reduce infant mortality rates and 
improve maternal and infant health. PRAMS is the only on-going population based 
surveillance system of maternal behaviours and experiences that occur before, during 
and after pregnancy worldwide.  
Methods 
 The objective of this study was to adapt, test and evaluate a modified CDC PRAMS 
methodology in Ireland. The birth certificate file which is the standard approach to 
sampling for PRAMS US was not available for the PRAMS Ireland study. Consequently, 
delivery record books for the period between three and five months before the study 
start date at a large urban obstetric hospital (8,900 births per year) were used to 
randomly sample 124 women. Name, address, maternal age, infant sex, gestational age 
at delivery, delivery method, APGAR score and birth weight were manually extracted 
from records. Stillbirths and early neonatal deaths were excluded using APGAR scores 
and hospital records. Women were sent a letter of invitation to participate including 
option to opt out, followed by a modified PRAMS survey, a reminder letter and a final 
survey.  
Results 
 The response rate for the pilot was 67%. Two per cent of women refused the survey, 
seven per cent opted out of the study and 24% did not respond. Survey items were at 
least 88% complete for all 82 respondents. Prevalence estimates of socially undesirable 
behaviours such as alcohol consumption during pregnancy were high (>50%) and 
comparable with international estimates.  
Conclusion 
PRAMS is a feasible and valid method of collecting information on maternal 
experiences and behaviours during pregnancy in Ireland. PRAMS may offer a potential 
solution to data deficits in maternal health behaviour indicators in Ireland with further 
work. This study is important to researchers in Europe and elsewhere who may be 
interested in new ways of tailoring an established CDC methodology to their unique 
settings to resolve data deficits in maternal health. 
Keywords: surveillance, maternal, pregnancy, behaviour, measurement tool 
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 Background  3.2
Maternal behaviours and experiences around the time of pregnancy have a significant 
impact on both the short and long term health and wellbeing of mother and infant. 
Modifiable determinants of preterm birth and low birth weight in developed countries 
include cigarette smoking during pregnancy (65) and  high body mass index (BMI) (66). 
A significant proportion of other adverse pregnancy outcomes such as pre-eclampsia, 
are also associated with pre-existing maternal conditions such as high BMI and high 
blood pressure that are modifiable by maternal behaviour change (67). Research has 
shown that these conditions are not only a significant cause of morbidity and mortality 
at birth but are associated with adverse health outcomes throughout the life course 
(68). Low birth weight infants are at increased risk of high blood pressure in adulthood 
(1), type 1 (69) and type 2 diabetes (2), overweight (4) and all-cause mortality including 
death from cancer and heart disease (70). Women diagnosed with pre-eclampsia are 
often at increased risk of future cerebrovascular or cardiovascular events (71). 
Consequently, surveillance of behaviour and experiences during pregnancy is essential 
for improving current maternal and infant health, as well as long term population 
health.  
Across Europe on-going, timely and nationally representative surveillance of 
behaviours and experiences that occur during pregnancy is lacking. The European 
Peristat Project which collated national data from over 26 European countries, 
including Ireland, illustrated many perinatal data deficits on health, social and clinical 
characteristics of women giving birth across Europe (11). Limited socio-demographic 
57 
 
and clinical data were provided as a by-product of routine data collection such as civil 
registration, hospital discharge data, and medical birth registries. This was 
supplemented by data from national cross sectional or panel surveys examining health 
behaviours such as smoking during pregnancy which provided sparse and intermittent 
population based estimates on maternal and infant health for comparison.  
Establishing on-going, standardised and systematic surveillance based data 
collection which monitors changes in important pregnancy experiences and behaviours 
that can often only be obtained through maternal self-report is essential for health 
policy and program development. This type of surveillance has been conducted in the 
US since 1987 when the PRAMS was established to monitor the experiences and 
behaviours of women before, during and after pregnancy (72). PRAMS is now in its 38th 
year and is operational in over 40 states and New York City (72). PRAMS is unique in its 
on-going, population based, standardised, data to action driven approach. It uses core 
questions which are administered two to six months after pregnancy via postal survey 
to on-going monthly samples of women in all PRAMS States to allow for reliable and 
appropriate comparisons between states and over time (72). However, the system is 
also highly flexible, facilitating the addition of a selection of other data points which 
address state level data needs (72). 
PRAMS surveillance in the United States has been used to monitor trends in 
maternal behaviours and experiences around the time of pregnancy, plan programs 
and policies, enact legislation and reduce health inequalities for population health 
improvement (73). The PRAMS system has been responsible for significant maternal 
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and infant health advancements in the US since 1987. Examples include examining the 
impact of state breastfeeding law on breastfeeding rates (74), development of 
programs and legislation to reduce high unintended pregnancy rates in Georgia, 
Washington and Oklahoma (75) and monitoring achievement toward Healthy People 
Objectives around multivitamin use, smoking and physical abuse during pregnancy 
(73). The data to action driven approach of PRAMS surveillance is an initiative which 
may be adaptable to the European context for policy and program development in 
maternal and infant health. 
The aim of this study was to assess the feasibility and validity of implementing a 
modified PRAMS methodology in Ireland.  The specific objectives included  
i) assessment of feasibility through development and implementation of a 
PRAMS Ireland survey and protocol and examination of response rates 
and characteristics associated with response 
ii) assessment of validity through examination of item completeness, 
comparison of participant demographics with hospital and national birth 
characteristics and comparison of prevalence estimates with the 
nationally representative GUI cohort 
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 Methods 3.3
3.3.1 Sampling strategy 
The standard approach to sampling in all 40 US states in which PRAMS is in operation 
involves use of state birth certificate files to generate stratified, random samples of 
women with recent live births (13). However, in Ireland, access to the Irish birth 
certificate file is restricted under the Data Protection Act 1988 (76). Consequently, 
CUMH, a large urban obstetric unit in the south of Ireland delivering almost 9,000 
babies per year (50) (approximately 12% (51) of all Irish births) was chosen to test the 
PRAMS methodology. 
Using a sampling frame of live births recorded three to five months before the 
study start date at CUMH, 124 women were randomly sampled using a random start 
and constant sampling fraction. The sample size for the pilot was based on methods 
recommended by Thabane et al., 2010 (64) using a confidence interval approach to 
estimate sample sizes for pilot studies.  To estimate a projected response of 65% 
(based on CDC minimum weighted response rates) with a lower confidence limit of 
60% and upper confidence limit of 75%, we sampled 124 women to the study. Women 
were included by manually counting and extracting a record from each of two delivery 
books, one recording caesarean sections and the other recording both spontaneous 
and instrumental vaginal births. In line with the PRAMS US protocol, mothers of 
stillbirths and neonatal deaths were excluded (13). This was done using the APGAR 
score recorded on the delivery record and cross-checking with hospital records for the 
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period. Sampling was done proportionally in a ratio of one to four to represent the 
underlying proportion of caesarean deliveries in the population of approximately 25% 
(51). Available information including name, address, maternal age, infant sex, 
gestational age at delivery, delivery method, APGAR score and birth weight were 
extracted from delivery records of selected women. 
3.3.2 PRAMS protocol and study materials 
Letters and information sheets were prepared explaining the purpose of the study and 
its importance to improving maternal and child health in Ireland (see Appendix I for 
materials used). The PRAMS US survey covers a range of topics including exposures 
during pregnancy such as alcohol and smoking, care received, and socio-demographic 
information (53). For PRAMS Ireland, questions were carefully modified for content, 
language and overall layout. Content which pertained specifically to the US such as 
Medicaid status and enrolment in the Women, Infants and Children Supplemental 
Nutrition Programme (WIC) were removed and replaced with medical card and private 
health insurance questions relevant to Ireland. Language changes were applied to 
conform to commonly used terms in Ireland such as; “antenatal”, “contraception” and 
“health care professional” rather than “prenatal”, “birth control” and “health care 
worker”. Demographic information including race/ethnicity, marital status, nationality, 
educational attainment and health insurance status provided by the birth certificate 
file in the US were added to the questionnaire, as these were not available from the 
CUMH delivery record. Validated questions from other longitudinal or cross sectional 
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studies were used to supplement the PRAMS Ireland questionnaire or replace 
questions where necessary including questions on pregnancy history from the ALSPAC 
(58), questions on complications during pregnancy from GUI (54) and Growing up in 
Australia (55) and questions on sexually transmitted infections from ISSHR (56). These 
questions were chosen over some PRAMS US Phase 6 questions for comparability. 
Recent research suggests that the ascertainment of alcohol exposure during 
pregnancy in studies focused on documenting patterns of alcohol consumption during 
gestation could be optimised by examining more carefully, the dose, pattern and 
timing of exposure (59). Moreover, the most recently available estimates in the Irish 
general population suggest that up to 77% of women regularly drink alcohol in Ireland 
compared to an European Union (EU) average of 68% while over 42% of all female 
drinkers in Ireland are classified as having harmful drinking patterns (60). As a result, 
we developed questions on maternal alcohol consumption specific to these needs for 
PRAMS Ireland which took into account the dose, pattern and timing of alcohol 
exposure during pregnancy based on work by O’Leary et al., 2010 (59).  
Diet around the time of pregnancy has a substantial impact on maternal and 
infant health but remains one of the key determinants of health that has never been 
addressed in PRAMS US. PRAMS US does not collect data on diet potentially due to 
feasibility issues and the impact on response. Furthermore, little is known about 
effective approaches by which dietary data can be collected in PRAMS. Thus, we chose 
to randomise participants to receive a validated semi-quantitative FFQ to collect 
information on maternal diet in order to assess its impact on response rates. Random 
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allocation was achieved using a random number generator in Microsoft Excel. For all 
124 women, a random number between zero and one was generated. The 50% of 
women with the highest numbers were selected to receive the validated FFQ. This FFQ 
was previously adapted from the EPIC study (60), validated in the Irish general 
population (62) and used in the SLÁN surveys 1998, 2002 and 2006 (60) in the Irish 
general population.  
The layout and design features of the questionnaire were also adjusted to 
incorporate the most recent evidence from a Cochrane systematic review on improving 
response rates to postal questionnaires (63). This involved changing PRAMS questions 
to a horizontal rather than vertical orientation which has been shown to increase 
response rates (63). This research protocol and all study materials administered within 
this study received ethical approval from the CREC. The protocol implemented is 
shown in Figure 3.1.  
3.3.3 Data analysis 
Statistical analyses were conducted in Stata V11. Descriptive statistics including mean 
for continuous variables and frequencies for categorical variable were used to examine 
response rates, characteristics associated with response and non-response and to 
examine completeness of the questionnaire. We compared available demographic and 
clinical information from the delivery record at CUMH between responders and non-
responders using a Pearson χ² (chi) squared test for the difference in proportions. 
Respondents were defined as eligible women who were selected to receive a survey, 
63 
 
and completed the survey within two months of the study start date. Demographic 
characteristics of respondents were also compared to recently available data for CUMH 
deliveries in 2010 (50) and data on all births in Ireland for 2009 (51). Rates of missing 
data for each question were calculated to examine the completeness of response per 
survey item. The average number of days to response from receipt of the first survey 
was also calculated. The prevalence of behaviours and experiences reported in the 
PRAMS study were also compared to findings from the GUI, a longitudinal study 
conducted in Ireland between 2008-2009 among mothers of live births, approximately 
nine months after delivery (52). GUI was chosen for comparison as it was nationally 
representative of all live births in 2009. 
 Results 3.4
The total pilot cost was $3500 dollars: $1000 for design costs for the PRAMS 
questionnaire, $1500 for printing and postage costs and $1000 for labour costs 
including study management and packaging. In total, 67% of sampled women 
responded to the PRAMS Ireland survey. The average number of days to response from 
distribution of the first survey was 18. The reminder letter contributed the highest 
proportion to the overall response rate.  After the second survey was administered, no 
further contact was made with women as the response rates had exceeded 65%, the 
minimum weighted response rate for PRAMS recommended by the CDC (77).  A 
comparison of characteristics of PRAMS US respondents to women delivering in CUMH 
in 2010 or nationally in 2009 is shown in Table 3.1. PRAMS Ireland respondents had a 
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higher proportion of Irish and married women than CUMH or all national singleton 
deliveries in 2009. PRAMS Ireland also reflected a higher proportion of caesarean 
delivered women and preterm births than either the CUMH population or national 
deliveries in 2010. Overall, women who did not respond were slightly younger than 
respondents and had a higher proportion of female babies, caesarean sections and 
preterm birth (Table 3.2). 
Table 3.3 shows minimum completion rates for all survey questions per section 
of the PRAMS Ireland pilot survey. Demographic data, labour and delivery questions, 
and the period since the baby was born were best completed which allowed for almost 
complete socio-demographic data for PRAMS Ireland respondents. 
PRAMS Ireland respondents reported a low prevalence of smoking during 
pregnancy, high prevalence of folic acid intake before and during pregnancy, high use 
of assisted reproductive technologies and high rates of ever having breastfed 
compared to participants in the GUI study (Table 3.4). The respondents also reported a 
high prevalence of alcohol use before and during pregnancy. The prevalence of nearly 
all complications or conditions associated with pregnancy was higher than those 
reported by GUI participants.  
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 Discussion 3.5
The results of this pilot study show that it is feasible to administer a modified PRAMS 
questionnaire (53) and protocol in Ireland. Previous population based postal surveys  in 
the Irish general population such as the SLÁN surveys administered in 1998 and 2002 
have achieved response rates of 62% and 53% respectively (60). The final response rate 
of the GUI study (78), a survey administered face to face by trained interviewers in six 
different languages to a population sample of over 10,000 mothers in 2008 was 70%. 
Our response rate of 67% compares favourably with these and shows the validity of 
the study materials and methodology. In addition, low opt out rates (7%) and high item 
completion rates indicate that the PRAMS Ireland materials, and protocol implemented 
were well received. Our response rate exceeded the CDC minimum response rates for 
PRAMS US of 65% without a third postal survey, a telephone follow-up, rewards or 
incentives which are included routinely in the US (13). 
The prevalence of behaviours and experiences collected in PRAMS is 
comparable to some recent population representative estimates from GUI. Overall, 
PRAMS may have over-represented married, Irish, educated women (80% had a third 
level education compared with 36% nationally based on SLÁN 2006 (60). This may 
explain the higher prevalence of protective health behaviours such as folic acid intake 
and breastfeeding.  In relation to the higher reported prevalence of alcohol use in 
pregnancy compared to GUI, our data are more comparable with prevalence estimates 
from the United Kingdom (79) and the Netherlands (28). It is possible that we may 
have obtained more reliable estimates of alcohol use due to anonymised postal data 
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collection, which has been shown to obtain more reliable responses on socially un-
desirable behaviours such as alcohol use (80). We also found a higher prevalence of 
pregnancy conditions and complications which may be the result of improved recall 
compared to the participants of GUI, who were sampled between nine months and one 
year postpartum.  
Although the use of one large hospital is a potential limitation of our work, as 
almost 99% of Irish births occur in Irish maternity hospitals, hospital based sampling 
does provide almost complete coverage of recent live births in Ireland including under-
served or disadvantaged groups, thus potentially allowing health disparities to be 
addressed.  In addition, as births in this unit represented 12% of all Irish births and 
almost 2/3 of all births in the health services region, we suggest that this pilot study 
could be broadly representative of the feasibility and validity of PRAMS in the hospital 
system in Ireland. However, though the pilot reveals PRAMS to be a feasible and 
potentially valid data collection tool for maternal behaviour surveillance in Ireland, 
other hospitals considering this sampling strategy may find the paper based approach 
used to be inefficient and time consuming if implemented as a routine data collection 
system particularly if done on a larger scale. Furthermore, record systems in each of 
the 20 Irish maternity hospitals vary substantially and thus, it may be difficult to 
replicate this protocol exactly as implemented here.  
A potentially more efficient hospital based approach which overcomes some of 
the challenges faced in this pilot includes the use of a national patient electronic record 
to sample women through the National Maternal Newborn Clinical Management 
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System due to replace the current paper based record system across Irish maternity 
hospitals in 2014. This approach would potentially allow for automated, stratified, 
random sampling at a national level which minimises data extraction error at the point 
of sampling. Moreover, it would provide reliable information on baseline 
characteristics of sampled participants, provide a sampling frame complete for almost 
99% of births in Ireland and allow over-sampling of vulnerable population groups which 
are under-represented in this pilot study. With the development and roll out of this 
system in 2014, an on-going hospital based PRAMS surveillance system with a capacity 
for over-sampling of minority population groups to address health disparities in Ireland 
could be feasible.  
3.5.1 Conclusion  
The PRAMS surveillance system is a unique behavioural surveillance initiative around 
the time of pregnancy which may offer a potential solution for European countries 
experiencing deficits in high quality, population based data on maternal behaviours 
and experiences during pregnancy that can only be obtained through maternal self-
report. The results of this study show that the PRAMS methodology is a feasible and 
valid approach to collecting information on maternal experiences and behaviours in 
Ireland. The extent to which the materials administered in the pilot study were well 
received highlights the adequacy of the modified study instruments and protocol for a 
full scale PRAMS surveillance system. The strong willingness to participate in the pilot 
study would be indicative of potentially high response rates in an on-going hospital 
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based surveillance project in Ireland. The distribution of response rates by type of 
contact reveals the potential effectiveness of the numerous and frequent contacts in 
the Irish context. The prevalence estimates obtained for many behaviours show 
participants willingness to report on socially undesirable behaviours such as alcohol 
use during pregnancy. High item completion rates illustrate the effectiveness of both 
the design of the survey and questions included at capturing valid and complete 
responses from participants. However, lower completion rates in antenatal care are a 
limitation and this must be addressed in design, layout and content revisions of the 
survey given the overall aims and objectives of PRAMS. Further work is now required to 
expand this approach for a nationwide surveillance effort across all hospitals 
potentially using the new National Maternal Newborn Clinical Management System. 
This would allow for efficient on-going data collection, complete coverage of all live 
births in Ireland and stratification or over-sampling among socially disadvantaged 
groups of women who are less likely to respond and more likely to be experiencing 
health disparities.  
 Summary 3.6
 PRAMS is the only on-going, population based surveillance system of maternal 
behaviours and experiences before, during and after pregnancy worldwide. 
 Many European countries lack reliable, on-going, population based data on 
maternal behaviours and experiences around the time of pregnancy. 
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 PRAMS is a feasible and valid approach to surveillance of behaviours and 
experiences during pregnancy in Ireland.   
 This study is important to maternal and child health researchers in Europe or 
elsewhere who may be interested in new ways of adapting an established CDC 
methodology to their own unique settings to build data capacities for policy and 
program development.  
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Figure 3.1 PRAMS pilot protocol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
 
 
 
 
* Response rates calculated excluding women with incorrect addresses  
Sampling frame 
1,483 live births between October and December 2011 
 
 
87 (70%) of total sample sent PRAMS reminder letter 
EXCLUDED 
Incorrect address: 1 
Opt out: 3 (2%) 
Response to this contact: 34 (39%) 
Total response: 28% 
 
Final pilot response rate: 82 (67%) 
 
 
124 women sampled in February 2012 and sent PRAMS invitation letter 
 
118 (95%) of total sample sent PRAMS survey 1 
EXCLUDED 
Incorrect address: 1 
Opt out: 5 (2%) 
 
Response to this contact: 31 (26%) 
Total response: 25% 
 
 
Re 
 
 
 
49 (40%) women sent PRAMS survey 2 
 
Response to this contact: 17 (35%) 
Total response: 14% 
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Table 3.1 Demographic characteristics by type of contact in PRAMS pilot study 
 PRAMS 
n=82 
n (%) 
CUMH deliveries 
n=8,898 
n (%) 
National deliveries 
n=72,709 
n (%) 
Age (mean (SD)) 33 (5) No data 31 (5) 
Nationality    
Irish 71 (86.6) 6,998 (80.3) 54,684 (75.2) 
Other* 11 (13.4) 1,714 (19.7) 18,025 (24.8) 
Married 72 (87.8) - 47,528 (65.4) 
Primiparous 30 (36.6) 3,604 (41.4) 30,099 (41.4) 
Education    
Second level 16 (19.5) No data No data 
Third level** 66 (80.5) No data No data 
Delivery mode    
Spontaneous vaginal 43 (52.4) 4,686 (52.7) 41,946 (57.8) 
Other vaginal*** 10 (12.2) 1,659 (18.6) 12,029 (16.5) 
Total vaginal 53 (64.6) 6,345 (71.3) 53,975 (74.3) 
Elective 15 (18.3) 1,302 (14.9) No data 
Emergency 4 (4.9) 1,138 (13.1) No data 
Total caesarean  19 (23.1) 2,440 (28.0) 20,373 (27.0) 
Low birth weight (<2500g) 4 (4.9) 463 (5.2) 2,598 (3.6) 
 
Data are mean and Standard Deviation (SD) or frequency and percentage.   
*Other includes Non-Irish EU National, Other White Background, African, Any Other Black Background, 
Chinese and Any Other Asian Background 
** Any third level qualification including Diploma/certificate, Primary degree or Postgraduate/higher 
degree 
***Ventouse, forceps, combined instrumental, vaginal breech 
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Table 3.2 Characteristics of PRAMS sample to available demographics for responders 
and non-responders 
 
 
PRAMS 
sample 
n=124 
n (%) 
Responders 
n=82 
n (%) 
Non-
responders 
n=42 
n (%) 
P 
value 
Age (mean (SD)) 32 (5) 33 (5) 31 (5) 0.050 
Infant gender     
Female 62 (50) 36 (43.9) 26 (61.9) 0.076 
Male 60 (48.4) 44 (53.7) 16 (38.1)  
Delivery mode     
Vaginal 83 (76.9) 61 (74.4) 27  (64.3) 0.928 
Caesarean section 41 (33.1) 21 (25.6) 14 (33.3)  
Birth weight (<2500g) 6 (4.8) 2 (2.4) 4 (9.5) P<0.01 
Preterm birth (<37 weeks 
gestation) 
8 (6) 4 (4.9) 4 (7.7) 0.319 
 
*p value is for the difference in proportions for categorical variables from χ² test or difference in means 
for continuous variables from t tests between responders and non-responders 
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Table 3.3 Minimum completion rate for survey items on the PRAMS survey 
Section Category No of survey items Completeness rate (%) 
Section A Demographics 11 98 
Section B Pregnancy history & before pregnancy 97 92 
Section C (i) During pregnancy 64 90 
Section C (ii) Alcohol use in pregnancy 21 93 
Section E Antenatal care 61 72 
Section F Labour & delivery 20 99 
Section G Time since baby was born 88 94 
 Total 362 91 
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Table 3.4 Prevalence of selected behavioural characteristics in the PRAMS study and 
estimates from GUI 2010 
 PRAMS 
n=82 
n (%) 
GUI 
n=10,953 
n (%) 
Smoking status   
Ever smoked 47 (57.3) 3,078 (37.9) 
Smoked in pregnancy 6 (7.3) 1,973 (18.0) 
Current smoking 12 (14.6) 2,798 (25.6) 
Alcohol consumption   
Consumed alcohol before pregnancy 60 (73.2) 9,185 (83.8) 
Consumed alcohol in pregnancy 43 (52.4) 2,164 (19.7) 
Consumed alcohol (1st Trimester) 23 (28.1) 1,100 (10.1) 
Consumed alcohol (2nd Trimester) 35 (42.7) 1,544 (14.1) 
Consumed alcohol (3rd Trimester) 30 (36.6) 1,513 (13.8) 
Folic acid use   
Used folic acid before pregnancy 60 (73.2) 6,861 (63.8) 
Used folic acid in the first trimester 80 (97.7) 10,760  (93.4) 
Pregnancy intention (wanted to be pregnant)  43 (52.4) 6,276 (58.4) 
Ever breastfed 54 (65.9)  6,116 (55.9) 
Care received/service use   
Used assisted reproductive technologies 7 (8.5) 456 (4.2) 
Admission to neonatal unit 7 (8.5) 1,574 (14.4) 
Shared care (hospital and general practitioner) 62 (75.6) 8,378 (77.8) 
Complications during pregnancy   
Any complication 43 (52.4) 5,943 (54.3) 
Nausea/vomiting 11 (13.4) 1,914 (17.5) 
Urinary tract Infection 15 (18.3)  1,589 (14.5) 
Raised blood pressure 14 (17.1) 1,196 (10.9) 
Pre-eclampsia 7 (8.5) 791 (7.2) 
Gestational diabetes (diet) 6 (7.3) 245 (2.2) 
Gestational diabetes (insulin dependent) 3 (3.7) 104 (1.0) 
Bleeding (2nd half of pregnancy) 12 (14.6) 645 (5.9) 
Placenta praevia 3 (3.7) 305 (2.8) 
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 Abstract  4.1
Objective: To describe response rates and characteristics associated with response to 
the PRAMS Ireland study. 
Methods: Using hospital discharge records for live births at a large, urban, obstetric 
hospital, a sampling frame of approximately 2,450 mother-infant pairs were used to 
alternately sample 1,200 women. Mothers’ information including name, address, 
parity, age and infant characteristics such as sex and gestational age at delivery were 
extracted from records. Modes of contact included an invitation letter with option to 
opt out of the study, three mail surveys, a reminder letter and text message reminder 
for remaining non-respondents.  
Results: Sixty one per cent of women responded to the PRAMS Ireland survey over a 
133 day response period. Women aged less than 30, single women, multiparous 
women and women with a preterm delivery were less likely to respond. Women 
participating in PRAMS Ireland were similar to the national birth profile in 2011 which 
had a mean age of 32, were 40% primiparous, 33% single or never married and had a 
28% caesarean section rate.  
Conclusion: Survey and protocol changes are required to increase response rates 
above recommended CDC thresholds of 65% within the recommended 90 day data 
collection cycle. Additional efforts such as stratification and over-sampling are required 
to increase representativeness among hard to reach groups such as younger, single and 
multiparous women before expanding the project to an ongoing, national surveillance 
system in Ireland. 
Keywords:  surveillance, behaviours, experiences, pregnancy, methods 
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 Introduction 4.2
Maternal behaviours and experiences around the time of pregnancy have a significant 
impact on maternal and child health across the life course (1, 2, 4, 65-70). In Ireland, 
although some adverse lifestyle determinants have experienced declines in the general 
female population, national  estimates from 2006 document high rates of overweight 
and obesity (59%), alcohol consumption (77%) and smoking (27%) (60) which are still 
among the highest in Europe (81). However, population based estimates of most 
lifestyle and health determinants around the time of pregnancy specifically, are lacking. 
Though some recent estimates of maternal health behaviours and experiences are 
provided from Irelands first national birth cohort in 2008, GUI (78), and other cohorts 
(82), data on a comprehensive range of the most important maternal lifestyle and 
health determinants are not available. In addition, Ireland lacks a  strategic process for 
setting, monitoring and achieving maternal and child health targets such as those set 
out in Healthy People 2020 in the United States (83, 84) and thus, timely and relevant 
data is needed to shape the maternal and child health agenda in Ireland and set future 
goals for health improvement. 
In 1987, the CDC established the PRAMS in the United States to monitor the 
experiences and behaviours of women around the time of pregnancy using 
standardised surveillance (14) to achieve strategic health targets, plan programs and 
policies, enact legislation and shape, in a data driven manner, the maternal and child 
health agenda (14). Building on findings from a pilot study of PRAMS in Ireland which 
showed PRAMS to be a valid and feasible method of surveillance during pregnancy 
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(85), this study describes the methodology, response rates and characteristics of 
respondents in a larger study of PRAMS Ireland at an urban obstetric unit in the south 
of Ireland.  
The aim of the study was to expand upon the previous assessment of feasibility 
and validity of PRAMS Ireland. The specific objectives included:  
 i) assessment of feasibility and identification of challenges in expanding PRAMS 
Ireland to a larger sample size 
ii) assessment of validity through examination of response rates, comparison of 
participant demographics with national birth characteristics in Ireland and 
comparison of characteristics of PRAMS Ireland responders and PRAMS Ireland 
non-responders 
 Methods 4.3
4.3.1 Sampling strategy 
In the US, PRAMS obtains stratified monthly samples from state birth certificate files. 
Using hospital discharge records, the sample for the present study was selected from 
recent live births at CUMH, a large urban, obstetric hospital in the south of Ireland 
where almost 9,000 live births per year occur (12% of all Irish births and 2/3 of all 
births in the health services region) (86). A constant sampling fraction of one in two 
records alternately sampled 1,212 from a sampling frame of approximately 2,424 
mother-infant pairs discharged between May 14th 2012 and August 18th 2012. Mothers 
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of stillbirths and neonatal deaths were excluded in line with the PRAMS US protocol 
(13). In order to ensure that our sample did not inadvertently include any other 
attendances to the hospital other than live births of the period, we also cross checked 
the sample for inclusion of miscarriages using hospital miscarriage records. Mothers’ 
information including name, address, parity, age, mobile telephone number, insurance 
status, marital status and religion and infant characteristics such as date of birth, sex, 
gestational age at delivery, APGAR score and birth weight were extracted from the 
records of sampled women.  
4.3.2 PRAMS protocol and study materials 
In line with the recommended CDC PRAMS protocol and methods (13), we 
administered a PRAMS Ireland pre-letter inviting women to participate in the study, 
three postal surveys, a reminder letter and a telephone follow-up which involved a text 
reminder instead of the telephone administered questionnaire which is usually 
administered in the final stages of PRAMS US (see Appendix I for materials used). Table 
11.1- Table 11.4 in Appendix I describe the source of each question and modifications 
to any original questions in the PRAMS Ireland survey. This research protocol and all 
study materials administered within this study received ethical approval from the 
CREC. The protocol implemented is shown in Figure 4.1.  
4.3.3 Statistical analysis 
All statistical analyses were conducted in Stata V12. We compared the characteristics 
of responders and non-responders (available from the hospital records of sampled 
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women) using simple descriptive statistics including a Pearson χ² (chi) squared test for 
categorical data and t tests for continuous variables. We compared the prevalence of 
demographic and obstetric characteristics of women to the national birth profile in 
2011 (86). We used logistic regression to examine the characteristics associated with 
survey response.   
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 Results 4.4
Overall, 718 of 1,185 sampled women responded to the PRAMS Ireland survey 
representing a valid response rate of 61% (having excluded 14 women with invalid 
postal addresses from the sample denominator of 1,199). The total duration of the 
study from when the first survey was sent to women was 133 days. Of the total 
response, the first survey and the reminder letter contributed the largest proportion, 
56% and 25% respectively while the lowest proportion of the response came from the 
text reminder (1.7%). Women who responded to the survey upon receipt of the first 
questionnaire had infants aged two to five months old. By the time the study closed 
out the oldest infant (born on May 14th) was 9.5 months old. Thus, the age range of the 
infants of responders was approximately two to 9.5 months.  
Table 4.1 shows the characteristics of the total sample and responders and non-
responders compared to the national birth profile in 2011. Our sample produced a 
largely representative sample with broadly similar characteristics to the national birth 
profile with a mean age of 32, 40% primiparous women, 33% single women, 5.8% 
preterm birth prevalence, 5.2% low birth weight prevalence and 28% caesarean section 
rate in 2011 as shown (86). In univariate analyses, age, health insurance status and 
marital status differed between responders and non-responders. Respondents of 
PRAMS Ireland indicated a high prevalence of excellent/very good or good self-rated 
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health. Sixty seven per cent of women overall had private health insurance1 during 
pregnancy. Twenty per cent of women had a full medical card2 . Of women who 
reported a previous pregnancy, 41% had a previous miscarriage, 5% reported a 
previous abortion or termination, 7.8% reported a previous low birth weight, 9.5% 
reported a previous preterm birth and 25.3% reported a previous caesarean section. 
Almost 30% of participants reported being overweight or obese (calculated from self-
reported weight and height).  
Table 4.2 shows results from logistic regression on predictors of response to 
PRAMS Ireland. In unadjusted analyses, age, insurance status and marital status were 
predictors of response. After adjustment for other available demographic and obstetric 
characteristics age, insurance status and marital status continued to predict response 
with parity and preterm birth also becoming predictors of response to PRAMS Ireland.  
Women aged less than 30 were less likely to respond than women aged 30-34. Women 
with private insurance were more likely to respond than women with public health 
cover. Single women were less likely to respond than married women. Multiparous 
women were less likely to respond than primiparous women and women with a 
preterm delivery were less likely to respond compared to women full term babies. 
                                                     
1
 Health insurance is used to pay for private care in hospital or from various health professionals in 
hospitals or in their practices which may substitute or supplement public health care provided by the 
state. 
2
 A medical card issued by the Health Service Executive (HSE) allows the holder to receive certain health 
services free of charge. To qualify for a medical card your weekly income must be below a certain figure 
for your family size. Cash income, savings, investments and property (except for your own home) are 
taken into account in the means test. The Irish medical card can be viewed as somewhat equivalent to 
Medicaid in the United States. 
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 Conclusion 4.5
An adapted hospital based PRAMS Ireland survey is a feasible and effective approach 
to surveillance of maternal health behaviours in Ireland. Our strategy provided a large 
representative sample from which stillbirths and neonatal deaths could be excluded. 
Our sample itself had characteristics comparable with the national birth profile (86) 
with many baseline characteristics and complete and accurate contact information 
with few incorrect postal addresses (14 (1.2%)). However, we were unable to achieve 
response rates beyond the CDC threshold for response to PRAMS of 65% (77) within 
the recommended 90 day PRAMS data collection cycle (13) and younger, multiparous 
and single women were under-represented. Furthermore, and as a consequence of an 
extended data collection cycle infants were of a broader age range in our study than 
anticipated (two to 9.5 months) which may lead to differential recall biases. 
Compared to the demographic profiles of US PRAMS respondents, our results 
showing lower response rates among younger, multiparous and single women are 
comparable to characteristics associated with response in some US PRAMS states (87), 
though women with normal weight infants were not more likely to respond in our 
study (87). On health service characteristics unique to Ireland, respondents had a 
significantly lower proportion of medical card holders (20%) but higher proportion of 
private health insurance (67%) than that recorded in the general population, 36% and 
47% respectively in 2010 (88). In addition, PRAMS Ireland respondents were likely to 
have potentially reported being a lower weight than they actually were and we found 
almost a 50% lower reported prevalence of overweight and obesity (29%) compared to 
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59% among women in a general population survey using clinically measured weight 
and height in 2006 (60). Thus, although the initial sample of women invited to 
participate in the study and the subsequent respondents of the survey are broadly 
representative of the national birth profile, PRAMS Ireland over-represents more 
educated, older, married and healthier pregnant women. 
Unlike response rates from a previous pilot study of PRAMS Ireland which this 
work builds upon (85), even with additional contacts via text and an extended 
collection cycle of 133 days, we did not reach recommended CDC response rates and 
our response rate is low with respect to the 67% response achieved in our pilot in half 
the data collection time and with fewer contacts. By day 94 of the present study 
response rates had reached only 56%. Extending our data collection period up to 133 
days since postal of the first survey did not increase response substantially and it is 
likely that the cost outweighed the absolute response benefit of 5%. One possible 
explanation for both reduced and slower response compared to our pilot includes the 
close proximity of the study to the Christmas holiday period, where women were likely 
to be more time constrained than other times of year. Another potential reason may 
include the long length of the survey particularly with the addition of the FFQ. Though 
we did evaluate the effect of the FFQ on response in our pilot and did not find reduced 
response among women randomised to receive the FFQ with the PRAMS Ireland 
survey, it is possible that the pilot was not adequately powered to detect differences in 
response between the groups. Furthermore, we chose to use a text message reminder 
in the telephone phase of PRAMS Ireland rather than a telephone administered 
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interview as completed in the US which contributed only 1.7% to the overall response 
compared to three to 25% increases in response due to the telephone administered 
interview in the US (89).  
The birth certificate file was not available to sample women to PRAMS Ireland 
like PRAMS USA. However, hospital based sampling provides a valid alternative in the 
Irish context with almost 99% coverage of all Irish live births unlike the hospitals in the 
US, thus providing almost complete coverage of under-served or disadvantaged 
groups. In addition though the use of one large hospital is a potential limitation, as one 
of the largest maternity hospitals in Europe and second largest of a total of 20 
maternity units in Ireland delivering 12% of all Irish births (86), our approach is broadly 
representative of the feasibility and validity of PRAMS in the hospital system in Ireland 
as a whole. Although record systems in each of the 20 Irish maternity hospitals vary 
substantially and thus, the extent to which our sampling strategy can be implemented 
in other hospitals may vary, a more efficient hospital based approach which overcomes 
some of the challenges faced in this study may soon be available through the National 
Maternal Newborn Clinical Management System due to replace the current paper 
based record system across Irish maternity hospitals in 2014. This would allow for 
automated, stratified, random sampling at a national level which minimises data 
extraction error at the point of sampling. Moreover, it would provide reliable 
information on baseline characteristics of sampled participants, provide a sampling 
frame complete for almost 99% of births in Ireland and allow over-sampling of 
vulnerable population groups which are under-represented in our study. However, 
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prior to the establishment of a national surveillance system in Ireland modelled on 
PRAMS USA, key issues of response rates, reduced response among disadvantaged 
women and considerable delays in response must be addressed through protocol and 
questionnaire adaptations.  
 Summary 4.6
The value of PRAMS in the United States lies with its repeat, on-going surveillance and 
comparability of estimates over time and between states to examine changing and 
dynamic health determinants during pregnancy. Though PRAMS Ireland presents itself 
as a cross-sectional study rather than an on-going surveillance project, our work has 
designed a PRAMS Ireland questionnaire addressing key data priorities, tests the 
established PRAMS methodology in an entirely new setting with an adapted sampling 
strategy and is a first step at measuring behaviours and experiences around the time of 
pregnancy in the Irish population. Moreover, it provides an insight into expected 
response rates and potential problems that can be addressed before an on-going 
project is commenced such as a longer data collection cycle which impacts maternal 
recall of behaviours under study. In addition, it provides an impetus for the 
investigation of mechanisms of oversampling harder to reach groups which may be 
under-represented in our study 
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* Response rates calculated excluding women with incorrect addresses 
 
 
Sampling frame 
2,424 live births between May 14th and August 18th 2013 
 
 
Day 1  1,141 women sent PRAMS survey 1 
Infants aged two to five months old 
 
Opt out: 24 
Response: 399 (55.6% of final response) 
 
Day 54   536 sent PRAMS survey 2 
(82) 
Sample 
1,212 women sampled in September 2012  
1,199 women sent PRAMS invitation letter  
 
 
EXCLUDED 
Duplicate entries: 10 
Neonatal deaths and stillbirths: 3 
Opt out: 44    Incorrect address: 14 
 
 
 
Re 
 
 
Day 21   718 women sent PRAMS reminder letter 
49 Opt out: 6 
Response: 176 (24.5% of final response) 
 
 
 
Day 94   432 women sent PRAMS reminder text 
(82) 
Opt out: 13 
Response:  91 (12.7% of final response) 
 
 
 
 
Opt out: 19 
Response: 12 (1.7% of final response) 
 
 
 Response: 40 (5.6% of final response) 
 
 
 
Day 108  275/401 women sent final survey (randomly selected) 
(82) 
Day 133  Final response rate: 718/1185 (61%) 
 
ox 
 
 
(82) 
Figure 4.1 PRAMS protocol implemented 
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Table 4.1 Characteristics of PRAMS sample to available demographics for PRAMS responders and PRAMS non-responders 
 
 
PRAMS 
sample 
n=1185 
n (%) 
PRAMS 
responders 
n=718 
n (%) 
PRAMS non-
responders 
n=467 
n (%) 
National 
deliveries 
n=74,080* 
n (%) 
 P value 
Age (mean (SD)) 32 (5) 33 (5) 31 (6) 31.7 (5)  P<0.001 
Age groups 17 (1.4) 4 (0.6) 13 (2.8) 1,684 (2.3)   
15-19       
20-24 77 (6.5) 24 (3.4) 53 (11.4) 7,347 (9.9)   
25-29 258 (21.8) 139 (19.4) 119 (25.5) 16,690 (22.5)   
30-34 427 (36.1) 286 (39.9) 141 (30.2) 26,758 (36.1)   
35-39 338 (28.5) 224 (31.2) 114 (24.4) 17,725 (23.9)   
40-44 57 (4.8) 35 (4.9) 22 (4.7) 3,703 (5.0)   
45-51 10 (0.8) 5 (0.7) 4 (1.1) 164 (0.2)   
Infant gender       
Male 593 (50.8) 362 (51.6) 230 (49.5 No Data  0.47 
Female 575 (49.2) 339 (48.4) 236 (50.5) No Data  
Insurance status       
Public 921 (77.7) 529 (73.7) 392 (83.9) No Data  P<0.001 
Private 264 (22.3) 189 (26.3) 75 (16.1) No Data  
Marital status       
Married 780 (67.1) 517 (73.8) 263 (56.9) 48,319 (65.2)  P<0.001 
Single  347 (29.8) 165 (23.5) 182 (39.4) 24,553 (33.2)  
Other 36 (3.1) 19 (2.7) 17 (3.7) 1,208 (1.6)  
Parity       
1 451 (38.1) 287 (40.0) 164 (35.2) 29,632 (40.0)  0.1 
>1 733 (61.9) 431 (60.0) 302 (64.8) 44, 448 (60.0)  
Final delivery mode       
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Vaginal 608 (51.9) 366 (51.6) 242 (52.5)   0.971 
Caesarean section 348 (29.7) 211 (29.7) 137 (29.7) 20,795 (28.1)  
Vacuum 150 (12.8) 92 (13.0) 58 (12.6) 8,488 (11.5)  
Forceps 65 (5.6) 41 (5.8) 24 (5.2) 3045 (4.1)  
Religious status       
Roman catholic 964 (81.4) 590 (82.2) 374 (80.3) No Data  0.367 
Other 221 (18.7) 128 (17.8) 93 (19.9) No Data  
Epidural received 531 (44.8) 327 (45.5) 204 (43.7) No Data  0.53 
Low birth weight(<2500g) 68 (5.7) 38 (5.3) 30 (6.4)  3852(5.2)  0.42 
Preterm birth (<37 weeks) 78 (6.6) 39 (5.5) 39 (8.4)  4297 (5.8)  0.05 
General health*       
Excellent/very good  530 (74.2)     
Good  174 (24.4)     
Fair/Poor  10 (1.4)     
Born outside Ireland  150 (21.0)     
Medical card status       
Full card  143 (20.0)     
GP only  36 (5.0)     
Insurance status (covered)   478 (66.9)     
Gravidity       
Primigravid  219 (30.6)     
Multigravid  497 (69.4)     
Previous miscarriage  202 (41.0)     
Abortion or termination  25 (5.1)     
Previous low birth weight  38 (7.8)     
Previous preterm birth  47 (9.5)     
Previous caesarean section  125 (25.3)     
Body mass index       
Underweight  26 (3.8)     
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Normal weight  464 (67.1)     
Overweight  151 (21.8)     
Obese  51 (7.4)     
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Table 4.2 Logistic regression for odds of response for available baseline demographic and clinical characteristics 
 OR* (95% CI) aOR** (95% CI) 
Age    
15-19 0.15 (0.05, 0.47) 0.11 (0.03, 0.42) 
20-24 0.22 (0.13, 0.38) 0.29 (0.16, 0.50) 
25-29 0.58 (0.42, 0.79) 0.63 (0.45, 0.89) 
30-34 Reference Reference 
35-39 0.97 (0.72, 1.31) 0.92 (0.67, 1.27) 
40-44 0.78 (0.44, 1.39) 0.88 (0.49, 1.60) 
45-51 0.49 (0.14, 1.73) 0.57 (0.14, 2.28) 
Infant gender   
Female Reference Reference 
Male 1.09 (0.86, 1.38) 1.13 (0.88, 1.44) 
Insurance status   
Public Reference Reference 
Private 1.87 (1.39, 2.51) 1.44 (1.03, 2.02) 
Marital status   
Married Reference Reference 
Single 0.46 (0.36, 0.60) 0.61 (0.45, 0.82) 
Other 0.57 (0.29, 1.11) 0.81 (0.39,1.67)  
Religious status   
Roman catholic Reference Reference 
Other 0.87 (0.65, 1.17) 0.87 (0.63, 1.19) 
Parity   
Primiparous Reference Reference 
Multiparous 0.82 (0.64, 1.04) 0.55 (0.41, 0.75) 
Final delivery mode   
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Vaginal Reference Reference 
Caesarean section 1.01 (0.78, 1.33) 0.80 (0.60, 1.08) 
Vacuum 1.05 (0.73, 1.51) 0.88 (0.49, 1.57) 
Forceps 1.13 (0.67, 1.92) 0.80 (0.53, 1.20) 
Birth weight    
Normal birth weight (>2500g) Reference Reference 
Low birth weight (<2500g) 0.82 (0.50, 1.34) 1.08 (0.51, 2.29) 
Gestation   
Term birth (>37 weeks gestation) Reference Reference 
Preterm birth (<37 weeks gestation) 0.63 (0.40, 1.00) 0.45 (0.22, 0.90) 
 
*Odds Ratio (OR) **adjusted Odds Ratio (aOR) 
 
 
93 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5 
5 Prevalence and predictors of alcohol use during pregnancy: findings 
from international multi-centre cohort studies 
Accepted for publication in BMJ Open December 2014 
O’Keeffe, LM 
Kearney, PM 
McCarthy, FP 
Khashan, AS 
Greene, RA 
North, RA 
Poston, L 
McCowan, LM 
Baker, PN 
Dekker, GA 
Walker, JJ 
Taylor, R 
Kenny, LC 
94 
 
 Abstract 5.1
Objectives: To compare the prevalence and predictors of alcohol use in multiple 
cohorts. 
Design: Retrospective and prospective studies. 
Setting: Population based studies in Ireland, UK, Australia and New Zealand. 
Participants: 17,244 women of predominantly Caucasian origin from two Irish 
retrospective studies [Growing up in Ireland (GUI) and Pregnancy Risk Assessment 
Monitoring System Ireland (PRAMS)] and one multi-centre prospective international 
cohort, Screening for Pregnancy Endpoints (SCOPE) Study. 
Primary and secondary outcome measures: Prevalence of alcohol use pre-pregnancy 
and during pregnancy across cohorts. Socio-demographic factors associated with 
alcohol consumption in each cohort. 
Results: Alcohol consumption during pregnancy in Ireland ranged from 20% in GUI to 
80% in SCOPE and from 40% to 80% in the UK, Australia and New Zealand. Levels of 
exposure also varied substantially among drinkers in each cohort ranging from 70% 
consuming more than one to two units per week in the first trimester in SCOPE Ireland 
to 46% and 15% in the retrospective cohorts. Smoking during pregnancy was the most 
consistent predictor of gestational alcohol use in all three cohorts and smokers were 
17% more likely to drink during pregnancy in SCOPE, relative risk (RR) 1.17 (95% (CI) 
1.12, 1.22), 50% more likely to drink during pregnancy in GUI, RR 1.50 (95% CI 1.36, 
1.65), and 42% more likely to drink in PRAMS, RR 1.42 (95% CI 1.18, 1.70). 
Conclusion: Our data suggest that alcohol use during pregnancy is prevalent and 
socially pervasive in the UK, Ireland, New Zealand and Australia. New policy and 
interventions are required to reduce alcohol prevalence both prior to and during 
pregnancy. Further research on biological markers of alcohol use and conventions for 
measuring alcohol use in pregnancy is required to improve the validity and reliability of 
prevalence estimates. 
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 Introduction  5.2
Worldwide, the majority of clinical and government guidelines advocate for pregnant 
women to abstain from alcohol consumption during pregnancy due to potential 
adverse effects on pregnancy outcomes (17, 90-92). However, the National Institute of 
Health and Care Excellence (NICE) guidelines in the UK conflict with these guidelines 
and suggest that one to two units up to twice per week are not shown to be harmful to 
the unborn baby (16).  
Conflicting results on the effects of gestational alcohol consumption on 
offspring health outcomes and subsequently, lack of coherence in clinical and 
government guidelines stem from a lack of biological markers of light or moderate 
alcohol use during pregnancy. Thus, studies of associations with offspring health 
outcomes rely on maternal self-reported alcohol consumption which may be biased by 
reporting and recall biases. For example, estimates of prevalence of alcohol use during 
pregnancy and its associated predictors in existing cohort data are highly variable and 
range from 36% in the Millennium Cohort Study (MCS) (93), to almost 60% in the 
ALSPAC (see Chapter 9). Consequently, whether exposure and its predictors are reliably 
measured in observational studies is difficult to decipher, and thus, approaches which 
reveal the validity and reliability of estimates and predictors are required. 
Cross cohort comparisons may be a useful way to examine plausible and valid 
self-reported prevalence estimates and predictors. Comparing multiple cohort 
estimates within the same population allows the validity of prevalence estimates and 
predictors of alcohol use to be compared when measured using different techniques; if 
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prevalence is accurately reported and not subject to substantial recall and reporting 
biases by socio-demographics, prevalence and predictors should be mostly consistent 
across studies. Comparing sub-population estimates within the same cohort allows for 
population variation in alcohol prevalence and predictors to be compared when 
exposure measurement is constant; if prevalence and predictors vary substantially 
across countries within the same study, using the same measurement methods, 
insights into the impact of culture and attitudes on alcohol consumption or reporting of 
alcohol can be revealed. Taken together, such techniques may provide increased 
insight into plausible prevalence estimates of alcohol use during pregnancy, improved 
alcohol exposure measurement during pregnancy and increased understanding of the 
social patterns of alcohol use across cohorts which can be used to inform antenatal 
care guidelines on alcohol use. 
The objectives of this study were to compare the prevalence of alcohol use 
across three studies; GUI (52, 54), Screening for Pregnancy Endpoints (SCOPE) Study 
(94) and PRAMS Ireland (methods previously described in Chapters 2-4) (85). GUI and 
PRAMS measured gestational alcohol use retrospectively while SCOPE obtained 
measures of alcohol use during pregnancy. Secondly, we compared the characteristics 
associated with alcohol use in all three studies and within SCOPE countries (New 
Zealand, Ireland, Australia, and United Kingdom) in order to examine cross cohort and 
cross country consistency in the prevalence and predictors of gestational alcohol use.  
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 Methods 5.3
5.3.1 Growing up in Ireland 
The National Longitudinal Study of Children is the first longitudinal study of its kind that 
focuses on the developmental trajectories of children in Ireland (52). Participants were 
sampled from the state Child Benefit Register using a simple systematic selection 
procedure pre-stratifying by parental marital status, country of residence, nationality 
and number of children (52). Surveys were completed with the primary and secondary 
caregivers of 11,134 infants aged six to nine months from September 2008 to April 
2009 selected from approximately 41,000 births on the register over the period 1st 
December 2007 to 30th June 2008 (52). This represented almost a quarter of all births 
in Ireland over that period (52). The main study questionnaire was administered to all 
study participants by trained study personnel in the home of the caregivers through a 
face to face interview six to nine months postpartum (52). Women were asked if they 
drank in each trimester of pregnancy separately.  
Women who reported alcohol use during pregnancy were asked how much on 
average they drank per week (pints of beer or cider, glasses of wine, measures of 
spirits or alcopops) in each trimester. Non-biological mothers or male primary 
caregivers who participated in the study were excluded from the present analysis 
(0.3%). Biological mothers who did not complete the questionnaire were also excluded 
from the present study (0.1%). All participants gave informed consent prior to 
participation in the study. 
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5.3.2 Screening for Pregnancy Endpoints study 
Screening for Pregnancy Endpoints is a prospective, multi-centre cohort study with the 
principal aim of developing screening tests to predict pre-eclampsia, small for 
gestational age (SGA), and spontaneous preterm birth (94). Participants were healthy 
nulliparous females with singleton pregnancies recruited between November 2004 and 
February 2011 in Auckland, New Zealand ; Adelaide, Australia ; Cork, Ireland, and ; 
Manchester, Leeds and London, United Kingdom as previously described (5, 67). 
Women were excluded if they were considered at high risk of preeclampsia, delivery of 
a SGA infant or spontaneous preterm birth because of underlying medical conditions, 
gynaecological history, three or more previous miscarriages, three or more 
terminations of pregnancy, or had received interventions, such as aspirin, that might 
modify pregnancy outcome (94). Study participants were interviewed and examined by 
study research midwives at 15 and 20 weeks of gestation. At the time of interview, 
data were entered on an internet accessed central database with a complete audit trail 
(MedSciNet) (95). Pregnancy information and pregnancy outcome data were collected 
prospectively by research midwives. All data entries were individually checked 
(including data entry errors in the lifestyle questionnaire) and a customised software 
program used to detect any systematic data entry errors.  
Alcohol consumption was reported as units consumed per week. At the 15 
weeks interview, participants were asked “were you drinking alcohol prior to 
pregnancy?”, “were you drinking alcohol earlier in the pregnancy in the first 
trimester?” and finally “are you still drinking alcohol?” If the participants answered 
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“yes” to any of the above, the amount of alcohol was then quantified including number 
of units and binges per week. Participants who confirmed that they had consumed 
alcohol during pregnancy were asked when they stopped drinking. At 20 weeks’ 
gestation, women were asked the number of units of alcohol per week consumed and 
the number of binges taken between the 15 week and 20 week interview. All 
participants gave informed consent prior to participation in the study. Only participants 
who delivered a live born baby were included in the present analysis. 
5.3.3 Pregnancy Risk Assessment Monitoring System Ireland 
The aim of PRAMS Ireland was to measure the prevalence of a wide range of maternal 
health behaviours and experiences before, during and after pregnancy. The sample for 
the study was derived using hospital discharge records of live births at CUMH, a large 
urban, obstetric hospital in the South of Ireland where almost 9,000 live births per year 
occur. A constant sampling fraction of one in two records alternately sampled 1,212 
from a sampling frame of approximately 2,424 mother-infant pairs discharged between 
May 14th 2012 and August 18th 2012. Mothers of stillbirths, neonatal deaths and early 
and late miscarriages were excluded as the objective of the study was to characterise 
maternal behaviours and experiences around the time of pregnancy in women with 
live-births. Women were invited to participate by post and were sent three postal 
surveys, a reminder letter and a telephone follow-up which involved a text reminder. 
The PRAMS Ireland questionnaire was based on PRAMS US phase six questions 
covering socio-demographics and health behaviours and experiences before during and 
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after pregnancy (13) including detailed information on dose, pattern and timing of 
alcohol exposure based on the work of O’Leary et al., 2010 and described earlier in 
Chapter 2. On date of receipt of the first survey, mothers were between two to five 
months postpartum. On the date of receipt of the final PRAMS Ireland survey, mothers 
were between seven and nine months post-delivery. Thus, respondents of the survey 
were anywhere between two months and nine months post-delivery when answering 
PRAMS Ireland questions. 
Women were asked to report the number of occasions per week or month 
alcohol was consumed ranging from never, less than one occasion per month, one to 
two occasions per month, one to two occasions per week, three to four occasions per 
week, and five or more occasions per week for the three months before pregnancy and 
each trimester separately. For the number of occasions indicated in each time period, 
women were asked to indicate the number of glasses or bottles of beer consumed, 
wine (100 millilitres (ml)), alcopop, sherry or port or spirits or liqueurs consumed per 
occasion. PRAMS Ireland used an opt-out consent system where-by women who did 
not wish to participate in the survey were permitted to opt-out at the beginning of the 
study. Women who did not opt-out were treated as willing participants. Ethical 
approval for PRAMS was received from the CREC. 
5.3.3.1  Definitions  
We selected to examine the association between low birth weight and preterm birth 
(traditionally examined in relation to the effects of gestational alcohol use) and 
common confounders of these associations and alcohol use during pregnancy. In all 
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analyses, covariates (age, education, ethnicity, marital status, parity, delivery mode, 
smoking, BMI, preterm birth and birth weight) were categorised in an identical manner 
for comparability.  
One unit of alcohol was equivalent to one glass of wine (approximately 100ml-
125 ml), one small glass of sherry, a single nip of spirits, or half a pint of lager (regular 
strength). A can or small bottle/glass of regular-strength beer (300–330 ml, 4–5% 
alcohol) was equivalent to 1.5 units of alcohol and a bottle of alcohol pop was 
equivalent to two units of alcohol. Where pre-pregnancy alcohol consumption was 
reported, it was defined as consumption of any alcohol in the three months prior to 
pregnancy. Where quantity of alcohol before pregnancy and by trimester was 
available, alcohol intake was classified as occasional (one to two units per week), low 
(three to seven units per week), moderate (eight to 14 units per week) and heavy 
(greater than 14 units per week). Median units of exposure were used as alcohol is not 
normally distributed and median number of units consumed was defined as number of 
units consumed per week in the three months before pregnancy or in each trimester 
separately when available. Binge consumption was defined as six or more standard 
units per occasion. 
In SCOPE, any alcohol consumption included any alcohol consumed from 
conception up to the 20 week interview, including any binge consumption. First 
trimester use was reported at the 15 week SCOPE visit. For second trimester use, 
consumption in the week preceding the 15 week SCOPE visit and preceding the 20 
week SCOPE visit were combined and divided by two to obtain a weekly average 
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consumption which was subsequently categorised as occasional, low, moderate or 
heavy as above. Binge drinking in the second trimester was defined as reporting 
binging in the week prior to 15 week SCOPE visit or between 15 and 20 week SCOPE 
visit.  
In GUI and PRAMS Ireland, any alcohol consumption or any binge consumption 
was defined as consumption of alcohol in the first, second or third trimester or 
consumption of a binge in any of the trimesters. Binge alcohol use by trimester was 
defined as any binge alcohol use in the first, second or third trimester separately. 
Alcohol use before pregnancy and binge alcohol consumption data was not available in 
GUI. 
5.3.4 Statistical analysis 
All statistical analyses were conducted in Stata V12. We used frequencies to describe 
the characteristics of each cohort and compare reported drinking in all three studies. 
We compared the characteristics of drinkers and non-drinkers during pregnancy in 
each cohort using descriptive statistics including Pearson χ² (chi) squared test for 
categorical data, student’s t-test for continuous variables and Kruskall wallis test for 
non-normally distributed continuous alcohol variables. We also used frequencies to 
compare reported drinking in each of the SCOPE countries. We used log linear binomial 
regression to examine the characteristics associated with alcohol consumption in each 
cohort and the characteristics associated with alcohol use in each SCOPE country, due 
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to the high prevalence of alcohol use. In the analysis of SCOPE countries, UK centres 
(Manchester, Leeds and London) were combined. 
 Results 5.4
Eleven thousand one hundred and thirty four participants were recruited to the GUI 
study of which 10,953 were included in the present analysis after exclusion of male 
primary caregivers and women who did not answer the sensitive questionnaire. Five 
thousand, five hundred and seventy three participants with live births in SCOPE were 
included (99% of total cohort). All PRAMS Ireland (n=718) participants were included in 
the analysis.  
SCOPE participants were younger (42% less than 30 compared to 33% of GUI 
participants and 23% of PRAMS Ireland participants), better educated (89% had tertiary 
education in SCOPE compared to 82% in PRAMS and 56% in GUI), more likely to be 
Caucasian (98% Caucasian in SCOPE compared to 93% in GUI and 95% in PRAMS 
Ireland) and had the highest smoking prevalence of all three cohorts (28%), Table 5.1. 
More married women participated in PRAMS Ireland than the other cohorts (93% vs. 
89% in SCOPE and 71% in GUI) and PRAMS Ireland participants reported the lowest 
rates of overweight and obesity of all three cohorts (30 % vs. 40% in SCOPE and 46% in 
GUI). GUI participants were generally more disadvantaged than SCOPE or PRAMS 
Ireland participants with the lowest proportions of tertiary education (56%), highest 
proportion of single women (29%) and highest proportion of overweight and obesity 
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(46%) of all three cohorts. All SCOPE participants were nulliparous and approximately 
40% of GUI and PRAMS Ireland participants were nulliparous (Table 5.1).  
SCOPE had the highest overall reported prevalence of alcohol both pre-
pregnancy (90% vs. 77% in PRAMS Ireland) and during pregnancy (82% vs. 46% in 
PRAMS Ireland) (Table 5.2). GUI reported the lowest overall consumption of alcohol 
use during pregnancy at 20%. SCOPE participants also reported the highest overall 
consumption levels both pre-pregnancy and during pregnancy and the highest binge 
consumption before (59%) and during pregnancy (45%). By the second trimester 
reported prevalence and reported consumption levels in SCOPE (29%) were almost 
equal to PRAMS Ireland (31%). Examining changes between the first and second 
trimesters, SCOPE alcohol prevalence dropped from 82% to 29% consumption between 
the first and second trimester although PRAMS Ireland and GUI alcohol consumption 
stayed relatively constant across all three trimesters at 30% in PRAMS Ireland and 10-
15% in GUI. Among the SCOPE participants who continued to drink in the second 
trimester, there were also substantial reductions in the level of drinking (70% drinking 
greater than one to two units per week in the first trimester compared to 2% in the 
second trimester). In addition to the marked variation in reporting of alcohol use 
across cohorts, reporting of alcohol use varied considerably across socio-demographics 
and health characteristics in each cohort, ( Table 5.3) with evidence of strong social 
gradients in alcohol consumption for all characteristics in GUI which were not apparent 
in SCOPE and PRAMS Ireland. 
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Table 5.4 shows the characteristics associated with alcohol consumption in each 
cohort. Compared to Caucasian ethnicities, non-Caucasian women were less likely to 
drink alcohol during pregnancy in all cohorts. Smoking was related to greater risk of 
consuming alcohol during pregnancy in all three cohorts (Relative risk (RR) range from 
1.17-1.50 for the three cohorts). Younger age was related to lower risk of alcohol use in 
GUI and women aged greater than 39 were more likely to drink alcohol during 
pregnancy compared to women aged 30-39 years. Having a second level education, 
being multiparous, BMI > 30 and delivery of a low birth weight infant were also related 
to lower risk of alcohol use during pregnancy in GUI. In SCOPE, single women were 
more likely to drink alcohol during pregnancy.  
Table 5.6 shows the distribution of alcohol use across each of the four 
participating countries in SCOPE. Reported alcohol use before and during pregnancy 
was high in all centres (>40%) but prevalence and quantity of consumption varied 
substantially by SCOPE centre (p<0.05 for differences in all indices of pre-pregnancy 
and early pregnancy alcohol consumption). Ireland had the highest prevalence of any 
alcohol consumption pre-pregnancy (90%) and during pregnancy (82%), and the 
highest reported binge consumption before (59%) and during (45%) pregnancy. 
Reported alcohol consumption dropped substantially for all countries in the second 
trimester as did reported binge consumption. In multivariate log linear binomial 
regression, factors associated with alcohol use consistently in each SCOPE centre were 
smoking during pregnancy (all countries) and ethnicity (Ireland, UK and New Zealand). 
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Other factors that were related to alcohol use but less consistently so, were age, 
marital status and education (New Zealand centre only). 
 Discussion 5.5
Our findings show a high prevalence of alcohol use during pregnancy [ranging from 
20% to 80% in Ireland] and from 40% upwards in the United Kingdom, Australia and 
New Zealand, low adherence to NICE guidelines advising consumption of no more than 
4 UK units per week(16) and high levels of binge drinking during pregnancy [in excess 
45% in the Irish centre of the SCOPE cohort]. We found that this high prevalence, was 
in general pervasive across all social groups and of the predictors of alcohol 
consumption examined, smoking was the only consistent predictor of alcohol use 
across all cohorts and countries examined.  
To our knowledge, this is the first cross cohort comparison of the prevalence 
and predictors of alcohol use during pregnancy. Our study goes beyond measurement 
of alcohol use during pregnancy with just one cohort or one measurement method, but 
examines prevalence and predictors using different measurement techniques in the 
same population. It also examines variation in prevalence keeping measurement 
constant across different settings. The study had a large sample size of almost 18,000 
women. We were able to examine prevalence using different modes of administration 
[anonymised self-administered postal survey in PRAMS, trained government interview 
in GUI, antenatal midwife collected data in SCOPE], timing of administration [two to 
nine months postpartum in PRAMS, nine to 12 months postpartum in GUI and in the 
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second trimester of pregnancy in SCOPE]. However, as we used self-reported alcohol 
consumption data, reporting and recall biases may exist and although our estimates of 
prevalence appear high, where the true estimate lies (ranging from 20% in GUI to 80% 
in SCOPE) is unclear. In addition, we have only included live born babies in our analysis 
and thus, there is a possibility that we have excluded women with the heaviest drinking 
patterns, since failure to give birth to a baby could have resulted from heavy drinking; 
for example, early miscarriage occurring due to early pregnancy chronic alcohol use or 
binge drinking. Participants in our studies could also be more advantaged than the 
general population and thus, the generalisability of our findings to all pregnancies or 
more diverse populations may be reduced. Nonetheless, the cross cohort comparison 
improves upon previously published single cohort analyses since it shows gestational 
alcohol use to be prevalent and socially pervasiveness during pregnancy as measured 
by various measurement methods and in different settings. Secondly, across different 
studies and settings maternal smoking is a strong and consistent predictor of alcohol 
consumption in pregnancy. In addition, from a methodological perspective the analysis 
points to the need for an agreed convention by which to measure gestational alcohol 
use to avoid substantial variation and heterogeneity in estimates and predictors of 
gestational alcohol use in future studies. 
Our findings of a range of gestational alcohol use from 20% to 80% are largely 
consistent with studies of similar design for each cohort respectively. In general, 
prospective ascertainment of exposure has been shown to be more accurate than 
retrospective reporting where it has been suggested that postpartum drinking levels 
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and poorer memory after the fact could influence reporting in retrospective studies 
(96). In the prospective SCOPE study, the high rates of pre-pregnancy and gestational 
alcohol consumption that were observed in Ireland are compatible with estimates from 
another large contemporary prospectively recruited urban Irish cohort (n=65,000) 
which had a similar prospective design but with both nulliparous and multiparous 
participants (29). However, GUI estimates are likely to substantially underestimate 
gestational alcohol consumption, especially when compared to 37% alcohol prevalence 
in the UK Millennium Cohort Study, a cohort of almost identical design where exposure 
was measured 9 months post-partum (93). Potential reasons why GUI and MCS 
estimates are not compatible include differences in interviewing techniques and 
administration of surveys which would easily influence reporting of socially undesirable 
behaviours such as gestational alcohol use. Alternately, the retrospective PRAMS 
estimate of alcohol consumption in pregnancy of almost 50% is comparable with 
estimates from a number of large European cohorts including Generation R (97), the 
Danish National Birth cohort (79), MCS (93) and another recent prospective cohort 
from Leeds in the United Kingdom (98). This suggests that the retrospective 
component in itself may not always result in an under-estimation of alcohol use and 
that retrospective measurement, as conducted in PRAMS could produce estimates as 
reliable as prospective techniques when administered in a way where under-reporting 
is minimised (anonymised postal questionnaire vs. face to face retrospective interview 
in GUI).  
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Our results for other SCOPE centres such as the UK are higher than some British 
birth cohorts (93), although SCOPE Australia and New Zealand estimates are consistent 
with some previous data in the region which was collected retrospectively (99-102). 
SCOPE Ireland overall alcohol consumption and binge estimates are far higher than 
most previous studies and far higher than estimates from the other SCOPE centres. 
Population differences in actual alcohol consumption are a plausible reason for 
variation in prevalence. In addition, variation in measurement methods may explain 
any variation in prevalence and its associated predictors such as differences in 
interviewing techniques across centres. Another potential reason for variation in 
reporting or indeed actual alcohol use may include variation in professional and patient 
attitudes to the acceptability of alcohol consumption during pregnancy across 
countries such that propensity to report alcohol use or consume alcohol during 
pregnancy would be easily influenced by a combination of interviewing technique and 
country-specific cultural attitudes to alcohol.  
The findings of this study have direct relevance for policy and practice. Alcohol 
use during pregnancy is highly prevalent and evidence from this cross-cohort and cross 
country comparison shows that gestational alcohol exposure may occur in over 75% of 
pregnancies the UK and Ireland. As we do not find compelling evidence that alcohol 
use is more prevalent in any particular socio-demographic group, in line with best 
practice clinical care guidelines, healthcare professionals should continue to advise all 
pregnant women to abstain from alcohol during pregnancy irrespective of 
professionally perceived risk of exposure. Given evidence of higher risk of drinking 
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during pregnancy among smokers which was consistent across cohorts and within 
countries examined, dual targeting of smoking and alcohol consumption should 
potentially be increased and delivered routinely upon a woman’s indication of either 
behaviour during pregnancy. New policy and interventions are also required to reduce 
alcohol prevalence both prior to and during pregnancy.  
This cross cohort comparison highlights the urgent need for a biological marker 
of gestational alcohol use, since even in more robust study designs (prospective 
measurement being the most superior), it is difficult to estimate to what extent 
estimates and their predictors are plausible, even when analysed in a comparative 
design such as ours. In addition, this research highlights the need for a clear convention 
and standard method of measurement of alcohol use across observational studies 
which minimise heterogeneity in measurement, insofar as is possible using self-
reported measurement of socially undesirable behaviours.  
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Table 5.1 Characteristics of women participating in GUI (2010), SCOPE Ireland (2008-
2011) and PRAMS Ireland (2012) 
 GUI 
n=10,953 
n (%) 
SCOPE Ireland 
n=1,766 
n (%) 
PRAMS 
n=718 
n (%) 
Age     
<20 198 (2) 38 (2) 4 (1) 
20-24 1053 (10) 167 (10) 24 (3) 
25-29 2311 (21) 543 (31) 139 (19) 
30-39 6688 (61) 996 (56) 510 (71) 
>40 703 (6) 22 (1) 40 (6) 
Education    
Secondary 4836 (44) 197 (11) 126 (18) 
Tertiary 6110 (56) 1569 (89) 587 (82) 
Ethnicity    
Caucasian 10207 (93) 1725 (98) 676 (95) 
Other 708 (7) 41 (2) 43 (5) 
Marital status    
Married 7796 (71) 1578 (89) 670 (93) 
Single 3157 (29) 188 (11) 47 (7) 
Parity    
0 4288 (39) 1766 (100) 282 (40) 
1+ 6725 (61) - 430 (60) 
Smoking 1831 (17) 485 (28) 143 (23) 
BMI (kg/m2)    
<18.5 289 (3) 21 (1) 26 (4) 
18.5-24.9  5372 (51) 1034 (59) 464 (67) 
25.0-29.9 3085 (30) 493 (28) 151 (22) 
>30 1677 (16) 218 (12) 51 (7) 
Preterm birth (<37 weeks 
gestation) 
721 (7) 86 (5) 39 (6) 
Birth weight (<2500g) 606 (6) 75 (4) 38 (5) 
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Table 5.2 Prevalence of alcohol consumption in GUI (2010), SCOPE Ireland (2008-2011) and PRAMS Ireland (2012) 
 GUI 
n=10,953 
n (%) 
SCOPE Ireland 
n=1,766 
n (%) 
PRAMS 
n=718 
n (%) 
Pre-pregnancy alcohol consumption Not recorded 1586 (90) 545 (77) 
Severity of consumption    
1-2 units per week Not recorded 287 (18) 168 (43) 
3-7 units per week Not recorded 602 (38) 96 (24) 
8-14 units per week Not recorded 451 (28) 73 (19) 
>14 units per week Not recorded 247 (16) 58 (15) 
Median (95% CI) units of exposure/week Not recorded 6 (6, 7) 4 (3,5) 
Pre-pregnancy binging Not recorded 1044 (59) 134 (24) 
Any alcohol in pregnancy 2198 (20) 1444 (82) 325 (46) 
Binge (any in pregnancy) Not recorded 795 (45) 23 (4) 
First trimester alcohol consumption 1127 (11) 1415 (80) 211 (30) 
1-2 units per week 572 (54) 424 (30) 142 (85) 
3-7 units per week 332 (31) 600 (42) 11 (7) 
8-14 units per week 117 (11) 266 (19) 8 (5) 
>14 units per week 41 (4) 125 (9) 7 (4) 
Median (95% CI) units of exposure/week 2 (2, 2) 4 (3.8, 4) 1 (1,1) 
Binge first trimester (yes) Not recorded 795 (45) 21 (3) 
Second trimester alcohol consumption 1585 (15) 500 (29) 216 (31) 
1-2 units per week 1006 (76) 486 (98) 153 (91) 
3-7 units per week 367 (25) 11 (2) 10 (6) 
8-14 units per week 93 (6) 1 (0.2) 5 (3) 
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>14 units per week 23 (2) 0 1 (1) 
Median (95% CI) units of exposure/week 1 (1, 2) 0.5 (0.5, 0.5) 1 (1,1) 
Binge second trimester (yes) Not recorded 7 (0.4) 4 (1) 
Third trimester alcohol consumption 1559 (14) Not recorded 225 (32) 
1-2 units per week 1016 (70) Not recorded 161 (90) 
3-7 units per week 341 (23) Not recorded 13 (7) 
8-14 units per week 78 (5) Not recorded 4 (2) 
>14 units per week 21 (1) Not recorded 1 (1) 
Median (95% CI) units of exposure/week 1 (1, 2) Not recorded 1 (1, 1) 
Binge third trimester (yes) Not recorded Not recorded 6 (1) 
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 Table 5.3 Characteristics of study participants by alcohol use during pregnancy 
 GUI 
n=10,953 
 SCOPE Ireland 
n=1,766 
 PRAMS 
n=718 
 Alcohol  Alcohol  Alcohol 
 Yes No P  Yes No P  Yes No P 
Age             
<20 19 (10) 169 (90) P<0.001  30 (82) 7 (18) 0.3  2 (50) 2 (50) 0.01 
20-24 130 (13) 908 (87)   137 (83) 29 (17)   4 (17) 19 (83)  
25-29 337 (15) 1938 (85)   433 (80) 110 (20)   53 (38) 85 (62)  
30-39 1528 (23) 5046 (77)   828 (83) 164 (17)   248 (49) 255 (51)  
>40 184 (27) 500 (73)   16 (73) 6 (27)   17 (44) 22 (56)  
Education            
Second 727 (15) 4004 (85) P<0.001  1286 (82) 279 (18) 0.7  47 (40) 72 (61) 0.1 
Tertiary 1470 (24) 4551 (76)   158 (81) 37 (19)   277 (47) 307 (53)  
Ethnicity            
Caucasian 2160 (22) 7868 (78) P<0.001  1433 (83) 286 (17) P<0.001  316 (47) 253 (53) P<0.01 
Other 36 (5) 657 (95)   11 (27) 30 (73)   3 (10) 26 (90)  
Marital status            
Married 1644 (22) 6021 (78) P<0.001  1277 (81) 296 (19) P<0.01  306 (46) 355 (54) 0.4 
Single 554 (18) 2540 (82)   167 (89) 20 (11)   18 (39) 28 (61)  
Parity            
0 760 (18) 3401 (82) P<0.001  1450 (82) 318 (18) -  128 (46) 151 (54) 0.97 
1+ 1438 (22) 5160 (78)   - - -  194 (46) 230 (54)  
Smoking            
Yes 445 (24) 1386 (76) P<0.001  448 (92) 38 (8) P<0.001  77 (55) 63 (45) 0.01 
115 
 
No 1753 (20) 7174 (80)   996 (78) 279 (22)   204 (43) 272 (57)  
BMI (kg/m2)            
<18.5 52 (18) 232 (82) P<0.001  838 (81) 194 (19) 0.2  9 (36) 16 (64) 0.5 
18.5-24.99  1143 (22) 4132 (78)   17 (82) 4 (18)   220 (48) 237 (52)  
25.0-29.9 626 (21) 2402 (79)   419 (85) 74 (15)   69 (46) 81 (54)  
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Table 5.4 Log linear binomial regression for risk of alcohol use pre-pregnancy 
 GUI 
n=10,953 
SCOPE Ireland 
N=1,766 
PRAMS 
N=718 
 aRR 
(95% CI) 
aRR 
(95% CI) 
aRR 
(95% CI) 
Age     
<20 0.48 (0.30, 0.77) 0.92 (0.85, 1.00) 1.31 (0.42, 4.14)  
20-24 0.56 (0.46, 0.68) 0.84 (0.71, 0.99) 0.26 (0.09, 0.77) 
25-29 0.69 (0.62, 0.78) 0.95 (0.91, 1.00) 0.84 (0.66, 1.08) 
30-39 Reference Reference Reference 
>40 1.18 (1.04, 1.35) 0.86 (0.66, 1.10) 0.97 (0.67, 1.39) 
Education3    
Secondary 0.65 (0.60, 0.72) 0.94 (0.88, 1.01) 0.81 (0.62, 1.07) 
Tertiary Reference Reference Reference 
Ethnicity    
Caucasian Reference Reference Reference 
Other 0.27 (0.19, 0.37) 0.34 (0.20, 0.56) 0.31 (0.11, 0.88) 
Marital status    
Married Reference Reference Reference 
Single 1.05 (0.96, 1.17) 1.09 (1.02, 1.17) 0.98 (0.65, 1.47) 
Parity    
0 Reference - Reference 
1+ 0.90 (0.83, 0.98) - 1.02 (0.86, 1.21) 
Smoking    
Yes 1.50 (1.36, 1.65) 1.17 (1.12, 1.22) 1.42 (1.18, 1.70) 
No Reference Reference Reference 
BMI (kg/m2)    
<18.5 1.01 (0.79, 1.29) 1.06 (0.86, 1.30) 0.80 (0.46, 1.41) 
18.5-24.99  0.98 (0.90, 1.07) Reference 0.96 (0.78, 1.18) 
25.0-29.9 Reference 1.02 (0.97, 1.07) Reference 
>30 0.84 (0.74, 0.94) 0.96 (0.89, 1.04) 0.89 (0.63, 1.27) 
Low birth weight (<2500g)    
No Reference Reference Reference 
Yes 0.76 (0.60, 0.96) 1.01 (0.89, 1.14) 0.66 (0.36, 1.22) 
Preterm birth (<37 weeks gestation)    
No Reference Reference Reference 
Yes 0.91 (0.74, 1.12) 0.94 (0.83, 1.07) 0.97 (0.56, 1.66) 
Log linear binomial regression showing adjusted Relative risk (aRR) was used to examine the 
characteristics associated with alcohol consumption in each cohort. 
                                                     
3
 Secondary includes all education up to university or post school institutions. Tertiary includes any 
tertiary education at a university or other post school institution. 
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Table 5.5 Comparison of alcohol use in SCOPE centres 
 Total 
n=5,573 
New 
Zealand 
n=2.006 
Ireland 
n=1,766 
Australia 
n=1,150 
UK* 
n=651 
P value  
Pre-pregnancy alcohol consumption 4319 (77) 1552 (77)  1586 (90) 539 (53) 544 (63) P<0.001  
Severity of consumption        
1-2 units per week 1126 (26) 503 (32) 287 (18) 232 (38) 104 (19) P<0.001  
3-7 units per week 1674 (39) 698 (45) 602 (38) 211 (34) 163 (30)   
8-14 units per week 963 (22) 253 (16) 451 (28) 94 (15) 165 (31)   
>14 units per week 528 (12) 98 (6) 246 (16) 76 (12) 108 (20)   
Median (95% CI) units of exposure/week  5 (5,5) 4 (4, 4) 6 (6, 7) 4 (4, 5) 7.5 (6, 8) P<0.001  
Pre-pregnancy binging 1741 (31) 337 (17) 1044 (59) 123 (11) 247 (38) P<0.001  
Any alcohol in pregnancy 3482 (63) 1107 (56) 1444 (82) 459 (40) 476 (75) P<0.001  
Binge (any in pregnancy) 1282 (23) 167 (9) 795 (45) 113 (10) 207 (33) P<0.001  
First trimester alcohol consumption 3370 (60) 1063 (53) 1415 (80) 440 (38) 451 (69) P<0.001  
Severity of consumption        
1-2 units per week 1078 (32) 361 (34) 424 (30) 142 (32) 151 (34) P<0.001  
3-7 units per week 1372 (41) 463 (44) 600 (42) 158 (36) 151 (34)   
8-14 units per week 624 (19) 175 (16) 266 (19) 80 (18) 103 (23)   
>14 units per week 296 (9) 65 (6) 125 (9) 60 (14) 46 (10)   
Binge first trimester (yes) 1279 (23) 167 (8) 795 (45) 111 (10) 206 (32) P<0.001  
Median (95% CI) units of exposure/week  4 (4, 4) 4 (4, 4) 4 (3.8, 4) 5 (4, 5) 4 (3.5, 4.7) 0.020  
Second trimester alcohol consumption 1018 (19) 232 (12) 500 (29) 73 (7) 213 (34) P<0.001  
Severity of consumption        
1-2 units per week 976 (97) 220 (97) 486 (98) 68 (93) 202 (96) 0.3  
3-7 units per week 30 (3) 7 (3) 11 (2) 4 (5) 8 (4)   
8-14 units per week 3 (0.3) 0  1 (0.2) 1 (1) 1 (0.5)   
>14 units per week 0 0 0 0 0   
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Binge second trimester (yes) 18 (0.4) 2 (0.1) 7 (0.4) 6 (1) 3 (1) 0.2  
Median (95% CI) units of exposure/week  0.5 (0.5, 
0.5) 
0.5 (0.5, 0.5) 0.5 (0.5, 
0.5) 
0.5 (0.3, 
0.5) 
0.8 (0.5, 
0.8) 
P<0.001  
*London, Manchester, Leeds. 
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Table 5.6 Log Linear binomial regression for risk of alcohol consumption during pregnancy 
 New Zealand 
n=2,006 
Ireland 
n=1,766 
Australia 
n=1,150 
UK* 
n=651 
 aRR (95% CI) aRR (95% CI) aRR (95% CI) aRR (95% CI) 
Age      
<20 0.78 (0.66, 0.93) 0.92 (0.85, 1.00) 0.94 (0.75, 1.17) 1.02 (0.90, 1.16) 
20-24 0.74 (0.56, 0.97) 0.84 (0.71, 0.99) 0.90 (0.70, 1.16) 0.86 (0.69, 1.07) 
25-29 0.83 (0.76, 0.91) 0.95 (0.91, 1.00) 1.03 (0.81, 1.30) 0.93 (0.84, 1.03) 
30-39 Reference Reference Reference Reference 
>40 0.71 (0.52, 0.98) 0.86 (0.66, 1.10) 1.33 (0.63, 2.84) 0.77 (0.45, 1.33) 
Education**     
Secondary 0.84 (0.74, 0.96) 0.94 (0.88, 1.01) 0.96 (0.82, 1.11) 0.93 (0.79, 1.09) 
Tertiary Reference Reference Reference Reference 
Ethnicity     
Caucasian Reference Reference Reference Reference 
Other 0.67 (0.58, 0.78) 0.34 (0.20, 0.56) 0.77 (0.58, 1.03) 0.57 (0.46, 0.71) 
Marital status     
Married Reference Reference Reference Reference 
Single 1.22 (1.02, 1.46) 1.09 (1.02, 1.17) 1.07 (0.89, 1.29) 1.08 (0.93, 1.26) 
Smoking     
Yes 1.50 (1.36, 1.66) 1.17 (1.12, 1.22) 1.82 (1.57, 2.11) 1.15 (1.05, 1.27) 
No Reference Reference Reference Reference 
BMI (kg/m2)     
<18.5 0.88 (0.55, 1.41) 1.06 (0.86, 1.30) 0.76 (0.47, 1.22) 0.67 (0.31, 1.44) 
18.5-24.99  Reference Reference Reference Reference 
25.0-29.9 1.01 (0.93, 1.10) 1.02 (0.97, 1.07) 1.18 (1.00, 1.38) 0.98 (0.88, 1.08) 
>30 0.86 (0.75, 1.00) 0.96 (0.89, 1.04) 0.84 (0.70, 1.01) 0.85 (0.73, 1.00) 
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Low birth weight (<2500g)     
No Reference Reference Reference Reference 
Yes 0.94 (0.76, 1.18) 1.01 (0.89, 1.14) 1.29 (0.88, 1.89) 1.22 (0.86, 1.73) 
Preterm birth (<37 weeks gestation)     
No Reference Reference Reference Reference 
Yes 0.81 (0.65, 1.00) 0.94 (0.83, 1.07) 1.02 (0.73, 1.42) 1.08 (0.79, 1.49) 
*London, Manchester, Leeds. 
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 Abstract 6.1
Background 
Eighty per cent of women in high income countries bear at least one child in their 
lifetime. Pregnancy is known to be a time of transition during which women are more 
likely to engage in positive behaviour change. Thus, pregnancy is a critical period in the 
life course where temporary behaviour changes of pregnancy could be harnessed to 
achieve long term improvements in womens’ lifestyles beyond pregnancy. The aim of 
this study was to examine adherence to National Clinical Guidelines on lifestyle before 
and during pregnancy in Ireland. 
 
Methods 
A sampling frame of approximately 2,450 mother-infant pairs recently discharged from 
a large, urban, obstetric hospital in the South of Ireland was used to alternately sample 
1,200 women to participate in a survey of behaviours and experiences around the time 
of pregnancy (PRAMS Ireland). We administered a postal survey to women 
approximately two to five months after birth which included validated questions on 
maternal lifestyle including alcohol consumption, smoking and folate intake before and 
during pregnancy. Usual diet in the 12 months preceding receipt of the questionnaire 
was collected using a self-completed FFQ. 
Results 
Of the 718 women surveyed, 24% were adherent to all three recommendations on 
alcohol consumption, smoking and folate before pregnancy. This increased to 39% for 
the same three behaviours during pregnancy, with greater increases in adherence 
observed among women with the lowest adherence before pregnancy such that age, 
education and ethnicity gaps in adherence before pregnancy appeared to narrow 
during pregnancy. Adherence to all seven food pyramid guidelines was less than 1% 
overall and less than a 1% of participants met all four micronutrient guidelines on 
vitamin D, folate, calcium and iron intake around the time of pregnancy. 
Conclusion 
Adherence to National Clinical Guidelines on health behaviours and diet around the 
time of pregnancy is low across all social groups in Ireland. Women with the lowest 
adherence to positive health behaviours before pregnancy experience the greatest 
increases in adherence to guidelines during pregnancy. The naturally changing health 
motivations of women around the time of pregnancy could be harnessed for more 
permanent lifestyle improvement in women and wider public health impact beyond 
pregnancy. 
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 Introduction 6.2
Birth cohorts and longitudinal studies in Europe and internationally have established 
the harmful effect of maternal health behaviours around the time of conception and 
during pregnancy in relation to offspring health effects throughout the life course (3, 
19). However, the importance of promotion of lifestyle changes during this period of 
transition also has a wider public health value, since the peri-conceptual window may 
be a “teachable moment” during which long term lifestyle changes beyond pregnancy 
could be realised (103). Since over 80% of women in high income countries bear at 
least one child, most women are exposed at least once in their lifetime to this period of 
transition during which they are more susceptible to behaviour change (104). Thus, 
pregnancy is a critical period in the life course where temporary behaviour changes 
could be harnessed to achieve long term improvements in womens’ lifestyles. In turn, 
these changes could have wider public health impacts through women’s strong 
influence on diet and lifestyle in the family unit as a whole. 
Interventions aimed at reducing the prevalence of adverse lifestyle behaviours 
during pregnancy have been heavily investigated (105-107) and antenatal care 
guidelines in the UK and Ireland outline specific recommendations around alcohol use, 
smoking and folate intake to assist health care professionals to address deleterious 
health behaviour’s in practice (16, 108). However, to what extent public health and 
clinical efforts are resulting in meaningful improvements in maternal lifestyle during 
the peri-conceptual period is generally not documented. Describing adherence to 
lifestyle guidelines during pregnancy is important for setting national targets for 
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lifestyle during pregnancy, since improvements in maternal lifestyle are not only 
worthwhile for the health of pregnant women and their offspring but may also be 
worthwhile as a general public health strategy beyond pregnancy.  
In this study, we use key guidelines from the Institute of Obstetricians and 
Gynaecologists, Royal College of Physicians in Ireland (RCPI) and Health Services 
Executive (HSE) (108) in Ireland including promotion of smoking cessation during 
pregnancy, abstinence from alcohol use, folic acid intake, exclusive breastfeeding and 
following a balanced diet in line with food pyramid guidelines to examine womens’ 
adherence to lifestyle guidelines during pregnancy in a cross sectional study of 718 
women in the South of Ireland, PRAMS Ireland. 
 Methods 6.3
6.3.1 Sampling strategy 
The details of PRAMS Ireland have been described previously in Chapters 2-4. Briefly, 
using hospital discharge records, a sample of women with recent live births was 
selected from delivery records at CUMH, a large urban, obstetric hospital in the South 
of Ireland where almost 9,000 live births per year occur (12% of all Irish births and 2/3 
of all births in the health services region) (86). A constant sampling fraction of one in 
two records alternately sampled 1,212 from a sampling frame of approximately 2,424 
mother-infant pairs discharged between May 14th 2012 and August 18th 2012. Name, 
address and other demographic and clinical characteristics were recorded. We 
administered a pre-letter inviting women to participate in the study, three postal 
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surveys, a reminder letter and a telephone follow-up which included a text reminder. 
The surveys asked women about their health behaviours and experiences before 
pregnancy and during pregnancy. A semi-quantitative FFQ was also administered with 
the survey asking women to report their usual weekly diet in the 12 months preceding 
receipt of the questionnaire. Participants were on average 4.6 (minimum two months 
and maximum nine months) post-delivery when they completed the questionnaire. 
This research protocol and all study materials received ethical approval from the CREC. 
6.3.2 Statistical analysis and variable definitions 
We examined adherence to major lifestyle guidelines for pregnancy by age, education, 
ethnicity, BMI and pregnancy intention using descriptive statistics in Stata V12. 
Variables were defined in line with National Clinical Guidelines on nutrition and 
lifestyle during pregnancy as set out by the Institute of Obstetricians and 
Gynaecologists in Ireland, RCPI and the HSE (108, 109). These included intake of a daily 
supplement of folic acid at least four weeks prior to conception and during the first 12 
weeks of pregnancy, not smoking before or during pregnancy, not consuming more 
than 11 units of alcohol per week before pregnancy, not consuming any alcohol during 
pregnancy and exclusive breastfeeding until six months postpartum.  
The ages of infants of respondents ranged from two to nine months from when 
the first and last woman responded. Thus, we calculated exclusive breastfeeding up to 
two months postpartum only given the range of infant ages at which women had 
responded to the survey. We examined adherence to food pyramid guidelines 
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including intake of six or more servings of carbohydrates a day, five or more servings a 
day of fruit and vegetables, three servings a day of dairy, two servings a day of cooked 
meat or protein, two portions of fats and oils and not more than one serving of foods 
high in salt, sugar and fat. We examined micronutrient intake from food for key 
vitamins and minerals necessary for a healthy pregnancy. This included folic acid intake 
of 400 micrograms (µg) or more per day, vitamin D intake of ten µg or more per day, 
calcium of 1000 milligrams (mg) or more per day, and iron intake of 14 mg or more per 
day.  
Participant’s age was derived from discharge data by subtracting date of birth 
from maternal date of birth and categorised into three age groups:15-29, 20-39 and 
40-51. Women were asked their highest level of education to date; response categories 
included, some primary (not complete), primary or equivalent, intermediate, junior, 
group certificate or equivalent, leaving certificate or equivalent, diploma or certificate, 
primary degree, postgraduate/higher degree. This was dichotomised to second level 
education up to and including leaving certificate or equivalent (12 years of education 
approximately) and third level education for education above leaving certificate (>12 
years). Women’s ethnic or cultural background was grouped into Irish or Other 
Background to include Other White Background, African, Any Other Black Background, 
Chinese or Any Other Asian Background. BMI was calculated based on self-reported 
weight in kilograms (kg) and height in meters (m) and categorised as underweight 
(<20), normal (20-25), overweight or obese (>25). Unintended pregnancy was defined 
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as a pregnancy that a woman wanted later (mistimed) or did not want at any time 
(unwanted). 
 Results 6.4
Of the 718 women participating in the study, 23% were aged 15-29, 71% were aged 30-
39, and 5.6% aged 40-51. Most women had a third level education (82.4%), and most 
women were White Irish (80.7%). Approximately 3.8% of respondents were 
underweight, 67% were normal weight and 29% were overweight or obese while one 
fifth of women did not intend on being pregnant at that time.  
Table 6.1 describes adherence to health behaviours before and during 
pregnancy by age, education, ethnicity, BMI and pregnancy intention. Overall, less than 
one quarter of women adhered to all three recommendations on smoking, alcohol and 
folate before pregnancy. Lower adherence was evident among younger women (8.7%), 
women with second level education only (9.6%), non-Irish women (11.3%) and women 
who did not wish to be pregnant at that time (6.3%). In addition, among women who 
did not intend to be pregnant, we found higher levels of hazardous drinking (37.7% vs. 
27.1% before pregnancy and 30.1% vs. 20.2% during pregnancy) compared to women 
planned their pregnancy. 
During pregnancy, adherence to guidelines on the same health behaviours 
increased across all socio-demographic groups to 39% overall. However, socio-
demographic differences in adherence reduced due to larger gains in adherence 
among women with the lowest adherence rates before pregnancy. During pregnancy, 
34% of younger women, 35% of women with a second level education, 45% of non-
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Irish women and 25% of women who did not wish to be pregnant became adherent to 
all three smoking, alcohol and folate guidelines. However, although overall adherence 
to all guidelines increased, gaps in adherence to smoking guidelines during pregnancy 
remained. For example, a 28% gap in adherence to smoking guidelines remained 
between the youngest (15-29) and oldest women (40-51) despite a narrowing gap 
between these groups for folate and alcohol use during pregnancy. 
Overall 30% of women breastfed exclusively up to two months postpartum. 
Lower adherence to this guideline was evident among younger women aged 15-29 
(21.7%) vs. 32.7% among women aged 30-39 and 30% among women aged 40-51. 
Lower adherence was also evident among less educated women (20.8%) compared to 
higher educated women (32.1%). Irish women (26.3%) also had lower adherence levels 
compared to non-Irish women. Overweight and obese women had lower adherence 
rates (23%) compared to underweight and normal weight participants, 32% and 33% 
respectively. However, breastfeeding rates among women who did not intend to be 
pregnant were similar to those of women who planned their pregnancy (~30%). 
Table 6.2 shows adherence to dietary guidelines in the 12 months preceding 
response to the survey. Less than 1% of women were adherent to all seven food 
pyramid guidelines during an average week in the 12 months preceding completion of 
the questionnaire. Only 7.7% of women reached the recommended guideline of 
consumption of less than one serving per day of foods high in salt, fat and sugar. 
However, 81% of women reported meeting fruit and vegetable consumption guidelines 
of five or more servings per day. For carbohydrate, dairy protein and oils intake, 
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between one quarter to one third of women met these guidelines. Similarly, adherence 
to physical activity guidelines of moderate intensity activity on five or more days of the 
week was low overall at 12.3%. In general, adherence to dietary and physical activity 
guidelines was low across all age groups and did not appear to substantially differ by 
age, education, ethnicity, BMI and pregnancy intention. 
Micronutrient analysis revealed that of some of the key nutrients necessary for 
a healthy pregnancy, only 26% of women reached folate recommendations, 0.9% 
reached vitamin D recommendations, 36% met calcium recommendations and 17.6% 
met iron recommendations, from food. Major differences in age and education related 
adherence to these did not emerge. However, non-Irish women appeared to have 
higher adherence to all micronutrient intakes compared to Irish women.  
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 Discussion 6.5
In this cross sectional study of 718 women in the South of Ireland we found low 
adherence to key lifestyle behaviours set out in Irish National Clinical Guidelines before 
(24%) and during (39%) pregnancy and lower adherence still in more vulnerable social 
groups such as younger women and less educated women. Among women who did not 
plan their pregnancy, we found a high prevalence of deleterious health behaviours 
before pregnancy that reduced somewhat during pregnancy; however, breastfeeding 
rates in the postpartum period were similar to those who planned their pregnancy. 
Across all social groups, we found almost little or no adherence to all seven nutrition 
guidelines based on food pyramid recommendations and very low proportions of 
women reaching micronutrient recommendations from food. However, despite low 
adherence to behavioural and nutrition guidelines generally, we found some evidence 
that adherence to behaviour guidelines during pregnancy increased for all social 
groups and that these increases may be most substantial in more vulnerable social 
groups who have the lowest adherence to positive health behaviours before 
pregnancy.  
6.5.1 Comparison with other studies 
Our findings of low adherence to nutritional guidelines are comparable with levels of 
compliance in Ireland’s most recent lifestyle survey, SLÁN, where less than 1% of 
women met all food pyramid guidelines in 2006 measured using the same FFQ (110). 
Similarly, the low level of compliance to individual food group recommendations found 
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here is also largely in line with patterns observed in the female general population in 
SLÁN 2006, where 24% of women met carbohydrate recommendations, 82% met fruit 
and vegetable recommendations, 19% met dairy recommendations and 41% met 
protein recommendations (60). Where mild discrepancies exist, changes in food 
pyramid guidelines which were introduced in 2011 and used in this study may explain 
the differences. For example, a lower proportion of women in our study met 
recommendations for top shelf items (high in sugar, salt and fat) compared to female 
SLÁN participants (7.7% here compared to 15% in SLÁN ). However, serving guidelines 
for top shelf foods also changed from < three servings per day in to < one serving per 
day in 2011, thus explaining why a lower proportion are adherent in our study. 
Our findings of low levels of adherence to micronutrient recommendations 
necessary for a healthy pregnancy have been reported previously and insufficient 
vitamin D intakes during pregnancy have been widely reported in pregnant women 
(111). In a small study of pregnant women in the same hospital where our study took 
place, no women met recommended daily intakes of vitamin D based on prospective 
measurement of serum vitamin D levels during pregnancy, a finding similar to ours 
(112). In another cohort of pregnant women in Dublin, the proportion of women 
meeting micronutrient recommendations was also low during pregnancy; reassuringly 
these data were prospectively collected through three day diet diaries suggesting that 
our findings on insufficient micronutrient intakes are valid. Similarly, in a prospective 
study of White women in London where micronutrient intakes were measured 
throughout pregnancy and in the postpartum period, between 23% and 28% met 
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recommendations for folate through dietary sources, between 19% and 28% met iron 
recommendations and less than 50% met calcium recommendations (113), findings 
broadly similar to ours. 
In relation to other health behaviours of pregnancy, our findings regarding 
smoking before and during pregnancy are compatible with national estimates in the 
female general population (60) and a recent retrospective cohort where almost 20% of 
women reported smoking during pregnancy (see Chapter 5 and 7 for further details of 
this cohort study). Our estimates for alcohol consumption are somewhat lower than 
estimates from a recent prospective cohort including the hospital where our study took 
place (80%); however, women of that study were nulliparous and recruitment was 
opportunistic which could have resulted in higher estimates of drinking during 
pregnancy (82) (see Chapter 5 and 8 for further details of these studies). Alternately, 
our estimates of drinking are higher than nationally representative estimates of 20% 
alcohol use during pregnancy from the recent GUI cohort (findings from this cohort are 
described in Chapter 5 and 7). Our results for alcohol consumption in PRAMS are 
comparable to most studies in UK and Europe which have suggested estimates upward 
of 40% during pregnancy (15, 28). Thus, given the potential validity of our estimates on 
health behaviours with known harmful effects, PRAMS Ireland estimates in general 
may be valid and reliable if even the most the deleterious and socially undesirable 
health behaviours are reported accurately. Our findings for folic acid intake prior to 
and during pregnancy are also compatible with a systematic review showing 
approximately less than 50% peri-conceptual folic acid use among women, with even 
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less adherence among younger, less educated, single women or women who have not 
planned their pregnancy, a finding similar to our findings (114). In relation to 
breastfeeding, PRAMS findings are somewhat compatible with overall estimates 
(~33%) and socio-demographic differences in exclusive breastfeeding two months 
postpartum in another Irish study (115). However, our finding that breastfeeding rates 
of women who did not plan to be pregnant are comparable with those who did plan 
their pregnancy is unexpected given poor adherence to other positive health 
behaviours among these women before and during pregnancy; a potential reason for 
this might include the improvement in women’s health intentions after pregnancy 
recognition and delivery of their baby despite an original lack of pregnancy intent, thus 
explaining breastfeeding rates in the postpartum period, identical to those for the 
overall cohort and those who planned to be pregnant.  
6.5.2 Strengths and limitations 
There are a number of strengths to this study including collection of data on a wide 
variety of important health behaviours and experiences including detailed nutritional 
data around the time of pregnancy. Our study is one of the first to look at adherence to 
clinical and nutrition guidelines together in the Irish population around the time of 
pregnancy. However, our data could be influenced by recall biases which reduce 
validity and women participating in the survey were also generally more advantaged 
than the national birth profile for the same period. The nutritional data has been 
collected by asking women to recall their usual diet in 12 months preceding receipt of 
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the questionnaire. Although FFQs are a validated form of collection of nutritional data 
generally (62), they do not take account of variation in dietary patterns. In addition, 
individuals are shown to differ systematically in their reporting accuracy resulting in 
significant reporting bias (116). This is of concern since the nutritional data of our 
survey captures both pregnancy and the postpartum period during which a variety of 
dietary transitions and changes are likely to occur. Nonetheless, given the compatibility 
of our data with dietary data from the female general population in Ireland, it is 
reasonable to assume our data to be somewhat reliable for dietary patterns of women 
in the postpartum period if not in pregnancy and the relatively poor diets reported by 
women during a time in the life course of higher nutritional demand is a public health 
concern.  
6.5.3 Conclusion 
Adherence to lifestyle behaviours and nutritional guidelines as outlined in National 
Clinical Guidelines is low in the peri-conceptual period in Ireland across all social groups 
and this requires further attention in policy and practice. The comparability of 
women’s nutritional patterns in this survey with the relatively poor diets of women in 
the last national population based survey of nutrition in Ireland in 2006; a population 
whom had not recently delivered babies is of particular concern. In addition, women 
participating in the study were generally older and more advantaged than the national 
birth profile, thus, suggesting that adherence to a healthy diet and positive health 
behaviours could be worse in a more representative sample. In relation to other key 
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maternal behaviours such as smoking, folate and alcohol use, our findings could 
suggest that pregnancy is a lifestyle transition during which even the most vulnerable 
social groups whom are typically more hard to reach and less receptive to prevention 
efforts engage in positive behaviour change, although this requires further 
investigation. As we could not evaluate if diet also improved during pregnancy, further 
work is also required to examine how dietary patterns of women change before and 
during pregnancy and in the immediate postpartum period, and how improvements in 
maternal diet which last beyond pregnancy can be harnessed. However, for other 
behaviours such as folate, smoking and alcohol use, pregnancy could be a “teachable 
moment” during the life course where the naturally changing health motivations of 
women could potentially be harnessed for long term behaviour change and wider 
public health benefits beyond pregnancy.   
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Table 6.1 Adherence to health behaviours before and during pregnancy by age, education, ethnicity, BMI and pregnancy intention 
  Age Education Ethnicity BMI Pregnancy intention 
 Total 
718 (100) 
15-29 
167 (23.3) 
30-39 
510 (71.1) 
40-51 
40 (5.6) 
2
nd
  level 
126 (17.6) 
3
rd
  level 
590 (82.4) 
Irish 
571 (80.7) 
Other 
137 (19.4) 
<20 
26 (3.8) 
20-25 
464 (67.1) 
>25 
202 (29.2) 
No 
138(79.3) 
Yes 
579 (80.8) 
Before*               
 Smoking 542 (76.1) 100 (60.6) 406 (80.2) 36 (90.0) 76 (60.8) 463 (79.4) 428 (75.6) 109 (79.6) 19 (73.1) 348 (75.5) 155 (77.1) 90 (65.2) 452 (78.8) 
Alcohol 263 (66.8) 44 (63.8) 201 (66.1) 18 (85.7) 27 (58.7) 235 (67.7) 217 (64.8) 45 (78.9) 7 (77.8) 186 (67.9) 61 (61.6) 52 (67.5) 211 (66.6) 
Folate  414 (58.1) 62 (37.1) 327 (64.8) 24 (60.0) 47 (37.9) 365 (62.4) 341 (60.0) 67 (49.3) 14 (53.9) 280 (60.9) 107 (53.0) 24 (17.5) 390 (67.7) 
Adherence**  121 (26.2) 10 (8.7) 102 (32.0) 9 (32.1) 9 (9.6) 112 (30.7) 109 (30.2) 11 (11.3) 2 (10.5) 87 (30.2) 31 (21.8) 5 (6.3) 116 (30.3) 
During***              
Smoking 542 (79.1) 100 (62.1) 406 (84.1) 36 (90.0) 76 (63.2) 463 (82.8) 428 (76.7) 109 (82.6) 19 (73.1) 348 (78.6) 155 (80.7) 90 (65.7) 452 (82.5) 
Alcohol  383 (54.1) 106 (64.2) 255 (50.7) 22 (56.4) 72 (60.5) 307 (52.6) 293 (51.9) 86 (64.7) 16 (64.0) 237 (51.9) 111 (55.2) 67 (49.3) 316 (55.3) 
Folate  601 (83.9) 139 (83.3) 430 (84.7) 31 (77.5) 98 (74.8) 500 (85.2) 483 (84.7) 109 (79.6) 22 (84.6) 400 (86.2) 159 (79.1) 104(75.9) 497 (85.8) 
Adherence****   263 (39.0) 54 (34.0) 193 (40.6) 16 (41.0) 40 (35.1) 221 (39.8) 202 (37.6) 58 (45.3) 12 (48.0) 168 (38.5) 72 (37.9) 33 (24.6) 230 (42.6) 
Since birth              
Breastfeeding 209 (30.1) 35 (21.7) 161 (32.7) 12 (30.0) 25 (20.8) 183 (32.1) 147 (26.3) 61 (47.7) 8 (32.0) 148 (33.0) 46 (23.1) 41 (29.9) 168 (30.1) 
 
*Three months before pregnancy ** Adherence to all three health behaviours before pregnancy *** During three trimesters of pregnancy ****Adherence to 
three health behaviours during pregnancy  
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Table 6.2 Adherence to nutritional and physical activity guidelines around the time of pregnancy by age, education, ethnicity, BMI 
and pregnancy intention 
  Age Education Ethnicity BMI Pregnancy intention 
 Total 
718 (100) 
15-29 
167 (23.3) 
30-39 
510 (71.1) 
40-51 
40 (5.6) 
2
nd
  level 
126 (17.6) 
3
rd
  level 
590 (82.4) 
Irish 
571 (80.7) 
Other 
137 (19.4) 
<20 
26 (3.8) 
20-25 
464 (67.1) 
>25 
202 (29.2) 
No 
138(79.3) 
Yes 
579 (80.8) 
Diet*               
Carbohydrates 179 (25.5) 26 (16.3) 139 (27.8) 15 (35.0) 30 (25.2) 147 (25.5) 136 (24.2) 40 (30.8) 10 (41.7) 118 (26.1) 43 (21.6) 29 (21.6) 149 (26.3) 
Fruit & veg 567 (80.9) 119 (74.4) 419 (83.8) 28 (70.0) 83 (69.8) 479 (83.0) 438 (78.1) 120 (92.3) 21 (87.5) 361 (79.7) 162 (81.4) 102(76.1) 464 (82.0) 
Dairy 192 (27.8) 48 (30.6) 136 (27.5) 8 (20.0) 30 (25.9) 161 (28.2) 156 (28.3) 36 (27.7) 5 (21.7) 112 (25.0) 63 (32.1) 40 (30.1) 152 (27.2) 
Protein 224 (32.0) 43 (26.9) 168 (33.6) 12 (30.0) 30 (25.2) 192 (33.3) 187 (33.3) 33 (25.4) 5 (20.8) 153 (33.8) 55 (27.6) 41 (30.6) 183 (32.3) 
Fats and oils  168 (24.0) 42 (26.3) 119 (23.8) 7 (17.5) 25 (21.0) 142 (24.6) 125 (22.3) 38 (29.2) 6 (25.0) 108 (23.8) 47 (23.6) 23 (17.2) 145 (25.6) 
Top shelf  54 (7.7) 18 (11.3) 33 (6.6) 3 (7.5) 8 (6.7) 46 (7.8) 42 (7.5) 11 (8.5) 1 (4.2) 33 (7.3) 15 (7.5) 9 (6.7) 45 (8.0) 
Total** 1 (0.1)   0 1 (0.2) 0 0 1 (0.2) 1 (0.2) 0 0 0 1 (0.5) 0 1 (0.2) 
Folate 183 (26.1) 40 (25.0) 135 (27.0) 8 (20.0) 31 (26.1) 151 (26.2) 131 (23.4) 51 (39.2) 8 (33.3) 120 (26.5) 48 (24.1) 35 (26.1) 147 (26.0) 
Vitamin D 6 (0.9) 2 (1.3) 4 (0.8) 0 (0) 1 (0.8) 4 (0.7) 2 (0.4) 3 (2.3) 0 5 (1.1) 0 1 (0.8) 4 (0.7) 
Iron 252 (36.0) 54 (33.8) 186 (37.2) 12 (30.0) 45 (37.8) 204 (35.4) 184 (32.8) 66 (50.8) 11 (45.8) 169 (37.3) 64 (32.2) 44 (32.8) 207 (36.6) 
Calcium 123 (17.6) 31 (19.4) 86 (17.2) 6 (15.0) 25 (21.0) 96 (16.6) 79 (14.1) 42 (32.3) 3 (12.5) 83 (18.3) 33 (16.6) 26 (19.4) 96 (17.0) 
Exercise***  88 (12.3) 22 (13.2) 61 (12.0) 4 (10.0) 14 (11.3) 74 (12.6) 73 (12.8) 14 (10.4) 3 (11.5) 68 (14.7) 13 (6.4) 13 (9.5) 75 (13.0) 
 
*Carbohydrate consumption of six or more servings per day, fruit and vegetable consumption of five or more servings per day, dairy consumption of two 
portions per day, protein consumption of three portions per day, fats and oils consumption of two portions per day and less than one serving per day of top 
shelf items (foods high in sugar, salt and fat) ** Adherence to all seven food group guidelines *** Physical activity guidelines of moderate intensity exercise five 
or more days per week 
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 Abstract 7.1
Background 
 
Research and guidelines on alcohol use in pregnancy have focused on setting a safe 
alcohol consumption threshold. The impact of different patterns, quantity and timing 
of alcohol use is not well understood. 
 
Methods 
 
Using regression models the association between light (up to 30 g per week in line with 
NICE guidelines), moderate (40-70g per week) and heavy (>80g per week) alcohol 
consumption throughout pregnancy, in early pregnancy followed by later reduction or 
cessation and in late pregnancy only was examined in relation to gestational age and 
birth weight in 10,559 mothers from the Growing up in Ireland cohort. Socio-
demographic and obstetric risk factors were included in the models. 
 
Main results 
We did not find an adverse association between drinking lightly throughout pregnancy, 
birth weight, 99 grams (g) (95% CI 45, 153) and gestational age, 2.9 days (d) (95% CI 
1.5, 4.3) or drinking lightly in late pregnancy, birth weight and gestational age, 62g 
(95% CI 9, 115), 1.3d (95% CI 0.1, 2.5). We found evidence of lower mean birth weight 
and gestational ages among moderate drinkers -70g (95% CI -262, 122), -1.4d (95% CI -
4.8, 2.0) and heavy drinkers throughout pregnancy -48g (95% CI -350, 255), -10.3d 
(95% CI -20.7, 0.1) for birth weight and gestational age respectively, though results 
were not statistically significant. Women who began drinking at a heavy level or 
increased their drinking to a heavy level in late pregnancy appeared to experience 
lower mean gestational age -7.1d (95% CI -22.2, 8.0) but higher mean birth weight 
157g (95% CI -61, 374).  
Conclusions 
 
The quantity and timing of alcohol exposure may play a role in determining foetal 
alcohol effects though our results should be interpreted with caution due to the 
potential effect of selection and reporting bias. The role of timing and quantity may 
also potentially differ for outcomes with different causal pathways particularly in late 
pregnancy. Further research examining pattern and timing of exposure in prospective 
studies is required. Based on the precautionary principle, women should continue to 
abstain from alcohol during pregnancy. 
 
Keywords: alcohol, preterm, birth weight, gestational age 
140 
 
 Introduction 7.2
Research and clinical care guidelines around gestational alcohol consumption have 
focused on setting a safe alcohol consumption threshold for pregnancy below which 
harm to the foetus does not occur (19). However, consensus on safe alcohol 
consumption recommendations for pregnant women has not been reached as the 
effects of gestational alcohol consumption are particularly difficult to measure and 
quantify reliably (117). Canada (91), the United States (92), Ireland (17) and New 
Zealand (90) advise complete abstinence from alcohol during pregnancy whereas the 
NICE (16) and Royal College of Obstetricians and Gynaecologists (RCOG) (118) in the UK 
suggest that one to two units (32g of alcohol) not more than once or twice per week is 
safe (16). 
Studies have estimated that 44% of women consume alcohol in the three 
months before pregnancy in the United States (25) with higher prevalence generally in 
Western Europe where recent studies have estimated that almost 70% and 90% of 
women are consuming alcohol before pregnancy in the UK and Ireland respectively (85, 
98, 119). During pregnancy itself, it is estimated that at least 37% and up to 81% of 
foetuses continue to be exposed to alcohol during pregnancy in some European 
countries and Australia through maternal alcohol consumption (15, 28, 29, 79, 82, 99). 
However, although previous studies have examined alcohol prevalence by trimester or 
the effects of continued drinking in pregnancy compared to abstinence, the impact of 
different timings and patterns of exposure from trimester to trimester on gestational 
age and birth weight remains unclear. Whitehead and Lipscomb examined patterns of 
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alcohol use during pregnancy and SGA and found only heavy drinking in late pregnancy 
was significantly associated with SGA birth while light drinking in late pregnancy was 
associated with a lower risk of SGA, albeit not statistically significant (25). However, an 
important limitation of this study was lack of information on drinking in other 
trimesters of pregnancy which could have resulted in inaccurate conclusions about the 
perceived importance of late pregnancy drinking. Alternately, a recent British cohort 
found that the first trimester was the most sensitive period for birth weight effects 
with no strong evidence of gestational age effects in later pregnancy (98). A major 
limitation of this cohort was examination of each trimester separately without 
reference to consumption in other trimesters which could confound the association. In 
another recent large multi-centre study, there was no association between occasional, 
low, moderate or heavy consumption in early pregnancy and birth outcomes but 
information on drinking in later pregnancy was not available (82).  
Using data from the GUI cohort (52), Ireland’s first nationally representative 
longitudinal study of infancy and childhood, this analysis examines the association 
between different patterns and quantities of alcohol consumption over three 
trimesters of pregnancy and its effect on gestational age and birth weight. We use 
drinking behaviour reported in each trimester separately to develop a composite 
variable revealing drinking patterns from trimester to trimester which may yield 
important information about the effect of pattern and timing of alcohol use on birth 
outcomes. 
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 Methods 7.3
7.3.1 Study population and data source 
The National Longitudinal Study of Children is the first longitudinal study to focus on 
the developmental trajectories of children in Ireland (52). Primary caregivers 
(n=19,141) were sampled from a total of 41,000 primary care givers registered on the 
state Child Benefit Register between September 2008 to April 2009 using a simple 
systematic selection procedure pre-stratifying by parental marital status, country of 
residence, nationality and number of children to obtain a sample nationally 
representative of all children aged six to nine months living in Ireland.  The average 
constant sampling fraction was approximately two primary caregivers with slight 
variation in some strata (52). The state Child Benefit Register is a register of all parents 
or guardians on the island of Ireland receiving child benefit on behalf of their infant. A 
validation exercise was completed to compare the Child Benefit Register and Vital Birth 
Statistics for three quarters in 2004 and 2005. The exercise indicated that the figures 
from vital statistics were highly consistent with those from the Child Benefit Register 
over the period showing the Child Benefit Register to be representative of Irish births 
(52). Of the 19,141 primary care givers sampled, 11,134 primary care-givers 
participated representing a response rate of 58% (52). This represented almost a 
quarter of all births in Ireland over that period (52). Data were weighted using Census 
2006 and Child Benefit Register figures to represent the characteristics of 73,662 
children registered on the Child Benefit Register as being born in the calendar year 
143 
 
2008 (52). The main study questionnaire was administered to all study participants by 
trained study personnel in the home of the caregivers through a face to face interview 
six to nine months after birth (52). Questions covered in the main study questionnaire 
included parenting, child functioning and relationships, baby’s development, habits 
and physical development, parent’s health and family context (54). A second 
questionnaire covering more sensitive items such as smoking, alcohol consumption and 
drug use in pregnancy, past relationships and mental health was also administered to 
all participants (54). Non-biological mothers (n=seven) and male primary caregivers 
(n=38) who participated in the study were excluded from the present analysis. 
Biological mothers who did not complete the sensitive questionnaire were also 
excluded from the present study (n=136). Figure 7.1 shows the sampling frame and 
population. 
7.3.2 Exposure classification 
Women were asked about alcohol consumption in each trimester of pregnancy 
separately. Women who reported alcohol use during pregnancy were asked how much 
on average they drank per week (pints of beer or cider, glasses of wine, measures of 
spirits or alcopops (54)) in each trimester. Drinks reported in each trimester were 
converted to standard drink equivalents in accordance with Irish Standard Drinks 
Guidelines (one standard drink is equivalent to ten grams of absolute alcohol) (120). 
Pre-pregnancy drinkers were defined as women who reported usual alcohol 
consumption (less than once per month up to five to six times per month) but did not 
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drink in any trimester of pregnancy. Non-drinkers were defined as women who 
reported never drinking alcohol usually or during pregnancy. We treated non-drinkers 
and pre-pregnancy drinkers separately due to their potentially different socio-
demographic and health characteristics. Women who reported drinking in pregnancy 
but did not report the quantity for each trimester were excluded from the analysis 
(Figure 7.2) (n=284). 
For each trimester women who reported consuming three standard drinks or 
less per week (30g) were defined as “light” drinkers (approximately equivalent to the 
UK NICE guidelines of 32g of alcohol per week), women who reported consuming 40-
70g of alcohol per week were classified as “moderate” drinkers and women who 
consumed 80g and above were classified as “heavy” drinkers. Women were then 
separated into  
a) Drinkers throughout pregnancy  
b) Drinkers in early pregnancy that reduced consumption by at least one level in at 
least one trimester after the first trimester  
c) Drinkers in early pregnancy who reduced or ceased alcohol consumption after the 
first trimester  
e) Women who began drinking in late pregnancy i.e. after the first trimester 
f) Women who increased their alcohol consumption after the first trimester.  
Details of these categories and their classification are included in Figure 7.2. 
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7.3.3 Covariates 
We assessed the effect of a range of potential confounders through a backward 
stepwise regression approach examining in turn the removal of each covariate from 
the model and examining its associated effect on the regression co-efficient. Where 
the removal of any covariate exerted a greater than 10% change on any single 
exposure-outcome coefficient, the covariate in question was retained. Potential 
confounders examined included age, ethnicity, marital status, parity, education, BMI, 
delivery mode, smoking, lifetime diagnosis of depression or anxiety, pre-eclampsia, 
hyperemesis, bleeding during the second half of pregnancy, kidney or urinary infection, 
placenta praevia, recreational drug use during pregnancy, pregnancy intention, partner 
BMI and partner age.  
Mother’s age based on maternal report was categorised into five categories of 
<20, 20-24, 25-29, 30-39 and >40. Women were asked their highest level of education 
to date which was included as a three category variable of lower secondary, higher 
secondary or third level. Women were asked their current marital status and this was 
collapsed into a binary variable to include married, separated, divorced, widowed or 
never married. Mode of delivery of the study child which included normal delivery, 
suction assisted birth, forceps assisted birth, planned/elective caesarean, vaginal 
breech delivery or other was dichotomised and included in our model as a binary 
variable with categories of vaginal or caesarean delivery. Maternal and partner weight 
was measured by the interviewer at the time of the interview using medically approved 
weighing scales. Maternal and partner height was recorded using a standard measuring 
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stick. Measures of height were standardised by converting to inches and dividing by 
2.54. All weights were converted to kilograms. BMI was calculated by dividing weight in 
kilograms by height in meters. Women with at least one previous live born pregnancy 
were categorised as multiparous. Smoking during pregnancy was included as a binary 
variable of smoked or did not smoke during pregnancy. Women were also asked if they 
were ever treated by a medical professional for clinical depression, anxiety or nerves 
which was included as a binary variable yes or no. Women reported the frequency of 
consumption of tranquillisers, cannabis, amphetamines or other stimulants, heroin or 
methadone and crack or cocaine during pregnancy which was combined into a binary 
variable of yes or no to use of recreational drugs during pregnancy. Women were 
asked if there were any complications during pregnancy to which they could answer 
yes to all that applied including urinary or kidney infection, persistent vomiting or 
nausea, bleeding during the second half of pregnancy, preeclampsia and placenta 
praevia, all of which were assessed as separate confounders in our initial models. 
Pregnancy intention was included as a binary variable to include women who wanted 
to be pregnant at that time or earlier (pregnancy intended) or (pregnancy not 
intended) which included wanted to be pregnant later, somewhat later, unsure/didn’t 
mind, other or no intention of ever becoming pregnant. 
7.3.4 Outcome definition and classification 
All outcomes were based on maternal self-report. Birth weight in grams and 
gestational age in days were examined as continuous outcomes.  
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7.3.5 Statistical analyses 
Statistical analyses were conducted in Stata V12. The SVY command was used 
throughout to produce an analysis weighted to represent the characteristics of all 
children born in Ireland in 2008. Linear regression was used to examine differences in 
mean birth weight between all categories of drinkers and non-drinkers compared to 
pre-pregnancy drinkers. Our final model for birth weight included education, maternal 
smoking, kidney infection during pregnancy, mode of delivery, lifetime treatment for 
depression or anxiety, recreational drug use, partner BMI, and partner age. Our final 
model for gestational age in days included maternal smoking, maternal BMI, bleeding 
during the second half of pregnancy, mode of delivery and recreational drug use. We 
also performed additional sensitivity analysis restricting our analysis to women of 
white ethnicity. 
 Results 7.4
In total 19,141 primary caregivers were sampled from the Child Benefit Register of 
which 11, 134 responded, representing a final valid response rate of 58.2% (Figure 7.1). 
Having excluded women with missing drinking data (Figure 7.2), the final weighted 
population for analysis was 10,559 of which 6,891 (72.4%) were pre-pregnancy 
drinkers, 1,699 (17.6%) were women who reported usually not drinking and not 
drinking in pregnancy (non-drinkers), 544 (5.2%) drank throughout pregnancy, 414 
(3.9%) drank in early pregnancy with reduction or cessation in one other trimester and 
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922 (8.7%) began drinking or increased their drinking after the first trimester. Figure 
7.2 shows the light, moderate and heavy drinkers among these groups. 
Table 7.1 shows the distribution of demographic, social and health 
characteristics by alcohol consumption during pregnancy. Overall, non-drinkers were 
younger, less well educated, of non-Irish ethnicity, with a higher prevalence of 
overweight and obesity and most pregnancy related complications than drinkers or 
pre-pregnancy drinkers. Women who reduced or stopped drinking in pregnancy were 
younger, less well educated, primiparous and single compared to women who drank 
throughout pregnancy. Overall, drinkers appeared to have lower rates of kidney 
infection, raised blood pressure and nausea than pre-pregnancy drinkers or non-
drinkers. Drinkers throughout pregnancy, non-drinkers, and pre-pregnancy drinkers 
had higher levels of pre-eclampsia. Women who drank in early pregnancy and 
throughout pregnancy had higher levels of bleeding during pregnancy. Drinkers also 
had a higher prevalence of depression or anxiety and smoking than non-drinkers.  
Table 7.2 displays the relationship between timing and pattern of alcohol 
consumption and birth outcomes. Women who never drank both prior to or during 
pregnancy (non-drinkers) delivered babies that were born on average one day earlier -
1.0 (95% CI -1.9, -0.1) and 50g smaller -50 (95% CI -89, -11) than infants of pre-
pregnancy drinkers. These results were not attenuated by adjustment for confounders 
but did reduce in magnitude and attenuate when analysis were restricted to white 
ethnicity in sensitivity analysis. 
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Of women drinking throughout pregnancy, light drinkers throughout pregnancy 
had infants that were born on average 3.1 days later, 3.1 (95% CI 1.7, 4.4) and weighed 
75g more at birth, 75 (95% CI 17, 132). Women who consumed alcohol lightly in early 
pregnancy and reduced their consumption had infants that were born on average one 
day earlier -1 (95% CI -3.5, 1.1) and 41g smaller -41 (95% CI -131, 49) than pre-
pregnancy drinkers. These results were not altered by adjustment for confounders or 
in sensitivity analysis restricting to white ethnicity. Women who began consuming 
alcohol lightly after the first trimester had infants that were born on average 1.3 days 
later, 1.3 (95% CI 0.1, 2.5) and 62g heavier, 62 95% CI 9, 115) than pre-pregnancy 
drinkers. These results were not attenuated by adjustment for confounders but results 
for gestation attenuated slightly when restricted to white ethnicity. 
Women who consumed alcohol moderately throughout pregnancy had infants 
that were on average born 0.5 days earlier -0.5 (95% CI -5.1, 2.1) and 119g lighter, -119 
(95% CI -296, 57) than infants of pre-pregnancy drinkers. These results were not 
altered by adjustment for confounders or in sensitivity analysis restricting to white 
ethnicity. Women who consumed alcohol moderately during the first trimester but 
reduced or stopped drinking experienced a 3.2 day, 3.2 (95% CI 0.4, 5.9) increase in 
gestation compared to pre-pregnancy drinkers which attenuated with adjustment for 
confounders to 2.2 days, 2.2 (95% CI -0.6, 5.0). These women also experienced an 82g 
increase in birth weight 82 (95% CI -66, 230) in our crude model though results were 
not statistically significant and not altered by adjustment for confounders or restriction 
to white ethnicity. Women who began drinking moderately or increased their alcohol 
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consumption to a moderate level after the first trimester had infants born on average 
three days earlier than pre-pregnancy drinkers -3.0 (95% CI -7.9, 2.0) which reduced in 
magnitude to 1.7 days after adjustment for confounders and reversed to a gain of 
almost one day when restricted to white ethnicity. Women who began or increased to 
moderate consumption had infants who weighed 199g less, -199 (95% CI -390, -9) in 
our crude model which attenuated after adjustment for confounders and decreased 
substantially in magnitude after restriction to white ethnicity. 
Infants of heavy drinkers throughout pregnancy were born on average 10 days 
earlier, -10 (95% CI -21, 1.0) and 370g lighter, -370 (95% CI -653, -87) than infants of 
pre-pregnancy drinkers though results for birth weight attenuated upon adjustment for 
confounders to a difference of 48g which was not statistically significant -48 (95% CI -
350, 255). Results for heavy drinking throughout pregnancy were not altered in 
sensitivity analysis restricting to white ethnicity. Women who consumed alcohol 
heavily in early pregnancy and reduced their consumption had infants born almost two 
days earlier, -1.7 (95% CI -9.6, 6.2) and 12g heavier, 12 (95% CI -227, 250) than infants 
of pre-pregnancy drinkers. However the association with birth weight reversed in 
direction to result in birth weights 202g lighter, -202 (95% CI -567, 161) in confounder 
adjusted analysis. Alternately, infants of women who drank heavily and stopped 
drinking had infants that were born 2.1 days later, 2.1 (95% CI 2.0, 6.3) and 199 g 
lighter -199 (95% CI -450, 52) than infants of pre-pregnancy drinkers in crude analysis. 
Results for gestation did attenuate after adjustment for confounders 2.3 (-2.2, 6.9) and 
results for birth weight changed in direction to a 172g gain in weight 172, (95% CI -172, 
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516). Restriction to white ethnicity did alter results for heavy drinking to cessation but 
only in crude analysis. Finally, infants of women who began heavy drinking or increased 
heavy drinking in late pregnancy had infants born seven days earlier and 196g lighter. 
However, results for birth weight changed in direction to a 157g gain after adjustment 
for confounders though results were not statistically significant. These results were not 
altered by restriction to white ethnicity.   
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 Discussion 7.5
In this large population based retrospective analysis, we found evidence to support the 
importance of overall quantity of exposure in determining the birth weight and 
gestational age effects of alcohol use during pregnancy with evidence of a protective 
effect of drinking lightly throughout pregnancy and evidence of harm for moderate and 
heavy drinking. We also found that non-drinkers had lower birth weight and shorter 
gestations than pre-pregnancy drinkers though this effect attenuated after restriction 
to white ethnicity suggesting confounding by cultural or social factors associated with 
ethnicity. We found evidence of a differential effect of timing of exposure at different 
levels of alcohol between early and late pregnancy with evidence of lower birth 
weights and shorter gestations for moderate drinkers in late pregnancy but higher 
birth weights and longer gestations for moderate drinkers in early pregnancy. This 
differential effect of timing of alcohol exposure was also evident for heavy drinking in 
early and late pregnancy with late pregnancy proving more detrimental. However, late 
pregnancy drinking had opposite effects on birth weight and gestation such that heavy 
drinking in late pregnancy resulted in shorter gestations but higher birth weights. 
7.5.1 Comparison with other studies 
Our results for women who never drink alcohol are compatible with data showing that 
non-drinkers have a higher risk of adverse birth outcomes (25, 121). These results 
attenuated after restriction to white ethnicity suggesting confounding by other social 
and cultural factors related to ethnicity rather than non-drinking itself. Our findings of 
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a protective association between light drinking and birth weight and gestation have 
been previously illustrated in a number of cohorts (122) and are supported by evidence 
on the tocolytic effect of alcohol in inhibiting labour through release of endogenous 
oxytocin and relaxation of the myometrium (40). In relation to birth weight, the 
protective effect of low levels of alcohol use on cardiovascular disease and suggested 
vascular etiology of SGA may imply a shared pathway that supports our findings of a 
protective effect on birth weight through alcohols role in stimulating vascular 
endothelial growth factors which could result in improved placental development and 
higher birth weight (45). In addition, the decreased gestational age among heavy 
drinkers is supported by data from previous observational cohorts (19) and data which 
suggests that alcohol may induce preterm delivery by increasing the production of 
prostaglandins (44). Increased productions of prostaglandins are often found in 
alcoholic mothers and their offspring (44). Our results showing, at least, no evidence of 
harm for light and moderate drinking during pregnancy (up to seven drinks per week) 
are also reasonably consistent with recent findings from a systematic review and meta-
analysis showing no effect on SGA of up to ten g per day (one drink per day) and no 
effect on preterm birth of up to 18g per day (two drinks per day) (19). However, the 
threshold at which harm began to occur in our study was just above 80g or about eight 
drinks per week or approximately one drink per day, thus suggesting that, in this 
cohort at least, evidence of harm occurs at a far lower threshold than previously 
suggested. 
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The opposing effects of heavy drinking in early pregnancy and heavy drinking in 
later pregnancy on gestational age are compatible with evidence suggesting a critical 
period of exposure in late pregnancy for outcomes such as SGA and thus, the 
importance of timing of exposure (24, 123). Similarly, the protective effect of light 
drinking in late pregnancy is compatible with results showing a protective effect of light 
drinking on SGA in a large US study (25). However, it contrasts with another recent 
British cohort showing no evidence of SGA effects in late pregnancy (98). Our finding 
that light drinkers in early pregnancy did not experience any benefit was also shown in 
a retrospective Australian cohort, the only cohort to our knowledge with examination 
of patterns most similar to ours (124). However, in contrast to our findings, a mildly 
protective association between moderate drinking in late pregnancy and SGA, and 
increased risk of SGA from moderate drinking in early pregnancy was reported. Small 
numbers were a considerable issue in this study, and in particular the use of 
dichotomous outcomes with small sample sizes may have resulted in unstable logistic 
regression models, thus, producing results not consistent with our examination of 
gestational age as a continuous measure, which had greater statistical power (124). 
Another strong potential reason for contradictory findings with previous cohorts 
examining the effect of alcohol patterns might relate to examining exposure by 
trimester without reference to drinking status in other trimesters which masks the 
association between late pregnancy drinking, such that late pregnancy drinkers in 
some cohorts were actually drinking in early pregnancy.  
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Our data reveals important information about the complex relationship 
between timing and quantity of exposure and its subsequent impact on birth 
outcomes. From a quantity perspective, it is possible that light drinkers who stop 
drinking do not reach the overall total quantity or threshold consumed by light drinkers 
throughout pregnancy to result in the postulated tocolytic or hormone effects that 
confer protection. Alternately, our findings might relate more strongly to the fact that 
the protective association between light alcohol use and birth outcomes is specific to 
late pregnancy exposure, hence explaining why it is only observed in drinkers of late 
pregnancy or throughout pregnancy. This would also be consistent with evidence on 
the tocolytic effect of alcohol in relaxing the myometrium, since, for such a tocolytic 
effect to take place we would expect alcohol to be consumed in late gestation. 
Similarly, moderate drinkers who reduce or stop drinking moderately after early 
pregnancy have potentially consumed a total quantity of alcohol similar to light 
drinkers throughout who experience protective effects suggesting quantity to be an 
important determinant, thus explaining why moderate drinkers who stop drinking 
experience on average longer gestations and higher birth weights than moderate 
drinkers throughout. However, it may also suggest that once one has exceeded the 
threshold at which protective effects become harmful (in this cohort not more than 
30g per week), timing of exposure becomes critical. This is also supported by the 
evidence among heavy drinkers who stop consuming alcohol given that there is less 
evidence of harm compared to women who only reduce their heavy consumption in 
late pregnancy but continue to drink. In this instance, women who stop drinking 
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heavily have reduced their overall consumption but also are not exposed in the last 
trimester, the potentially critical period of exposure. In contrast, heavy drinkers who 
only reduce their consumption in late pregnancy may be exceeding an overall 
threshold but more critically, continue to be exposed in the last trimester. A potential 
reason why we do not observe associations of the same direction for heavy drinking in 
late pregnancy and birth weight and gestation might include the separate causal 
pathways of gestational age and birth weight (125) such that the role of late pregnancy 
alcohol exposure in their aetiology might differ. 
7.5.2 Strengths and limitations  
Although our results are supported by previous observational cohorts and some 
biological evidence, our findings could still be the result of residual confounding by 
other health conditions associated with drinking such that for example, women who 
begin drinking in late pregnancy or continue do so, do so for other reasons that we 
have not been able to fully adjust for such as psychological factors. In addition, in 
relation to associations of light drinking and protective effects, results could also be the 
consequence of residual confounding such that women who consume alcohol lightly 
are already healthier and more likely to have positive birth outcomes than those who 
do not. In addition, binge drinking data was not collected and intensity of drinking per 
drinking occasion which may be important determinant of risk to the fetus could not be 
addressed (59). Specifically, it is difficult to determine among the heavy drinkers those 
women who engaged in binge drinking, compared to those who were chronic heavy 
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alcohol users or engaged in both. Therefore, it is difficult to determine the exact 
mechanisms driving the associations between heavy exposure and adverse outcomes.  
Although, the compatibility of our findings with some prospectively recruited 
cohorts may provide validity to our data, the estimated prevalence of alcohol use 
during pregnancy in this study is significantly lower than reported alcohol consumption 
in both another Irish retrospective cohort (81% prevalence) (29), the Millennium 
Cohort Study in the United Kingdom (35% prevalence) (15) and the Danish National 
Birth Cohort Study (45% prevalence) (27) and thus, selection to the cohort based on 
exposure is a possibility. For example, if we selected less drinkers than are actually 
present in the population, then our results may not be representative of actual 
drinking patterns in Ireland and have reduced external validity. In addition, differential 
recall bias might threaten the internal validity of our findings such that if women who 
had a preterm delivery over-estimated their drinking, our observations of smaller birth 
size and shorter gestations among heavy drinkers would be inflated. Alternately and 
more crucially, from a public health perspective, if women with poorer birth outcomes 
under-estimated their drinking, our results might under-estimate the true association 
and conceal alcohol related harm.  
Our study does however, have a number of strengths including its large 
population based design which was weighted to represent over 75,000 Irish live births 
between 2008 and 2009. The study also controlled for many demographic and clinical 
confounders that previous cohort studies had not measured (19). Our study extends 
beyond using average weekly alcohol consumption or examining single trimester use in 
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isolation with reference to other trimesters in order to categorise women’s drinking 
based on actual reported drinking and cessation patterns for all trimesters  
7.5.3 Conclusions and implications 
 Although our results should be interpreted with caution due to selection and 
recall biases, our findings do not indicate any evidence of harm up to 30g of 
alcohol or approximately three standard drinks per week during pregnancy. 
Above this threshold we find evidence of lower mean birth weights and shorter 
gestations.  
 Our data suggest both quantity and timing of exposure are critical determinants 
of foetal risk and that associations with birth outcomes might vary depending 
on the nature of the outcome under study. Thus, given the variable and 
relatively unpredictable effects of gestational alcohol use on birth outcomes 
which could be time, threshold and quantity sensitive, abstinence from alcohol 
during pregnancy remains the most prudent choice.  
 Efforts to counsel women to reduce their alcohol intake should continue even 
in late pregnancy and among all drinkers to reduce the risk of adverse 
outcomes. Further research is required to investigate alcohol consumption 
patterns and birth outcomes in large prospective cohorts. 
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Figure 7.1 Flow diagram for GUI study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sampling frame 
Child Benefit Register of 41, 185 infants (September 2008-April 2009) 
11, 134 primary caregiver’s respondents (58.2% response rate) 
 
Excluded from this study 
1. Infants with non-biological mothers (n=7) and male 
primary caregivers as respondents (n=38) 
2. Sensitive questionnaire not completed (n=136) 
Final study population  
n=10, 953 infant mother pairs for analysis (un-weighted)  
n=10,945 (weighted population) 
19,141 infants and primary caregivers sampled  
 160 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2 Alcohol consumption patterns in GUI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Early pregnancy drinker but reduced or 
ceased consumption 414 (3.9%) 
 
Total alcohol consumption for analysis 
1,880 (77.0%) 
Light 
drinking in 
each 
trimester 
442 
(4.2%)  
Consumed alcohol throughout pregnancy 
 544 (5.2 %) 
EXCLUDED: Quantity of alcohol 
use not reported 
284 (13.1%) 
 
 
Moderate 
drinking in 
each 
trimester 
71 (0.7%) 
Heavy 
drinking in 
each 
trimester 
32 (0.3%) 
Light to 
none in 
2nd &/or 
3rd 
trimester 
154 
(1.5%)  
Moderate 
to light in 
2nd &/or 
3rd 
trimester 
56 (0.5%)
  
Heavy to 
mod/ light 
in 2nd 
&/or 3rd 
trimester 
34 (0.3%) 
 Total reported alcohol consumption in GUI cohort 
2,164 (20%)  
 
 
Began drinking in late pregnancy or 
increased drinking in late pregnancy 922 
(8.7%) 
Light to 
total 
cessation 
in 2nd & 
3rd 
trimester 
101 
(1.0%) 
Moderate 
to total 
cessation 
in 2nd & 
3rd 
trimester 
43 (0.4%) 
Heavy to 
total 
cessation 
in 2nd & 
3rd 
trimester 
26 (0.2%) 
Began 
drinking 
lightly in 
2nd or 3rd 
trimester 
775 
(7.3%) 
Began 
drinking 
lightly in 
2nd or 3rd 
trimester 
116 
(1.1%) 
 
Began 
drinking 
lightly in 
2nd or 3rd 
trimester 
31 (2.9%) 
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Table 7.1  Characteristics of participants by alcohol consumption in pregnancy 
 
 
Total before weighting =10,554 
Weighted Total = 10,559 
Abstinent during pregnancy Consumed alcohol during pregnancy 
Pre-pregnancy 
drinker 
n=6,981 
n (%) 
Non drinker 
n=1,699 
 
n (%) 
Early pregnancy 
n=414 
 
n (%) 
Throughout pregnancy 
n=544 
 
n (%) 
Increased/began intake 
in late pregnancy 
n=922 
n (%) 
Maternal age (Standard error (SE)) 31 (0.08) 31 (0.17) 32 (0.32) 34 (3.24) 33 (0.19) 
Partner age (SE) 35 (0.08) 35 (0.19) 35 (0.34) 36 (0.26) 36 (0.19) 
Education      
Lower secondary 190 (2.7) 124 (7.3) 4 (0.1) 15 (2.7) 22 (2.4) 
Upper secondary 3440 (4.9) 891 (52.5) 186 (44.9) 180 (33.1) 313 (33.9) 
Higher education 3348 (48) 682 (40.2) 222 (53.6) 350 (64.3) 587 (63.7) 
Married 5009 (71.8) 1241 (73.1) 265 (64.1) 417 (76.6) 735 (79.8) 
Ethnicity      
White Irish/Other white 6812 (97.6) 1315 (77.4) 402 (97.1) 542 (99.5) 903 (98.0) 
African/Black  70 (1) 185 (10.9) 3 (0.8) 1 (0.1) 23 (1.3) 
Asian 21 (0.3) 20 (1.2) 4 (1.1) 0 3 (0.3) 
Other 61 (0.9) 171 (10.1) 1 (0.3) 2 (0.4) 3 (0.4) 
Delivery mode      
Vaginal 5085 (72.8) 1245 (73.3) 295 (71.2) 412 (75.8) 684 (74.3) 
Caesarean 1896 (27.2) 453 (26.7) 119 (28.8) 132 (24.3) 237 (25.8) 
Maternal BMI      
Underweight (<18.5) 180 (2.6) 46 (2.7) 11 (2.7) 14 (2.5) 19 (2.1) 
Normal weight (18.5-24) 3429 (49.1) 683 (40.2) 207 (50) 319 (58.6) 462 (52.5) 
Overweight (25-30) 1966 (25.2) 497 (29.3) 113 (27.3) 145 (26.6) 257 (29.2) 
Obese (>29) 1080 (15.5) 376 (22.1) 51 (12.4) 52 (9.5) 143 (16.2) 
Paternal BMI      
Underweight (<18.5) 9 (0.2) 13 (1.1) 0 2 (0.5) 0 
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Normal Weight (18.5-24) 1445 (28.4) 351 (30.8) 75 (26.2) 130 (31.8) 213 (29.4) 
Overweight (25-30) 2567 (50.4) 533 (46.8) 157 (55.0) 220 (54.1) 377 (52.1) 
Obese (>29) 1068 (21.0) 241 (21.2) 54 (18.8) 55 (13.5) 134 (18.5) 
Parity      
Primiparous 2877 (41.2) 622 (36.6) 194 (46.9) 180 (33.0) 284 (30.8) 
Multiparous 4104 (58.8) 1077 (63.4) 220 (53.1) 365 (70.0) 6403 (60.6) 
Smoked during pregnancy 1231 (17.6) 297 (17.5) 118 (28.4) 157 (28.9) 132 (1.3) 
Pregnancy intended 4556 (65.3) 1070 (63.1) 204 (49.2) 361 (66.3) 643 (69.9) 
Depression/anxiety(Lifetime treatment) 874 (12.5) 199 (11.7) 74 (17.9) 89 (16.2) 149 (16.1) 
Recreational drug use 65 (0.9) 25 (1.5) 12 (2.8) 21 (3.8) 17 (1.8) 
Kidney infection 1048 (15) 258 (15.2) 62 (15) 56 (10.3) 118 (12.8) 
Raised blood pressure 805 (11.5) 206 (12.1) 30 (7.3) 35 (6.4) 74 (8.0) 
Persistent vomiting or nausea 1273 (18.2) 311 (18.3) 50 (12.1) 72 (13.3) 146 (15.8) 
Placenta praevia 214 (3.1) 24 (1.4) 17 (4.1) 13 (2.3) 22 (2.4) 
Bleeding 427 (6.1) 108 (6.3) 15 (3.6) 18 (3.3) 62 (6.7) 
Preeclampsia 516 (7.4) 33 (8.1) 19 (3.5) 155 (9.1) 37 (4.0) 
Gestation in days 276 275 276 278 277 
Birth weight (mean) 3472  3422 3450 3495 3515 
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Table 7.2 Association between pattern and timing of alcohol consumption and birth outcomes 
Total cohort, n=10,559 
  
n 
Gestation 
Unadjusted 
Gestation 
Adjusted 
  
n 
Birth weight 
Unadjusted 
Birth weight 
Adjusted 
Pre-pregnancy drinkers  6,981 Reference Reference  6981 Reference Reference 
Non drinkers  1,699 -1 (-1.8, -0.1) -1.0 (-1.9, -0.1)  1699 -50 (-89, -11) -57 (-103, -12) 
Light drinking         
<30g per week  442 3.1 (1.7, 4.4) 2.9 (1.5, 4.3)  442 75 (17, 132) 99 (45, 153) 
<30g per week to reduction  101 -1.0 (-4.6, 2.6) -0.8 (-4.5, 2.8)  101 24 (-113, 162) -15 (-157, 127) 
<30g per week to cessation  154 -1.4 (-4.3, 1.6) -1.1 (-4.0, 1.7)  154 -84 (-200, 35) -93 (-235, 50) 
Began light consumption in late pregnancy  775 1.3 (0.2, 2.5) 1.3 (0.1, 2.5)  775 88 (42, 134) 62 (9,115) 
Moderate drinking         
40-70 g per week  71 -.5 (-5.1, 2.1) -1.4 (-4.8, 2.0)  71 -119 (-296, 57) -70 (-262, 122) 
40-70 g per week to reduction  56 4.1 (0.6, 7.6) 3.3 (-0.4, 7.1)  56 211 (-14, 436) 165 (-56, 386) 
40-70 g per week to cessation  43 2.4 (-.5, 6.4) 1.2 (-2.8, 5.2)  43 -10 (-198, 178) 60 (-115, 234) 
Began/increased to moderate consumption in late pregnancy  116 -3.0 (-7.9, 2.0) -1.7 (-5.9, 2.4)  116 -199 (-390, -9) -178 (-372, 16) 
Heavy drinking         
>80 g per week  32 -10 (-21.0, 1.0) -10.3 (-20.7, 0.1)  32 -370 (-653, -87) -48 (-350, 255) 
>80 g per week to reduction  34 -1.7 (-9.6, 6.2) -2.0 (-9.6, 5.5)  34 12 (-227, 250) -202 (-567, 161) 
>80 g per week to cessation  26 2.1 (2.0, 6.3) 2.3 (-2.2, 6.9)  26 -199 (-450, 52) 172 (-172, 516) 
Began/increased to heavy consumption in late pregnancy  31 -6.6 (-21, 7.3) -7.1 (-22.2, 8.0)  31 -196 (-613, 221) 157 (-61, 374) 
Sensitivity analysis restricted to white ethnicity, n=9,974 
  
n 
Gestation 
Unadjusted 
Gestation 
Adjusted 
  
n 
Birth weight 
Unadjusted 
Birth weight 
Adjusted 
Pre-pregnancy drinkers  6,812 Reference Reference  6812 Reference Reference 
Non drinkers  1,315 -0.9 (-1.9, 0.2) -0.9 (-1.9, 0.1)  1315 -37 (-80, 6) -33 (-83, 16) 
Light drinking         
<30g per week  440 3.0 (1.7, 4.4) 2.8 (1.4, 4.2)  440 73 (15, 130) 96 (42, 150) 
<30g per week to reduction  99 -1.2 (-4.8, 2.5) -0.9 (-4.6, 2.7)  99 9 (-128, 147) -17 (-159, 125) 
<30g per week to cessation  248 -1.4 (-4.4, 1.7) -1.0 (-3.9, 1.8)  248 -81 (-200, 37) -85 (-227, 57) 
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Began light consumption in late pregnancy  776 1.2 (0.1, 2.4) 1.2 (-0.1, 2.4)  776 83 (36, 129) 55 (1.0, 108) 
Moderate drinking         
40-70 g per week  71 -1.6 (-5.2, 2.0) -1.6 (-5.0, 1.7)  71 -123 (-300, 54) -80 (-271, 112) 
40-70 g per week to reduction  41 4.4 (0.8, 8.0) 3.5 (-0.3, 7.4)  41 210 (-24, 443) 186 (-43, 415) 
40-70 g per week to cessation  55 3.0 (-1.2, 6.9) 1.7 (-2.3, 5.8)  55 3 (-189, 195) 56 (-18, 229) 
Began/increased to moderate consumption in late pregnancy  106 -0.2 (-4.0, 3.5) 0.8 (-2.5, 4.1)  106 -85 (-223, 53) -29 (-149, 124) 
Heavy drinking         
>80 g per week  32 -10.1 (-20.7, 0.5) -10.6 (-21.1, -0.1)  32 -373 (-657, 91) -43 (-341, 256) 
>80 g per week to reduction  34 -1.8 (-9.8, 6.2) -2.2 (-9.8, 5.4)  34 -202 (-454, 50) -201 (-562, 160) 
>80 g per week to cessation  26 2.0 (-2.2, 6.2) 2.2 (-2.3, 6.8)  26 8 (-230, 247) 170 (-175, 515) 
Began/increased to heavy consumption in late pregnancy  31 -6.8 (-20.8, 7.2) -7.2 (-22.3, 8.0)  31 -202 (-621, 218) 162 (-57, 381) 
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 Abstract 8.1
Objective 
To investigate the association between alcohol consumption and binge drinking before 
and during early pregnancy and adverse pregnancy outcomes.   
Methods 
We utilised data from 5,628 nulliparous pregnant participants recruited to the SCOPE 
study, a prospective cohort study. Participants were interviewed at 15 weeks of 
gestation and information on alcohol intake before pregnancy and until the time of 
interview was obtained using a standardised questionnaire. Alcohol intake was 
classified as occasional (one to two units/week), low (three to seven units/week), 
moderate (eight to 14 units/week) and heavy (greater than 14 units/week). Binge 
alcohol consumption was defined as consumption of six or more alcohol units in one 
session.  
Results 
Of the 5,628 participants, 1,090 (19%) reported occasional alcohol consumption, 1,383 
(25%) low alcohol consumption, 625 (11%) moderate alcohol consumption, and 300 
(5%) heavy alcohol consumption. Overall, 1,905 (34%) of participants reported binge 
alcohol consumption in the three months before pregnancy, and 1,288 (23%) of these 
participants reported binge alcohol consumption during the first 15 weeks of 
pregnancy. Participants who consumed occasional to heavy amounts of alcohol in early 
pregnancy did not have altered odds of a SGA infant, reduced birth weight, 
preeclampsia or spontaneous preterm birth. Similarly, those who binge drank in early 
pregnancy did not have altered odds of these adverse pregnancy outcomes.  
Conclusion 
Alcohol consumption in early pregnancy was prevalent in this nulliparous cohort. There 
was no association between alcohol consumption before 15 weeks of gestation and 
SGA, reduced birth weight, preeclampsia or spontaneous preterm birth.  
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 Introduction 8.2
Up to 50% of women continue to drink alcohol in pregnancy despite many advisory 
bodies recommending alcohol avoidance (126, 127). The United Kingdom’s Royal 
College of Obstetricians and Gynaecologists advises that although an increasing body 
of evidence suggests harm to the foetus from alcohol consumption during pregnancy, 
there is no evidence of harm from low levels of alcohol consumption (defined as one to 
two units of alcohol once or twice a week) (118). The Royal College of Obstetricians 
and Gynaecologists report highlighted that binge drinking in early pregnancy may be 
particularly harmful. Furthermore, long-term prospective cohort studies to investigate 
the effect of alcohol exposure in pregnancy were recommended (118). The American 
College of Obstetricians and Gynaecologists recommends that obstetricians give 
“compelling and clear advice to avoid alcohol use” in pregnancy and women at risk of 
pregnancy (128). These strict recommendations come, despite other advisory bodies 
such as the NICE acknowledging that there is no consistent evidence of adverse effects 
from low to moderate prenatal alcohol consumption (16). As a result, NICE take the 
more modest approach of suggesting that women limit alcohol consumption to no 
more than one standard unit per day while the Department of Health in the United 
Kingdom now recommends that women trying to conceive should avoid drinking 
alcohol and during pregnancy women should drink no more than one to two units of 
alcohol once or twice a week and avoid getting drunk (129).  
A recent systematic review and meta-analysis examined the dose-response 
relationship between alcohol consumption before and during pregnancy and the risks 
 168 
 
of low birth weight, preterm birth and delivery of a SGA infant (less than 10th 
percentile of gestational age-adjusted birth weight) and demonstrated that 
consumption of more than 10 g/1.25 units alcohol per day during pregnancy increased 
the risk of all three outcomes. The greater the exposure to alcohol the greater the risk; 
for example, a twofold increase in SGA when the mother consumed more than 52 
grams of alcohol per day and a 23% increase in preterm birth with more than 36 grams 
of alcohol per day. In contrast, lower levels of alcohol consumption were not 
associated with an increased risk of preterm birth or SGA infant (19). This meta-
analysis was limited by significant heterogeneity across studies and poor quality study 
design, with some studies not controlling for confounders. Publication bias is also a 
recognised limitation (130). 
We performed this study to clarify the association between early pregnancy 
alcohol consumption and pregnancy outcomes. We hypothesised that increased 
exposure to alcohol in early pregnancy would result in an increased risk of SGA infants, 
low birth weight infants, and spontaneous preterm birth. Secondary aims were to 
investigate whether those who engaged in binge drinking in early pregnancy were at 
any increased risk of adverse pregnancy outcomes and whether cessation of alcohol 
consumption in the first 15 weeks of pregnancy was associated with any observed 
adverse pregnancy outcomes. 
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 Materials and methods  8.3
Ethical approval was obtained from local ethics committees (New Zealand 
AKX/02/00/364, Australia REC 1712/5/2008, London and Manchester 06/MRE01/98 
and Cork ECM5 (10)05/02/08) and all participants provided written informed consent. 
SCOPE is a prospective, multi-centre cohort study with the principal aim of developing 
screening tests to predict preeclampsia, SGA infants, and spontaneous preterm birth 
(94). Participants were healthy nulliparous females with singleton pregnancies 
recruited between November 2004 and January 2011 in Auckland, New Zealand, 
Adelaide, Australia, Cork, Ireland, and Manchester, Leeds and London, United 
Kingdom, and were recruited as previously described (5, 67). Exclusion criteria were 
high risk of preeclampsia, delivery of a SGA infant or spontaneous preterm birth 
because of underlying medical conditions, gynaecological history, three or more 
previous miscarriages, three or more terminations of pregnancy, or had received 
interventions, such as aspirin, that might modify pregnancy outcome (94). 
Study participants were interviewed and examined by study research midwives 
at 14 6/7 to 15 6/7 weeks of gestation. At the time of interview, data were entered on 
an internet accessed central database with a complete audit trail (MedSciNet). 
Pregnancy information and pregnancy outcome data were collected prospectively by 
research midwives. All data entries were individually checked (including data entry 
errors in the lifestyle questionnaire) and a customised software program used to 
detect any systematic data entry errors. Outcomes were spontaneous preterm birth, 
SGA infant, preeclampsia and birth weight.  
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Alcohol consumption was reported as units consumed per week. At the 15 
weeks interview, participants were asked “were you drinking alcohol prior to 
pregnancy?”, “were you drinking alcohol earlier in the pregnancy?” and finally “are you 
still drinking alcohol?” If the participants answered yes to any of the above, the 
amount of alcohol was then quantified. Participants who confirmed that they had 
consumed alcohol during pregnancy were asked when they stopped drinking.  
One unit of alcohol was defined as eight grams or ten ml (1 decilitre (dl)) of 
pure alcohol. The number of units was calculated by multiplying the volume drunk (ml) 
by the percent of alcohol (by volume) and dividing by 1,000. One unit of alcohol was 
equivalent to one glass of wine (approximately 125 ml, one small glass of sherry, a 
single nip of spirits, or half a pint of lager (regular strength). A can or small bottle of 
regular-strength beer (300–330 mL, 4–5% alcohol) was equivalent to 1.5 units of 
alcohol and a bottle of alcohol pop was equivalent to two units of alcohol. Binge 
alcohol consumption was defined as six or more units per drinking session. For 
example, if the participant had only one drink per month, 0.25 units per week was 
recorded; two drinks per month was recorded as 0.5 units per week. If the participant 
had one binge drinking session (six or more units) per month and no other drinking 
during the month, then six units over four weeks is 1.5 units per week. If the 
participant had a regular alcohol intake of five units per week plus one episode of 
binge drinking per month, the total number of units per month was divided by four; 
that is (20+6)/4=6.5 units per week. The timing of cessation of alcohol consumption 
was also recorded. For the purpose of this study, alcohol intake was classified as 
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occasional (one to two units per week), low (three to seven units per week), moderate 
(eight to fourteen units per week) and heavy (greater than 14 units per week). In 
addition, information about the number and duration of binges prior to 15 weeks of 
gestation was recorded separately. Hard drug use was defined as the consumption of 
any of cocaine, substance P, amphetamines or opiates. 
Small for gestational age was defined as birth weight below the 10th customised 
centile adjusted for maternal weight, height, parity, ethnic group, gestational age and 
infant sex (131). Spontaneous preterm birth was defined as spontaneous onset of 
labour (before 37 weeks) resulting in preterm birth at less than 37 weeks of gestation. 
Preeclampsia was defined as systolic blood pressure 140 millimetres of mercury 
(mmHg) or more, diastolic blood pressure 90 mmHg or more, or both on at least two 
occasions four hours apart after 20 weeks of gestation, but before the onset of labour 
or postpartum, with proteinuria (24-hour urinary protein 300 mg or more, or spot urine 
protein-to-creatinine ratio 30 mg or millimoles (mmol) creatinine, or urine dipstick 
protein 2+ or more) or any multisystem complication of preeclampsia (132). Birth 
weight was measured to the nearest gram.  
Analysis of variance (ANOVA) was used to compare continuous variables and χ2 
(chi) was used to compare categorical variables in relation to quantity of alcohol 
consumed per week. In all the statistical tests participants with either no alcohol intake 
prior to or during pregnancy or those with no binge drinking prior to or during 
pregnancy represented the reference group. Logistic regression and linear regression 
were used to analyse the binary (all outcomes excluding birth weight) and continuous 
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(birth weight) outcome measures, respectively. Logistic regression models were 
adjusted for maternal age, smoking, ethnicity, BMI, infant sex, marital status, family 
income and drug use. All analyses were adjusted for the potential clustering effect of 
study centres. The linear regression for birth weight was adjusted for the same 
variables as the logistic models in addition to gestational age at delivery. Analyses were 
further adjusted for multiple testing. As 32 tests were planned in the initial analyses, 
P<0.0016 was considered statistically significant. Results are interpreted using this 
multiple testing adjusted P value.  
Initial analysis examined the association between the amount of alcohol 
consumed during pregnancy on pregnancy outcome. For clarity of presentation and 
interpretation, results are presented as two groups (occasional and low combined and 
moderate and heavy combined). The separate groupings are presented in the Appendix 
III. 
Two further analyses were performed to assess the association between further 
classifications of exposure to alcohol during or before pregnancy and the outcome. The 
first examined alcohol consumption status at 15 weeks of gestation. This was done by 
generating a four-category variable: 1) abstinent (reference group), 2) quit before 
conception, 3) quit before 15 weeks, and 4) continued at 15 weeks. The impact of 
binge drinking in pregnancy was examined by generating a three-category variable: 1) 
participants with no history of binging pre-pregnancy or during pregnancy (reference 
group), 2) binge drinking pre-pregnancy but stopped during pregnancy and 3) pre-
pregnancy binge drinking and binge drinking in pregnancy before 15 weeks. Binge 
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drinking in pregnancy was further stratified into those with one binge before 15 weeks 
and those with two or more binge episodes before 15 weeks.  
One further subgroup analysis was performed. Participants who reported binge 
drinking in pregnancy were excluded from the initial analysis. This ensured any alcohol 
effects observed did not occur secondary to binge drinking and allowed us examine the 
effects of chronic alcohol exposure in pregnancy.  
 Results  8.4
Of the 5,628 participants in the study cohort, 2,230 (40%) participants reported no 
alcohol consumption in pregnancy, 1,090 (19%) occasional alcohol consumption, 1,383 
(25%) low alcohol consumption, 625 (11%) moderate alcohol consumption, and 300 
(5%) reported heavy alcohol consumption in pregnancy when interviewed at 15 weeks 
of gestation. Overall 1,905 (34%) participants reported binge alcohol consumption in 
the three months pre-pregnancy. Of these, 1,288 (23%) participants also reported 
binge alcohol consumption during the first 15 weeks of pregnancy. Of these 1,288 
participants, 840 (15%) reported at least two episodes before 15 weeks.  
Participants who consumed greater amounts of alcohol in early pregnancy were 
more likely to be younger, Caucasian, single, smokers and admit to a history of drug 
use compared with those who did not consume any alcohol in pregnancy. Significant 
geographical variation was observed between study centres; 65–80% of participants in 
the United Kingdom and Ireland consumed some alcohol in pregnancy, compared with 
38% in Australia and 53% in New Zealand  (
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Table 8.1). 
Overall there was no association between the level of alcohol consumption and 
the odds of a SGA or reduced birth weight infant (Table 8.2). The timing of early 
pregnancy exposure to alcohol did not influence the odds of SGA or affect birth weight 
(Table 8.3). Furthermore, women who binge drank in pregnancy did not have an 
increased risk of a SGA or reduced birth weight infant (Table 8.4).  
The consumption of occasional to low and moderate to heavy amounts of 
alcohol in early pregnancy was not associated with any significant reduction in the 
odds of spontaneous preterm birth (adjusted OR 0.82, 95% CI 0.62–1.07 and OR 0.75, 
95% CI 0.55–1.03 for occasional to low and moderate to heavy alcohol consumption, 
respectively) compared with those who did not consume any alcohol in pregnancy 
(Table 8.2). Similarly, binge drinking before pregnancy or continuing during the first 
trimester of pregnancy was not associated with altered odds of spontaneous preterm 
birth (adjusted OR 0.78, 95% CI 0.33–1.80 and adjusted OR 0.90, 95% CI 0.70–1.16, 
respectively) (Table 8.4).  
The consumption of occasional to low and moderate to heavy amounts of 
alcohol in early pregnancy was not associated with any significant change in the odds 
of developing preeclampsia (adjusted OR 0.73, 95% CI 0.51–1.06 and adjusted OR 0.66, 
95% CI 0.39–1.14 for occasional to low and moderate to heavy alcohol consumption, 
respectively) compared with those who did not consume any alcohol in pregnancy 
(Table 8.2). The timing of exposure to alcohol in pregnancy did not alter these findings 
(adjusted OR 0.65, 95% CI 0.41–1.02 and adjusted OR 0.78, 95% CI 0.34–1.79 for those 
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who quit alcohol before conception and those who continued to drink at 15 weeks of 
gestation, respectively) (Table 8.3). No association was observed between participants 
who developed preeclampsia and those exposed to binge drinking either before 
conception (adjusted OR 1.11, 95% CI 0.65–1.89) or those who continued to binge 
drink in pregnancy (adjusted OR 1.09, 95% CI 0.54–2.19).  
Subgroup analyses were then performed. Participants who reported binge 
drinking in pregnancy were excluded from the analysis shown in Table 8.2. The results 
were unchanged (see Appendix III).  
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 Discussion 8.5
Using predefined quantities and timings of exposure to alcohol, this study provides a 
detailed assessment of the variable associations between alcohol intake in the first 15 
weeks of pregnancy and major adverse pregnancy outcomes. The majority of 
participants (60%) consumed some alcohol in pregnancy, with over 20% admitting to 
binge drinking in pregnancy. These figures are significantly higher than reported in 
other research in a North American setting (any alcohol use among pregnant women 
12%, range 10–16%; binge drinking among pregnant women 2%, range 1–3%). This 
may reflect differences in patterns of alcohol consumption by young women and the 
varying advice on alcohol consumption while pregnant in different countries (133).  
The strengths of our study are that information about the timing of and degree 
of exposure to alcohol in pregnancy was recorded in a detailed standardised fashion 
with birth outcomes then collected prospectively. This allowed us to examine multiple 
exposures and timing of exposure. Pregnancy outcome data were available in more 
than 99% of participants. Pregnancy outcome was assigned according to pre-specified 
criteria and stringent data monitoring protocols ensured the quality of the data. Access 
to a wide range of potential confounders missing in other studies such as smoking, 
income, education, and drug use were available on all participants. Recall bias may 
have resulted in an underreporting of alcohol consumption as no objective test or 
measure exists to record alcohol exposure over a long period of time. However, all data 
were collected in a careful standardised sensitive manner in an effort to limit this 
potential bias (134). Our study specifically examined exposure to alcohol in early 
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pregnancy and did not provide habitual drinking data for the whole of pregnancy. 
While every effort was made to cautiously interpret the data where numbers were 
limited, some of our groupings did have small numbers and may have been 
underpowered to examine specific outcomes. 
Comparisons with other studies must be interpreted with caution as the 
majority of other studies reflect exposure to alcohol in pregnancy at any gestation. In 
contrast, this study specifically examined early pregnancy exposure to alcohol. In a 
systematic review which did not address specific timing of exposure, Patra et al 
showed no effect of alcohol consumption up to ten grams pure alcohol per day (an 
average of about one drink per day) and low birth weight and SGA infants (19). Our 
study did not demonstrate a strong association between the level of alcohol 
consumption in early pregnancy and SGA infants. Patra et al also demonstrated an 
increased association between alcohol consumption and preterm birth but not until 
more than 18 grams pure alcohol per day (an average of 1.5 drinks per day). However, 
our study did not demonstrate any association between either alcohol consumption or 
binge drinking in pregnancy and spontaneous preterm birth, while other studies have 
reported a reduction in spontaneous preterm birth in women who consumed alcohol 
in pregnancy (24, 27, 135). The difference from the report by Patra et al may relate to 
their inclusion of preterm birth due to all causes (spontaneous and iatrogenic). In 
contrast with other studies, we did not demonstrate occasional to low amounts of 
alcohol to be protective against growth restriction (21, 24, 123). Our findings concur 
with those of another systematic review by Henderson et al which found no significant 
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association between occasional to low amounts of alcohol exposure and adverse 
pregnancy outcomes including low birth weight and SGA (136). 
It remains unclear whether any safe level of alcohol consumption in pregnancy 
exists and there is currently inadequate information to determine if there are discrete 
gestational windows of vulnerability for different adverse outcomes. Longitudinal 
studies are required to assess interaction with the influences of cessation, continuous 
consumption or binge drinking in the second and third trimesters. The variation in 
alcohol consumption across study centres was significant with 65–80% of participants 
in the United Kingdom and Ireland consuming some alcohol in pregnancy compared 
with 38–53% in Australia and New Zealand. This may reflect different 
recommendations for alcohol consumption in pregnancy by country (abstinence in 
Australia compared with avoiding heavy alcohol intake in pregnancy in the United 
Kingdom) (16).  
Although the effects of alcohol consumption in pregnancy are likely to be varied 
depending on quantity consumed and timing of exposure, this study did not 
demonstrate a strong association between occasional to heavy amounts of alcohol 
consumption in early pregnancy and increased risks of SGA infants, preeclampsia, 
spontaneous preterm birth or reduced birth weight infants. This study did not evaluate 
the association between alcohol consumption in pregnancy and long term 
neurocognitive outcomes of children exposed as foetuses to alcohol. This potential for 
neurocognitive dysfunction remains one of the single most important reasons for 
pregnant women to avoid alcohol intake during pregnancy. 
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Figure 8.1 Participants recruited to SCOPE 
 
EXCLUDED 
Declined to participate (n=2,542) 
Unable to enrole due to discontinued funding (n=17) 
Miscarriage or termination after agreed (n=193) 
Ineligible (n=64) 
Declined consent (n= 25) 
EXCLUDED 
Ineligible status post recruitment (n=14) 
Missing outcome data (n=48) 
 
Recruited to study at 15±1 weeks (n=5,690) 
 
Final study population at 15±1 weeks (n=5,628) 
Invited to participate (n=8,531) 
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Table 8.1 Characteristics by degree of maternal alcohol consumption in first trimester 
 Abstinent 
(n=2,230) 
Occasional 
(n=1,090) 
Low 
(n=1,383) 
Moderate 
(n=625) 
Heavy 
(n=300) 
P* 
Age (years)            
14-24 624 28 187 17 231 17 124 20 120 40 <0.001 
25-29 669 30 308 28 389 28 162 26 80 27 
30-34 667 30 455 42 568 41 251 40 76 25 
35-45 270 12 140 13 195 14 88 14 24 8 
Education            
More than 12 years 1160 52 739 68 1003 73 416 67 186 62 <0.001 
Marital status            
Single 169 8 76 7 125 9 96 15 74 25 <0.001 
Ethnicity            
Asian 124 6 24 2 13 1 8 1 1 0.3 <0.001 
Caucasian 1863 84 1009 93 1319 95 599 96 271 90 
Other 243 11 57 5 51 4 18 3 28 9 
Study centre            
Adelaide 718 32 144 13 160 12 80  13 62  21 <0.001 
Auckland 956 47 366  18 468  23 176 9 66 3  
Cork 353  20 427  24 603  34 266  15 125 7  
United Kingdom 203 31 153 23 152 23 103 16 47 7  
BMI (kg/m2)            
18.5 or less 43 2 16 2 15 1 4 1 6 2 <0.001 
18.6-24.9 1191 53 601 55 820 59 351 56 160 53 
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25-29.9 577 26 334 31 398 29 179 29 88 29 
35 or higher 419 19 139 13 150 11 91 15 46 15 
Smoking status†            
Non-smoker 1857 83 893 82 1029 74 374 60 110 37 <0.001 
Quit during pregnancy 146 7 115 11 232 17 160 26 105 35 
Smoker 227 10 82 8 122 9 91 15 85 28 
Hard drug use†  
9 
 
0.4 
 
7 
 
1 
 
10 
 
1 
 
16 
 
3 
 
14 
 
5 
 
<0.001 
Marijuana use†  
66 
 
3 
 
29 
 
3 
 
48 
 
4 
 
36 
 
6 
 
38 
 
13 
 
<0.001 
Data are mean (standard deviation) or n (%) unless otherwise specified.   
*Using Student t test or χ2 test, P<.05.  †At time of 15 week interview  
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Table 8.2 Adverse pregnancy outcomes and quantity of maternal alcohol consumption in first trimester 
 Abstinent* 
(n=2,230) 
  
 
Occasional to Low 
(n=2,473) 
  
 
Moderate to Heavy 
(n=925) 
   n OR 
(95% CI) 
aOR 
(95% CI) 
 n OR 
(95% CI) 
aOR 
(95% CI) 
SGA 240(10.9)  275 1.03(0.77,1.39) 1.09(0.86,1.38)  118 1.21(0.83,1.76) 1.10(0.80,1.52) 
Birth weight (g) 3371(604)  2473 52(-3,107) -13(-52,26)  925 41(-32,114) -31(-149,88) 
Preterm birth 109(4.9)  93 0.76(0.48,1.20) 0.82(0.62,1.07)  34 0.74(0.39,1.39) 0.75(0.55,1.03) 
Preeclampsia 138(6.2)  103 0.66(0.43,1.00) 0.73(0.51,1.06)  37 0.63(0.35,1.14) 0.66(0.39,1.14) 
 
All endpoints, except for birth weight, were analysed using logistic regression and results are presented as odds ratios (95% 
confidence intervals). Birth weight was analysed using linear regression with robust variance estimation and is presented as adjusted 
mean difference in grams (95% confidence intervals). The reference group was women who did not drink alcohol during pregnancy. 
All regression models were adjusted for maternal age, smoking, education, ethnicity, body mass index, infant sex, marital status, 
family income and drug use in pregnancy. All analyses were adjusted for potential clustering effect of study centres. Birth weight 
models were also adjusted for gestational age at delivery.  
*Data are n (%) or mean (SD)  
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Table 8.3 Adverse pregnancy outcomes and maternal alcohol consumption classified by status at 15 Weeks 
 Quit Before Conception 
(n=937) 
 Quit Before 15 Weeks 
(n=2,865) 
 Continued at 15 Weeks 
(n=572) 
 n OR 
(95% CI) 
aOR 
(95% CI) 
 n OR 
(95% CI) 
aOR 
(95% CI) 
 n OR 
(95% CI) 
aOR 
(95% CI) 
SGA 87 0.78(0.50,1.22) 0.83(0.42,1.66)  326 0.97(0.70,1.36) 1.02(0.77,1.34)  74 1.13(0.70,1.82) 1.12(0.83,1.52) 
Birth weight 937 94(14,175) 33(-83,148)  2865 91(28,154) -1(-73,71)  572 95(1,189) -1(-100,98) 
Preterm birth 40 0.78(0.41,1.48) 0.79(0.64,0.99)  108 0.68(0.41,1.12) 0.73(0.56,0.94)  20 0.63(0.28,1.43) 0.64(0.43,0.95) 
Preeclampsia 50 0.77(0.43,1.37) 0.84(0.56,1.27)  116 0.57(0.36,0.91) 0.65(0.41,1.02)  26 0.65(0.31,1.33) 0.78(0.34,1.79) 
 
All endpoints, except for birth weight, were analysed using logistic regression and results are presented as odds ratios (95% 
confidence interval). Birth weight was analysed using linear regression with robust variance estimation and is presented as adjusted 
mean difference in grams (95% confidence interval). The reference group was women who did not drink alcohol during pregnancy. 
All regression models were adjusted for maternal age, smoking, education, ethnicity, body mass index, infant sex, marital status, 
family income and drug use in pregnancy. All analyses were adjusted for potential clustering effect of study centres. Birth weight 
models were also adjusted for gestational age at delivery. 
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Table 8.4 Adverse pregnancy outcomes and maternal alcohol consumption by antenatal binge drinking status 
  Binge drinking pre-pregnancy 
only 
 (n=617) 
  Binge Drinking pre-pregnancy and before 15 weeks 
(n=1,288) 
      One binge 
(n=448) 
Two or more binges 
(n=840) 
 n OR 
(95% CI) 
aOR 
(95% CI) 
n  OR 
(95% CI) 
aOR 
(95% CI) 
n OR 
(95% CI) 
aOR 
(95% CI) 
SGA 64 0.97(0.62,1.52) 0.99(0.86,1.14) 59  1.27(0.79,2.03) 1.29(0.75,2.23) 114 1.31(0.91,1.88) 1.22(0.94,1.57) 
Birth weight 617 86(5, 167) 12(-45, 69) 448  30(-63,123) -20(-118,78) 840 12(-59,83) -41(-108,27) 
Preterm birth 20 0.69(0.32,1.48) 0.78(0.33,1.80) 13  0.61(0.24,1.54) 0.68(0.23,2.06) 31 0.79(0.42,1.48) 0.90(0.70,1.16) 
Preeclampsia 31 1.02(0.54,1.90) 1.11(0.65,1.89) 20  0.89(0.42,1.91) 0.96(0.50,1.83) 43 1.03(0.60,1.79) 1.09(0.54,2.19) 
 
All endpoints, except for birth weight, were analysed using logistic regression and results are presented as odds ratios (95% 
confidence interval). Birth weight was analysed using linear regression with robust variance estimation and is presented as adjusted 
mean difference in grams (95% confidence interval). The reference group was women who did not binge drink pre-pregnancy or 
during pregnancy. All regression models were adjusted for maternal age, smoking, education, ethnicity, body mass index, infant sex, 
marital status, family income and drug use in pregnancy. All analyses were adjusted for potential clustering effect of study centres. 
Birth weight models were also adjusted for gestational age at delivery. 
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 Abstract 9.1
Background 
Previous studies have examined associations between alcohol use in pregnancy and 
offspring birth size but evidence on whether associations persist during childhood is 
limited.  
Methods 
We examined the association between maternal drinking during pregnancy and 
trajectories of offspring weight and height from birth to ten years in 7,597 mother-
child pairs in the Avon Longitudinal Study of Parents and Children. To strengthen the 
inference, we compared maternal drinking with partner drinking, to partially control 
for unmeasured confounding. We also performed sensitivity analyses restricting our 
analysis to women of white ethnicity and participants with three or more growth 
measures.  
Results 
Maternal occasional or light daily drinking during pregnancy was not associated with 
reduced birth weight, birth length or offspring growth trajectories up to age ten years. 
The infants of heavy drinking mothers were born 0.78 centimetres (cm) shorter (95% CI 
-1.34, -0.22) and 0.22 kg lighter (95% CI -0.34, -0.09) than infants of pregnancy 
abstainers but by age ten offspring of heavy drinking mothers were of comparable 
height (mean difference 0.59 cm, 95% CI -0.93, 2.11) and weight (mean difference 0.41 
kg, 95% CI -0.70, 1.52). These associations were not observed for heavy partner 
drinking and were not altered in sensitivity analyses. 
Conclusion 
Maternal occasional or light daily drinking is not associated with birth weight, birth 
length or postnatal growth but residual confounding may persist. Maternal heavy 
drinking may have an intrauterine association with reduced birth weight and length 
that is overcome during childhood. 
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 Introduction 9.2
Upwards of 35% of women in contemporary European birth cohorts and cross sectional 
studies report alcohol use during pregnancy (15, 28, 29, 79, 82, 85, 99). Public health 
guidelines are polarised on the existence of a safe alcohol consumption threshold 
during pregnancy. Guidelines from Canada (91), the United States (92), Ireland (17) and 
New Zealand (90) advise complete abstinence from alcohol during pregnancy while the 
NICE (16) and Royal College of Obstetricians and Gynaecologists (118) in the United 
Kingdom advise an upper limit of one to two units (28g) not more than once or twice 
per week.  
A recent systematic review demonstrated that heavy alcohol consumption in 
pregnancy was associated with preterm birth, lower birth weight and size for 
gestational age but found little evidence of harm at moderate levels (19). However, 
whether the smaller size at birth associated with heavy alcohol consumption persists 
into childhood or is overcome with age is not known. Moreover, the safety of lower 
consumption levels set out in the NICE guidelines is not established in relation to 
postnatal growth trajectories. 
Given evidence of strong social patterning of alcohol use in pregnancy, there is 
the potential for residual confounding in its association with offspring outcomes 
because simple adjustment for one or two measures of socioeconomic position (as is 
often done in studies that have explored its relationship to perinatal and later 
outcomes) is likely to be inadequate to fully capture this confounding (137). 
Specifically, studies that have shown modest consumption to be unrelated to 
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outcomes might be masking a detrimental effect of even low levels of consumption, 
since this pattern of exposure is common amongst those from more affluent and 
middle-class backgrounds in whom adverse outcome are likely to be low (138). By 
contrast, any influence of heavy consumption might be exaggerated as this pattern of 
consumption is more common amongst those from lower socioeconomic positions. 
Comparisons of maternal and partner associations can be used to investigate the 
likelihood that residual confounding might explain associations of maternal pregnancy 
exposures with offspring outcomes (139, 140). These comparisons assume that the 
confounding structure for maternal and partner drinking in pregnancy is the same and 
that the association of maternal drinking and partner drinking with later offspring 
anthropometry (partly through later drinking and parenting styles) are similar. With 
respect to the question of intrauterine effects of maternal alcohol consumption in 
pregnancy, if associations with offspring growth trajectories are similar for maternal 
and partner alcohol consumption, this may be indicative of residual confounding by 
shared familial environmental or genetic factors. A stronger maternal, compared with 
partner, alcohol consumption – offspring growth trajectory association could be 
explained by maternal intrauterine effects, which are not plausible for partner 
consumption. 
Previous work in the ALSPAC cohort has shown that infants born to women who 
reported drinking one to two drinks daily with at least one binge, or three or more 
drinks daily with or without binges had a mean birth weight approximately 150 grams 
less than infants whose mothers drank prior to pregnancy but reported abstinence 
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during pregnancy (141). Building on this work, we describe the association between 
maternal alcohol use during pregnancy and individual trajectories of height and weight 
between birth and ten years of age. Secondly, we investigate potential residual 
confounding of estimates by comparing the associations of maternal drinking during 
pregnancy with that of her partner’s drinking during pregnancy.  
 Participants and methods 9.3
ALSPAC is a prospective birth cohort study in Southwest England. Pregnant women 
resident in one of the three Bristol-based health districts with an expected delivery 
date between April 1, 1991 and December 31, 1992 were invited to participate and the 
study has been described elsewhere in detail (6, 7). ALSPAC initially enrolled a cohort 
of 14,451 pregnancies of which 13,867 live births occurred representing 13,761 unique 
women. Follow-up has included parent and child completed questionnaires, links to 
routine data and clinic attendance. Ethical approval was obtained from the ALSPAC Law 
and Ethics Committee and the local research ethics committees. Please note that the 
study website contains details of all the data that is available through a fully searchable 
data dictionary (142).  
9.3.1.1 Exposure classification 
Maternal alcohol consumption 
Postal questionnaires at 18 weeks gestation collected information on the mother’s and 
partner’s alcohol consumption before pregnancy and during the first trimester. 
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Response categories were never, less than once a week, at least once a week, one to 
two glasses every day, three to nine glasses every day, or ten glasses a day. Examples 
were provided to specify that one glass was equivalent to one unit (eight g) of alcohol. 
Questions also asked about the number of binging days occurring during the preceding 
month which corresponded to approximately the 4th month of pregnancy. A binge was 
defined as consumption of the equivalent of two pints of beer, four glasses of wine or 
four pub measures of spirit on a single day (approximately four standard sized alcohol 
drinks or 40-45 grams of absolute alcohol). In line with the summary index of maternal 
drinking created previously in the ALSPAC cohort (141) we combined the information 
on binging behaviour in the second trimester and drinking patterns in early pregnancy. 
The final categories for women and their partners were: 
i) pregnancy abstainer: drank alcohol pre-pregnancy, abstained in early pregnancy and 
did not binge mid pregnancy (women only) 
ii)  general non-drinkers: reported not drinking three months prior to conception, not 
drinking in early pregnancy and not binging mid pregnancy 
iii) occasional pregnancy drinker: drank less than daily in early pregnancy and did not 
binge mid pregnancy 
iv) occasional binge drinkers during pregnancy: drank less than daily in early pregnancy 
and binged at least once in mid pregnancy 
v) light daily pregnancy drinker: drank one or two drinks per day in early pregnancy, did 
not binge in mid pregnancy 
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vi) heavy pregnancy drinker: drank one or two drinks per day in early pregnancy and 
binged at least once in mid pregnancy, or drank at least three drinks per day in early 
pregnancy with or without any reported binge in mid pregnancy.  
Due to evidence of poorer birth outcomes in non-drinkers compared with alcohol 
consumers (25, 29), for all analyses of maternal alcohol consumption, pregnancy 
abstainers were the reference group and for partner drinking, occasional drinkers 
served as the reference group. Only participants who provided information on their 
drinking habits both before and in early pregnancy (i.e. data available for both mother 
and her partner), with infants born after 23 weeks gestation, valid data on birth weight 
and birth length and complete data on all confounders were included, leading to a total 
sample of 7,957 women-partner-offspring trios.  
Height and weight were available for ALSPAC offspring from research clinics, 
routine healthcare records and parent-reports (see Appendix II and IV for further 
detail). Height and weight at birth, three months, one, three, seven and ten years was 
predicted for all individuals from multilevel models, details of which are provided in 
Appendix IV and have been published previously (143). We included maternal and 
partner alcohol in the multilevel models and estimated at each age the mean 
height/weight differences for each category of alcohol consumption compared with 
the reference category. Analyses were carried out using the statistical packages 
Stata12 (StataCorp,LP, Texas), MLwiN v2.27 (Centre for Multilevel Modelling, Bristol, 
UK) (144) and the Stata command ‘runmlwin’(145). 
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We considered the following as potential confounders: maternal education, 
parity, maternal smoking, maternal age, maternal height, maternal BMI and partner 
drinking (all measured by mother- or partner-completed questionnaires; details in 
Appendix IV), and included interactions between each confounder and the intercept 
and linear slopes in the multilevel models. We examined whether associations differed 
between females and males by looking at stratified results and computing a test for 
interaction between infant gender and maternal/partner alcohol consumption. In 
order to assess the robustness of our results to the exclusion of offspring with missing 
exposure, outcome or confounder data we examined the association between 
maternal and partner alcohol consumption and birth weight and length among 
excluded participants. We performed sensitivity analyses restricting our analysis to i) 
women of white ethnicity and ii) participants with three or more growth measures and 
we also evaluated whether adjusting for the following variables altered our findings: 
gestational age at birth (a potential mediator), pregnancy intention, partner education, 
partner smoking, maternal hospital admission, marital status, household social class 
and partner height (potential confounders not included in main analyses due to 
considerable amounts of missing data) (measurement of variables, descriptive statistics 
of these confounders and results of sensitivity analyses detailed in Appendix IV). 
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 Results 9.4
Amongst the 7,957 trios included (approximately 55% of the cohort recruited at birth), 
57% of women and 96% of their partners consumed alcohol during the woman’s 
pregnancy (Appendix IV Table 14.2). Participants included in our analysis were less 
likely to smoke and tended to be of higher socioeconomic position than those excluded 
due to missing data but there was no clear pattern of difference in terms of maternal 
or partner alcohol consumption.  
Women classified as general non-drinkers and occasional binge drinkers during 
pregnancy tended to have lower educational attainment than pregnancy abstainers. 
Light daily pregnancy drinkers were more likely to have a degree than all other 
categories of drinker while heavy pregnancy drinkers and pregnancy abstainers had 
similar educational distributions (Table 9.1). Maternal heavy pregnancy drinking or 
light daily pregnancy drinking was correlated with partner heavy or daily use during 
pregnancy. Among women who drank during pregnancy, increasing severity of 
consumption was correlated with the severity of smoking. Associations of maternal and 
partner drinking with maternal characteristics (Table 9.2) are broadly similar, although 
maternal smoking is more strongly associated with maternal than partner drinking. 
Maternal general non-drinking is associated with a 0.22 cm lower birth length 
compared with pregnancy abstainers (95% CI -0.47, 0.04); this height differential 
persists across childhood, with the difference at age ten being -0.56cm (95% CI -1.23, 
0.10) (Table 9.3). No clear differences, however, were seen for the maternal general 
non-drinking category in terms of weight at birth or later in childhood.  
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Maternal occasional drinking, occasional binge drinking during pregnancy and 
light daily pregnancy drinking are not strongly associated with lower birth weight or 
birth length or height or weight later in childhood compared with pregnancy abstainers 
after adjustment for confounders and mutual adjustment for partner drinking (Table 
9.3).  
Heavy maternal drinking during pregnancy is associated with 0.78cm lower 
birth length (95% CI -1.34, -0.22) and 0.26kg lower birth weight (95% CI -0.34, -0.09) 
(Table 9.3). By age two years, however, infants of heavy drinkers have similar heights 
and weights to the infants of abstainers (mean difference in height 0.11cm, 95% CI -
0.56, 0.78) and (mean difference in weight-0.09kg, 95% CI -0.41, 0.22) (Table 9.3). By 
age ten, any weight or height differences have been entirely attenuated such that 
infants of heavy drinkers are of comparable height and weight to the offspring of 
pregnancy abstainers (mean difference in height 0.59cm, 95% CI -0.93, 2.11) and 
(mean difference in weight 0.41kg, 95% CI -0.70, 1.52) although these estimates also 
have wide confidence intervals that span positive as well as negative values. This 
increased growth in the offspring of maternal heavy drinkers tends to occur after the 
age of three months for height growth (Appendix IV Table 14.3) and after age one year 
for weight (Appendix IV Table 14.4). For all analyses of maternal alcohol use, 
unadjusted and confounder-adjusted results were similar (Appendix IV Table 14.5).  
Although, the reference groups for the maternal and partner alcohol 
comparisons differ, in contrast to the observed associations for maternal drinking, 
there is very little evidence of an association between heavy partner alcohol use during 
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pregnancy and smaller length or weight at birth but the offspring of partners who drink 
heavily tend to be shorter and lighter at two and ten years (Table 9.4 and Appendix III 
Table 14.6 and Table 14.7).  
9.4.1  Sensitivity analyses 
Our results for the associations of maternal drinking during pregnancy were similar in 
sensitivity analyses using observed height and weight at two and ten years rather than 
the values predicted by the multilevel model, providing reassurance that our modelling 
strategy was appropriate (Appendix IV Table 14.8). Results were also similar when 
restricting analysis to offspring with three or more growth measures or women of 
white ethnicity (Appendix IV Table 14.9 and Table 14.10). Findings were also robust to 
further adjustment for gestational age at birth, pregnancy intention, partner 
education, partner smoking, maternal hospital admission, marital status, household 
social class, and partner height (Appendix IV Table 14.11-Table 14.18). Despite the 
participants included in our analysis being more socioeconomically advantaged than 
those excluded due to missing data, our analysis of the association between maternal 
alcohol consumption and birth weight and birth length (Appendix IV Table 14.19) 
showed that the observed associations did not differ between included and excluded 
participants, providing reassurance that missing data is unlikely to have biased our 
findings. 
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 Discussion 9.5
In this large prospective birth cohort in the South West of England, we found evidence 
that heavy alcohol consumption during pregnancy was associated with lower birth 
length and birth weight but that these associations were subsequently overcome with 
age. By age ten, infants of heavy maternal drinkers are of comparable height and 
weight to infants of women who abstained from alcohol during pregnancy. The 
associations were not attenuated by adjustment for confounders or partner drinking. 
We did not find any evidence that heavy alcohol use in partners was associated with 
lower offspring birth weight or length and in contrast to the maternal drinking results, 
heavy partner drinking was associated with shorter height and lighter weight later in 
childhood. Although the reference groups for maternal and partner exposure were 
different making maternal, compared with partner, alcohol consumption – offspring 
growth trajectory associations not fully compatible, the overall discordance between 
the maternal and partner associations could imply that the detrimental effect of 
maternal heavy drinking during pregnancy on birth weight and length occurs through 
intra-uterine mechanisms. However, it should be noted that maternal smoking was 
more strongly associated with maternal alcohol use than with partner alcohol use, so 
we cannot exclude residual confounding by maternal smoking since our measure of 
smoking may not fully capture all aspects of smoking behaviour. For all other 
categories of gestational drinkers, we did not find any evidence of birth length or 
weight differences or height and weight growth differences up to ten years.  
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Our findings demonstrating no evidence of adverse associations between 
occasional or light daily drinking and birth length and weight are consistent with 
evidence on the observational associations of moderate alcohol use with head 
circumference, abdominal circumference, femur length in utero (28) and birth weight 
and a recent meta-analysis (19) demonstrating no association of up to one drink per 
day on birth weight (19). However, evidence on the impact of occasional or light daily 
consumption on growth outcomes postnatally is sparse and less consistent; some 
studies have also shown no association between more moderate drinking levels and 
postnatal growth/body size (146) but some previous studies have demonstrated height 
and weight deficits persisting into childhood (30, 31, 39, 147, 148). Reasons for 
conflicting results include dissimilarities in the measurement and classification of 
exposure to alcohol during pregnancy, follow-up time, analysis differences and 
population differences where most studies showing an adverse association between 
light or moderate drinking and growth have been carried out in far more 
disadvantaged populations than the relatively socially advantaged ALSPAC cohort. 
Our findings on birth weight and length differences among heavy drinkers are 
consistent with a number of large population based prospective cohort studies and 
results from meta-analysis showing adverse associations with growth at birth among 
heavy alcohol users during pregnancy (19). Similarly, our data illustrating catch up 
growth among heavy drinkers is compatible with evidence of associations with alcohol 
that are not evident at age 14 in a cohort of middle class, white, married women in 
Seattle, a group similar to ALSPAC participants (35). However, our results conflict with 
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evidence demonstrating a deleterious effect of heavy alcohol consumption on growth 
during childhood among more disadvantaged populations including African-American 
women (33), teenagers in Pittsburgh (32), socioeconomically disadvantaged women in 
South Africa (34) and women of lower socioeconomic position in Northern France 
(149). Genetic, nutritional, ethnic and socioeconomic differences and dissimilarities in 
the measurement and classification of exposure relating to the range and burden of 
the distribution of alcohol in each category may explain discordance between studies.  
Although we did not observe associations between our moderate drinker 
categories (occasional/light daily drinkers) in pregnancy and offspring growth 
trajectories, residual confounding even after adjustment for socio-demographic and 
other characteristics of women can still obscure true associations between alcohol and 
growth. We have used maternal-partner exposure comparisons in this study to explore 
whether residual confounding is likely. An underlying assumption of this approach is 
that confounders are similarly related to the maternal and partner exposure in 
question. This approach works well for examining potential confounding due to shared 
postnatal familial socioeconomic, lifestyle, environmental or genetic characteristics but 
may not work well for confounding by maternal characteristics that might also have 
intrauterine effects. In our case, maternal smoking was more strongly associated with 
maternal than partner alcohol use. Given the known associations between maternal 
smoking and birth size and offspring growth (3, 140) and difficulty in capturing smoking 
status fully and accurately in a questionnaire, the observed associations between 
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maternal alcohol use and growth might reflect an effect of maternal smoking, or at 
least in part be explained by this, rather than fully due to their alcohol consumption.  
9.5.1 Strengths and limitations 
This study of postnatal growth trajectories among alcohol exposed offspring represents 
one of the largest and most robust studies of gestational alcohol and off-spring 
postnatal growth to date, with a sample size close to 8,000 women, complete data on 
exposure, outcomes and confounders, prospective follow up and multiple repeated 
measures of growth. However, due to loss to follow-up and missing data our analysis 
represents less than 60% of the original ALSPAC cohort recruited at birth, thus 
potentially undermining generalisability of results due to attrition bias. In relation to 
broader generalisability, our cohort is predominantly of Caucasian ethnicity and 
relatively affluent, thus, potentially reducing generalisability to other more diverse 
populations. We relied on self-reported measures of alcohol consumption, but 
ascertainment of exposure has been done concurrently before women knew the 
outcomes of their pregnancy, reducing the risk of recall bias. Moreover, as data was 
collected in 1991 and 1992 under-reporting may be less of a concern due to much less 
awareness of the potential foetal effects of alcohol use during pregnancy. However, for 
the light daily drinking category, our associations may be underpowered due to small 
numbers (n=33) and thus, these results should be interpreted carefully. Habitual daily 
alcohol intake as well as binge consumption is combined in a summary index to reduce 
the risk of misclassification of exposure. However, because of the definition of ‘non-
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drinker’ (none in the three months prior to pregnancy or in early pregnancy), 
misclassification may occur in this category due to an inability to differentiate women 
abstaining from alcohol prior to pregnancy due to intention to get pregnant versus 
those who never drink alcohol regardless of pregnancy intention. We have also 
performed multiple sensitivity analyses which support the chosen analytical approach 
and strengthen the validity of our findings.  
9.5.2  Conclusion 
Maternal heavy drinking is associated with lower birth weight and birth length but 
these associations are overcome with increasing offspring age. Our data do not 
demonstrate an adverse association between occasional or light daily drinking and 
birth weight, birth length or postnatal growth, weight and height up to age ten. 
However, residual confounding cannot be discounted and abstinence from alcohol 
during pregnancy should continue to be emphasised in routine antenatal care.
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Table 9.1 Characteristics of women by their pregnancy alcohol consumption, n=7,957 
 
 Pregnancy 
abstainer, 
(Reference) 
n=2,919 
General non-
drinker, 
 
n=504 
Occasional 
pregnancy 
drinker, 
n=3,253 
Occasional 
binge 
drinker, 
n=1,172 
Light daily 
pregnancy 
drinker, 
n=33 
Heavy 
pregnancy 
drinker, 
N=76 
P value for 
comparison 
Partner alcohol consumption        
Occasional pregnancy drinker (reference) 488 (16.7) 97 (19.3) 422 (13.0) 63 (5.4) 1 (3.0) 2 (2.6) p<0.001 
General non-drinker 116 (4.0) 138 (27.4) 68 (2.1) 12 (1.0) 0 2 (2.6) 
Occasional binge drinker 1818 (62.3) 217 (43.1) 2034 (62.5) 785 (67.0) 6 (18.2) 27 (35.5) 
Light daily pregnancy drinker 8 (0.3) 2 (0.4) 10 (0.3) 1 (0.1) 1 (3.0) 0 
Heavy pregnancy drinker 490 (16.8) 50 (10.0) 722 (22.1) 311 (26.5) 25 (75.8) 45 (59.2) 
Maternal education        
Less than O level 712 (24.4) 204 (40.5) 661 (20.3) 384 (32.8) 7 (21.2) 21 (27.6) p<0.001 
O level 1066 (36.5) 179 (35.5) 1118 (34.4) 423 (36.1) 7 (21.2) 27 (35.5) 
A level 724 (24.8) 77 (15.3) 840 (25.8) 268 (22.9) 6 (18.2) 17 (22.4) 
Degree or above 417 (14.3) 44 (8.7) 634 (19.5) 97 (8.3) 13 (39.4) 11 (14.5) 
Parity        
0 1541 (52.8) 193 (38.3) 1466 (45.1) 475 (40.5) 18 (54.6) 43 (56.6) p<0.001 
1 982 (33.6) 178 (35.3) 1201 (36.9) 404 (34.5) 9 (27.3) 15 (19.7) 
2+ 396 (13.6) 133 (26.4) 586 (18.0) 293 (25.0)  6 (18.2) 18 (23.7)  
Maternal smoking (1
st
 Trimester)        
No  2481 (85.0) 376 (74.6) 2675 (82.2) 784 (66.9) 23 (69.7) 30 (39.5) p<0.001 
 <10 per day 226 (7.7) 53 (10.5) 309 (9.5) 166 (14.2) 2 (6.1) 16 (21.1) 
10-19 per day 155 (5.3) 47 (9.3) 215 (6.6) 173 (14.8) 7 (21.2) 22 (29.0)  
>19 per day 57 (2.0) 28 (5.6) 56 (1.7) 49 (4.2) 1 (3.0) 8 (10.5)  
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)  
Maternal age 28.2 (4.6) 27.6 (4.8) 29.2 (4.6) 28.4 (4.7) 32.1 (4.4) 30.8 (5.5) p<0.001 
Maternal height (cm) 164 (6.6) 163.2 (6.5) 164.4 (6.7) 164.1 (6.7) 165.6 (5.8) 165.3 (7.1) 0.001 
Maternal BMI 23.0(4.0) 23.0 (4.2) 22.8 (3.6) 23.3 (3.8) 22.8 (2.8) 23.5 (3.7) 0.005 
Gestational age at birth (weeks) 39.5 (1.8) 39.2 (2.1) 39.5 (1.8) 39.5 (1.8) 39.5 (1.4) 39.2 (2.1) 0.06 
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Table 9.2 Characteristics of women’s partner’s level of drinking during the woman’s pregnancy, n=7,597 
 
 Occasional 
drinker, 
(Reference) 
n=1,073 
General non-
drinker, 
n=336 
Occasional 
pregnancy 
drinker, 
n=4,887 
Light daily 
pregnancy 
drinker, 
n=22 
Heavy 
pregnancy 
drinker, 
n=1,639 
P value for 
comparison 
Maternal education       
Less than O level 271 (25.3) 136 (40.5) 1277 (26.1) 1 (4.6) 306 (18.6) p<0.001 
O level 342 (31.9) 119 (35.4) 1821 (37.3) 7 (31.8) 531 (32.4) 
A level 283 (26.4) 49 (14.6) 1129 (23.1) 9 (40.9) 462 (28.2) 
Degree or above 177 (16.5) 32 (9.5) 660 (13.5) 5 (22.7) 342 (20.9) 
Parity       
0 420 (39.1) 152 (45.2) 2353 (48.2) 4 (18.2) 807 (49.2) p<0.001 
1 405 (37.8) 102 (30.4) 1706 (34.9) 9 (40.9) 567 (34.6) 
2+ 248 (23.1) 83 (24.4) 828 (16.9) 9 (40.9) 265 (16.2) 
Smoking (1st Trimester)       
No  920 (85.7) 242 (72.0) 3888 (79.6) 19 (86.4) 1298 (79.2) p<0.001 
 <10 per day 62 (5.8) 39 (11.6) 491 (10.1) 1 (4.6) 179 (10.9) 
10-19 per day 69 (6.4) 35 (10.4) 385 (7.9) 1 (4.6) 129 (7.9) 
>19 per day 22 (2.1) 20 (6.0) 123 (2.5) 1 (4.6) 33 (2.0) 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)  
Maternal age 28.8 (5.0) 27 (5.5) 28.4 (4.5) 32.4 (3.8) 29.7 (4.7) p<0.001 
Maternal height 164 (6.6) 163.5 (6.8) 164 (6.7) 163.1 (9.0) 164.7 (6.5) 0.003 
Maternal BMI 23.0 (4.1) 23.0 (4.6) 23 (3.8) 22.3 (2.1) 22.7 (3.5) 0.14 
Gestational age at birth 
(weeks) 
39.5 (1.7) 39.3 (2.2) 39.4 (1.8) 39.3 (3.0) 39.5 (1.8) 0.27 
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Table 9.3 Association between maternal alcohol consumption in pregnancy and offspring length/height and weight at birth and 
ages two and ten years 
 Mean (SD) 
values in 
pregnancy 
abstainers 
(the reference 
category) 
Mean difference (95% confidence interval) compared with pregnancy abstainers 
 Pregnancy 
abstainer 
General non-
drinker 
Occasional 
pregnancy drinker 
Occasional binge 
drinker 
Light daily 
pregnancy drinker 
Heavy pregnancy 
drinker 
       
Height (cm)       
Birth 50.22 (1.46) -0.22 (-0.47, 0.04) 0.06 (-0.06, 0.19) 0.04 (-0.14, 0.21) 0.42 (-0.49, 1.33) -0.78 (-1.34, -0.22) 
2 years 85.95 (2.41) -0.27 (-0.56, 0.02) -0.14 (-0.29, 0.00) -0.16 (-0.36, 0.04) -0.25 (-1.27, 0.76) 0.11 (-0.56, 0.78) 
10 years 141.03 (5.20) -0.56 (-1.23, 0.10) -0.25 (-0.57, 0.08) -0.19 (-0.65, 0.27) 0.31 (-1.84, 2.46) 0.59 (-0.93, 2.11) 
Weight (kg)       
Birth 3.49 (0.42) -0.03 (-0.09, 0.02) 0.00 (-0.03, 0.03) 0.01 (-0.03, 0.05) -0.01 (-0.20, 0.18) -0.22 (-0.34, -0.09) 
2 years 12.56 (1.17) 0.01 (-0.13, 0.14) -0.04 (-0.11, 0.03) -0.02 (-0.11, 0.07) -0.09 (-0.56, 0.37) -0.09 (-0.41, 0.22) 
10 years 23.23 (6.02) -0.08 (-0.89, 0.73) -0.05 (-0.71, 0.61) 0.05 (-0.64, 0.73) 0.36 (-1.03, 1.76) 0.41 (-0.70, 1.52) 
 
Offspring height and weight values are predicted from the multi-level models, based on models adjusted for gender, confounders 
and partner’s alcohol consumption. Values are for females and the baseline category of all covariates. No evidence of gender 
interaction for the association between alcohol consumption and height/weight trajectories was observed. Height/lengths are in 
centimetres, weight is in kilograms. 
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Table 9.4 Association between partner alcohol consumption in pregnancy and offspring length/height and weight at birth and 
ages two and ten years 
 Mean (SD) values in 
pregnancy abstainers 
(the reference 
category) 
Mean difference (95% confidence interval) compared with pregnancy abstainers 
 Occasional pregnancy 
drinker 
General non-drinker 
 
Occasional binge 
drinker 
Light daily pregnancy 
drinker 
Heavy pregnancy 
drinker 
      
Height (cm)      
Birth 50.24 (1.43) -0.25 (-0.57, 0.07) -0.03 (-0.20, 0.14) 0.43 (-0.75, 1.61) -0.07 (-0.27, 0.13) 
2 years 86.05 (2.55) -0.35 (-0.74, 0.01) -0.01 (-0.20, 0.19) -0.56 (-0.75, 1.86) -0.25 (-0.48, -0.02) 
10 years 141.29 (5.32) -0.85 (-1.70, 0.00) -0.42 (-0.86, 0.01) -0.83 (-1.94, 3.61) -0.93(-1.44, -0.42) 
Weight (kg)      
Birth 3.48 (0.42) -0.07 (-0.14, 0.00) -0.02 (-0.05, 0.02) 0.10 (-0.14, 0.34) -0.02 (-0.06, 0.03) 
2 years 12.57 (1.15) -0.30 (-0.48, 0.13) 0.03 (-0.07, 0.12) -0.16 (-0.76, 0.43) -0.05 (-0.15, 0.06) 
10 years 24.21 (5.90) -0.55 (-1.60, 0.50) -0.12 (-0.65, 0.41) 0.16 (-3.11, 3.43) -0.61 (-1.23, 0.00) 
 
Values are predicted from the multi-level models, based on models adjusted for gender, confounders and mother’s alcohol 
consumption. Values are for females (baseline category) and no evidence of gender interaction for the association between alcohol 
consumption and height/weight trajectories was observed. Height/lengths are in centimetres, weight is in kilograms.
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Chapter 10 
10 Thesis discussion  
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 Summary of main findings 10.1
10.1.1 Aim #1: To implement PRAMS in Ireland 
The first aim of this thesis was to implement the PRAMS surveillance programme in 
Ireland in order to collect valid and reliable information on maternal behaviours and 
experiences around the time of pregnancy. Findings from Chapter 2 and 3 reported on 
the design and implementation of the PRAMS Ireland pilot study at CUMH and showed 
that PRAMS was a feasible and valid method of surveillance for maternal behaviours 
and experiences in Ireland; PRAMS Ireland had a 67% response rate, questions were 
88% complete for all respondents and prevalence estimates of socially undesirable 
behaviours were high and comparable with international estimates. Findings also 
showed that administration of a validated FFQ with the PRAMS  Ireland survey did not 
reduce response and that PRAMS could potentially be an effective approach to 
obtaining nutritional data around the time of pregnancy. However, women 
participating in the PRAMS Ireland pilot study appeared to be more advantaged than 
women who did not participate. 
In Chapter 4, PRAMS Ireland was extended to a larger sample of 1200 women at 
CUMH. Here, layout and content changes based on pilot findings were implemented 
and an FFQ was administered with each PRAMS survey. Findings showed that PRAMS 
Ireland still remained valid and effective, producing a sample and response rate 
broadly representative of the national birth profile. However, we found that the 
response rate (61%) and time to achieve this response (133 days) were lower and 
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longer respectively, than in our pilot study of PRAMS Ireland. Possible reasons for 
lower response rates and longer average response time included the effect of the FFQ 
on reducing response, since the pilot may not have been adequately powered to detect 
differences in response. Further reasons included the proximity of the data collection 
to Christmas where women may have been more time constrained than other times of 
year. We also found that although the response appeared generally representative, 
reduced response was evident among single, multiparous and unmarried women 
based on a comparison of responders and non-responders. 
10.1.2 Aim #2: To describe the prevalence of health behaviours around 
the time of pregnancy 
A second aim of this thesis was to examine the prevalence of health behaviours around 
the time of pregnancy in Ireland. In Chapter 5, the prevalence of alcohol use during 
pregnancy was compared across SCOPE, GUI and PRAMS Ireland. Findings indicated 
that alcohol use during pregnancy was prevalent in all countries studied and as 
common as 80% in Ireland. Alcohol use was pervasive across all social groups and 
smoking was the only consistent predictor of alcohol use during pregnancy across all 
three studies and in each SCOPE country included in the analysis. We concluded that 
alcohol use during pregnancy may not always be related to social advantage as some 
studies have indicated and suggested that the observed social patterns of alcohol use 
may in fact be an artefact of social patterns of reporting of alcohol use rather than 
social patterns of gestational alcohol consumption itself in pregnancy. Among the 
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studies included in the analysis, a strong potential reason for variation in alcohol 
reporting included different  methods of data collection; however, re-assuringly the 
estimates produced from the PRAMS Ireland data compared favourably to estimates 
from other European studies suggesting that retrospective data collection in and of 
itself may not always result in under-reporting.  
 In Chapter 6, we examined adherence to National Clinical Guidelines on health 
behaviours and nutrition around the time of pregnancy in the PRAMS Ireland study. 
Findings indicated that in general women were not adhering to National Clinical 
Guidelines around the time of pregnancy; less than 24% of women were adherent to 
folate, smoking and alcohol guidelines before pregnancy but this increased to 39% 
adherence for the same three guidelines during pregnancy. Adherence to all seven 
food groups in line with food pyramid guidelines was less than 1% and less than 1% 
also met all four micro-nutrient guidelines for vitamin D, folate, calcium and iron 
around the time of pregnancy. Poor adherence to guidelines was apparent across all 
social groups but adherence was lower still among more disadvantaged women 
(younger and less educated women). However, these women experienced the greatest 
improvements in adherence to guidelines during pregnancy. Women participating in 
the study were older and more advantaged than the national birth profile, and thus, 
we concluded that adherence to positive health behaviours could be potentially worse 
in a more representative population sample. 
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10.1.3 Aim #3: To examine the effect of alcohol use during pregnancy on 
infant and childhood growth 
The third aim of this thesis was to examine the impact of alcohol use during pregnancy 
on growth outcomes in different cohorts. In Chapter 7, we examined the impact of 
pattern and timing of alcohol use during pregnancy on gestational age and birth weight 
in the Growing up in Ireland cohort study. Here, findings indicated that 20% of women 
consumed alcohol during pregnancy. Findings also suggested that quantity and timing 
of alcohol exposure may play a role in determining foetal alcohol effects and that the 
effect of timing and pattern may potentially differ for outcomes with different causal 
pathways particularly in late pregnancy. In relation to levels of alcohol consumption, 
we found that light and moderate alcohol use during pregnancy did not appear to be 
detrimental to gestational age and birth weight. However, we cautioned that findings 
should be interpreted carefully due to selection bias, reporting bias and residual 
confounding in GUI influenced by retrospective reporting of alcohol use by women and 
administration of the survey by a trained government interviewer, which may have 
biased response. 
In Chapter 8, we conducted a further exploration of the effects of alcohol use 
during pregnancy on birth outcomes, this time in the prospectively recruited 
nulliparous cohort study, SCOPE. Findings from this cohort indicated a high prevalence 
of alcohol use before (77%) and during pregnancy (63%) in the full cohort. Findings also 
indicated that alcohol use at all levels from low to high and including binge drinking 
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before 15 weeks gestation did not impact birth outcomes including SGA, birth weight, 
pre-eclampsia or spontaneous preterm birth. However, women were healthy 
nulliparous participants that did not have previous miscarriages or poor pregnancy 
history, thus potentially reducing the generalisability of study findings. In particular, as 
we did not find deleterious associations with pregnancy outcomes in this affluent 
population, the socially advantaged nature of the cohort and their voluntary 
participation in the study could be masking harmful health effects of gestational 
alcohol use. 
In Chapter 9, we examined the effect of alcohol use during pregnancy on the 
longitudinal growth trajectories of children in the large Bristol based cohort, ALSPAC. 
Here, we compared the effect of maternal alcohol use during pregnancy to that of her 
partner’s alcohol use in relation to individual trajectories of height and weight between 
birth and ten years of age. Findings indicated that heavy alcohol consumption resulted 
in reduced infant birth weight and birth length after adjustment for confounders. This 
effect was not attenuated in sensitivity analysis and not evident for partner heavy 
drinking. However by age 10, infants of women who drank heavily, were of similar 
weights and heights to offspring of non-drinkers during pregnancy. All other levels of 
consumption did not impact infant birth weight, birth length or longitudinal growth 
trajectories. We concluded that since the maternal alcohol use-offspring growth 
trajectory association and partner alcohol use-offspring growth trajectory association 
were dissimilar, maternal heavy alcohol use could have an intrauterine effect on infant 
birth weight and length. Moreover, as ALSPAC was a large prospectively recruited birth 
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cohort study conducted during a time period when gestational alcohol use was less 
socially stigmatised and in a relatively advantaged group, it is likely that that less 
reporting and selection bias exist compared to both GUI and SCOPE. Thus, we suggest, 
that of the three studies conducted, results from ALSPAC may be the most reliable. 
 Strengths and limitations 10.2
10.2.1 Key strengths 
Data on health behaviours during pregnancy are sparse in Ireland. Unlike in the UK 
where numerous cross sectional studies and cohort studies exist to provide estimates 
of maternal health behaviours, Ireland lacks nationally representative data on most 
important health determinants around the time of pregnancy. This study of PRAMS in 
Ireland is one of the first to examine the potential feasibility and implementation of a 
surveillance system in Ireland which would address such data deficits. The study was 
modelled on the only surveillance program of maternal behaviours and experiences 
world-wide and tests an established methodology in an entirely new setting, providing 
an initial glimpse of a wide range of important lifestyle determinants during pregnancy. 
The methodological findings and prevalence estimates generated from the 
implementation of PRAMS Ireland may be used to shape further research and 
stimulate further investigation of surveillance methods for maternal experiences and 
behaviours at a national level in Ireland. This thesis has also introduced new elements 
to the PRAMS system and has collected dietary data around the time of pregnancy for 
the first time using PRAMS, which appears to be reliable and valid.  
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In relation to the examination of prevalence of behaviours and effects of foetal 
alcohol exposure on growth, strengths include use of multiple datasets to examine 
plausible prevalence estimates and the potential effects of measurement bias. Large, 
robust, prospective studies such as SCOPE and ALSPAC were also used to shed light on 
the growth effects of alcohol use during pregnancy. In each of these studies, we have 
controlled for a wide range of key measured confounders and performed multiple 
sensitivity analyses, where appropriate. Our study of longitudinal growth trajectories 
is, to my knowledge, one of the most robust studies of alcohol use and childhood 
growth trajectories to date; with prospective alcohol measurement, repeated 
measurements of growth at clinics and use of robust statistical methods. In addition, 
we have also employed more advanced methods to identify potential residual 
confounding through the use of the maternal-partner alcohol use comparisons in 
ALSPAC which yields important insights about the potential intra-uterine effects of 
gestational alcohol use versus those that are mediated by other unmeasured genetic or 
environmental influences. 
10.2.2 Key limitations 
One of the original primary aims of this thesis was to explore the feasibility and validity 
of implementing the PRAMS surveillance system as an on-going surveillance system in 
Ireland. However, due to resource constraints and lack of a national sampling frame, it 
was necessary to restrict the implementation to CUMH where we had ready access to a 
complete sampling frame and ethical approval to conduct the study. Thus, while the 
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study was successful in CUMH and was well received, whether PRAMS Ireland could be 
successfully implemented in other units with greater patient diversity has not been 
evaluated nor has a national sampling frame been tested.  
For all sources of data used in the thesis, residual confounding, selection bias 
and reporting biases may exist and are limitations related to the methods, design and 
population of each cohort. In PRAMS Ireland, women participating were more 
advantaged than non-participants which potentially impacts the generalisability of our 
estimates, since advantaged women could be more likely to be light and moderate 
drinkers than heavy drinkers. Similarly, for heavy drinkers who participated, either 
drinking levels could have been underestimated or those that did participate may not 
be representative of heavy alcohol users in the general population, thus resulting in 
estimates of heavy alcohol use far lower than in the general population. With the GUI 
study, where we examined pattern and timing of alcohol use, selection bias could have 
existed where the women with heavier alcohol consumption who chose to participate 
were somehow different from heavy alcohol users who did not. For example, heavy 
drinkers who participated in GUI could be more advantaged than heavy gestational 
alcohol users that did not participate. As a result, effect sizes for heavy drinking could 
be under-estimated, such that findings which showed heavy alcohol use not to be 
harmful are biased by selection of heavy drinkers to the cohort whose relative 
advantage masks the harmful effect of heavy alcohol use. In SCOPE, participants were a 
generally healthy cohort of first time mothers; selection bias could explain why all 
levels of early alcohol consumption did not impact birth outcomes, since in a more 
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advantaged cohort, the adverse effects of a deleterious exposure could be negated as 
compared to its effect in a less advantaged or more representative population. Within 
ALSPAC, initial selection bias to the study and loss to follow-up is also a threat to 
validity, since children who did not participate to begin with or no longer participate in 
the study (and excluded from the analysis) could be different in some way from those 
who continue to participate. For example, if children with significant growth deficits in 
childhood resulting from heavy gestational alcohol exposure in utero were lost to 
follow-up but children of heavy drinkers whom had normal growth were retained in 
the study, the observed lack of association between heavy alcohol use and later growth 
trajectories of children may be the result of attrition bias. Similarly, the observed lack 
of association between light and moderate alcohol exposure and initial birth outcomes 
and later trajectories could be related to the same types of initial selection and 
attrition bias occurring in the cohort. 
Another potential limitation of the work includes reporting and recall biases. In 
PRAMS and GUI, retrospective data collection could impede accurate recall of women. 
In addition, differential recall of exposures could exist where women who had an 
adverse infant outcome are more likely to recall exposures accurately than those who 
did not. In GUI, recall bias could result in women whom had smaller infants recalling 
their alcohol consumption differently, which, for example, could inflate the effects of 
heavy gestational alcohol consumption. Alternately, in the prospective studies, if 
women tended to under or overestimate alcohol use in a differential manner; for 
example where heavy drinkers over-estimated their alcohol consumption and 
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moderate drinkers reported their consumption more accurately, associations could be 
masked. 
Where possible, we have attempted to adjust for all available appropriate 
confounders; however, unmeasured confounding may still exist after adjustment, such 
that other factors not measured by the study or measured inaccurately underlie 
observed associations between the exposures and outcomes examined. For example, a 
common theme in all studies of growth was the lack of effect of alcohol use at lower or 
moderate levels; this is a key issue of contention in relation to antenatal care 
guidelines internationally around alcohol use, since lack of evidence of harm tends to 
be interpreted as an indication of the safety of low levels of alcohol use during 
pregnancy which may not necessarily be the case. However, because low and 
moderate drinking is often associated with other socio-economic and lifestyle 
characteristics which are related to better health outcomes, a truly harmful effect of 
lower or moderate levels of alcohol use could be masked in all our studies because 
residual confounding may persist. In the advantaged and healthy SCOPE cohort where 
binge and heavy use did not have an effect, residual confounding by social and lifestyle 
factors not measured or inaccurately measured could explain the lack of association. 
Similarly, in ALSPAC, we found that heavy alcohol use impacted on birth weight and 
birth length; however, if heavy alcohol users smoked more than non-drinkers and 
smoking in ALSPAC was not accurately measured due to measurement error or 
underreporting, residual confounding by smoking status could persist after adjustment 
such that the association between heavy alcohol use during pregnancy and birth 
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weight and birth length would be the result of residual confounding by higher smoking 
levels among heavy drinkers. That said, residual confounding is problematic in many 
study designs and across observational epidemiological research and thus, it is not a 
limitation unique to this thesis. 
 Implications for further research 10.3
Further research which expands on the PRAMS Ireland surveillance system developed 
here would be useful to acquire national estimates of maternal health behaviours and 
experiences given the data presented through this local implementation of PRAMS 
showing high levels of deleterious health behaviours around the time of pregnancy in 
an urban obstetric population in the South of Ireland. Future research on monitoring 
health behaviours and experiences in Ireland would benefit from identification of a 
national sampling strategy and exploration of methods to increase representativeness 
among harder to reach groups followed by a subsequent implementation of the 
methodology implemented in this thesis at a national level, in order to provide a 
baseline assessment of key health behaviours around the time of pregnancy for the 
whole population in Ireland. Over-sampling of vulnerable population groups would be 
central to future research using PRAMS in Ireland, to ensure that those experiencing 
the greatest health inequalities are well represented to obtain reliable population 
health estimates. Weighting post-response to represent the national population from 
which samples are drawn would also be a useful endeavour in order to extrapolate 
findings at the national level in order to exert an influence on policy and practice. In 
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this study, we have conducted a cross sectional study of health behaviours and 
experiences; however, in order to operate as a surveillance program as PRAMS does in 
the US, future research could explore the repeated measurement of behaviours and 
experiences which was not possible in this thesis. This would be essential in monitoring 
changes in heath behaviours over time and particularly, in monitoring the success of 
health programmes and initiatives to tackle deleterious health behaviours at a 
population level. 
In relation to improving our understanding of the effects of gestational alcohol 
use, problems associated with conventional observational epidemiological studies such 
as residual confounding, selection and reporting bias must be addressed and 
minimised in future research. Here a number of directions for future research are 
discussed which specifically address how such bias and confounding could be reduced. 
10.3.1 Use of repeated measurement based on dose, pattern and timing 
The PRAMS Ireland study specifically examined alcohol use based on dose, pattern and 
timing of alcohol exposure both before pregnancy and in each trimester separately. 
Findings showed that the prevalence of alcohol use was comparable to larger, 
prospective cohorts in Europe and highlighted the effectiveness of anonymised postal 
surveys with repeated and specific measurement of alcohol use for each time period, 
at obtaining reliable and valid prevalence estimates. Future research which seeks to 
measure alcohol prevalence may benefit from collection of data in a similar manner 
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where prospective measurement of data with repeat measurement in each trimester 
separately is not possible. 
10.3.2 Methods to examine residual confounding  
The thesis used two key methods for examination of residual confounding in studies of 
gestational alcohol use including a cross cohort comparison and comparison of 
maternal and paternal comparisons in the ALSPAC. The concept of a cross cohort 
comparison is based on the premise that if an association is likely to be causal, then 
such an association would persist even in cohorts with very different confounding 
structures. We used the concept of comparison of cohorts with different confounding 
structures and measurement techniques in this manner to examine plausible alcohol 
prevalence estimates. Such a method may be of use in future research to examine the 
plausibility of estimates or the potential causality of associations. Secondly, the use of 
maternal exposure – offspring health effects comparisons with paternal exposure – 
offspring health effect may be of use in future research of similar exposures which are 
strongly socially patterned and where we suspect underlying residual confounding by 
environmental or genetic variables to persist. 
10.3.3 Methods to improve causality 
One of the key findings of the thesis included that low to moderate alcohol 
consumption did not impact offspring growth at birth or to age ten years. However, 
this finding could be related to residual confounding by factors more prevalent among 
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light and moderate drinkers, such as relative affluence which could obscure 
detrimental alcohol effects if they existed. As shown in Figure 10.1, when using self-
reported alcohol consumption data as in a conventional observational cohort study, 
selection to the cohort may be related to certain social and demographic 
characteristics. Alcohol use may be related to these social and demographic 
characteristics such that those who participate are more advantaged and report 
different patterns of use to those who do not participate. Thus, the association 
between maternal alcohol use and growth outcomes could be confounded by these 
social and demographic characteristics that initially influenced women’s participation 
in the cohort and which may not be adequately adjusted for or may still confound 
associations because standard approaches to adjustment for confounders are 
inadequate. As a result findings that show light and moderate alcohol consumption not 
to be harmful to foetal growth could be invalid because its effects are counteracted by 
social advantage or other characteristics which make them more likely to have 
healthier infants to begin with. Even when socio-economic characteristics, as often 
measured in questionnaires, for example, through income and education, are adjusted 
for, residual confounding can still persist, since such measures may not full capture or 
capture accurately socio-economic position and relative social advantage. 
Consequently, if such residual confounding persists, it may negate a detrimental foetal 
alcohol effect or even make gestational alcohol use appear beneficial. 
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Confounders 
 
 
 
Maternal alcohol use                            Growth 
Figure 10.1 Conventional cohort design 
 
The use of “Mendelian Randomisation” (MR), a method that uses genotype-
disease associations to make inferences about environmentally modifiable causes of 
disease has been used in relation to alcohol exposure during pregnancy and other child 
outcomes and would be extremely valuable in future studies of gestational alcohol use 
and growth (150). MR refers to the random assortment of alleles at the time of gamete 
formation and results in population distributions of genetic variants that are generally 
independent of behavioural and environmental factors that typically confound 
epidemiological associations such as those examined in this thesis (150).  
 In Figure 10.2 the use of the maternal alcohol dehydrogenase (ADH) variant 
could help to resolve the question of unmeasured residual confounding masking 
detrimental associations between, for example, low and moderate alcohol 
consumption and growth outcomes. Alcohol dehydrogenase is a critical enzyme in the 
metabolism of alcohol. Genetic variation in the expression of these genes has been 
reported resulting in differences in a) propensity to drink alcohol and b) in the ability to 
metabolise alcohol. Individuals with fast alcohol metabolising genes drink less alcohol 
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and metabolise alcohol faster. Individuals with other genes metabolise alcohol slower 
and drink more alcohol. If maternal alcohol use as reported by the mother is related to 
offspring growth at lower or moderate levels, then maternal genotype (that which 
codes faster metabolism and greater propensity to drink) should only affect growth 
outcomes in alcohol consumers (since it is assumed that the only pathway alcohol 
dehydrogenase would affect growth is through alcohol use). Consequently, if the 
maternal genotype that encodes faster metabolism and greater propensity to drink 
only affects growth outcomes in alcohol consumers and not in non-drinkers, then the 
finding would be potentially indicative of a causal association which does not suffer 
from selection bias, reporting bias and residual confounding because the maternal 
alcohol dehydrogenase genotype is a random phenomenon which is not typically 
related to social and lifestyle confounders that mask associations in conventional 
cohort studies.  
Figure 10.2 shows how MR has been in used in alcohol research thus far and 
how it could be used in future research to provide insights into the impacts of 
gestational alcohol use on infant and childhood growth. The ADH genotype is 
associated with maternal alcohol consumption but this exposure (maternal genotype) 
is less likely to be influenced by social and demographic characteristics that influence 
participation in the cohort like self-reported alcohol use in Figure 10.1 i.e. there is no 
association between the genotype and the confounding factors; genotype is randomly 
assigned at birth. Here, the genotype does not affect the outcome by any path other 
than maternal alcohol consumption; however in Figure 10.1 maternal alcohol use could 
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be influencing growth through unmeasured confounders. By testing the association 
between maternal ADH genotype and offspring growth (which can only operate 
through maternal alcohol exposure because ADH is specific to alcohol metabolism), we 
are testing the association between maternal alcohol use and offspring growth. This 
association is less likely to be confounded than in a conventional observational cohort 
study using only self-reported maternal alcohol use, because genotype results from the 
random allocation of alleles during gamete formation and such random allocation is 
not related to social and demographic factors that confound associations as self-
reported alcohol consumption data is. This random allocation of alleles to result in the 
maternal alcohol genotype can be seen as something akin to a randomised control trial 
with the random assignment of treatment and control followed by an intention to treat 
analysis. The use of MR in future research may help to dis-entangle the effect of 
alcohol use in relation to infant growth and later childhood growth trajectories. 
 
Confounders 
 
 
 
Maternal ADH                           Maternal alcohol use                           Growth 
Figure 10.2 Mendelian randomisation design 
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 Implications for policy, practice and public health 10.4
10.4.1 Policy 
Nationally available estimates of most maternal behaviours and experiences during 
pregnancy are not available in Ireland. The findings of this thesis may be of use for 
policymakers since it develops and tests a method of surveillance of maternal 
behaviours and experiences around the time of pregnancy which could be expanded to 
a national surveillance system. In turn, national surveillance could be used to provide 
Ireland’s first national estimates of many behaviours and experiences that can be used 
to inform policy and practice, set targets and monitor achievement of improvements in 
maternal health in Ireland. In chapter 6, we found low adherence to key health 
behaviours during pregnancy including abstinence from alcohol use during pregnancy 
and smoking. The future implementation of PRAMS emanating from this work could be 
used to identify both problem behaviours and vulnerable population health groups 
where more focused policy initiatives are required. These could include new polices 
focusing on reducing unintended pregnancy rates but also focusing on identifying these 
women in practice to provide more intensive counselling on hazardous health 
behaviours, as well as using women’s interaction with health services during this 
sensitive period as an opportunity to identify other issues including intimate partner 
violence and depression. Other examples of policy impacts could include new policies 
around the promotion of breastfeeding among women even prior to pregnancy to 
increase breastfeeding among all population groups or policy aiming to achieve 
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complete coverage of folic acid intake in women of childbearing age.  Subsequently, 
following the initiation of such new policy focusing on problem behaviours and 
vulnerable population groups identified through PRAMS surveillance, ongoing data 
collection would allow measurement of the effects of such policy change on 
behaviours at a population level, in order to assess progress over time. In the case of 
women with untended pregnancies, repeated PRAMS surveillance would allow us to 
identify whether efforts to reduce unintended pregnancy are effective while also 
examining potential improvement in the behaviours of women with unplanned 
pregnancy over time.   
This research has implications for other countries like Ireland struggling with 
data deficits in maternal and child health, since it takes an established and effective 
CDC surveillance program and implements it in a new setting. Evidence that this work 
has already been replicated in resource poor settings where little data is available on 
maternal behaviours and experiences comes by way of a recent implementation of the 
PRAMS system in Iran where the methods of PRAMS from this thesis (published in 
Maternal and Child Health Journal) were used to implement and test a similar system 
among Iranian women with recent live births. Therefore, the work also has a potential 
policy impact in other countries mediated through its effect on encouraging 
surveillance to be conducted at the population level, which can subsequently be used 
to identify key problem behaviours around the time of pregnancy and vulnerable 
population groups.  Thereafter, estimates can be used to leverage, implement and 
monitor new policy. 
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Relating to findings on alcohol use, our findings illustrate the conflicting nature 
of the association between alcohol consumption and birth outcomes and offspring 
growth which are undermined by reporting bias, selection bias and residual 
confounding which are linked to methodological differences across studies, as 
previously discussed. Moreover, the findings highlight that across all papers, even 
when data is prospectively obtained, residual confounding is a major threat to validity 
of findings in studies of gestational alcohol use. Thus, at a policy level, the findings have 
implications for guidelines which suggest that low and moderate alcohol consumption 
during pregnancy may be safe such as those outlined in NICE in the UK. The findings 
highlight that basing guidelines such as these on observational studies of gestational 
alcohol consumption may result in provision of advice which is based on poor and sub-
optimal evidence that masks a detrimental effect of low and moderate alcohol 
consumption. This has been shown to be the case where low and moderate levels of 
alcohol use previously shown to have no effect on intelligence quotient (IQ) in 
conventional cohort studies were in fact detrimental to IQ in later, more robust MR 
studies using the same data (138). Consequently, until more objective approaches to 
measurement of alcohol use are available, which minimise the biases and confounding 
problems outlined, guidelines which advise upper consumption thresholds should be 
revised to a message of complete abstinence. 
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10.4.2 Practice 
For the general practitioner and those involved in delivering antenatal care, the 
findings may be of use, since they illustrate the lack of adherence to most National 
Clinical Guidelines including those around alcohol consumption, smoking and folate 
intake and illustrate a distinct need for general practitioners, obstetricians and health 
professionals to set aside more time for pre-conceptual and peri-conceptual 
counselling on adverse lifestyle behaviours and experiences in practice. Despite 
guidelines which advise abstinence from alcohol use in Ireland, alcohol use during 
pregnancy is highly prevalent and assuming prospectively measured data to be more 
reliable, up to 80% of Irish women may consume some level of alcohol during 
pregnancy. Therefore, professionals involved in providing guidance to women in 
Ireland should be aware that increased and more intensive advice needs to be 
provided to encourage positive behavioural change during pregnancy in relation to 
these behaviours. Moreover, such advice needs to be occurring well in advance of 
pregnancy to all women and without regard to perceived risk, since much of the 
evidence suggests that the most harmful health behaviours are socially pervasive and 
not confined to vulnerable population groups. However, given decreasing healthcare 
resources which impacts on availability of services and contact with healthcare 
professionals, the lack of adherence to key health behaviours during pregnancy among 
women in Ireland also highlights the need to increase the role of health promotion 
initiatives generally at the community level, in advance of pregnancy and to all women 
of child bearing age, since the communication of health messages around these 
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behaviours must be occurring across the life course to ensure better health status 
among women of child bearing age at conception. It is also important to highlight, that 
as we do not find compelling evidence that alcohol use is more prevalent in any 
particular social group, in line with best practice clinical care guidelines, health care 
professionals should be aware that all women need be advised to abstain from alcohol 
during pregnancy irrespective of whether they are perceived to be at risk of exposure. 
Furthermore, the findings highlight that some risks may co-occur and that given 
evidence of higher risk of drinking during pregnancy among smokers which was 
consistent across all cohorts and countries studied, dual targeting of smoking and 
alcohol consumption should potentially be increased and delivered routinely upon a 
woman’s indication of either behaviour during pregnancy. In addition, these 
interactions can also be used to screen more effectively for other adverse life 
experiences such as intimate partner violence and depression, since women who are 
most likely to experience such events are likely to be least engaged with services in 
general. 
Anecdotally, many practitioners are said not to believe that low levels of 
alcohol consumption are harmful. Our findings on the effects of alcohol use examined 
here in three cohort studies highlight the subjectivity of alcohol reporting; with 
substantial variation in population characteristics, measurement methods and 
reporting biases across studies that impact on associations with health outcomes. 
Furthermore, the variation in findings between the more robust cohorts of the thesis 
(SCOPE and ALSPAC), where for example the alcohol birth-weight associations were 
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heterogeneous between the studies for heavy alcohol consumption, highlight that 
even when more robust observational designs are implemented, self-reported alcohol 
consumption data is more often than not suffering from residual confounding, 
reporting bias and selection biases. Thus, in practice, professionals should be aware 
that even the most robust studies showing lack of harm or even some benefit from 
alcohol consumption in pregnancy may not be reliable. Therefore, advice of abstinence 
from alcohol use remains the most prudent recommendation given the evidence 
currently available. 
10.4.3 Public health  
Since 80% of women in Ireland will bear at least one child in their lifetime, the findings 
also have wider public health relevance for womens’ health and wider public health in 
Ireland and may feed directly into goals set out in “Healthy Ireland”, Irelands new 
national framework for action to improve health and wellbeing in Ireland over the 
coming generation (84). For example, pregnancy could be a “teachable moment” 
during the life course where the naturally changing health motivations of women could 
be harnessed for long term behaviour change and wider public health benefits beyond 
pregnancy, given women’s pivotal role in nurturing healthy lifestyle and nutrition 
choices in the wider family unit. Our findings that women are not adhering to clinical 
guidelines during pregnancy in a relatively advantaged cross section, suggest that these 
health behaviours may be even worse in the female general population, and thus, such 
findings highlight a need for policy interventions which focus on women’s diet and 
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lifestyles on wider scale in Ireland. For example, up to 80% of many chronic diseases 
are preventable through early intervention and lifestyle modification (151, 152). 
Pregnancy presents a unique opportunity, early in the life course during which women 
are engaged with their health professional and when behaviours could be more 
modifiable. Thus, pregnancy is a prime location in the life course to influence maternal 
lifestyle for immediate offspring benefits of that pregnancy but potentially wider public 
health benefits beyond pregnancy for women, their children and the wider family unit. 
These findings may be relevant to the achievement of the “Healthy Ireland” goal aimed 
at increasing the proportion of people who are healthy at all stages of life (84). In 
addition, for disadvantaged and high risk groups, the findings illustrate that 
disadvantaged women could experience substantial gains in health behaviour 
improvement around the time of pregnancy, and thus, it points to the value of 
pregnancy in general for changing health behaviours but also particularly for groups 
whom are harder to reach and typically less amenable to health behaviour change at 
other junctures in the life course. These findings are of direct relevance to the “Healthy 
Ireland” goal aimed at reducing health inequalities (84). This may be particularly 
relevant to women with unintended pregnancy who represent a particularly vulnerable 
social group who may otherwise not be in contact with the health service or a health 
professional and typically may be more likely to have higher rates of risk taking 
behaviours. Public health can harness women’s interaction with pregnancy to capitalise 
on the changing motivations of such population groups whom have otherwise low 
rates of help seeking behaviour; this could be used to identify hazardous drinking 
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patterns, screen for physical, sexual and emotional violence in the home, refer to 
further services and enable health behaviour change among the most disadvantaged 
subgroups in the population. 
 Conclusion 10.5
In summary, we found that PRAMS was a valid and feasible method of surveillance of 
behaviours during pregnancy in Ireland which may be an effective method of 
surveillance of health behaviours around the time of pregnancy in the Irish context. 
Moreover, we found that such a surveillance program is immediately warranted given 
the high levels of alcohol consumption, poor diets, smoking and low folate intake 
among women in Ireland. We also found that contrary to guidelines which suggest low 
level of alcohol consumption to be safe, it is possible that selection, recall and 
confounding biases which are common in observational research of this nature are 
likely to be masking harmful effects and that given the quality of evidence available, 
abstinence and provision of advice of abstinence from alcohol may be the most 
prudent choice for patients and healthcare professionals respectively. In relation to 
other health behaviours, pregnancy may be an opportunity in life course where long 
term behaviour change can be harnessed, since we find some limited but none the less 
interesting evidence that even among more disadvantaged women, health behaviour 
improves in pregnancy. Thus, further studies of maternal behaviours and policies and 
interventions to improve maternal behaviour for immediate offspring health benefits 
but longer term, wider societal impacts in women’s health are required in Ireland. 
 231 
 
Further studies of the effects of gestational alcohol use are required; particularly those 
which can reduce the biases and confounding typically associated with studies of this 
nature, improve our understanding of the impact of alcohol use during gestation  and 
the accuracy and reliability of evidence used to support clinical guidelines in practice.  
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Table 11.1 Source and rationale for each PRAMS question 
Concept  Item  Source  Rationale 
Demographics  Infant gender  New 
question 
 Gender was provided through the 
delivery record. However, we chose to 
open the survey with this question for 
two reasons a) cross checking and 
validation with birth record b) gentle 
opening question to ease woman into the 
survey. 
 Age moved to Ireland   Many health behaviours and experiences 
of pregnancy are likely to vary by 
duration of time spent living in the 
country. 
 General health  SLÁN  Self-rated health questions are predictive 
of overall morbidity and mortality and 
important in assessing a woman’s overall 
perception of her health.  
 Ethnicity   Many health behaviours and experiences 
of pregnancy are likely to vary by 
ethnicity. 
 Education   Many health behaviours and experiences 
of pregnancy are likely to vary by 
education. 
 Marital status   Many health behaviours and experiences 
of pregnancy are likely to vary by marital 
status. 
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 Nationality   Many health behaviours and experiences 
of pregnancy are likely to vary by 
nationality. 
 Household income and 
dependents 
  Socio-economic status is often measured 
by equvalised income. Behaviours, 
experiences and health outcomes differ 
by socioeconomic status. 
 Height  PRAMS   Required for calculation of BMI. 
 Weight   Required for calculation of BMI. 
 Weight since pregnancy   Low pre-pregnancy weight for height, low 
maternal height, and low weight gain 
during pregnancy are all associated with 
low birth weight (13). 
 Baby alive now   Reducing infant mortality and 
investigating how infant mortality relates 
to risk factors before and during 
pregnancy are two of the primary goals of 
the PRAMS program in the United States 
and are also primary goals of PRAMS 
Ireland. Studying neonatal mortality and 
its association with risk factors during 
pregnancy and/or since birth will assist in 
targeting intervention programs both 
before and during pregnancy (13). 
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 Medical card status  GUI 
 
 Many health behaviours and experiences 
and health service use characteristics of 
pregnancy are likely to vary by medical 
card status. 
 Private health insurance 
status 
  Many health behaviours and experiences 
and health service use characteristics of 
pregnancy are likely to vary by health 
insurance status. 
 Working full time, return 
to work and reasons for 
going back to work 
  Ireland is currently undergoing economic 
recession. We chose these questions to 
estimate women’s level of employment 
prior to and since pregnancy.  
Pregnancy History  Gravidity  ALSPAC  Many health behaviours and experiences 
of pregnancy are likely to vary by a 
woman’s pregnancy and reproductive 
history. 
 Number of gravidities   
 First pregnancy with 
current partner 
  
 No of live births   
 Previous Miscarriage   
 Previous abortion or 
termination 
  
 Previous stillborn   
 Previous neonatal death   
 Previous low birth weight   
 Previous preterm   
 Previous c section   
 Age first pregnant   
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 Outcome of last 
pregnancy 
  
 Breastfed last baby   
Health before pregnancy  Sexually transmitted 
infections (STIs) 
 ISSHR  STIs can affect fertility and complicate 
pregnancy and may have serious effects 
both on a woman and her developing 
baby. Some of these problems may be 
seen at birth; others may not be 
discovered for months or years later. 
  Health conditions before 
pregnancy 
 PRAMS  Health status prior to pregnancy is an 
important predictor of health during 
pregnancy and subsequent infant and 
maternal health. 
Pregnancy Intention  Pre-pregnancy readiness    Assessing a woman’s readiness for 
pregnancy is an important determinant of 
a woman’s health behaviours during 
pregnancy and subsequently maternal 
and infant health. 
 Pregnancy intention   Women who are unaware of pregnancy 
may engage in risk taking behaviours such 
as smoking and drinking early in 
pregnancy that can affect foetal growth 
and development. Unwanted pregnancies 
carried to term may be associated with 
maternal risk taking behaviours 
throughout pregnancy and with infants 
who receive poor care and nurturing (13). 
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  Pregnancy recognition   Information about the month of 
pregnancy when the mother first 
suspected/first knew that she was 
pregnant is important for assessing 
initiation of antenatal care and changes in 
cigarette and alcohol use (13). 
Intimate partner violence  Intimate partner violence 
in the year before 
pregnancy 
   It is not clear what role pregnancy plays in 
decreasing or escalating physical abuse. 
One potential risk factor is unintended 
pregnancy. A better understanding of the 
relationship between pregnancy, 
pregnancy intention and physical violence 
could have important clinical and public 
health implications (13). 
 Intimate partner violence 
during pregnancy 
  
 Intimate partner violence 
since pregnancy 
  
Physical activity  Physical activity before 
pregnancy and in the last 
three months 
 
   Physical activity is a major determinant of 
population health. Engaging in physical 
activity prior to and during pregnancy is 
part of ensuring health status during 
pregnancy. 
Folic acid  Folic acid before 
pregnancy 
   All women of childbearing age who are 
capable of becoming pregnant should 
consume 0.4 mg of folic acid per day in 
order to reduce the risk of having a child 
with a neural tube defect (NTD). 
Determining the proportion of women 
 Folic acid intake in the 
first 3 months of 
pregnancy 
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Knowledge of folic acid 
intake 
  who take folic acid prior to pregnancy is 
vital (13). 
Assessing a women’s knowledge of the 
reasons for folic acid intake around the 
time of pregnancy allows us to estimate 
the extent to which this vital public health 
message is understood by women and 
what further work is required to ensure 
that all women of child bearing age are 
aware of the importance of folic acid use. 
Multivitamin use  Multivitamin use before 
pregnancy 
   Iron, folic acid and other vitamins are 
essential for a healthy pregnancy.  
 Multivitamin use during 
pregnancy 
  
Contraception & Assisted 
Reproductive Technologies (ART) 
 Contraception use before 
pregnancy 
   The contraceptive behaviour of women is 
of interest because of its relationship to 
unintended pregnancy, abortion, and STIs 
(13). 
 ART before pregnancy   As maternal age increases in Ireland so 
too does the demand and use of 
reproductive technologies. We sought to 
determine the prevalence of ART is our 
sample. 
Smoking  Lifetime smoking history 
 
   To obtain prevalence of smoking to see if 
women reduce or quit during pregnancy 
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 Smoking three months 
before pregnancy 
 
  and to see if women restart smoking 
during the postnatal period. Cigarette 
smoking has been associated with lower 
fecundity and with higher rates of 
spontaneous abortion, abruptio placenta, 
placenta previa, preterm delivery, and 
small-for-gestational age birth. The 
children of mothers who smoke during 
pregnancy may continue to be smaller 
than average and may have slight deficits 
in neurological development. Children 
exposed to environmental tobacco smoke 
are at increased risk for several health 
problems, including lower respiratory 
infection, ear infection, and asthma. 
Infants exposed to tobacco smoke are at 
increased risk of SIDS. Measuring 
cigarette smoking before pregnancy and 
during the last three months allows us to 
assess change during pregnancy (13). 
 Smoking quit status 
around the time of 
pregnancy 
 
  
 Smoking in the last 
trimester of pregnancy 
 
  
 Smoking in home   
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Medications  Prescribed medicines 
during pregnancy 
 
Over the counter (OTC) 
medicines during 
pregnancy 
 
Psycho-
actives/recreational drug 
use during pregnancy 
 Growing 
up in 
Australia  
 Medication use has a significant impact 
on infant outcomes. Documenting the 
prevalence of the use of medicines and 
drugs during pregnancy is important to 
determine the burden of use and trends 
in use over time. 
Alcohol  Alcohol before and during 
pregnancy 
 New 
Question  
 Alcohol use during pregnancy can 
produce a range of teratogenic effects in 
the foetus. The most severe is foetal 
alcohol syndrome, which may include 
facial anomalies, reduced head 
circumference, and mental 
retardation(13). Few studies examine the 
dose, pattern and timing of alcohol use 
during pregnancy which may be 
important in determining risk to the 
foetus (59). 
Stress  Life stressors during 
pregnancy 
 National 
Women’s 
Health 
Survey 
 Low birth weight is associated with 
objective adverse major life events and 
lack of social supports. Documenting the 
prevalence of adverse life events around 
the time of pregnancy is important. 
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Complications  Complications during 
pregnancy 
 GUI  Complications during pregnancy have a 
significant impact on subsequent 
maternal and infant health. Additionally 
complications of pregnancy are related to 
lifestyle and behaviours around the time 
of pregnancy. 
Breastfeeding  Ever breastfed current 
baby 
 PRAMS  Breastfed infants have lower rates of 
hospital admissions, ear and respiratory 
infections, and diarrheal illnesses. 
Breastfeeding also can reduce health care 
expenditures by reducing infant morbidity 
(13). 
 Reasons for not 
breastfeeding 
  Investigating reasons for not 
breastfeeding is important in designing 
interventions and policy around 
breastfeeding. 
 Duration of breastfeeding   The longer the duration of breastfeeding, 
the greater the health benefits (13). 
 Reasons for stopping 
breastfeeding 
  The longer the duration of breastfeeding, 
the greater the health benefits (13). Thus, 
investigating reasons for stopping is 
important in increasing the duration of 
breastfeeding in the population. 
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 Exclusive breastfeeding   While any breastfeeding is beneficial to 
the infant, exclusive breastfeeding 
confers the most benefits to the growing 
infant. Increasing exclusive breastfeeding 
prevalence is an important public health 
goal. 
 Hospital support for 
breastfeeding 
  Women who initiate breastfeeding at 
birth are more likely to continue to 
breastfeed once leaving hospital (13). 
Developing a supportive and encouraging 
atmosphere with appropriate resources 
at the hospital of birth is key in increasing 
breastfeeding prevalence. 
Depression/Psychological 
wellbeing 
 Feelings since birth    Postnatal depression is a cause of 
reduced quality of life, family problems 
and infant bonding after birth (13). 
Examining the prevalence of feelings of 
depression and low mood and its 
correlates is important in developing 
strategies and policy to address 
postpartum depression (PPD) in Ireland. 
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  Postnatal depression care 
received 
  Women may experience symptoms of 
PPD but not receive treatment; care or 
even a diagnosis of PPD. Examining 
diagnoses of PPD and reported feelings of 
PPD is an interesting and worthwhile 
process which can be used to inform 
improved diagnosis and prevention 
strategies in high risk groups. 
Sleep position  Sleep position    SIDS is the leading cause of infant death 
in the postnatal period and accounts for 
36% of deaths. Prone (on the stomach) 
infant sleeping position has emerged as a 
major modifiable risk factor for SIDS (13). 
Data on sleep position is not available in 
Ireland. 
Health care before, during and 
after pregnancy 
 Health advice before 
pregnancy 
   Many pregnancies are unplanned. Advice 
which helps women adopt healthy 
behaviours before pregnancy can 
improve maternal and child health. 
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  Initiation and provision of 
antenatal care 
 
Barriers to receiving 
antenatal care 
 
Satisfaction with 
antenatal care 
 
Content of antenatal care 
   Inadequate use of antenatal care has 
been associated with increased risk of 
low-birth weight births, premature births, 
neonatal mortality, infant mortality, and 
maternal mortality. The receipt of early 
and consistent antenatal care allows for 
diagnosis and management of medical 
conditions that may affect the health of 
both mother and infant (13). Identifying 
barriers to antenatal care is important in 
increasing access to at risk groups (13). 
Satisfaction with antenatal care is 
important in determining the quality of 
care being delivered to women during 
pregnancy. The content of care itself is 
important given its role in providing 
targeted health advice to women to 
improve health outcomes (13). 
  Content of antenatal care: 
delivery mode 
  Caesarean section is rising dramatically in 
many countries including Ireland. 
Investigating the drivers of c section 
including advice given in antenatal care 
may allow us to investigate reasons for c 
section increases. 
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  Gestational diabetes 
mellitus (GDM) care 
  GDM affects approximately 12% of all 
pregnancies. If gestational diabetes is not 
detected and controlled, it can increase 
the risk of birth complications, such as 
shoulder dystocia (when the baby's 
shoulder gets stuck during the birth). It 
can also lead to babies being large for 
their gestational age (13). Thus, assessing 
the adequacy of care given to women 
with GDM is vital. 
  Reasons for c section   Caesarean section is rising dramatically in 
many countries including Ireland. 
Investigating the drivers of c section 
including the reasons women choose to 
have c section is important. Furthermore 
investigating the reasons for c section 
allows us to determine if they are 
emergency or elective sections. 
  Neonatal/special care 
admission 
  Admission to the neonatal/special care 
unit is an indication that a baby requires 
intensive medical attention. As the 
objective of PRAMS is to reduce infant 
mortality and morbidity investigating the 
prevalence of such admissions and factors 
associated with admission is an important 
goal of PRAMS in Ireland. 
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  Ventilator use   Ventilator use may be a marker for poor 
health status in a new-born baby. As the 
objectives of PRAMS are to reduce infant 
mortality and morbidity, ventilator use 
combined with other health outcomes 
may allow us to identify infants with 
increased morbidities. 
  Infant care: two week 
check-up, six week check-
up and vaccines at two 
months 
   Appropriate well-child care has the 
potential to reduce infant morbidity and 
mortality through anticipatory guidance 
and early detection or prevention of 
health problems (13). 
  Postnatal check up   Postnatal check-ups ensure women are 
receiving appropriate care and services 
they need after birth. 
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Table 11.2  Examples of alcohol questions used in major cohort studies and surveys for coverage of timing, quantity and frequency of alcohol 
consumption 
Questionnaire Time of 
collection 
Overall First trimester Second 
trimester 
Third trimester Quantity per 
occasion 
Frequency 
SCOPE 
 
Pregnancy 
(prospective) 
 
 ✓ ✓    
UK 
Millennium 
cohort 
Pregnancy 
(retrospective) 
✓     ✓ 
ALSPAC 
 
Antenatal 
(18 weeks & 
32 weeks) 
  ✓ ✓ ✓ ✓ 
Norwegian Mother 
and Child cohort 
study 
Antenatal 
(15 weeks & 
30 weeks) 
 ✓ ✓ ✓ ✓ ✓ 
Danish National 
Birth Cohort 
Antenatal (12 
weeks and 
30 weeks) 
(plus 2x 
postnatal 
follow- up) 
 ✓  ✓   
Generation R 
Netherlands 
Antenatal 
(similar 
Questionnair
es at <18 
weeks, 18-25 
  ✓    
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weeks, >25 
weeks) 
 
(plus 
postnatal 
follow-up) 
Mater University 
of Queensland 
Study of 
Pregnancy 
Antenatal at 
first 
visit (mean 
19.8 weeks) 
and 
immediately 
postpartum 
✓    ✓ ✓ 
PRAMS 
 
Pregnancy 
(retrospective) 
   ✓   
Aarhus Antenatal 
Cohort 
Aarhus Midwifery 
Centre, Denmark 
Antenatal  ✓ ✓    
American Indian 
Antenatal Survey 
Antenatal ✓     ✓ 
Comparing 
Standard 
Maternity care 
with One to one 
midwifery 
Support 
La Trobe 
University, 
Pregnancy 
(retrospective) 
✓      
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Melbourne 
Victorian 
Adolescent 
Health 
Cohort 
Murdoch 
Children’s 
Research 
Institute, 
Melbourne 
Antenatal 
(third 
trimester) 
 ✓ ✓ ✓  ✓ 
Families First 
Screening Form 
(Canada) 
Pregnancy 
(retrospective) 
 ✓   ✓ ✓ 
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Table 11.3 Modifications made to original questions in PRAMS Ireland survey 
Item Source Original Question (Deletions and changes highlighted) 
Q26 PRAMS Before you got pregnant with your new baby, did a doctor, nurse, 
or other health care workermidwife or other healthcare 
professional  talk with you about any of the things listed below? 
Please count only discussions, not reading materials or videos.  For 
each item, tick Yes if someone talked with you about it or No if no 
one talked with you about it. 
 
Taking vitamins with folic acid before pregnancy 
Being a healthy weight before pregnancy 
Getting my vaccines updated before pregnancy 
Visiting a dentist or dental hygienist before pregnancy  
Getting counselling for any genetic diseases that run in my family 
Controlling any medical conditions such as diabetes and high blood 
pressure 
Getting counselling or treatment for depression or anxiety  
The safety of using prescription or over-the-counter medicines 
during pregnancy 
How smoking during pregnancy can affect a baby 
How drinking alcohol during pregnancy can affect a baby 
How using illegal drugs during pregnancy can affect a baby affect a 
baby 
Q27 PRAMS During the three months before you got pregnant with your new 
baby, did you have any of the following health problems? For each 
one tick Yes if you had the problem or No if you did not. 
 
Asthma 
High blood pressure (hypertension)  
Anaemia (poor blood, low iron) 
Heart problems 
Epilepsy (seizures)  
Thyroid problems   
Depression 
Anxiety 
Coeliac Disease 
Cystic Fibrosis 
Blood clotting disorders 
Colitis 
Gum disease 
Diabetes 
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Q28 PRAMS This question is about things that may have happened during the 
12 months before you got pregnant with your new baby.  
 
During the year (12 months) before you got pregnant did any of the 
following happen to you? 
 
For each thing tick Yes if it happened to you or tick No if it did not.  
 
During the 12 months before you got pregnant did: 
  
Your husband, partner threatened you or made you feel unsafe in 
some way 
You were frightened for the safety of yourself or your family 
because of the anger or threats of your husband or partner 
Your husband or partner tried to control your daily activities for 
example controlling who you could talk to or where you could go 
Your husband or partner forced you to take part in touching or any 
physical activity when you did not want to  
An ex-husband or ex-partner pushed, hit, slapped, kicked, choked, 
or physically hurt you in any other way 
Anyone else physically hurt you in any way 
Your husband or partner pushed, hit, slapped, kicked, choked, or 
physically hurt you in any other way .  
Q29 PRAMS At any time during the 12 months before you got pregnant with 
your new baby, did you do any of the following things?  For each 
item, tick Yes if you did it or No if you did not.   
 
I was dieting (changing my eating habits) to lose weight  
I was exercising 3 or more days of the week  
I was regularly taking prescription medicines other than birth 
control contraception (“the pill”) 
I visited a health care worker health care professional  to be 
checked or treated for diabetes  
I visited a health care worker  health care professional to be 
checked or treated for high blood pressure  
I visited a health care worker health care professional to be 
checked or treated for depression or anxiety 
I talked to a health care worker health care professional about my 
family medical history  
I had my teeth cleaned by a dentist or dental hygienist 
Q31 PRAMS During the month before you got pregnant with your new baby, 
how many times a week did you take a multivitamin, a prenatal 
vitamin or folic acid vitamin folic acid supplement? (Tick one 
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answer) 
 
I didn’t take multivitamins, prenatal vitamins or folic acid vitamins 
at allfolic acid supplements at all 
4  to 6 times a week 
1 to 3 times a week 
Every day of the week 
Q32 PRAMS During the month before you got pregnant with your new baby, 
how many times a week did you take a multivitamin, a prenatal 
vitamin or folic acid vitamin or an antenatal vitamin? (Tick one 
answer) 
 
I didn’t take multivitamins, prenatal vitamins or folic acid vitamins 
at all multivitamins or antenatal vitamins 
4  to 6 times a week 
1 to 3 times a week 
Every day of the week 
Q34 PRAMS When you got pregnant with your new baby, were you or your 
husband or partner doing anything to keep from getting pregnant? 
(Some things people do to keep from getting pregnant include not 
having sex at certain times (natural family planning or rhythm) or 
withdrawal, and using birth control contraception methods such as 
the pill, condoms,  vaginal ring, IUD, having their tubes tied, or their 
partner having a vasectomy.) 
 
No 
Yes 
Q35 PRAMS What were your reasons or your husband’s or partner’s reasons for 
not doing anything to keep from getting pregnant? Tick all that 
apply 
 
I didn’t mind if I got pregnant  
I thought I could not get pregnant at that time 
I had side effects from the birth control contraception I was using 
I had problems getting birth control contraception when I needed it 
I thought my husband or partner or I was sterile (could not get 
pregnant at all)  
My husband or partner didn’t want to use anything 
Other 
Q37 PRAMS Have you smoked any cigarettes in the past 2 years? Have you ever 
smoked cigarettes in your life? 
 
No  
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Yes 
Quit more than two years ago 
Q42 PRAMS During the last three months first three months of your most 
recent pregnancy, how many times a week did you take a 
multivitamin or an antenatal vitamin, a prenatal vitamin or folic 
acid vitamin? (Tick one answer) 
 
I didn’t take multivitamins or antenatal vitamins at all, prenatal 
vitamins or folic acid vitamins at all 
4  to 6 times a week 
1 to 3 times a week 
Every day of the week 
Q43 PRAMS During the last three months  first three months of your most 
recent pregnancy, how many times a week did you take a 
multivitamin, a prenatal vitamin or folic acid vitaminfolic acid 
supplement? (Tick one answer) 
 
I didn’t take multivitamins, prenatal vitamins or folic acid vitamins 
at allfolic acid supplements at all 
4  to 6 times a week 
1 to 3 times a week 
Every day of the week 
Q44 Growing up in 
Australia 
What prescribed medicines or tablets were taken did you take 
during pregnancy? Tick all that apply 
 
Antibiotics/penicillin 
Asthma Medication 
Diabetes Medication 
Nausea/sickness tablets 
Blood pressure tablets 
Iron tablets 
Heartburn tablets 
Anticonvulsants 
Steroids 
Anti-depressants 
Thyroid tablets 
Other 
Don’t know 
Q45 Growing up in 
Australia 
What over the counter medications were used? Tick all that apply 
 
Painkillers (Paracetamol, codeine, aspirin Panadol) 
Iron tablets 
Folic acid/folate 
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Dietary supplements (vitamins) 
Heartburn medicines (Mylanta etc.) (Gaviscon) 
Cold and flu tablets 
Anti-allergy tablets 
Herbal preparations 
Asthma medications (Vent Olin etc) 
Other 
Don’t know 
Q46 Growing up in 
Australia 
How often did Did you take any of the following during your 
pregnancy with baby? Often, Most days, Sometimes, Once or twice, 
Not at all Yes/No 
 
Sleeping pills 
Tranquillisers 
Pills for depression 
Cannabis / Marijuana 
Painkillers (aspirin, paracetamol, etc.) 
Amphetamines or other stimulants  
Heroin, Methadone, Crack, Cocaine 
Esctasy 
Other recreational drugs: Please specify 
Anticonvulsants 
Steroids   
Q50 National 
Women’s 
Health Survey 
Did you experience any event which caused you emotional or 
physical trauma/stress in the 3 months or in the first 12 weeks of 
your last pregnancy? 
 
Job was general demanding and/or stressful 
Loss or change of job, or job security 
Loss of job or job security of husband or partner 
Separation or divorce from husband or partner 
Moving house or major building work 
Serious financial problems 
Accident 
Serious illness 
Miscarriage, termination or death of a baby 
Serious illness of someone close to you 
Death of someone close to you 
Other 
 
During your pregnancy with your new baby did any of the following 
happen to you? 
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For each item tick Yes if it happened to you or No if it did not.  
 
It may help to look at the calendar included when you answer 
these questions. 
 
a) I moved to a new address 
b) I was homeless 
c) Loss of job\job security 
d) Husband or partner lost their job\job insecurity 
e) Separation\divorce  
f) Serious financial problems 
g) Accident 
h) Serious illness 
i) Serious illness of someone close 
j) Death of someone close 
k) Death of child 
l) I had anxiety that was diagnosed by a GP 
m) I had depression that was diagnosed by a GP 
n) I argued with my husband or partner more than usual 
o) My husband or partner said he didn’t want me to be 
pregnant 
p) I was in a physical fight 
q) Someone very close to me had a problem with drinking or 
drugs 
Other stressful\traumatic event 
 
Q51 PRAMS This question is about things that may have happened during your 
most recent pregnancy.  
 
For each thingone, circle tick Y (Yes)Yes if it happened to you or 
circle N (No)or No if it did not.  
 
During your most recent pregnancy did any of the following happen 
to you? 
   
Your husband, partner threatened you or made you feel unsafe in 
some way   
You were frightened for the safety of yourself or your family 
because of the anger or threats of your husband or partner   
Your husband or partner tried to control your daily activities, for 
example, controlling who you could talk to or where you could go 
Your husband or partner forced you to take part in touching or any 
sexual activity when you did not want to 
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Your husband or partner pushed, hit, slapped, kicked, choked, or 
physically hurt you in any other way 
An ex-husband or ex-partner pushed, hit, slapped, kicked, choked, 
or physically hurt you in any other way 
Anyone else physically hurt you in any way 
Q54 PRAMS How many weeks or months pregnant were you when you were 
sure you were pregnant? (For example, you had a pregnancy test or 
a doctor, or nurse, midwife or other healthcare professional said 
you were pregnant.)  
Q55 GUI How many weeks into your pregnancy did you have your first 
prenatal antenatal booking appointment with your 
hospital/independent Midwife? 
 
 GP  
 Hospital/Independent Midwife 
 
____Weeks OR 
I did not go for antenatal care 
Q57 PRAMS Did you get prenatal care  antenatal care as early in your pregnancy 
as you wanted?  
 
No  
Yes  
Q58 PRAMS Did any of these things keep you from getting prenatal antenatal 
care at all or as early as you wanted?  
 
For each item, circle T (True) tick yes if it was a reason that you 
didn’t get prenatal antenatal care when you wanted or circle F 
(False) tick No if it was not a reason for you or if something does 
not apply to you  
 
I couldn’t get an appointment when I wanted one 
I didn’t have enough money or insurance to pay for my visits  
I had no transportation to get to the clinic or doctor’s office.  
The doctor or my health plan would not start care as early as I 
wanted  
I had too many other things going on  
I couldn’t take time off from work or school  
 I didn’t have my Medicaid (or state Medicaid name) card  
I had no one to take care of my children  
I didn’t know that I was pregnant  
I didn’t want anyone else to know I was pregnant  
I didn’t want prenatal antenatal  care  
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Q59 PRAMS We would like to know how you felt about the prenatal antenatal 
care you got during your most recent pregnancy. If you went to 
more than one place for prenatal care, answer for the place where 
you got most of your care. For each item, circle Yes if you were 
satisfied or circle No if you were not satisfied.  
 
 Were you satisfied with 
   
The amount of time you had to wait after you arrived for your visits 
The amount of time the doctor, nurse, or midwife spent with you 
during your visits  
The advice you got on how to take care of yourself 
The understanding and respect that the staff showed toward you 
as a person 
Q61 PRAMS During any of your prenatal antenatal; care visits, did a doctor, 
nurse, or other health care worker professional talk with you about 
any of the things listed below? Please count only discussions, not 
reading materials or videos. For each item, circle Y (Yes) if someone 
talked with you about it or circle N (No) if no one talked with you 
about it.  
 
How smoking during pregnancy could affect my baby  
Breastfeeding my baby  
How drinking alcohol during pregnancy could affect my baby  
Using a seat belt during my pregnancy 
Medicines that are safe to take during my pregnancy  
How using illegal drugs could affect my baby  
Doing tests to screen for birth defects or diseases that run in my 
family 
The signs and symptoms of preterm labour (labour more than 3 
weeks before the baby is due  
What to do if my labour starts early  
Getting tested for HIV (the virus that causes AIDS)  
What to do if I feel depressed during my pregnancy or after my 
baby is born  
Physical abuse to women by their husbands or partners 
If you planned to use birth control after your baby was born 
Talk with you about how eating fish containing high levels of 
mercury could affect your baby   
Talk with you about how much weight you should gain during your 
pregnancy 
Talked with you about family size 
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Q61 PRAMS How did the doctor, nurse, midwife or other health care worker 
professional who provided your prenatal antenatal care suggest 
you deliver your new baby? Tick one answer 
 
He or she suggested I deliver my baby vaginally (naturally)  
He or she suggested I have a caesarean delivery (c-section)  
He or she didn’t suggest how I deliver my baby 
Q63 ISSHR Can you tell me what STI that was? Tick all that apply 
 
Herpes  
Trichomonas (Trich, TV)  
Gonorrhoea  
Syphilis  
Chlamydia  
Bacterial Vaginosis (gardnerella)  
Hepatitis A  
Hepatitis B 
Hepatitis C  
NSU (Non Specific Urethritis) 
NGU (Non Gonococcal Urethritis)  
Genital warts (venereal warts, Human Papilloma Virus, HPV)  
Pelvic Inflammatory Disease (PID, Salpingitis) 
Pubic lice 
HIV or AIDS  
Yes, but can’t remember which  
Other  
Q64 ISSHR When were you diagnosed with this (your last) STI (s)?  
 
During Pregnancy  
Last In the 12 months before you got pregnant with your new baby  
5 – 10 years ago   
1 to 5 years ago 
More than 10 years ago  
More than one year before you got pregnant 
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Q65 PRAMS A. During your most recent pregnancy, when you were told 
that you had gestational diabetes, did the doctor, nurse, or 
other health care worker tell you to make an appointment 
with a different doctor because of your gestational 
diabetes?professional  do any of the things listed below?  
 
No  
Yes  
 
B. During your most recent pregnancy, when you were told 
that you had gestational diabetes, did a doctor, nurse, or 
other health care worker do any of the things listed below? 
For each item, circle Y (Yes) if it was done or circle N (No) if 
it was not done.  
 
Refer you to a nutritionist  
Talk to you about the importance of exercise  
Talk to you about getting to and staying at a healthy weight after 
delivery  
Suggest that you breastfeed your new baby  
Talk to you about your risk for Type 2 diabetes 
Tell you to make an appointment with a different specialist/clinic  
because of your gestational diabetes 
Give you a glucose tolerance test 
Q74 PRAMS A. Does your husband or partner smoke inside your home?  
No  
Yes  
 
B. Not including yourself or your husband or partner, does 
anyone else smoke cigarettes inside your home?  
No  
Yes 
 
Does anyone smoke in your home (you, your husband or partner or 
anyone else)? 
No 
Yes 
Q75 PRAMS Did you ever breastfeed or pump express breast milk to feed your 
new baby after delivery, even for a short period of time? 
 
No    
Yes  
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Q77 PRAMS A. How many weeks or months did you breastfeed or pump 
express milk to feed your baby? 
 
____weeks _____months 
 
Less than 1 week 
 
B. Are you currently breastfeeding or feeding pumped milk to 
your new baby? 
 
No  
Yes     
 
I am currently breastfeeding my baby 
Q78 PRAMS What were your reasons for stopping breastfeeding? Tick all that 
apply 
 
My baby had difficulty latching or nursing  
Breast milk alone did not satisfy my baby 
I thought my baby was not gaining enough weight 
My nipples were sore, cracked, or bleeding 
It was too hard, painful, or too time consuming 
I thought I was not producing enough milk 
I had too many other household duties 
I felt it was the right time to stop breastfeeding 
I got sick and was not able to breastfeed 
I went back to work or school 
My baby was jaundiced (yellowing of the skin or whites of the eyes)  
I had enough and I wanted to stop 
Other  
Q81 PRAMS This question asks about things that may have happened at the 
hospital where your new baby was born. For each item, tick Yes if it 
happened or circle No if it did not happen. 
 
Hospital staff gave me information about breastfeeding 
My baby stayed in the same room with me at the hospital 
I breastfed my baby in the hospital 
I breastfed in the first hour after my baby was born  
Hospital staff helped me learn how to breastfeed 
My baby was fed only breast milk at the hospital 
Hospital staff told me to breastfeed whenever my baby wanted 
The hospital gave me a breast pump to use  
The hospital gave me a gift pack with formula 
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The hospital gave me a telephone number to call for help with 
breastfeeding 
My baby used a soother in the hospital 
Q82 PRAMS Below is a list of feelings and experiences that women sometimes 
have after childbirth.  Read each item to determine how well  
it describes your feelings and experiences.  Then, circle the choice 
that best describes how often you have felt or experienced  
things this way since your new baby was born.  Use the scale when 
 answering:  
Never                  Rarely              Sometimes               Often                 Always 
 
 
I felt down, depressed or sad 
I felt hopeless  
I felt slowed down  
I felt lonely  
I felt panicky 
I felt restless 
I felt that I could not cope 
Q83 PRAMS A. Since your new baby was born (Tick all that apply) 
A.B. , has a doctor, nurse, or other health care worker 
told you that you had depression? 
 
No   
Yes 
B.C. Since your new baby was born, have you taken 
prescription medicine for your depression? 
 
No 
Yes 
 
C.D. Since your new baby was born, has a doctor, nurse, 
or other health care worker told you that you had anxiety? 
 
No   
Yes 
 
D.E. Since your new baby was born, have you taken 
prescription medicine for your anxiety? 
 
No 
Yes 
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Q85 PRAMS Since your new baby was born, have you had a postpartum  
postnatal check-up for yourself? (A postpartum  postnatal check-up 
is the regular check-up a woman has about 6 weeks after she gives 
birth.) 
 
No  
Yes 
Q87 PRAMS What kind of medical problem caused you to go into the hospital? 
Check all that apply 
 
Vaginal bleeding 
Fever or infection 
Blood pressure 
Urinary tract infection (UTI) 
Mastitis (Infection in your breasts) 
Wound infection 
Other   
Q88 PRAMS This question is about things that may have happened since your 
most recent delivery. For each thing, circle Y (Yes) if it happened to 
you or circle N (No) if it did not.  
 
Since your most recent deliverynew baby was born: 
  No Yes 
Your Has your husband or partner threatened you or made you feel 
unsafe in some way 
You Have you were frightened for the safety of yourself or your 
family because of the anger or threats of your husband or partner  
Your Has your husband or partner tried to control your daily 
activities, for example, controlling who you could talk to or where 
you could go Your Has your husband or partner forced you to take 
part in touching or any sexual activity when you did not want to 
Has your husband or partner pushed, hit, slapped, kicked, choked, 
or physically hurt you in any other way 
Has an ex-husband or ex-partner pushed, hit, slapped, kicked, 
chocked, or physically hurt you in any other way 
Has anyone else physically hurt you in any other way 
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Table 11.4 Evidence used in decision making on PRAMS design features based on cost, practicality and appearance 
Evidence used in decision making in PRAMS n OR (95% CI) Included in PRAMS 
Ireland* 
Decisions made based on cost effectiveness    
Colour vs. white questionnaire 14 1.04 (0.99, 1.10) Colour 
Colour vs. standard  (black, blue)  ink 3 1.16 (0.95, 1.42) Black 
Questionnaire printed on high vs. standard quality paper or thick 
vs. thin paper 
2 0.80 (0.60, 1.06) Standard 
Larger paper size vs. smaller 2 0.88 (0.56, 1.39) Smaller 
Respond on questionnaire vs. on separate form 1. 1.13 (0.57, 2.27) Questionnaire 
Postal & optional internet response vs. only postal response 1 0.93 (0.82, 1.05) Only postal 
Study logo on several items vs. questionnaire only 1 0.92 (0.72, 1.18) Questionnaire 
Window vs. regular envelope 2 0.96 (0.61, 1.49) Regular 
Questionnaire posted in large vs. standard/small envelope 1 0.93 (0.74, 1.17) Small 
Brown vs. white envelope 5 1.23 (0.81, 1.87) Brown 
Stamped vs. franked outward envelope 6 0.95 (0.88, 1.03) Franked 
Stamped addressed return envelope vs. address label only included 1 0.86 (0.45, 1.65) Stamped addressed 
University printed envelope vs. plain 1 0.88 (0.61, 1.28) Plain 
Offer of survey results vs. no offer 12 0.90 (0.76, 1.07) No offer 
Decisions made based on practicality    
Questions ordered by time period vs. other order 1 1.48 (0.84, 2.59) Time ordered 
More general questions first vs. Last 3 0.95 (0.83, 1.09) General first 
Demographic items first vs. last 4 1.08 (0.94, 1.25) First 
Open ended vs. closed questions 3 0.31 (0.09, 1.04) Closed 
Don’t know boxes included vs. not 1 1.03 (0.82, 1.29) No don’t knows 
Cartoons included vs. not 1 1.00 (0.62, 1.62) No cartoons 
Picture of researcher vs. none 4 1.07 (0.76, 1.53) No picture 
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Identifying feature on return vs. none 8 1.12 (0.82, 1.52) Identifying 
Questionnaire sent to work vs. home address 2 1.16 (0.89, 1.52) Home 
Consent form included vs. not 1 1.32 (0.89, 1.95) Not 
Questionnaire posted on Monday vs. Friday 1 0.83 (0.58, 1.17) When suitable 
Questionnaire received on Monday vs. Friday 1 1.00 (0.64, 1.56) When suitable 
Pre-contact by phone vs. postal 7 1.18 (0.77, 1.80) Postal 
Follow-up by phone vs. postal 5 0.86 (0.54, 1.36) Postal 
Follow-up interval less than 31 days vs. 31-60 days 2 0.97 (0.75, 1.26) Less than 31 
Decisions made based on appearance/desirability/perceived 
credibility of study to participant 
   
Large vs. small font  1.26 (0.87, 1.82) Large 
Matrix vs. standard form 2 0.58 (0.29, 1.16) Standard 
Circle answer vs. tick box format 2 0.96 (0.74, 1.26) Tick box 
Check categories or specify numbers vs. check categories only 1 0.80 (0.60, 1.06) Check categories 
Questionnaire sent with supplement vs. alone 1 0.86 (0.70, 1.07) Alone 
Folder or booklet vs. stapled pages 3 1.10 (0.99, 1.23) Booklet 
Detailed vs. brief cover letter 1 1.08 (0.74, 1.58) Brief 
Signed vs. unsigned 2 1.34 (0.97, 1.85) Signed 
Sent or signed by more vs. less senior/well-known person 10 1.05 (0.89, 1.23) Both 
Pre-contact by medical researcher vs. non-medical researcher 2 1.01 (0.55, 1.86) Both 
Male vs. female investigator 2 1.07 (0.72, 1.58) Both 
Colour vs. black & white letterhead 2 1.08 (0.91, 1.28) Colour 
Dot matrix print vs. letter quality print 1 1.15 (0.63, 2.10) Letter quality print 
Header vs. no header 1 1.13 (0.90, 1.41) Header 
Choice to opt out from the study vs. none 4 0.92 (0.66, 1.28) Choice to opt out 
Appeal vs. none 2 1.06 (0.76, 1.42) Appeal 
Appeal stresses benefit to society vs. other 10 1.09 (0.92, 1.29) Society 
Request for participants signature vs. none 1 1.19 (0.65, 2.18) None 
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Instructions given vs. not 1 0.89 (0.74, 1.06) Not 
Response deadline given vs.no deadline 6 1.00 (0.84, 1.19) No deadline 
Mention of follow-up contact vs. none 7 1.02 (0.91, 1.15) None 
Explanation for non-participation requested vs. not 2 1.14 (0.83, 1.57) Not 
Time estimate for completion given vs. not 1 1.10 (0.76, 1.58) Not 
Pre-paid return envelope vs. not pre-paid 4 1.09 (0.71, 1.68) Prepaid 
Questionnaire sent 1-5 weeks vs. 9-14 weeks after hospital 
discharge 
2 2.26 (0.69, 7.37) 9-14 weeks  
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  Opt out consent form 11.1
Study ID Number:«Study_ID» 
Title of Protocol: Learning more about mothers experiences and behaviours 
before, during and after pregnancy: a postal survey to a postnatal population with 
recent deliveries at Cork University Maternity Hospital 
Doctor Directing Research: Professor Richard Greene  Phone: 086-
7842264 
You are being asked to participate in a research study.  The doctors at University 
College Cork study the nature of disease and attempt to develop improved methods of 
diagnosis and treatment.  In order to decide whether or not you want to be a part of 
this research study, you should understand enough about its risks and benefits to 
make an informed judgment.  This process is known as informed consent.  This consent 
form gives detailed information about the research study.  After you have read and 
understood the study and should you decide that you do NOT wish to participate 
please sign this form and return it to us.  
If you want to participate please do not sign or return this form. 
Section B 
NATURE AND DURATION OF PROCEDURE: The Pregnancy Risk Assessment Monitoring 
System (PRAMS) is a research project sponsored by the National Perinatal 
Epidemiology Centre, University College Cork and the Health Research Board. The 
purpose of this study is to find out more about things that happen before, during and 
after your pregnancy. We are asking mothers who recently delivered a baby at Cork 
University Maternity Hospital to answer the same questions. All of your names were 
picked from Information Patient Management System in the hospital that records your 
details on arrival at the hospital.  
If you choose to take part in this study, we will send you a survey in the post which we 
would like you to answer. It takes about 40 minutes to answer the questions. Later we 
may send you the same survey again to remind you to answer the questions if you 
have forgotten to do so. We may also contact you by telephone. 
Your answers will be grouped with the answers of other women. We are asking about 
1200 other women like you who recently had a baby in Cork University Maternity 
Hospital the same questions. What we learn from PRAMS will be used to help mother 
and babies in Ireland.  
 
POTENTIAL RISKS AND BENEFITS: We ask that you fill out the survey because your 
answers are important, and could help other mothers and babies in the future. Some 
questions may be sensitive such as questions about smoking or drinking during 
pregnancy. By answering some questions about your recent pregnancy you can help us 
find out why some babies are born healthy and others are not. Your answers can also 
help improve the health care that babies and mothers get in Ireland in the future. If 
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you choose to participate in the survey your answers will be kept confidential as per 
the Data Protection Act 1988/2003 and will be used for research purposes only. Your 
name will not appear on any reports from PRAMS. The booklet has an identification 
number so we will know whether it is returned or not.  
POSSIBLE ALTERNATIVES: You are free to do the survey or not. If you don’t want to 
participate at all or if you don’t want to answer a particular question, that’s ok. There 
is no penalty for not participating in the survey and your treatment and care will not 
be affected now or in the future. 
 
Only complete and return this form if you do not want to participate and do not wish 
to be contacted further.  
Section C          
 Note: Only sign and return this form if you                                                    
   do not want to participate in this research study 
 
The research project and the treatment procedures associated with it have been fully 
explained to me.  All experimental procedures have been identified and no guarantee 
has been given about the possible results.  I have had the opportunity to ask questions 
concerning any and all aspects of the project and any procedures involved.  I am aware 
that participation is voluntary.  I am aware that my decision not to participate or to 
withdraw will not restrict my access to health care services normally available to me.  
Confidentiality of records concerning my involvement in this project will be maintained 
in an appropriate manner.  As required by law, the records of this research may be 
reviewed by government agencies and sponsors of the research. 
 
I understand that the sponsors and investigators have such insurance as is required by 
law in the event of injury resulting from this research. 
 
I, the undersigned, do not want to participate as a subject in the above described 
project conducted at the Cork Teaching Hospitals.  I have received a copy of this 
consent form for my records.  I understand that if I have any questions concerning this 
research, I can contact the doctor listed above.  If I have further queries concerning my 
rights in connection with the research, I can contact the Clinical Research Ethics 
Committee of the Cork Teaching Hospitals, Lancaster Hall, 6 Little Hanover Street, 
Cork. 
 
After reading the entire consent form, if you have no further questions about giving 
consent, please sign where indicated and return to us if you do not want to 
participate in this survey. If you want to participate please do not sign or return this 
form. Your questionnaire will soon arrive in the post.  
 
I understand that if I am under the age of 18 years and I do not wish to participate in 
this survey that I must sign below. My parent or guardian must also sign below if I am 
under the age of 18 in order to indicate that I do not wish to participate.  
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Signature of Subject:_______________________________________________ 
 
Guardian (if subject is under 18 years of age):___________________________ 
 
Date:                            Time:  AM □ PM □ 
 
If you have any questions about the project or your rights please contact 
Linda O’Keeffe 
: 086 7842264   l.okeeffe@ucc.ie  
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  About PRAMS information sheet 11.2
 
About PRAMS 
 The Pregnancy Risk Assessment Monitoring System is a research project 
sponsored by the National Perinatal Epidemiology Centre, University College 
Cork and the Health Research Board, Dublin.  
 
 The purpose of this study is to find out more about the experiences and 
behaviours of women before, during and after their pregnancy.  
 
 We are asking mothers who recently delivered a baby at Cork University 
Hospital to answer the same questions. All of your names were picked at 
random from the delivery book in the hospital that records your name and 
address after you have delivered your baby.  
 
 It takes about 40 minutes to answer the questions. Some questions may be 
sensitive in nature, such as questions about smoking or drinking during 
pregnancy.  
 
 Taking part in this survey is completely voluntary. If you do not wish to 
participate there is no penalty and your treatment and care will not be affected 
now or in the future. 
 
 If you choose to participate in the survey your answers will be kept confidential 
as per the Data Protection Act 1988/2003 and will be used for research 
purposes only.  
 
 Your name will not appear anywhere in the PRAMS study. This is achieved by 
using an identification number which is unique to you. You will see this number 
on the inside of your PRAMS booklet. Your answers will be grouped with those 
from other women to help us to learn more about the health of mothers and 
babies. 
 
 If you don’t want to participate at all in this survey and do not wish to be 
contacted further in any way, please read and sign the form included which 
says “I do not wish to participate” and return it to us in the pre-paid envelope 
enclosed. 
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 If you have any questions relating to PRAMS please contact  
Linda O’Keeffe 
Researcher at the National Perinatal Epidemiology Centre 
E-mail: l.okeeffe@ucc.ie 
Mobile: 086 7842264 
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  Letter 1: study invitation letter 11.3
 
Coláiste an Leighis agus na Sláinte 
College of Medicine and Health 
Roinn na Cnáimhseachas agus Liacht Bhan 
Department of Obstetrics and Gynaecology 
Cork University Maternity Hospital 
Wilton 
Cork, Ireland 
 
T 353 (0)21 420 5053  
M 353 (0)86 7842264 
 
Professor  R.A. Greene, MB, MRCOG, MRC 
Director 
   
Dear Ms. «Last_Name» 
We are writing to you to ask you to participate in a new and exciting study of maternal 
and infant health in Ireland called Pregnancy Risk Assessment Monitoring System 
(PRAMS). PRAMS’ is the first study of maternal and infant health in Ireland which seeks 
to collect information on an on-going basis from new mothers about their pregnancy 
and their baby.  
The study is an initiative of the National Perinatal Epidemiology Centre (NPEC). The 
NPEC is part of University College Cork and is based in Cork University Maternity 
Hospital (CUMH). The NPEC is committed to improving maternal and infant health in 
Ireland. PRAMS is also supported and funded by the Health Research Board, Dublin. 
This study is important because every year in Ireland over 75,000 babies are born. 
However, we know very little about the experiences, feelings and behaviours of 
women before, during and after pregnancy. The focus of PRAMS is to learn more about 
the experiences and behaviours of women in order to improve maternal and infant 
health and plan programs and health services for mothers both now and in the future. 
In doing so, we should be able to direct policy and achieve lasting maternal and infant 
well-being in Ireland.  
You have been chosen to take part in this study because you recently had a baby at 
CUMH where your details were randomly selected from the information Patient 
Management System. We would like to learn more about your experiences and 
behaviours around the time of your pregnancy. Sometimes mothers and babies have 
traumatic and difficult experiences. The NPEC acknowledges that undertaking a 
questionnaire for some mothers who have had a traumatic maternal experience can be 
difficult. If you or your baby have experienced a traumatic experience following the 
birth of your baby, your answers are especially important to us. By participating, you 
will help us to learn more about the various health outcomes babies can have. 
 
 272 
 
If you choose to participate you can expect to receive a booklet in the post in the next 
7-10 days. We would like you to answer the questions in this booklet and return it to us 
in the pre-paid envelope included. It should not take you more than 40 minutes to 
complete. If you have not returned the booklet after one week we may send you the 
booklet again as a reminder and we may also contact you by telephone. If you decide 
that you do not want to participate you must return the “opt out consent form” 
included here. We have also included a copy of this for you to keep for your own 
records.  
In this study 1200 other women like you are being invited to participate and share their 
experiences and behaviours. All information collected in the course of the study is 
completely confidential in line with the Data Protection Act 1988/2003 and will only be 
used for research purposes. Taking part in this study is completely voluntary. If you do 
not wish to participate there is no penalty and your treatment and care will not be 
affected now or in the future.   
Ethical approval for this study was granted to us from the Cork Research Ethics 
Committee (CREC). If you have any queries about the study or your involvement in it, 
please do not hesitate to contact our PRAMS research contact Miss Linda O’Keeffe on 
mobile at 086 – 7842264 or by email at l.okeeffe@ucc.ie.  
We would like to thank you for taking the time to read this letter. We understand how 
busy mothers with a newborn can be. We greatly appreciate the time you have 
devoted to participating in this study. 
Thanking you in advance.  
Yours sincerely,  
 
_____________________    ______________________ 
Professor Richard Greene     Miss Linda O’Keeffe 
Director      HRB PhD Scholar 
National Perinatal Epidemiology Centre  PRAMS  
       National Perinatal Epidemiology 
Centre 
       Email: l.okeeffe@ucc.ie 
       Mobile: 086-7842264 
----------------------------------------------------------------------------------------------------------------
------ 
Study ID:«F1» 
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If you want to participate but do not want to be contacted by telephone please tick 
this box  and return this slip to us in the postage paid envelope provided. 
If you do not wish to participate at all in the survey please read and complete the form 
included with this letter and return it to us in the envelope provided. 
 274 
 
  Letter 2: letter accompanying first PRAMS survey 11.4
 
Coláiste an Leighis agus na Sláinte 
College of Medicine and Health 
Roinn na Cnáimhseachas agus Liacht Bhan 
Department of Obstetrics and Gynaecology 
Cork University Maternity Hospital 
Wilton 
Cork, Ireland 
T 353 (0)21 420 5053 
M 353 (0)86 7842264 
Professor  R.A. Greene, MB, MRCOG, MRC 
Director 
 
Dear «Ms» «Last_Name» 
I wrote to you on October 1st to request your participation in a research project called 
PRAMS (Pregnancy Risk Assessment Monitoring System).  
We have enclosed the PRAMS booklet which asks questions about your experiences 
and behaviours before, during and after your recent pregnancy. PRAMS is an exciting 
new project that seeks to understand more about the health of mothers and babies 
and we are very grateful for your contribution. Your time is valuable and we thank you 
sincerely for your participation. Your answers can really help to improve the health of 
mothers and babies in Ireland. 
There is more information about this research project on the page called “About 
PRAMS” enclosed. If you have any queries about the study or your involvement in it, 
please do not hesitate to contact our PRAMS research contact Linda O’Keeffe on 
mobile at 086 – 7842264 or by email at l.okeeffe@ucc.ie.  
Once you have completed the survey, please return the booklet to us in the enclosed 
pre-paid envelope. Once again thank you. We really appreciate how busy mothers with 
new-born’s can be and we are very grateful for your time. 
 Yours sincerely,    
 
_____________________    ______________________ 
Professor Richard Greene     Ms Linda O’Keeffe 
Director      HRB PhD Scholar  
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National Perinatal Epidemiology Centre  National Perinatal Epidemiology 
Centre 
       Email: l.okeeffe@ucc.ie 
       Mobile:086-7842264 
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  Letter 3: reminder letter 11.5
 
Coláiste an Leighis agus na Sláinte 
College of Medicine and Health 
Roinn na Cnáimhseachas agus Liacht Bhan 
Department of Obstetrics and Gynaecology 
Cork University Maternity Hospital 
Wilton 
Cork, Ireland 
T 353 (0)21 420 5053 
M 353 ())86 7842264 
Professor  R.A. Greene, MB, MRCOG, MRC 
Director 
    
Dear Ms. «Last_Name» 
I wrote to you on X date to request your participation in a research project called 
PRAMS (Pregnancy Risk Assessment Monitoring System). We also sent you the PRAMS 
booklet to complete which asks questions about your experiences and behaviours 
before, during and after your recent pregnancy. PRAMS is an exciting new project that 
seeks to understand more about the health of mothers and babies.  
If you have already sent the completed PRAMS booklet to us, we thank you very much. 
If not, would it be possible to take some time today to answer the questions and return 
it to us. Your time is valuable and we thank you sincerely for your contribution. Your 
answers can really help to improve the health of mothers and babies in Ireland.  
We appreciate how valuable your time is and we thank you for your participation. 
There is more information about this research project on the page “About PRAMS” 
enclosed. If you have any queries about the study or your involvement in it, please do 
not hesitate to contact our research contact for PRAMS Miss Linda O’Keeffe on mobile 
at 086 – 7842264 or by email at l.okeeffe@ucc.ie. Once you have completed the 
survey, please return it to us in the prepaid envelope that we enclosed with the 
booklet. 
Once again thank you. We really appreciate how busy mothers with newborn’s can be 
and we are very grateful for your time. Your answers are very important to us and can 
really make a difference.  
Sincerely, sincerely,  
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_____________________    ______________________ 
Professor Richard Greene     Ms Linda O’Keeffe 
Director      HRB PhD Scholar  
National Perinatal Epidemiology Centre  National Perinatal Epidemiology 
Centre 
       Email:l.okeeffe@ucc.ie 
Mobile:086-7842264 
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  Letter 4: letter accompanying the second PRAMS survey 11.6
 
 
Coláiste an Leighis agus na Sláinte 
College of Medicine and Health 
 
Roinn na Cnáimhseachas agus Liacht Bhan 
Department of Obstetrics and Gynaecology 
 
Cork University Maternity Hospital 
Wilton 
Cork, Ireland 
 
T 353 (0)21 420 5017 
M 353 (0)86 7842264 
 
Professor  R.A. Greene, MB, MRCOG, MRC 
Director 
   
Dear Ms. «Last_Name» 
 
We previously wrote to you to request your participation in a research project called 
PRAMS (Pregnancy Risk Assessment Monitoring System). Enclosed with this letter was 
the PRAMS booklet. The PRAMS study is now coming to an end and we are very 
grateful for your contribution. 
 
We have enclosed a final copy of the PRAMS booklet and would be very thankful if you 
could complete and return to us. Your time is valuable and we thank you sincerely for 
your participation. Your answers can really help to improve the health of mothers and 
babies in Ireland. 
 
If you have already returned the PRAMS booklet to us, we thank you very much and 
please disregard this letter 
 
If you have any queries about the study or your involvement in it, please do not 
hesitate to contact our research contact for PRAMS Miss Linda O’Keeffe on mobile at 
086 – 7842264 or by email at l.okeeffe@ucc.ie.  
Once you have completed the survey, please return the booklet to us in the enclosed 
pre-paid envelope. 
 
Thank you once again, we are very grateful for your time.  
Sincerely, 
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_____________________    ______________________ 
Professor Richard Greene     Miss Linda O’Keeffe 
Director      HRB PhD Scholar 
National Perinatal Epidemiology Centre  PRAMS  
       National Perinatal Epidemiology 
Centre 
       Email: l.okeeffe@ucc.ie 
       Mobile: 086-7842264 
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  Text reminder 11.7
 
 
REMINDER from the PRAMS team at Cork University 
Maternity Hospital. We really hope you can 
participate in the PRAMS Study. Please return your 
completed PRAMS booklet in the freepost envelope 
provided. If you have misplaced your survey text 
"Lost" to this number and we will forward another 
booklet to you. Your answers really can make a 
difference. Thanks again for your contribution. Linda 
at NPEC, CUMH. (This is a text only service). 
PRAMS 
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 Ethical approval letters for PRAMS 11.8
 
 282 
 
 283 
 
 284 
 
 285 
 
 
 286 
 
 
 287 
 
 288 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix II 
12 Statistical methods  
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In the present thesis a number of basic and more complex modelling techniques were 
employed to model change in behaviours before, during and after pregnancy and to 
model the relationships between alcohol exposure and growth outcomes. In this 
chapter, these statistical methods will be described in additional detail to the statistical 
methods section of all relevant papers in Chapters 2-9. 
  Latent variable methods 12.1
In Chapter 6, adherence to health behaviours around the time of pregnancy was 
examined in the PRAMS Ireland study using descriptive statistics. However, prior to 
completing this analysis a more advanced approach called Latent Class Analysis (LCA) 
was explored. Latent variable methods (which include LCA, path analysis, Structural 
Equation Modelling (SEM) and Latent Transition Analysis (LTA) are person centred 
approaches to data analysis which focus on identifying individual subtypes of people 
who exhibit similar patterns of individual characteristics (153). This contrasts with a 
variable centred approach which focuses on identifying relationships between all 
variables, assumed to hold for all individuals (153). Latent variable methods are useful 
when the variable being examined or measured cannot be measured directly but 
rather indirectly observed through observation of related variables (154). For example, 
alcoholism is an unobserved latent variable that may not be directly observed but 
rather observed through diagnostic criteria for alcoholism (154).  
In Chapter 2-4, the collection of data on behaviours three months before 
pregnancy and during pregnancy in the retrospective PRAMS Ireland survey at CUMH is 
described. These included folic acid intake, smoking, alcohol use and physical activity. 
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We postulated that a latent variable approach would be a suitable method to examine 
an indirectly observed latent variable through these observed related variables in order 
to divide the population into homogeneous subgroups with similar behaviour profiles 
during pregnancy. Thus, the rationale for the use of a latent variable approach on the 
analysis of maternal behaviours during pregnancy stemmed from an underlying 
assumption that behaviours would potentially cluster within individuals and that such 
clustering of maternal behaviours would be represented by some underlying 
unmeasured latent construct that explains the dependence and relationship between 
all of the variables under study. Secondly, due to the presence of two time points at 
which these behaviours were measured (before and during pregnancy in PRAMS 
Ireland), it seemed not only appropriate to examine the latent structure of health 
behaviours at each time point separately but also examine the incidence of transition 
in latent class membership  between the two time points i.e. if a woman is a “risk 
taker” prior to pregnancy where does she transition to, based on the latent structure 
of health behaviour during pregnancy and what factors predict this change. Figure 12.1 
displays a basic conceptual model of a latent variable approach to the analysis of data 
on maternal behaviours during pregnancy, showing the unobserved latent variable of 
interest and the observed measured variables X1-X6 which are used to approximate 
this latent variable. E1-E6 represent the measurement error associated with each 
observed indicator variable.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12.1 Latent class analysis model 
As part of the thesis we explored the potential use of LCA and by extension LTA 
as a more advanced and potentially more useful method of examining and measuring 
the clustering of health behaviours during pregnancy. We focused on five major health 
determinants collected in PRAMS Ireland and examined their potential clustering using 
LCA. These included physical activity, folic acid use, multivitamin use, smoking and 
alcohol use during pregnancy. 
 
Latent 
Variable 
 
X₂ 
 
X₃ X₄ X₅ X₆ X₁ 
e₁ e₂ e₃ e₄ e₅ e₆ 
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12.1.1 Results of the latent class analysis exploration 
The marginal distribution of health behaviours during pregnancy in PRAMS Ireland is 
shown in Figure 12.2. Most women did not meet recommendations regarding exercise, 
did not take multivitamin supplements and did consume alcohol. However, most 
women were non-smokers and a majority reported taking folic acid seven days per 
week. 
 
Figure 12.2 The marginal distributions of health behaviours during pregnancy 
 
Subsequently, we evaluated the degree of clustering amongst these health behaviours 
using a latent class model. The model is specified as follows: 
𝜋𝑖𝑗𝑘𝑙𝑚𝑡
𝐴𝐵𝐶𝐷𝐸𝑋 =  𝜋𝑡
𝑋𝜋𝑖𝑡
?̅?𝑋𝜋𝑗𝑡
?̅?𝑋𝜋𝑘𝑡
𝐶̅𝑋𝜋𝑙𝑡
?̅?𝑋𝜋𝑚𝑡
?̅?𝑋     
Equation 12.1 Latent class model 
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The letters A-E represent observed, categorical variables that can respectively take on 
levels i-m; X represents a categorical latent variable with levels t, the number of which 
is specified by the user; 𝜋 is a probability; and a horizontal bar over a letter reflects 
that its probability is conditional on the value of what follows. Thus, the model above 
says that the joint probability of our six variables (five observed and one latent) is the 
product of the probability of being in a given class X = t, and the probabilities for each 
of the five variables conditional on class membership. Importantly, this model states 
that the probabilities of the five observed variables are independent, given class 
membership. This model was estimated multiple times, each time specifying a different 
number of latent classes X (one through six), using the expectation-maximization 
algorithm, implemented in Mplus Version 6 with 5000 random starts.  
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Figure 12.3 gives model fit information for all of the models in terms of Akaike 
Information Criterion (AIC), Bayesian Information Criterion (BIC), Adjusted Bayesian 
Information Criterion (aBIC) (which is further adjusted for sample size). Since lower 
values of AIC, BIC and aBIC indicate better model fit, these model fit statistics indicated 
that a two class solution best fit the data, though the differences from the two class 
and one class model were minimal.  
 
Figure 12.3 Model fit for the latent class model with one through six latent classes 
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Figure 12.4 gives the estimated prior probabilities of class membership in the latent 
classes for each model. Overall, these suggested the presence of a single dominant 
class, regardless of the number of classes specified.  
 
Figure 12.4 Prior probability of class membership for each model with two through 
six classes 
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Figure 12.5 gives the estimated class-specific distributions of the five observed 
variables from the two class model. We can see that the distributions for exercise, 
smoking, and alcohol consumption are essentially identical comparing the two classes. 
The key difference is that class one includes women who are very likely to take a folic 
acid supplement and more likely than average to take a multivitamin supplement; 
while women in class two are less likely than average to take either supplement (key 
differences circled). Thus, based on these results, it was reasonable to conclude that 
there was no strong clustering of health behaviours before pregnancy and that given 
application of a latent class model with two classes, the difference between the classes 
was marginal and only evident for folic acid use and multivitamin use. We repeated the 
analysis using indicators of the same behaviours during pregnancy, with qualitatively 
similar results.  
 
Figure 12.5 Class specific probabilities for the five observed variables in the two class 
model 
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Figure 12.6- Figure 12.15 show the distribution of each behaviour before and during 
pregnancy and the change between the two time points. These figures show that there 
was little variation between behaviours before and during pregnancy. Consequently, 
given lack of clustering of behaviours before pregnancy, similarity of distribution with 
behaviours during pregnancy (similar lack of clustering) and little variation between the 
two time points neither LCA nor LTA were suitable methods of analysis for our data. 
Therefore, we chose to analyse the data in a more basic data driven way by looking at 
adherence to pregnancy guidelines on behaviours. 
 
Figure 12.6 Physical activity distribution before and during pregnancy 
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Figure 12.7 Change in physical activity before and during pregnancy 
 
 
Figure 12.8 Folic acid distribution before and during pregnancy 
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Figure 12.9 Change in folic acid use before and during pregnancy 
 
 
Figure 12.10 Multivitamin distribution before and during pregnancy 
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Figure 12.11 Change in multivitamin use before and during pregnancy 
 
 
Figure 12.12 Smoking distribution before and during pregnancy 
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Figure 12.13 Change in smoking before and during pregnancy 
 
 
Figure 12.14 Alcohol consumption distribution before and during pregnancy 
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Figure 12.15 Change in alcohol distribution before and during pregnancy 
 
12.1.2 Summary 
Latent variable methods are a person centred approach to data analysis which aim to 
identify underlying subgroups in the population based on an underlying latent 
construct. In this thesis, the use of latent variable methods were explored and applied 
to examine the potential clustering of health behaviours around the time of pregnancy 
in PRAMS. As clustering was not evident, LCA emerged to be an unsuitable analysis for 
the data and thus, more basic and data driven approaches using descriptive statistics 
were used to examine adherence to health behaviour guidelines in Chapter 6.  
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 Analysing continuous outcomes  12.2
12.2.1 Regression 
Regression analysis is a statistical technique for investigating the relationship between 
variables where the outcome variable of interest is continuous (155). Regression uses 
least squares to estimate the regression coefficients for the associated change in the 
outcome variable  𝛾   for a given change in a predictor variable x (156). In Chapter 7, the 
effect of different alcohol patterns during pregnancy on birth weight and gestational 
age was estimated with linear regression using the Growing up in Ireland dataset. By 
applying linear regression to the alcohol-birth weight analysis the average change in 
birth weight in grams for a one unit change in the categorical alcohol exposure variable 
was estimated. The alcohol variable was first regressed on birth weight to estimate the 
change in birth weight for a one unit change in alcohol given by the following straight 
line equation: 
𝛾𝑖 = 𝛽0 + 𝛽1  𝑎𝑖 +  𝑒𝑖 
Equation 12.2 Simple linear regression 
where 𝛾𝑖 is the outcome variable birth weight or gestational age, 𝑎𝑖 is the categorical 
alcohol variable (the factor to be regressed on  𝛾𝑖,), 𝛽0  is the intercept (value of 𝛾   
when x =0), 𝛽1   is the unknown constant (partial regression coefficient) for the 
independent alcohol variable 𝑎𝑖, and 𝑒𝑖 is the random error component (the difference 
between the observed value of  𝛾𝑖 and that predicted by the straight line).  
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In the multivariate regression analysis with the addition of covariates, the 
average change in birth weight for a one unit change in alcohol was estimated 
adjusting for other potential confounders of interest. Thus, the same alcohol variable 
was regressed on birth weight with the addition of covariates of interest, here 
represented as letters for (b, c, d): 
𝛾𝑖 = 𝛽0 +  𝛽1  𝑎𝑖 + 𝛽2  𝑏𝑖+ 𝛽3  𝑐𝑖 +  𝛽4  𝑑𝑖  +  𝑒𝑖 
Equation 12.3 Covariate adjusted linear regression 
where 𝛾𝑖 is the outcome variable birth weight, 𝑎𝑖 is the categorical alcohol variable (the 
factor to be regressed on 𝛾𝑖), 𝛽0  is the intercept, 𝛽1   is the unknown constant for 
alcohol (the partial regression coefficient), 𝛽2 ,𝛽3 ,𝛽4  are the unknown constants (partial 
regression coefficients) for covariates b, c and d, and 𝑒𝑖  is the random error 
component.  
12.2.2 Other approaches to this analysis 
An alternative approach to this analysis might have included treatment of alcohol use 
as a continuous exposure variable. However, this approach was not used due to the 
heavily skewed nature of the alcohol data collected and due to potential difficulties in 
interpretation of the analysis. In particular, as the aim of this thesis was to investigate a 
safe alcohol consumption threshold during pregnancy, categorisation of data in line 
with alcohol guidelines was a more suitable approach to the analysis rather than 
examining mean or median consumption. Another possible alternative might have 
included logistic regression by categorising the birth weight variable using a threshold 
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of 2500g in order to examine the association between alcohol and the likelihood of 
being low birth weight using logistic regression. However, due to the low prevalence of 
alcohol exposure in the GUI dataset and relatively uncommon outcome of low birth 
weight, using birth weight as a continuous outcome was chosen to increase statistical 
power. Similarly, linear regression was chosen for gestation in days where statistical 
power may have been an issue if analysed as a binary outcome. 
12.2.3 Analysis of repeated measures: an extension of linear regression 
Linear regression models the average change in an outcome variable 𝛾𝑖 for a given 
value or change in an exposure variable x in a cohort study design. If the relationship 
between the variables being examined is not linear this equation can be modified to 
give a curve of appropriate shape that best represents the relationship between two 
variables. However, when measurements are repeated on the same subjects over time 
in a longitudinal design, new analytical challenges arise as a two level hierarchy is 
established with measurement repetitions or occasions at one level and subjects as 
two level units (157). An assumption of linear regression involves that of uncorrelated 
error terms, thus the assumption of independence is violated in a situation where 
parameters are repeatedly measured over time as standard errors will be correlated. 
Secondly, if multiple measures of the same parameter are included in the same model, 
the problem of multi-collinearity can arise due to strong correlations between 
measurements from the same individual (143). Thus, more complex modelling 
techniques are required to address this problem. 
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Multilevel models are one approach that can be used to overcome the 
challenges associated with longitudinal or repeatedly measured data and were used in 
this thesis in the analysis of weight and height in the ALSPAC study in Chapter 9. The 
advantages of multilevel models include their ability to capture the shape of growth 
over time and that changing measurement over time can be explicitly modelled (143). 
Furthermore, there is no requirement for individuals to have been measured at the 
same ages and all individuals with at least one observation can contribute to the model 
under a missing at random (MAR) assumption i.e. that the probability of an 
observation being missing is related to other observed variables for that individual but 
does not depend on the true value of the missing observation (158). If we had 
repeatedly measured weight in the analyses of GUI data in Chapter 7 detailed in 12.2.1 
above, and assuming that childhood growth were linear, the simple linear regression 
equation would be expanded to take account of the two level hierarchies which would 
include the occasion level and subject level variation. In modelling the relationship 
between alcohol and repeatedly measured weight in that scenario, we would not only 
model the average slope as typically modelled in standard single level regression 
analysis but most importantly also model each individuals deviation from the average 
trajectory (individual level random effects) and measurement error i.e. the deviation of 
observed measures from values predicted by the model (143). An equation from a 
multilevel linear model would be given by the following: 
𝛾𝑖𝑗   =  𝛽0 +  𝑢0𝑗 +  𝛽1 𝑥 (𝑎𝑔𝑒)𝑖𝑗 +  𝑢1𝑗𝑥 (𝑎𝑔𝑒)𝑖𝑗 + 𝑒0𝑖𝑗 
Equation 12.4 Linear multilevel model 
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where 𝛾𝑖𝑗   is the weight for individual j at time i,  𝛽0 and 𝛽1  are the fixed coefficients 
representing the average intercept and slope respectively (as in a single level 
regression equation in a standard linear regression), 𝑒0𝑖𝑗 is the occasion level residual 
representing the measurement error, and 𝑢0𝑗 and 𝑢1𝑗  are the random coefficients 
which represent the deviation from the average intercept and average slope for 
individual j.  
Figure 12.16 and Figure 12.17 illustrate how linear regression and multilevel 
modelling are related. In Figure 12.16, the average trajectory of weight and height of 
ALSPAC participants is modelled; this is what we would expect from a single level linear 
regression model i.e. in single level regression models, we model the average for the 
total cohort. In Figure 12.17, we see each individual’s deviation from the average 
trajectory in the same cohort as modelled in a multilevel modelled. Here, we now 
model the average trajectory as in a single level regression equation as in Figure 12.16 
but with the additional 𝑢0𝑗 and 𝑢1𝑗  (the random coefficients) which represent the 
deviation from the average intercept and average slope for each individual, thus each 
line in Figure 12.17 represent an individual’s trajectory. The latter is the method that 
was used in Chapter 9.
  
𝛾𝑖 = 𝛽0 + 𝛽1  𝑎𝑖 +  𝑒𝑖 
 
 
𝛾𝑖𝑗   =  𝛽0 +  𝑢0𝑗 +  𝛽1 𝑥 (𝑎𝑔𝑒)𝑖𝑗 +  𝑢1𝑗𝑥 (𝑎𝑔𝑒)𝑖𝑗 +  𝑒0𝑖𝑗 
 
 
c 
 
 
 
 
 
 
  
In Figure 12.16, we model the average line with average intercept, 𝛽0  and slope,  𝛽1  .  In Figure 12.17, we model the average as in 
Figure 12.16 but with the additional individual trajectories with random intercepts (baseline weight) and slopes (growth rates) 
showing each individuals deviation from the average line. i.e. the multilevel model allows each individual to have their own unique 
baseline weight value and differing growth rates as given by the varying slope. 
 
Figure 12.16 Average predicted weight in a standard 
single level linear regression 
Figure 12.17 Individual predicted weight from 
multilevel models 
  
12.2.3.1 Linear versus non-linear growth 
In 12.2.3 where we discussed the use of linear regression to model the association 
between alcohol use and birth weight, the assumption of linear growth (i.e. that the 
shape of the relationship between alcohol and growth is linear) is implicit when using 
this model. Where a linear relationship cannot be assumed and we suspect the 
continuous variable of interest to take another shape, this too can be modelled in a 
variety of ways both in a single level regression where we estimate the average change 
in our outcome or in multilevel models where we have repeatedly measured data 
which has individual level and occasion level variation that we wish to model. It is 
important to be able to model non-linear growth because most biological processes 
are not always linear (143). For example, growth itself is not exactly linear (although for 
the sake of argument we have assumed it linear in Figure 12.16 and Figure 12.17). 
Thus, while linear regression was appropriate for the analysis of birth weight in the 
Growing up in Ireland cohort in Chapter 7, modelling patterns of growth in children or 
any other biological processes in a linear manner is not always appropriate and may be 
a mis-specification of the data. 
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12.2.3.2 Linear spline multilevel models 
Although well-fitting multilevel models estimating a curve can be useful, polynomial 
terms used in these models or other terms are not always easily interpreted (143). One 
approach that can yield more interpretable growth coefficients is to use a series of 
linear splines, joined at knot points to model the growth trajectory, also known as 
piecewise linear or broken stick (143). In the ALSPAC analysis, multilevel linear spline 
modelling was applied for height and weight with knot points at different ages (See 
12.2.4 for further details), allowing the slope to vary between each knot point and 
slopes varying for each individual. In a multilevel model, as was used in ALSPAC, this 
was extended to model individual trajectories in a piecewise linear fashion taking 
account of occasion level and individual level variation from the mean trajectory 
estimated in a single level regression model. In the analysis of the effect of alcohol use 
during pregnancy on growth in Chapter 9, it was these previously modelled individual 
trajectories which were examined in relation to maternal alcohol use. 
12.2.4 Details of statistical modelling of growth trajectories 
In ALSPAC, the dimensionality of the data was reduced by summarising the patterns of 
height/weight change in a meaningful way. Individual trajectories were estimated 
using mixed-effects models (159) with random effects at measurement occasion and 
individual levels, fitted using the statistical software package MLWiN version 2.27. Such 
models allow for the change in scale and variance of height/weight over time and use 
all available data from all the eligible children under a MAR assumption. Multilevel 
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models are an appropriate method for modelling longitudinal data, since they take 
account of the non-independence of repeated measures on the same individual and 
estimate a full trajectory for all participants, regardless of the number and timing of 
their measurements (160). The models estimate average and individual-specific 
trajectories, since random effects allow each individual to have different intercepts and 
slopes (rates of growth in each linear spline period). Linear spline models separate age 
into periods during which the average growth rate is approximately linear.  
The standard way of modelling the relationship between a continuous outcome 
(in our example height and weight) and a continuous exposure (in our example age) 
would be to fit a polynomial curve (i.e. age raised to the appropriate power). The 
patterns of growth across childhood, however, follow a complex pattern and may not 
be accurately represented by a simple polynomial curve. For this reason, we used 
fractional polynomials to find the best-fitting average height and weight trajectory for 
each of our models from birth to ten years.  Fractional polynomials are an approach to 
modelling the relationship between an outcome and one or more continuous 
covariates in which the continuous covariate is raised to a large number of 
combinations of powers, resulting in a wide range of possible curves and offering more 
flexibility than standard polynomial approaches (161). In our example, age was raised 
to various combinations of powers (each of the following single powers, plus each 
combination of two powers: 0.5, 1, 2, 3, -0.5, -1, -2, natural log), from which we 
selected the best fitting curve (the one with the lowest likelihood value). Although 
fractional polynomials provide a flexible way to examine such relationships, they do 
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not provide parameters that are clinically relevant, easily interpreted, or readily used 
to assess the impact of different growth periods on later outcomes. We therefore used 
the best-fitting fractional polynomial to derive a piecewise linear spline model. From 
the best fitting curves, we derived approximate knot-points for the linear spline model, 
i.e. the approximate turning points of the curve between which changes in height and 
weight were approximately linear.  
To optimise the knot points, we fitted a series of models with the knot points 
placed at one month intervals around the estimated knot point identified from the 
shape of the fractional polynomial curve.  The model with the lowest likelihood value 
was selected as the knot point for the final model.  This confirmed that there were: 
 four periods of growth (length/height) : birth to three months, three to 12 
months, 12 to 36 months, 36 to 120 months. 
 five periods of weight change: birth to three months, three to 12 months, 12-36 
months, 36 to 84 months and 84 to 120 months. 
Individual-level random effects allowed intercepts and slopes for each period to 
vary between individuals.  Implausible height and weight measurements (>four SD) 
from the mean for gender and age specific category, approximately 0.1% of all 
measurements) were re-coded as missing. All other available measures were used in 
analyses. To account for the likely reduced accuracy of parent-reported measurements 
(162), a binary indicator of measurement source (research clinic or health records 
versus parent-report) was included in the multilevel models. An age term was included 
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as a random effect at the occasion level, which allows the measurement error to vary 
with age. 
Actual and predicted measurements (from the multilevel models) were 
compared to assess model fit. We also checked for auto-correlation (residual 
correlation between an individual’s measurements as a decreasing function of the 
difference in the age at measurement), a phenomenon that can cause problems in 
growth models, particularly when repeated measurements are close together in time 
as they are in these analyses (163). We examined autocorrelation by computing the 
correlation between the difference between a measurement and the measurement 
predicted by the model (predicted measurementn – measurementn) and this difference 
for the previous measurement (predicted measurementn-1 - measurementn-1). To verify 
that the models were not dominated by individuals with large numbers of 
measurements, models were re-run with a random subsample of observations within 
each individual, such that no individual had more than the 75th centile number of 
measurements. The coefficients from these models were very similar to those from the 
full model, as were residual estimates for a given individual (R≥0.9). 
Associations between growth trajectories and maternal/partner drinking were 
estimated by including interaction terms in the multilevel models between the drinking 
variables and the intercept (birth length or weight) and each growth coefficient (rate of 
height growth and weight change). To simplify the presentation of our results, we 
calculated predicted height and weight, and differences between levels of maternal 
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and partner alcohol consumption from the multilevel models at birth and ages two and 
ten years. 
12.2.4.1 Alternative analysis 
One possible alternative approach to linear spline models for multilevel data as 
mentioned previously would include transformations of the data using simple 
polynomials. However, these are not very flexible for analysis of growth and results of 
the curves are often difficult to interpret (143). A second potential approach to this 
analysis might include the use of Z score based analysis approach, but this approach 
relies on standardising the scale and variance of growth measures which is less 
advantageous than the multilevel models used, due to their ability to capture the 
shape of growth over time and changing measurement over time (143).  
 Analysing categorical data 12.3
The approach to the analysis of continuous outcome data differs to the analysis of 
categorical data. In this section, the analysis of categorical data is detailed. 
12.3.1 Logistic regression 
In 12.2.1 linear regression for continuous outcomes was discussed in relation to its use 
in Chapter 7 for the analysis of timing and pattern of alcohol during pregnancy and 
birth weight. However, in Chapter 8 we treated birth weight and gestational age as 
binary outcomes and thus, they were analysed used logistic regression. Although the 
reasons for the use of logistic regression and linear regression differ as well as their 
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underlying assumptions, the methods employed in a logistic regression analysis follow 
the same general principles used in linear regression (164). However, logistic 
regression focuses instead upon the relative probability (odds) of obtaining a given 
result category. With logistic regression the mean response variable y, explained in 
terms of an explanatory variable 𝑎𝑖 is modelled relating 𝛾   and 𝑎𝑖through the equation 
 𝛽0 +  𝛽1  𝑎𝑖 as in linear regression. However, in logistic regression this is not a good 
model because extremes of 𝑎𝑖 will give values of  𝛽0 𝑎𝑛𝑑   𝛽1   that do not fall between 
0 and 1 (plausible values of probability). Thus, the solution in logistic regression for a 
binary outcome is to transform the odds using the natural log of the probability of an 
event occurring such that p is the probability of an event occurring, 1-p is the 
probability of an event not occurring, and  the odds of the event occurring are ( 𝜌
1−𝜌
). 
In Chapter 8, alcohol use in the SCOPE study was regressed on preterm birth 
and SGA in order to predict the likelihood of preterm birth or SGA for a given value of 
the categorical alcohol variables under study. As logistic regression provides the odds 
of an outcome for a one unit change in our regressor variable, the unadjusted model 
with one regressor (exposure of interest) would be written as follows:  
ln(
𝜌
1−𝜌
) = 𝛽0 +  𝛽1  𝑎𝑖 
Equation 12.5 Logistic regression 
where p represents the probability of an event, 1-p is the probability of the event not 
occurring,  𝜌
1−𝜌
  is the odds of the event occurring,  𝛽0  is the y intercept, 𝛽1  is the 
independent variables association with the outcome (the estimated increase in the 
odds of the outcome per unit increase in the value of the independent variable. To 
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obtain the odds ratio for 𝑎𝑖 (alcohol consumption), we thus must exponentiate 𝛽1   (the 
log odds) of the event occurring i.e. 𝑒𝛽1 where e=2.718. 
12.3.2 Log linear binomial regression 
As discussed in 12.3.1 logistic regression was used for estimating the odds of a 
particular outcome given a value of the independent variable of interest. However, 
when an outcome variable is common, logistic regression tends to over-estimate the 
association between our independent variable of interest and the outcome. In a study 
where the outcome is common (>5%), the relative risk tends to be a more appropriate 
measure of association because the odds ratio tends to over-estimate the relationship 
between exposure and outcome. For studies where the prevalence of the outcome is 
less than 5%, the relative risk and odds ratio are approximately equal.  
In Chapter 5, the prevalence and predictors of alcohol use during pregnancy 
were compared between three cohorts (SCOPE, PRAMS and GUI). Alcohol consumption 
during pregnancy was common in all three cohorts (20% in GUI, 50% in PRAMS and 
80% in SCOPE). Consequently, an alternative to logistic regression was required to 
examine the predictors of gestational alcohol use. We chose to use log linear binomial 
regression to estimate the risk of alcohol use during pregnancy for various covariates 
of interest. Log linear binomial regression is a Generalised Linear Model (GLM) of the 
binomial family with a log link function and is useful for estimating risk ratios. As 
convergence issues were encountered in the SCOPE cohort, Poisson regression with 
“robust” variance estimation was used instead of log linear binomial regression (165). 
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Table 13.1 Association between quantity of maternal alcohol consumption in the first trimester compared to abstinence during 
pregnancy and adverse pregnancy outcomes 
  
 
Occasional 
(n=1,090) 
 
 
Low 
(n=1,383) 
 
 
Moderate 
(n=625) 
 
 
Heavy 
(n=300) 
 n OR (95% CI) aOR(95% 
CI)* 
n OR(95% CI) aOR(95% 
CI)* 
n OR(95% CI) aOR (95% 
CI)* 
n OR(95% CI) aOR(95% 
CI)* 
SGA 110 0.93(0.63,1.
37) 
0.99(0.67,1.
45) 
165 1.12(0.80,1.
57) 
1.18(0.99,1.
40) 
74 1.11(0.71,1.
73) 
1.06(0.74,1.
53) 
44 1.42(0.81,2.
49) 
1.19(0.74,1.
92) 
Birth 
weight 
109
0 
63(-6,132) -6(-50,38) 138
3 
44(-20,108) -19(-73,35) 62
5 
65(-20,149) -26(-129,78) 30
0 
-9(-124,106) -42(-
239,155) 
Preterm  45 0.84(0.47,1.
49) 
0.91(0.64,1.
28) 
48 0.70(0.40,1.
22) 
0.74(0.52,1.
06) 
22 0.71(0.33,1.
50) 
0.74(0.36,1.
54) 
12 0.81(0.30,2.
16) 
0.77(0.45,1.
31) 
Preeclamp
sia 
42 0.61(0.34,1.
07) 
0.66(0.38,1.
15) 
61 0.70(0.42,1.
15) 
0.79(0.62,1.
01) 
21 0.52(0.25,1.
11) 
0.57(0.29,1.
11) 
16 0.85(0.36,2.
01) 
0.87(0.42,1.
80) 
 
All endpoints, except for birth weight, were analysed using logistic regression and the results are presented as odds ratios (95% CI). 
Birth weight was analysed using linear regression with robust variance estimation and is presented as adjusted mean difference in 
grams (95% CI). The reference group was women who did not drink alcohol during pregnancy. All regression models were adjusted 
for maternal age, smoking, years of schooling, ethnicity, BMI, infant sex, marital status, family income and drug use in pregnancy. All 
analyses were adjusted for potential clustering effect of SCOPE centres. Birth weight models were also adjusted for gestational age 
at delivery. 
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Table 13.2 Association between quantity of maternal alcohol consumption in the first trimester compared to abstinence during 
pregnancy and adverse pregnancy outcomes excluding women who binged during pregnancy 
  
 
Occasional 
(n=936) 
 
 
Low 
(n=876) 
 
 
Moderate 
(n=228) 
 
 
Heavy 
(n=74) 
 n OR(95% CI) aOR (95% CI)* n OR (95% CI) aOR(95% CI)* n OR(95% CI) aOR(95% CI)* n OR(95% CI) aOR(95% CI)* 
SGA 85 0.83(0.55,1.27) 0.88(0.55,1.43) 101 1.08(0.73,1.61) 1.12(0.82,1.53) 25 1.03(0.51,2.07) 1.01(0.66,1.55) 11 1.47(0.51,4.23) 1.31(0.59,2.92) 
Birth weight 936 78(5,150) 4(-82,91) 876 39(-36,113) -15(-89,58) 228 45(-85,174) -43(-198,111) 74 70(-152,292) -7(-290,276) 
Preterm  41 0.89(0.49,1.61) 0.97(0.70,1.34) 32 0.73(0.38,1.40) 0.74(0.48,1.15) 7 0.61(0.18,2.14) 0.58(0.38,0.89) 3 0.83(0.13,5.46) 0.73(0.13,4.13) 
Preeclampsia 32 0.54(0.28,1.01) 0.59(0.35,0.99) 35 0.63(0.34,1.15) 0.72(0.55,0.95) 7 0.48(0.14,1.65) 0.58(0.21,1.61) 3 0.64(0.1,4.23) 0.76(0.03,18.26) 
 
All endpoints, except for birth weight, were analysed using logistic regression and the results are presented as odds ratios (95% CI). 
Birth weight was analysed using linear regression with robust variance estimation and is presented as adjusted mean difference in 
grams (95% CI). The reference group was women who did not drink alcohol during pregnancy. All regression models were adjusted 
for maternal age, smoking, years of schooling, ethnicity, BMI, infant sex, marital status, family income and drug use in pregnancy. All 
analyses were adjusted for potential clustering effect of SCOPE centres. Birth weight models were also adjusted for gestational age 
at delivery. 
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 Details of measurement of height and weight at research clinics in 14.1
ALSPAC 
Birth length and weight were available for most children. Between birth and age five 
years, measures were available from routine child health clinics for most children, and 
from research clinic measurements on a random 10% subsample of the cohort. All 
cohort members were invited to research clinics from age seven onwards. Across all 
ages parent-reported measures were available. Birth length (crown-heel) was 
measured by ALSPAC staff soon after birth (median one day, range one to 14 days) 
using a Harpenden Neonatometer (Holtain Ltd). Birth weight was extracted from 
medical records.  Length and weight measurements were extracted from health visitor 
records, which form part of standard child care in the UK. In this cohort we had up to 
four measurements taken on average at six weeks, 10, 21, and 48 months of age, which 
previous work has shown to have good accuracy (166). From seven years upwards, all 
children were invited to annual clinics.  Across all ages, parent-reported child heights 
and weights are also available from questionnaires.  
At the clinics between four months and five years, crown-heel length for 
children aged four to 25 months was measured using a Harpenden Neonatometer and 
from 25 months onwards standing height was measured using a Leicester Height 
Measure; weight was measured using Fereday 100kg combined scale (four month 
clinic), Soenhle scale or Seca scale model 724 (eight month clinic), Seca 724 or Seca 835 
(12 month clinic), Seca 835 (18 months onwards). From age seven years upwards, all 
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children were invited to annual clinics, at which standing height was measured to the 
last complete mm using the Harpenden Stadiometer and weight was measured to the 
nearest 0.1kg using the Tanita Body Fat Analyser (Model TBF 305). 
The number of measurements per child ranged from 1 to 36 for height (median 
and Interquartile Range [(IQR) 8, 5 to 11)]. The number of measurements per child 
ranged from  one to 34 for weight (median and IQR 9, 7-11). 
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 Measurement of confounding variables  14.2
A questionnaire at 32 weeks gestation asked mothers to report their educational 
attainment, which was categorised as below O-Level (Ordinary Level; exams taken in 
different subjects usually at age 15-16 at the completion of legally required school 
attendance, equivalent to today’s UK General Certificate of Secondary Education), O-
Level only, A-Level (Advanced-Level; exams taken in different subjects usually at age 
18), or university degree or above. Parity was defined as the number of previous 
pregnancies that had resulted in a live- or still-born infant collected at 18 weeks 
gestation. Smoking in the first trimester of pregnancy was self-reported by mothers at 
18 weeks gestation; responses to smoking any tobacco (cigarettes, cigars, pipes, or 
other) were grouped as follows: no smoking, <ten per day, 10-19 per day or greater 
than 19 per day.  Maternal age was reported in the mother’s antenatal questionnaires.  
Maternal height and weight were self-reported from the questionnaire administered at 
12 weeks gestation; these were used to calculate maternal BMI.  
  Measurement of variables used in sensitivity analyses 14.3
Maternal ethnicity was self-reported on antenatal questionnaires. Gestational age at 
birth was estimated from clinical records. For all live births the gestation was recorded 
in a variety of ways on the “stork database”, using last menstrual period, pediatric 
assessment, obstetric assessment and ultrasound assessment. Pregnancy intention was 
obtained from antenatal questionnaires.  A questionnaire at 32 weeks gestation asked 
partners to report their educational attainment, which was categorised as below O-
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Level (Ordinary Level; exams taken in different subjects usually at age 15-16 at the 
completion of legally required school attendance, equivalent to today’s UK General 
Certificate of Secondary Education), O-Level only, A-Level (Advanced-Level; exams 
taken in different subjects usually at age 18), or university degree or above. Mothers 
were also asked in the 18 week antenatal questionnaire whether their partners 
smoked. Admission to hospital during pregnancy was obtained from 18 week antenatal 
questionnaires. Household social class was measured as the highest of the mother’s or 
her partner’s occupational social class using data on job title and details of occupation 
collected about the mother and her partner from the mother’s questionnaire at 32 
weeks gestation.  Social class was derived using the standard occupational classification 
(SOC) codes developed by the United Kingdom Office of Population Census and Surveys 
and classified as I professional, II managerial and technical, IIINM non-manual, IIIM 
manual, and IV&V part skilled occupations and unskilled occupations Partner height 
was self-reported from questionnaire administered at 12 weeks gestation. Marital 
status was obtained from antenatal questionnaires and classified as never married, 
widowed, divorced, separated, first marriage, marriage two or three. 
 
  
 Sensitivity analysis 14.4
Table 14.1 Characteristics of women by their pregnancy alcohol consumption (confounders examined in sensitivity analyses) 
 Pregnancy 
abstainer 
 
General 
non-drinker 
 
Occasional 
pregnancy 
drinker 
Occasional 
binge 
drinker  
Light daily 
pregnancy 
drinker 
Heavy 
pregnancy 
drinker 
P value for 
comparison 
Marital status        
Never married 385 (13.3) 66 (13.3) 364 (11.3) 218 (18.8) 6 (18.2) 17 (22.7) P<0.001 
Widowed 1 (0) 0 4 (0.1) 3 (0.3) 0 1 (1.3) 
Divorced 76 (2.6) 11 (2.2) 112 (3.5) 71 (6.1) 2 (6.1) 8 (10.7) 
Separated 22 (0.8) 10 (2.0) 31 (1.0) 15 (1.3) 3 (1.0) 5 (6.7) 
1
st
 Marriage 2222 (76.9) 374 (75.3) 2463 (76.3) 762 (65.7) 22 (66.7) 36 (48.0) 
Marriage 2 or 3 182 (6.3) 36 (7.2) 255 (7.9) 91 (7.8) 2 (6.1) 8 (10.7)  
Admitted to hospital during pregnancy 103 (3.7) 19 (4.0) 83 (2.7) 39 (3.6) 2 (6.5) 3 (4.6) 0.219 
Partner smokes        
No 2036 (70.7) 323 (65.5) 2224 (69.2) 635 (55.4) 23 (69.7) 37 (50.0) P<0.001 
Yes, cigarettes 694 (24.1) 150 (30.4) 781 (24.3) 427 (37.3) 8 (24.2) 29 (39.2)  
Yes, cigars 90 (3.1) 14 (2.8) 124 (3.9) 30 (2.6) 1 (3.0) 3 (4.1) 
Yes, pipe 6 (0.2) 0 11 (0.3) 5 (0.4) 0 0  
Yes, other 56 (1.9) 6 (1.2) 72 (2.2) 49 (4.3) 1 (3.0) 5 (6.8)  
Partners highest educational qualification        
Less than O level 786 (27.4) 190 (38.9) 752 (23.6) 397 (35.1) 6 (18.8) 20 (27.4) P<0.001 
O level 668 (23.3) 127 (26.0) 710 (22.3) 247 (21.8) 4 (12.5) 18 (24.7) 
A level 820 (28.6) 109 (22.3) 910 (28.5) 328 (29.0) 8 (25.0) 14 (19.2)  
Degree or Above 594 (20.7) 63 (12.9) 819 (25.7) 160 (14.1) 14 (43.8) 21 (28.8)  
Household social class        
Professional 434 (15.5) 45 (9.5) 554 (17.7) 119 (10.6) 6 (18.8) 17 (24.6) P<0.001 
Managerial & technical 1228 (43.9) 180 (38.0) 1476 (47.1) 458 (40.9) 14 (43.8) 27 (39.1)  
Non-manual 723 (25.8) 123 (26.0) 713 (22.8) 299 (26.7) 6 (18.8) 12 (17.4)  
Manual 305 (10.9) 80 (16.9) 288 (9.2) 156 (13.9) 5 (15.6) 9 (13.0)  
Part Skilled & unskilled 110 (3.9) 46 (9.7) 101 (3.2) 87 (7.8) 1 (3.1) 4 (5.8)  
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Pregnancy intention 2330 (80.1) 359 (71.5) 2376 (73.3) 819 (70.2) 21 (63.6) 44 (57.9)  
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)  
Partner height 176.3 (6.9) 174.8 (7.3) 176.5 (6.8) 176.0 (6.6) 176.7 (7.3) 176.2 (6.3) P<0.001 
  
Table 14.2 Characteristics of the 7,957 children included in analysis of associations between alcohol consumption during 
pregnancy and height and weight in childhood compared to full ALSPAC cohort 
 Participants included 
n= 7,957 
Participants excluded 
n=5000 (approx.)* 
P value for comparison** 
 n (%) n (%)  
Maternal alcohol use     
Pregnancy abstainer (Reference) 2919 (36.7) 1651 (33.1) p<0.001 
General non drinker 504 (6.3) 530 (10.6) 
Occasional pregnancy drinker 3253 (40.9) 1820 (36.5) 
Occasional binge drinker 1172 (14.7) 850 (17.0 
Light daily pregnancy drinker 33 (0.4) 38 (0.8) 
Heavy pregnancy drinker 76 (1.0) 98 (2.0) 
    
Partner alcohol use    
Occasional pregnancy drinker (Reference) 1073 (13.5) 233 (13.4) p<0.001 
General non-drinker 336 (4.2) 124 (7.1)  
Occasional binge drinker 4887 (61.4) 1070 (61.4) 
Light daily pregnancy drinker 22 (0.3) 8 (0.5) 
Heavy pregnancy drinker 1639 (20.6) 307 (17.6) 
    
Maternal education    
Less than O level 1989 (25.0) 1756 (38.9) p<0.001 
O level 2820 (35.4) 1506 (33.4) 
A level 1932 (24.3) 865 (19.2) 
Degree or above 1216 (15.3) 388 (8.6) 
    
Parity    
0 3736 (47.0) 2077 (41.2) p<0.001 
1 2789 (35.1) 1767 (35.0)  
2+ 1432 (18.0) 1202 (23.8)  
    
Maternal smoking (1
st
 Trimester)    
No  6367 (80.0) 3545 (67.9) p<0.001 
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<10 per day 772 (9.7) 666 (12.8) 
10-19 per day 619 (7.8) 697 (13.4) 
>19 per day 199 (2.5) 312 (6.0) 
 Mean (SD) Mean (SD) P value 
Maternal age 28.6 (4.7) 27.2 (5.2)(N=6102) p<0.001 
Maternal height 164.1 (6.7) 163.7 (6.9)(N=4327) p<0.001 
Maternal BMI 22.9 (3.8) 22.9 (3.9)(N=3647) 0.55 
Gestational age at birth 39.4 (1.8) 39.2 (2.3) (N=6109) p<0.001 
*Denominator for participants excluded due to missing exposure, outcome or confounder data varies  
**p value is for the difference in proportions for categorical variables from χ² test or difference in means for continuous variables from t tests between 
included and excluded participants 
  
Table 14.3 Associations between maternal drinking during pregnancy and height growth in offspring, n=7,957 
 Pregnancy 
abstainer, 
n=2,919 
General non-drinker, 
 
n=504 
Occasional pregnancy 
drinker, 
n=3,253 
Occasional binge 
drinker, 
n=1,172 
Light daily pregnancy 
drinker,  
n=33 
Heavy pregnancy 
drinker, 
N=76 
Height       
Crude       
Birth length 50.18 (1.48) -0.27 (-0.51, -0.03) 0.06 (-0.07, 0.19) 0.03 (-0.14, 0.21) 0.35 (-0.55, 1.25) -0.81 (-1.37, -0.25) 
Growth 1  3.56 (0.16) 0.00 ( -0.10, 0.11) -0.02 (-0.08, 0.03) -0.12 (-0.19, -0.04) -0.56 (-0.91, -0.21) -0.00 (-0.23, 0.22) 
Growth 2  1.64 (0.14) -0.02 (-0.06, 0.02) -0.02 (-0.04, 0.00) 0.01 (-0.02, 0.04) 0.12 (-0.01, 0.26) 0.11 (0.02, 0.20) 
Growth 3  0.83 (0.73) -0.01 (-0.03, 0.00) 0.00 (-0.01, 0.01) 0.00 (-0.01, 0.01) 0.01 (-0.04, 0.06) 0.01 (-0.03, 0.04) 
Growth 4  0.53 (0.04) -0.01 (-0.01, 0.00) 
 
0.00 (-0.00, 0.00) -0.00 (-0.01, 0.00) 0.01 (-0.01, 0.03) 
 
0.01 (-0.00, 0.03) 
 
Adjusted*       
Birth length 50.19 (1.46) -0.26 (-0.50, -0.02) 0.07 (-0.06, 0.19) 0.04 (-0.14, 0.21) 0.41 (-0.49, 1.31) -0.80 (-1.36, -0.24) 
Growth 1  3.61 (0.14) 0.03 (-0.08, 0.13) -0.02 (-0.08, 0.03) -0.10 (-0.17, -0.02) -0.59 (-0.94, -0.24) 0.03 (-0.19, 0.26) 
Growth 2 1.65 (0.13) -0.02 (-0.05, 0.03) -0.01 (-0.03, 0.01) 0.01 (-0.02, 0.04) 0.12 (-0.02, 0.25) 0.08 (-0.00, 0.17) 
Growth 3  0.84 (0.07) -0.00 (-0.02, 0.01) -0.00 (-0.01, 0.01) 0.00 (-0.01, 0.01) -0.00 (-0.06, 0.05) -0.00 (-0.04, 0.03) 
Growth 4 0.53 (0.03) -0.00 (-0.01, 0.00) 
 
-0.00 (-0.00, 0.00) 
 
-0.00 (-0.01, 0.00) 0.00 (-0.02, 0.03) 
 
0.00 (-0.01, 0.020) 
 
Adjusted**        
Birth length 50.22 (1.46) -0.22 (-0.47, 0.04) 0.06 (-0.06, 0.19) 0.04 (-0.14, 0.21) 0.42 (-0.49, 1.33) -0.78 (-1.34, -0.22) 
Growth 1 3.62 (0.14) 0.05 (-0.06, 0.16) -0.03 (-0.08, 0.03) -0.10 (-0.17, -0.02) -0.60 (-0.96,-0.25) 0.03 (-0.20, 0.25) 
Growth 2 1.65 (0.13) -0.02 (-0.06, 0.02) -0.01 (-0.03, 0.01) 0.00 (-0.02, 0.04) 0.13 (-0.00, 0.27) 0.10 (0.01, 0.18) 
Growth 3  0.84 (0.07) -0.00 (-0.02, 0.01) -0.00 (-0.01, 0.01) 0.00 (-0.01, 0.01) -0.00 (-0.06, 0.05) -0.00 (-0.04, 0.03) 
Growth 4  0.54 (0.03) -0.00 (-0.01, 0.00) -0.00 (-0.00, 0.00) -0.00 (-0.01, 0.00) 0.01 (-0.01, 0.03) 0.01 (-0.01, 0.02) 
 
*Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI 
**Additional adjustment for partner drinking during pregnancy 
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Table 14.4 Associations between maternal drinking during pregnancy and weight growth in offspring, n=7,957 
 Pregnancy 
abstainer, 
n=2,919 
General non-drinker, 
 
n=504 
Occasional pregnancy 
drinker, 
n=3,253 
Occasional binge 
drinker, 
n=1,172 
Light daily pregnancy 
drinker,  
n=33 
Heavy pregnancy 
drinker, 
N=76 
Weight       
Crude       
Birth weight 3.48 (0.42) -0.04 (-0.09, 0.01) 0.002 (-0.03, 0.03) 0.01 (-0.03, 0.05) -0.01 (-0.20, 0.18) -0.22 (-0.35,-0.09) 
Growth 1  0.89 (0.15) -0.01 (-0.04, 0.01) 0.003 (-0.01, 0.02) -0.01 (-0.02, 0.01) -0.08 (-0.17, 0.00) 0.02 (-0.04, 0.08) 
Growth 2  0.45 (0.09) 0.00 (-0.01, 0.01) -0.004 (-0.01, 0.00) -0.00 (-0.01, 0.01) 0.03 (-0.01, 0.08) 0.00 (-0.02, 0.03) 
Growth 3  0.19 (0.04) -0.01 (-0.01, 0.00) -0.002 (-0.01, 0.00) 0.00 (-0.01, 0.00) -0.01 (-0.03, 0.02) 0.01 (-0.01, 0.03) 
Growth 4  0.19 (0.05) -0.00 (-0.01, 0.01) 0.000 (-0.00, 0.00) 0.00 (-0.00, 0.01) 0.01 (-0.01, 0.04) 0.01 (-0.01, 0.03) 
Growth 5 0.32 (0.09) -0.00 (-0.02, 0.02) 
 
-0.003 (-0.01, 0.01) 0.01 (-0.00, 0.02) 
 
-0.02 (-0.07, 0.03) 
 
0.01 (-0.03, 0.05) 
 
Adjusted*       
Birth weight 3.48 (0.42) -0.04 (-0.09, 0.01) 0.002 (-0.03, 0.03) 0.01 (-0.03, 0.05) -0.01 (-0.20, 0.18) -0.22 (-0.34,-0.09) 
Growth 1  0.89 (0.15) -0.01 (-0.03, 0.02) 0.003 (-0.01, 0.02) -0.00 (-0.02, 0.01) -0.09(-0.18, -0.00) 0.02 (-0.04, 0.08) 
Growth 2 0.46 (0.08) 0.00 (-0.01, 0.02) -0.003 (-0.01, 0.00) -0.00 (-0.01, 0.01) 0.03 (-0.01, 0.07) -0.01 (-0.03, 0.02) 
Growth 3  0.19 (0.04) -0.00 (-0.01, 0.00) -0.002 (-0.01, 0.00) 0.00 (-0.00, 0.01) -0.01 (-0.03, 0.01) 0.01 (-0.01, 0.02) 
Growth 4 0.19 (0.04) -0.00 (-0.01, 0.01) -0.001 (-0.00, 0.00) 0.00 (-0.00, 0.01) 0.01 (-0.02, 0.03) 0.01 (-0.01, 0.02) 
Growth 5 0.33 (0.09) -0.00 (-0.02, 0.02) 
 
-0.003 (-0.01, 0.01) 
 
0.00 (-0.01, 0.02) 
  
-0.03 (-0.08, 0.02) -0.01 (-0.04, 0.03) 
 
Adjusted**        
Birth weight 3.49 (0.42) -0.03 (-0.09, 0.02) 0.002 (-0.03, 0.03) 0.01 (-0.03, 0.05) -0.01 (-0.20, 0.18) -0.22 (-0.34,-0.09) 
Growth 1 0.89 (0.15) 0.00 (-0.02, 0.03) 0.002 (-0.01, 0.02) -0.00 (-0.02, 0.01) -0.09 (-0.18,-0.01) 0.02 (-0.04, 0.08) 
Growth 2 0.45 (0.08) 0.01 (-0.01, 0.02) -0.003 (-0.01, 0.00) -0.00 (-0.01, 0.01) 0.04 (-0.01, 0.08) -0.00 (-0.03, 0.03) 
Growth 3  0.19 (0.04) -0.00 (-0.01, 0.01) -0.002 (-0.01, 0.00) 0.00 (-0.00, 0.01) -0.01 (-0.03, 0.01) 0.01 (-0.01, 0.02) 
Growth 4  0.19 (0.04) -0.00 (-0.01, 0.01) 0.000 (-0.00, 0.00) 0.00 (-0.00, 0.01) 0.01 (-0.01, 0.04) 0.01 (-0.01, 0.03) 
Growth 5 0.33 (0.09) 0.00 (-0.02, 0.02) -0.003 (-0.01, 0.01) 0.01 (-0.00, 0.02) -0.03 (-0.08, 0.03) -0.00 (-0.04, 0.03) 
*Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI **Additional adjustment for partner drinking during 
pregnancy 
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Table 14.5 Association between maternal alcohol consumption in pregnancy and offspring height and weight at birth and ages 
two and ten years (unadjusted) 
 Mean (SD) values in 
pregnancy abstainers 
(the reference 
category) 
Mean difference (95% confidence interval) compared with pregnancy abstainers 
 Pregnancy abstainer, 
 
N=2,919 
General non-drinker, 
 
N=504 
Occasional pregnancy 
drinker, 
n=3,253 
Occasional binge 
drinker, 
n=1,172 
Light daily pregnancy 
drinker, 
n=33 
Heavy pregnancy 
drinker, 
N=76 
       
Height (cm)       
Birth 50.18 (1.48) -0.27 (-0.51, -0.03) 0.06 (-0.07, 0.19) 0.03 (-0.14, 0.21) 0.35 (-0.55, 1.25) -0.81 (-1.37, -0.25) 
2 years 85.53 (2.65) -0.55 (-0.85, -0.25) -0.16 (-0.31, -0.00) -0.24 (-0.46,  -0.03) -0.11 (-1.18, 0.97) 0.26 (-0.45, 0.97) 
10 years 140.25 (5.80) -1.16 (-1.84, -0.47) -0.11 (-0.05, 0.02) -0.32 (-0.80, 0.17) 0.95 (-1.37, 3.27) 1.25 (-0.37, 2.87) 
       
Weight (kg)       
Birth 3.48 (0.42) -0.42 (-0.94, 0.01) 0.00 (-0.03, 0.03) 0.01 (-0.03, 0.05) -0.01 (-0.20, 0.18) -0.22 (-0.35, -0.09) 
2 years 12.47 (1.23) -0.15 (-0.28, -0.02) -0.05 (-0.12, 0.02) -0.04 (-0.14, 0.05) -0.02 (-0.50, 0.45) -0.01 (-0.31, 0.33) 
10 years 23.00 (6.43) -0.44 (-1.25, 0.37) -0.16 (-0.82, 0.50) -0.08 (-0.76, 0.61) 0.37 (-1.07, 1.81) 0.64 (-0.49, 1.77) 
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Table 14.6 Association between partner drinking during pregnancy and height growth in offspring, n=7,957 
 Occasional drinker, 
 
n=1,073 
General non-drinker, 
 
n=336 
Occasional pregnancy 
drinker, 
n=4,887 
Light daily pregnancy 
drinker, 
n=22 
Heavy pregnancy 
drinker, 
n=1,639 
Height      
Crude      
Birth length 50.24 (1.46) -0.33 (-0.64, -0.02) -0.01 (-0.17, 0.16) 0.44 (-0.73, 1.62) -0.06 (-0.26, 0.13) 
Growth 1  3.56 (0.16) -0.09 (-0.22, 0.04) -0.03 (-0.10, 0.04) -0.01 (-0.58, 0.56) -0.02 (-0.10, 0.06) 
Growth 2  1.62 (0.14) 0.03 (-0.02, 0.08) 0.02 (-0.01, 0.04) 0.03 (-0.16, 0.23) -0.01 (-0.04, 0.03) 
Growth 3  0.83 (0.07) -0.01 (-0.03, 0.01) 0.00 (-0.01, 0.01) -0.05 (-0.11, 0.02) 0.01 (-0.01, 0.02) 
Growth 4  0.54 (0.04) -0.01 (-0.02, 0.00) 
 
-0.01 (-0.01, -0.00) 
 
0.01 (-0.02,0.03) -0.01 (-0.01, -0.00) 
 
Adjusted*      
Birth length 50.25 (1.44) -0.34 (-0.65, -0.02) -0.01 ( -0.18, 0.15) 0.40 (-0.78, 1.57) -0.07 (-0.26, 0.13) 
Growth 1  3.61 (0.15) -0.07( -0.20, 0.07) -0.03 (-0.10, 0.05) 0.11 (-0.47, 0.68) -0.02 (-0.11, 0.06) 
Growth 2 1.65 (0.13) 0.02 (-0.03, 0.07) 0.01( -0.02, 0.04) 0.04 (-0.16, 0.23) -0.01 (-0.05, 0.02) 
Growth 3  0.84 (0.07) -0.00 (-0.02, 0.02) 0.00 ( -0.01, 0.01) -0.04 (-0.11, 0.02) 0.00 (-0.01, 0.01) 
Growth 4 0.54 (0.03) -0.01 (-0.02, 0.00) 
 
-0.01 (-0.01, -0.00) 0.01 (-0.02, 0.04) -0.00 (-0.01, -0.00) 
 
Adjusted**       
Birth length 50.24 (1.44) -0.25 (-0.57,  0.07) -0.03 (-0.20, 0.14) 0.43 (-0.75, 1.61) -0.07 (-0.27, 0.13) 
Growth 1 3.63 (0.15) -0.09 (-0.23, 0.05) -0.02 (-0.09, 0.06) 0.11 (-0.47, 0.68) 0.00 (-0.08, 0.08) 
Growth 2 1.65 (0.13) 0.02 (-0.03, 0.07) 0.01 (-0.02, 0.03) 0.04 (-0.16, 0.23) -0.02 (-0.05, 0.01) 
Growth 3  0.84 (0.07) -0.00 (-0.02, 0.02) 0.01 (-0.01, 0.01) -0.04 (-0.11, 0.02) 0.00 (-0.01, 0.01) 
Growth 4  0.54 (0.03) -0.01 (-0.01, 0.00) -0.01 (-0.01, -0.00) 0.01 (-0.02, 0.04) -0.01 (-0.01, -0.00) 
 
*Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI 
**Additional adjustment for partner drinking during pregnancy 
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Table 14.7 Associations between partner drinking during pregnancy and weight growth in offspring, n=7,957 
 Occasional drinker, 
 
n=1,073 
General non-drinker, 
 
n=336 
Occasional pregnancy 
drinker, 
n=4,887 
Light daily pregnancy 
drinker, 
n=22 
Heavy pregnancy drinker, 
 
n=1,639 
Weight      
Crude      
Birth weight 3.48 (0.42) -0.08 (-0.15, -0.01) -0.01 (-0.05, 0.02) 0.10 (-0.14, 0.34) -0.02 (-0.06, 0.02) 
Growth 1  0.89 (0.15) -0.04 (-0.07, -0.00) 0.01 (-0.01, 0.02) 0.06 (-0.06, 0.17) 0.00 (-0.02, 0.02) 
Growth 2  0.45 (0.09) 0.00 (-0.01, 0.02) 0.01 (-0.00, 0.02) -0.04 (-0.09, 0.02) 0.00 (-0.01, 0.01) 
Growth 3  0.19 (0.04) -0.01 (-0.02, -0.01) -0.00 (-0.01, 0.00) -0.02 (-0.05, 0.01) 0.00 (-0.00, 0.01) 
Growth 4  0.19 (0.05) 0.00 (-0.01, 0.01) -0.00 (-0.01, 0.00) -0.02 (-0.05, 0.01) -0.01 (-0.013-0.00) 
Growth 5 0.32 (0.09) -0.00 (-0.03, 0.02) 
 
0.00 (-0.01, 0.01) 
 
0.02 (-0.05, 0.09) 
 
-0.01 (-0.02, 0.01) 
Adjusted*      
Birth weight 3.48 (0.35) -0.08 (-0.15, -0.01) -0.014 (-0.05, 0.02) 0.10 (-0.14, 0.34) -0.02 (-0.06, 0.02) 
Growth 1  0.89 (0.15) -0.03 (-0.07, -0.00) 0.005 (-0.01, 0.02) 0.07 (-0.05, 0.18) -0.00 (-0.02, 0.02) 
Growth 2 0.46 (0.09) 0.00 (-0.01, 0.02) 0.004 (-0.00, 0.01) -0.03 (-0.09, 0.03) -0.00 (-0.01, 0.01) 
Growth 3  0.19 (0.04) -0.01 (-0.02, -0.00) -0.002 (-0.01, 0.00) -0.02 (-0.05, 0.01) 0.00 (-0.01, 0.01) 
Growth 4 0.19 (0.04) 0.00 (-0.01, 0.01) -0.002 (-0.01, 0.00) -0.01 (-0.05, 0.02) -0.01 (-0.01, 0.00) 
Growth 5 0.33 (0.08) -0.01 (-0.03, 0.02) 
 
0.000 (-0.01, 0.01) 
 
0.03 (-0.03, 0.10) 
 
-0.00 (-0.02, 0.01) 
Adjusted**       
Birth weight 3.48 (0.42) -0.07 (-0.14, 0.00) -0.02 (-0.05, 0.02) 0.10 (-0.14, 0.34) -0.02 (-0.06, 0.03) 
Growth 1 0.88 (0.15) -0.04 (-0.07, -0.00) 0.01 (-0.01, 0.02) 0.07 (-0.04, 0.19) 0.00 (-0.02, 0.02) 
Growth 2 0.46 (0.08) 0.00 (-0.02, 0.02) 0.01 (-0.00, 0.01) -0.03 (-0.09, 0.03) -0.00 (-0.01, 0.01) 
Growth 3  0.19 (0.04) -0.01 (-0.02, -0.00)  -0.00 (-0.01, 0.00) -0.02 (-0.05, 0.01) 0.00 (-0.01, 0.01) 
Growth 4  0.19 (0.04) 0.00 (-0.01, 0.01) -0.00 (-0.01, 0.00) -0.02 (-0.05, 0.02) -0.01 (-0.02, -0.00) 
Growth 5 0.33 (0.08) -0.01 (-0.03, 0.02) 0.00 (-0.01, 0.01) 0.03 (-0.03, 0.10) -0.00 (-0.02, 0.01) 
 
*Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI 
**Additional adjustment for partner drinking during pregnancy
  
Table 14.8 Association between maternal drinking during pregnancy and observed weight and height at two and ten years 
 Observed weight  Observed height 
 2 years 
n=576 
10 years 
n=329 
 2 years 
n=576 
10 years 
n=329 
Maternal drinking      
Pregnancy abstainer Ref Ref  Ref Ref 
General non-drinker 0.04 (-0.12, 0.19) 0.31 (-0.69, 1.31)  -0.34 (-0.72, 0.03) 0.10 (-0.78, 0.98) 
Occasional pregnancy drinker -0.02 (-0.10, 0.06) -0.33 (-0.80, 0.14)  -0.16 (-0.35, 0.03) -0.17 (-0.58, 0.25) 
Occasional binge drinker -0.01 (-0.13, 0.10) 0.14 (-0.55, 0.83)  -0.32 (-0.58, -0.06) 0.06 (-0.55, 0.66) 
Light daily pregnancy drinker -0.51 (-1.10, 0.07) 0.99 (-2.06, 4.05)  0.21 (-1.18, 1.59) 0.59 (-2.20, 3.37) 
Heavy pregnancy drinker -0.00 (-0.37, 0.36) 0.14 (-2.01, 2.28)  0.26 (-0.58, 1.10) 1.30 (-0.58, 3.18) 
  
Table 14.9 Association between maternal drinking during pregnancy and height and weight at birth, two and ten years among 
offspring with three or more growth measures 
 Mean (SD) values in 
the reference category 
Mean difference (95% confidence interval) compared with reference category 
 Pregnancy abstainer 
 
General non-drinker Occasional pregnancy 
drinker 
Occasional binge 
drinker 
Light daily pregnancy 
drinker 
Heavy pregnancy 
drinker 
Height (cm) 
N=7,724 
n=2,831 n=484 n=3,176 n=1,125 n=33 n=75 
Birth 50.22 (1.46) -0.24 (-0.49, 0.02) 0.05 (-0.07, 0.18) 0.05 (-0.12, 0.23) 0.41 (-0.49, 1.31) -0.82 (-1.38, -0.25) 
2 years 85.98 (2.41) -0.31 (-0.60, -0.02) -0.16 (-0.31, -0.02) -0.14 (-0.35, 0.06) -0.26 (-1.27, 0.75) 0.09 (-0.59, 0.76) 
10 years 141.04 (5.23) -0.59 (-1.26, 0.08) -0.26 (-0.59, 0.07) -0.16 (-0.62, 0.30) 0.30 (-1.85, 2.45) 0.57 (-0.96, 2.09) 
       
Weight (kg) 
N=7,860 
n=2,886 n=492 n=3,216 n=1,157 n=33 n=76 
Birth 3.49 (0.42) -0.04 (-0.09, 0.02) 0.00 (-0.03, 0.03) 0.01 (-0.03, 0.05) -0.02 (-0.20, 0.17) -0.22 (-0.34, -0.09) 
2 years 12.56 (1.18) 0.01 (-0.13, 0.14) -0.04 (-0.11, 0.03) -0.02 (-0.12, 0.07) -0.10 (-0.56, 0.7) -0.10 (-0.41, 0.22) 
10 years 23.23(6.04) -0.07 (-0.88, 0.75) -0.04 (-0.70, 0.63) -0.06 (-0.63, 0.75) 0.37 (-1.03, 1.77) 0.43 (-0.68, 1.53) 
 
Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI and partner drinking during pregnancy 
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Table 14.10 Association between maternal drinking during pregnancy and height and weight at birth, two and ten years restricted 
to women of white ethnicity, n=7,760 
 Mean (SD) values in 
the reference category 
Mean difference (95% confidence interval) compared with reference category 
 Pregnancy abstainer, 
 
n=2,537 
General non-drinkers, 
 
n=405 
Occasional pregnancy 
drinker, 
n=2,822 
Occasional binge 
drinker, 
n=983 
Light daily pregnancy 
drinker, 
n=30 
Heavy pregnancy 
drinker, 
n=58 
       
Height (cm)       
Birth 50.25 (1.45) -0.11 (-0.37, 0.15) 0.06 (-0.07, 0.18) 0.03 (-0.15, 0.20) 0.39 (-0.51, 1.30) -0.74 (-1.30, -0.17) 
2 years 85.95 (2.41) -0.31 (-0.61, -0.01) -0.16 (-0.30, -0.01) -0.17 (-0.38, 0.03) -0.26 (-1.27, 0.75) 0.13 (-0.55, 0.81) 
10 years 141.00 (5.20) -0.75 (-1.43, -0.07) -0.28 (-0.61, 0.05) -0.25 (-0.71, 0.21) 0.29 (-1.86, 2.43) 0.64 (-0.90, 2.18) 
       
Weight (kg)       
Birth 3.50 (0.42) -0.01 (-0.07, 0.04) -0.00 (-0.03, 0.03) 0.01 (-0.03, 0.05) -0.02 (-0.21, 0.17) -0.20 (-0.33, -0.07) 
2 years 12.57 (1.16) 0.02 (-0.11, 0.16) -0.05 (-0.12, 0.02) -0.04 (-0.13, 0.06) -0.10 (-0.57, 0.36) -0.08 (-0.40, 0.23) 
10 years 23.26 (6.04) -0.12 (-0.95, 0.71) -0.06 (-0.73, 0.61) 0.01 (-0.69, 0.71) 0.34 (-1.06, 1.74) 0.44 (-0.68, 1.56) 
 
Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI and partner drinking during pregnancy 
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Table 14.11 Association between maternal drinking during pregnancy and height and weight at birth, two and ten years with 
additional adjustment for gestational age at birth, n=7,957 
 Mean (SD) values in 
the reference category 
Mean difference (95% confidence interval) compared with reference category 
 Pregnancy abstainer 
 
General non-drinker 
 
Occasional drinker 
 
Occasional binge 
drinker 
Light daily pregnancy 
drinker 
Heavy pregnancy 
drinker 
       
Height (cm)       
Birth 50.23 (1.39) -0.23 (-0.48, 0.03) 0.06 (-0.07, 0.19) 0.03 (-0.14, 0.21) 0.43 (-0.48, 1.33) -0.76 (-1.32, -0.20) 
2 years 85.98 (2.43) -0.29 (-0.58, 0.00) -0.14 (-0.29, 0.00) -0.16 (-0.37, 0.04) -0.25 (-1.27, 0.77) 0.10 (-0.58, 0.78) 
10 years 141.10 (5.24) -0.62 (-1.28, 0.05) -0.24 (-0.57, 0.09) -0.20 (-0.65, 0.26) 0.33 (-1.83, 2.50) 0.54 (-0.99, 2.06) 
       
Weight (kg)   
 
    
Birth 3.49 (0.42) -0.03 (-0.09, 0.02) 0.00 (-0.03, 0.03) 0.11 (-0.03, 0.05) -0.01 (-0.20, 0.18) -0.22 (-0.34, -0.09) 
2 years 12.59 (1.19) -0.00 (-0.14, 0.13) -0.03 (-0.10, 0.04) -0.02 (-0.12, 0.08) -0.08 (-0.56, 0.39) -0.11 (-0.43, 0.21) 
10 years 23.27 (6.04) -0.13 (-0.94, 0.69) -0.06 (-0.72, 0.60) 0.03 (-0.66, 0.72) 0.36 (-1.05, 1.76) 0.36 (-0.76, 1.47) 
 
Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI, partner drinking during pregnancy and gestational 
age at birth 
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Table 14.12 Association between maternal drinking during pregnancy and height and weight at birth, two and ten years with 
additional adjustment for pregnancy intention, n=7,854 
 Mean (SD) values in 
the reference category 
Mean difference (95% confidence interval) compared with reference category 
 Pregnancy abstainer 
 
General non-drinker 
 
Occasional drinker 
 
Occasional binge 
drinker 
Light daily pregnancy 
drinker 
Heavy pregnancy 
drinker 
       
Height (cm)       
Birth 50.23 (1.46) -0.22 (-0.47, 0.04) 0.06 (-0.06, 0.19) 0.03 (-0.14, 0.21) 0.41 (-0.50, 1.32) -0.79 (-1.35, -0.22) 
2 years 85.94 (2.40) -0.28 (-0.57, -0.01) -0.16 (-0.30, -0.01) -0.18 (-0.38, 0.03) -0.28 (-1.30, 0.73) 0.08 (-0.60, 0.75) 
10 years 140.99 (5.19) -0.58 (-1.25, 0.08) -0.26 (-0.59, 0.06) -0.24 (-0.70, 0.22) 0.25 (-1.90, 2.41) 0.53 (-0.99, 2.05) 
       
Weight (kg)       
Birth 3.49 (0.42) -0.03 (-0.09, 0.02) 0.00 (-0.03, 0.03) 0.01(-0.03, 0.05) -0.01 (-0.20, 0.18) -0.22 (-0.34,  -0.09) 
2 years 12.56 (1.17) 0.00 (-0.13, 0.14) -0.04 (-0.11, 0.03) -0.03 (-0.12, 0.07) -0.10 (-0.57, 0.36) -0.10 (-0.42, 0.21) 
10 years 23.21 (6.02) -0.13 (-0.94, 0.68) -0.09 (-0.75, 0.57) -0.01 (-0.70, 0.68) 0.31 (-1.09, 1.70) 0.35 (-0.76, 1.46) 
 
Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI, partner drinking during pregnancy and pregnancy 
intention 
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Table 14.13 Association between maternal drinking during pregnancy and height and weight at birth, two and ten years with 
additional adjustment for partner education, n=7,807 
 Mean (SD) values in 
the reference category 
Mean difference (95% confidence interval) compared with reference category 
 Pregnancy abstainer 
 
General non-drinker 
 
Occasional drinker 
 
Occasional binge 
drinker 
Light daily pregnancy 
drinker 
Heavy pregnancy 
drinker 
       
Height (cm)       
Birth 50.22 (1.46) -0.23 (-0.49, 0.02) 0.07 (-0.06, 0.20) 0.06 (-0.12, 0.24) 0.43 (-0.47, 1.34) -0.73 (-1.30, -0.16) 
2 years 86.06 (2.40) -0.20 (-0.49, -0.10) -0.13 (-0.28, 0.01) -0.19 (-0.39, 0.02) -0.22 (-1.24, 0.80) 0.14 (-0.54, 0.83) 
10 years 141.00 (5.21) -0.48 (-1.15, 0.19) -0.22 (-0.55, 0.11) -0.21 (-0.67, 0.25) 0.44 (-1.73, 2.62) 0.82 (-0.73, 2.37) 
       
Weight (kg)       
Birth 3.50 (0.42) -0.03 (-0.09, 0.02) 0.01 (-0.02, 0.03) 0.02 (-0.02, 0.05) -0.01 (-0.20, 0.18) -0.22 (-0.35, -0.09) 
2 years 12.58 (1.17) 0.03 (-0.11, 0.16) -0.03 (-0.10, 0.04) -0.02 (-0.12, 0.07) -0.08 (-0.55, 0.39) -0.09 (-0.41, 0.23) 
10 years 23.27 (6.02) -0.16 (-0.98, 0.66) -0.15 (-0.82, 0.52) -0.07 (-0.76, 0.63) 0.28 (-1.13, 1.69) 0.29 (-0.83, 1.41) 
 
Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI, partner drinking during pregnancy and partner 
education 
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Table 14.14 Association between maternal drinking during pregnancy and height and weight at birth, two and ten years with 
additional adjustment for partner smoking, n=7,861 
 Mean (SD) values in 
the reference category 
Mean difference (95% confidence interval) compared with reference category 
 Pregnancy abstainer 
 
General non-drinker 
 
Occasional drinker 
 
Occasional binge 
drinker 
Light daily pregnancy 
drinker 
Heavy pregnancy 
drinker 
       
Height (cm)       
Birth 50.21 (1.46) -0.24 (-0.50, 0.01) 0.067 (-0.060 0.20) 0.06 (-0.12, 0.23) 0.43 (-0.48, 1.34) -0.76 (-1.32, -0.19) 
2 years 85.93 (2.41) -0.31 (-0.60, -0.02) -0.153 (-0.30, -0.01) -0.17 (-0.37, 0.04) -0.24 (-1.25, 0.78) 0.19 (-0.50, 0.87) 
10 years 140.97 (5.18) -0.59 (-1.26, 0.08) -0.248 (-0.58, 0.08) -0.18 (-0.64, 0.29) 0.34 (-1.81, 2.49) 0.65 (-0.88, 2.19) 
       
Weight (kg)       
Birth 3.49 (0.43) -0.04 (-0.09, 0.02) 0.002 (-0.03, 0.03) 0.01 (-0.03, 0.05) -0.01 (-0.20, 0.18) -0.20 (-0.33, -0.07) 
2 years 12.54 (1.17) -0.01 (-0.14, 0.13) -0.043 (-0.11, 0.03) -0.02 (-0.12, 0.08) -0.09 (-0.56, 0.37) -0.07 (-0.39, 0.24) 
10 years 23.21 (6.03) -0.15 (-0.96, 0.67) -0.093 (-0.76, 0.57) 0.00 (-0.69, 0.69) 0.33 (-1.07, 1.72) 0.40 (-0.71, 1.52) 
 
Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI, partner drinking during pregnancy and partner 
smoking 
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Table 14.15 Association between maternal drinking during pregnancy and height and weight at birth, two and ten years with 
additional adjustment for maternal hospital admission during pregnancy, n=7,946 
 Mean (SD) values in 
the reference category 
Mean difference (95% confidence interval) compared with reference category 
 Pregnancy abstainer 
 
General non-drinker 
 
Occasional drinker 
 
Occasional binge 
drinker 
Light daily pregnancy 
drinker 
Heavy pregnancy 
drinker 
       
Height (cm)       
Birth 50.18 (1.45) -0.17 (-0.43, 0.09) 0.06 (-0.07, 0.19) 0.05 (-0.13, 0.23) 0.24 (-0.70, 1.18) -0.99 (-1.59, -0.38) 
2 years 86.07 (2.42) -0.24 (-0.54, 0.06) -0.13 (-0.28, 0.03) -0.14 (-0.35, 0.07) -0.35 (-1.40, 0.69) 0.21 (-0.51, 0.93) 
10 years 141.23 (5.22) -0.54 (-1.22, 0.14) -0.26 (-0.60, 0.07) -0.14 (-0.61, 0.33) 0.50 (-1.73, 2.73) 0.56 (-1.07, 2.18) 
       
Weight (kg)       
Birth 3.49 (0.42) -0.02 (-0.07, 0.04) 0.00 (-0.03, 0.03) 0.02 (-0.02, 0.05) -0.01 (-0.20, 0.19) -0.27 (-0.40, -0.13) 
2 years 12.52 (1.18) 0.03 (-0.11, 0.17) -0.03 (-0.10, 0.04) -0.01 (-0.11, 0.09) -0.03 (-0.52, 0.45) -0.08 (-0.41, 0.26) 
10 years 23.36 (6.04) -0.04 (-0.87, 0.79) -0.04 (-0.72, 0.63) 0.07 (-0.64, 0.77) 0.14 (-1.30, 1.57) 0.54 (-0.63, 1.71) 
 
Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI, partner drinking during pregnancy and maternal 
hospital admission during pregnancy 
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Table 14.16 Association between maternal drinking during pregnancy and height and weight at birth, two and ten years with 
additional adjustment for marital status, n=7,905 
 Mean (SD) values in 
the reference category 
Mean difference (95% confidence interval) compared with reference category 
 Pregnancy abstainer 
 
General non-drinker 
 
Occasional drinker 
 
Occasional binge 
drinker 
Light daily pregnancy 
drinker 
Heavy pregnancy 
drinker 
       
Height (cm)       
Birth 50.23 (1.46) -0.19 (-0.44, 0.06) 0.06 (-0.07, 0.19) 0.05 (-0.12, 0.23) 0.42 (-0.48, 1.33) -0.73 (-1.29, -0.16) 
2 years 85.96 (2.41) -0.25 (-0.54, 0.04) -0.15 (-0.29, 0.00) -0.16 (-0.36, 0.05) -0.26 (-1.27, 0.75) 0.13 (-0.55, 0.80) 
10 years 140.93 (5.21) -0.53 (-1.20, 0.14) -0.26 (-0.59, 0.07) -0.20 (-0.66, 0.26) 0.27 (-1.88, 2.43) 0.84 (-0.70, 2.38) 
       
Weight (kg)       
Birth 3.50 (0.42) -0.03 (-0.08, 0.03) 0.00 (-0.03, 0.03) 0.01 (-0.03, 0.05) -0.02 (-0.20, 0.17) -0.21(-0.33, -0.08) 
2 years 12.59 (1.17) 0.02 (-0.11, 0.16) -0.04 (-0.11, 0.03) -0.03 (-0.13, 0.06) -0.10 (-0.57, 0.37) -0.07 (-0.38, 0.25) 
10 years 23.13 (6.04) -0.04 (-0.86, 0.77) -0.03 (-0.69, 0.64) -0.07 (-0.63, 0.76) 0.38 (-1.02, 1.78) 0.51 (-0.61, 1.62) 
 
Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI, partner drinking during pregnancy and marital status 
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Table 14.17 Association between maternal drinking during pregnancy and height and weight at birth, two and ten years with 
additional adjustment for household social class, n=7,646 
 Mean (SD) values in 
the reference category 
Mean difference (95% confidence interval) compared with reference category 
 Pregnancy abstainer 
 
General non-drinker 
 
Occasional drinker 
 
Occasional binge 
drinker 
Light daily pregnancy 
drinker 
Heavy pregnancy 
drinker 
       
Height (cm)       
Birth 50.21 (1.45) -0.22 (-0.48, 0.04) 0.07 (-0.06, 0.20) 0.05 (-0.13, 0.23) 0.36 (-0.57, 1.28) -0.96 (-1.55, -0.37) 
2 years 85.69 (2.41) -0.25 (-0.55, -0.05) -0.152 (-0.30, -0.00) -0.16 (-0.37, 0.05) -0.39 (-1.42, 0.64) 0.05 (-0.66, 0.75) 
10 years 141.01 (5.20) -0.46 (-1.14, 0.22) -0.262 (-0.59, 0.07) -0.20 (-0.66, 0.27) 0.29 (-1.90, 2.48) 0.36 (-1.21, 1.93) 
       
Weight (kg)       
Birth 3.49 (0.42) -0.03 (-0.09, 0.025) 0.001 (-0.03, 0.03) 0.01 (-0.02, 0.05) -0.01 (-0.19, 0.20) -0.26 (-0.39, -0.13) 
2 years 12.55 (1.17) 0.04 (-0.10, 0.18) -0.037 (-0.11, 0.03) -0.02 (-0.12, 0.07) -0.10 (-0.57, 0.37) -0.07 (-0.39, 0.26) 
10 years 23.28(5.95) 0.05 (-0.77, 0.87) -0.013 (-0.68, 0.66) -0.07 (-0.63, 0.77) 0.06 (-1.36, 1.47) 0.47 (-0.67, 1.61) 
 
Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI, partner drinking during pregnancy and household 
social class 
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Table 14.18 Association between maternal drinking during pregnancy and height and weight at birth, two and ten years with 
additional adjustment for partner height, n=6,761 
 Mean (SD) values in 
the reference category 
Mean difference (95% confidence interval) compared with reference category 
 Pregnancy abstainer 
 
General non-drinker 
 
Occasional drinker 
 
Occasional binge 
drinker 
Light daily pregnancy 
drinker 
Heavy pregnancy 
drinker 
       
Height (cm)       
Birth 50.18 (1.44) -0.17 (-0.44, 0.11) 0.05 (-0.09, 0.19) 0.03 (-0.16, 0.22) 0.67 (-0.26, 1.61) -0.93 (-1.56, -0.30) 
2 years 85.90 (2.26) -0.14 (-0.45, 0.16) -0.26 (-0.30, 0.01) -0.15 (-0.37, 0.06) -0.01 (-1.04, 1.02) 0.05 (-0.66, 0.76) 
10 years 141.02 (4.86) -0.44 (-1.13, 0.25) -0.30 (-0.64, 0.03) -0.21 (-0.69, 0.26) 0.63 (-1.56, 2.82) 1.14 (-0.46, 2.75) 
       
Weight (kg)       
Birth 3.49 (0.42) -0.03 (-0.08, 0.03) -0.01 (-0.04, 0.02) 0.02 (-0.020, 0.06) 0.05 (-0.16, 0.25) -0.23 (-0.37, -0.09) 
2 years 12.55 (1.15) 0.05 (-0.10, 0.19) -0.03 (-0.11, 0.04) -0.00 (-0.10, 0.10) -0.18 (-0.66, 0.31) -0.13 (-0.47, 0.21) 
10 years 23.19 (5.86) 0.21 (-0.66, 1.08) 0.12 (-0.59, 0.83) 0.27 (-0.47, 1.00) 0.68 (-0.79, 2.16) 0.67 (-0.54, 1.87) 
 
Adjusted for maternal education, parity, maternal smoking, maternal age, maternal height, maternal BMI, partner drinking during pregnancy and partner 
height 
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Table 14.19 Association between maternal drinking during pregnancy and birth length amongst participants included in our 
analysis compared with participants excluded from our analyses due to missing data on confounders 
 Included participants Excluded participants  Included participants Excluded participants 
 Birth weight  Birth length 
Maternal alcohol use n=7,796 n=4,865  n=6,134 n=3,629 
Pregnancy abstainer Ref Ref  Ref Ref 
General non-drinker -0.04 (-0.09, 0.14) -0.10 (-0.16, -0.05)  -0.17 (-0.42, 0.08) -0.40 (-0.68, -0.13) 
Occasional pregnancy drinker 0.01 (-0.02, 0.03) 0.02 (-0.02, 0.06)  0.01 (-0.12, 0.15) -0.01 (-0.19, 0.18) 
Occasional binge drinker 0.00 (-0.04, 0.04) 0.04 (-0.01, 0.09)  0.02 (-0.16, 0.21) 0.09 (-0.13, 0.32) 
Light daily pregnancy drinker -0.03 (-0.02, 0.16) -0.14 (-0.33, 0.04)  0.77 (-0.22, 1.76) -1.01 (-1.84,-0.17) 
Heavy pregnancy drinker -0.18 (-0.31, -0.06) -0.13 (-0.24, -0.01)  -0.67 (-1.24, -0.09) -0.47 (-1.02, 0.09) 
      
Partner alcohol use n=7,796 n=1,687  n=6,134 n=1,168 
Occasional pregnancy drinker Ref Ref  Ref Ref 
General non-drinker -0.08 (-0.15, -0.02) -0.086 (-0.22, 0.05)  -0.27 (-0.60, 0.06) -0.04 (-0.71, 0.62) 
Occasional binge drinker -0.01 (-0.05, 0.02) 0.010 (-0.08, 0.10)  -0.02 (-0.20, 0.16) 0.16 (-0.28, 0.60) 
Light daily pregnancy drinker 0.08 (-0.15, 0.31) -0.164 (-0.62, 0.29)  0.84 (-0.50, 2.18) 0.24 (-1.65, 2.12) 
Heavy pregnancy drinker -0.03 (-0.07, 0.02) -0.079 (-0.18, 0.03)  -0.11 (-0.32, 0.09) -0.17 (-0.69, 0.36) 
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